Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2023 shares | |
Entity Information [Line Items] | |
Entity registrant name | UBS AG |
Entity central index key | 0001114446 |
Entity current reporting status | Yes |
Entity voluntary filers | No |
Current fiscal year end date | --12-31 |
Entity filer category | Non-accelerated Filer |
Entity well known seasoned issuer | No |
Entity common stock shares outstanding | 3,858,408,466 |
Document type | 20-F |
Document period end date | Dec. 31, 2023 |
Amendment flag | false |
Document fiscal year focus | 2023 |
Document fiscal period focus | FY |
Entity emerging growth company | false |
Entity shell company | false |
Entity interactive data current | Yes |
Auditor name | Ernst & Young Ltd |
Auditor firm ID | 1460 |
Auditor location | Basel, Switzerland |
Icfr auditor attestation flag | true |
Document Accounting Standard | International Financial Reporting Standards |
Entity Address Address Line 1 | Bahnhofstrasse 45 |
Entity Address City Or Town | Zurich |
Entity Address Postal Zip Code | CH-8001 |
Entity Address Country | CH |
Entity File Number | 1-15060 |
Entity Incorporation State Country Code | V8 |
Document Registration Statement | false |
Document Annual Report | true |
Document Transition Report | false |
Document Shell Company Report | false |
Document Fin Stmt Error Correction Flag | false |
Business Contact [Member] | |
Entity Information [Line Items] | |
Contact Personnel Name | David Kelly |
Entity Address Address Line 1 | 600 Washington Boulevard |
Entity Address City Or Town | Stamford |
Entity Address State Or Province | CT |
Entity Address Postal Zip Code | 06901 |
City Area Code | 203 |
Local Phone Number | 719 3000 |
Other Address [Member] | |
Entity Information [Line Items] | |
Entity Address Address Line 1 | Aeschenvorstadt 1 |
Entity Address City Or Town | Basel |
Entity Address Postal Zip Code | CH-4051 |
Entity Address Country | CH |
Consolidated Income Statement
Consolidated Income Statement - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $ 22,444 | $ 11,803 | $ 8,534 |
Interest expense from financial instruments measured at amortized cost | (19,643) | (6,696) | (3,366) |
Net interest income from financial instruments measured at fair value through profit or loss and other | 1,765 | 1,410 | 1,437 |
Net interest income | 4,566 | 6,517 | 6,605 |
Other net income from financial instruments measured at fair value through profit or loss | 9,934 | 7,493 | 5,844 |
Fee and commission income | 20,399 | 20,846 | 24,422 |
Fee and commission expense | (1,790) | (1,823) | (1,985) |
Net fee and commission income | 18,610 | 19,023 | 22,438 |
Other income | 566 | 1,882 | 941 |
Total revenues | 33,675 | 34,915 | 35,828 |
Credit loss expense / (release) | 143 | 29 | (148) |
Personnel expenses | 15,655 | 15,080 | 15,661 |
General and administrative expenses | 11,118 | 9,001 | 9,476 |
Depreciation, amortization and impairment of non-financial assets | 2,238 | 1,845 | 1,875 |
Operating expenses | 29,011 | 25,927 | 27,012 |
Operating profit / (loss) before tax | 4,521 | 8,960 | 8,964 |
Tax expense / (benefit) | 1,206 | 1,844 | 1,903 |
Net profit / (loss) | 3,315 | 7,116 | 7,061 |
Net profit / (loss) attributable to non-controlling interests | 25 | 32 | 29 |
Net profit / (loss) attributable to shareholders | $ 3,290 | $ 7,084 | $ 7,032 |
Consolidated Statement of Compr
Consolidated Statement of Comprehensive Income - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement Of Comprehensive Income [Line Items] | |||
Net profit / (loss) | $ 3,315 | $ 7,116 | $ 7,061 |
Financial assets measured at fair value through other comprehensive income | |||
Reclassification of financial assets to Other financial assets measured at amortized cost | (449) | ||
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | (103) | 40 | |
Own credit on financial liabilities designated at fair value | |||
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax | (861) | 867 | 46 |
Total comprehensive income | |||
Total other comprehensive income | 1,311 | (4,396) | (2,235) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 2,235 | (5,260) | (2,368) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (924) | 864 | 132 |
Total comprehensive income | 4,625 | 2,719 | 4,826 |
Comprehensive income attributable to shareholders | |||
Statement Of Comprehensive Income [Line Items] | |||
Net profit / (loss) | 3,290 | 7,084 | 7,032 |
Foreign currency translation | |||
Foreign currency translation movements related to net assets of foreign operations, before tax | 1,747 | (869) | (1,046) |
Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax | (912) | 319 | 492 |
Foreign currency translation differences on foreign operations reclassified to the income statement | 58 | 32 | (1) |
Effective portion of changes in fair value of hedging instruments designated as net investment hedges reclassified to the income statement | (28) | (4) | 10 |
Income tax relating to foreign currency translations, including the effect of net investment hedges | (17) | 4 | 35 |
Subtotal foreign currency translation, net of tax | 849 | (519) | (510) |
Financial assets measured at fair value through other comprehensive income | |||
Net unrealized gains / (losses), before tax | 4 | (440) | (203) |
Net realized (gains) / losses reclassified to the income statement from equity | 1 | 1 | (9) |
Reclassification of financial assets to Other financial assets measured at amortized cost | 449 | ||
Income tax relating to net unrealized gains / (losses) | 0 | (3) | 55 |
Subtotal financial assets measured at fair value through other comprehensive income, net of tax | 5 | 6 | (157) |
Cash flow hedges of interest rate risk | |||
Effective portion of changes in fair value of derivative instruments designated as cash flow hedges, before tax | (36) | (5,758) | (992) |
Net (gains) / losses reclassified to the income statement from equity | 1,745 | (159) | (1,073) |
Income tax relating to cash flow hedges | (309) | 1,124 | 390 |
Subtotal cash flow hedges, net of tax | 1,400 | (4,793) | (1,675) |
Cost of hedging | |||
Cost of hedging, before tax | (19) | 45 | (32) |
Income tax relating to cost of hedging | 0 | 0 | 6 |
Subtotal cost of hedging, net of tax | (19) | 45 | (26) |
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | (103) | 40 | 133 |
Income tax relating to defined benefit plans | (33) | 41 | (31) |
Subtotal defined benefit plans, net of tax | (136) | 81 | 102 |
Own credit on financial liabilities designated at fair value | |||
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax | (861) | 867 | 46 |
Income tax relating to own credit on financial liabilities designated at fair value | 71 | (71) | 0 |
Subtotal own credit on financial liabilities designated at fair value, net of tax | (790) | 796 | 46 |
Total comprehensive income | |||
Total other comprehensive income | 1,308 | (4,383) | (2,220) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 2,235 | (5,260) | (2,368) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (927) | 877 | 148 |
Total comprehensive income | 4,598 | 2,701 | 4,813 |
Comprehensive income attributable to non-controlling interests | |||
Statement Of Comprehensive Income [Line Items] | |||
Net profit / (loss) | 25 | 32 | 29 |
Total comprehensive income | |||
Total other comprehensive income | 2 | (14) | (16) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 2 | (14) | (16) |
Total comprehensive income | $ 27 | $ 18 | $ 13 |
Consolidated Statement of Com_2
Consolidated Statement of Comprehensive Income (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Statement Of Comprehensive Income [Line Items] | ||
Gains / (losses) on defined benefit plans, before tax | $ (103) | $ 40 |
Major defined benefit plans | ||
Statement Of Comprehensive Income [Line Items] | ||
Gains / (losses) on defined benefit plans, before tax | (95) | 32 |
Swiss defined benefit plan | ||
Statement Of Comprehensive Income [Line Items] | ||
Gains / (losses) on defined benefit plans, before tax | (56) | (173) |
UK defined benefit plan | ||
Statement Of Comprehensive Income [Line Items] | ||
Gains / (losses) on defined benefit plans, before tax | $ (31) | $ 162 |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Assets | ||
Cash and balances at central banks | $ 171,806 | $ 169,445 |
Amounts due from banks | 28,206 | 14,671 |
Receivables from securities financing transactions measured at amortized cost | 74,128 | 67,814 |
Cash collateral receivables on derivative instruments | 32,300 | 35,033 |
Loans and advances to customers | 405,633 | 390,027 |
Other financial assets measured at amortized cost | 54,334 | 53,389 |
Total financial assets measured at amortized cost | 766,407 | 730,379 |
Financial assets at fair value held for trading | 135,098 | 108,034 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 44,524 | 36,742 |
Derivative financial instruments | 131,728 | 150,109 |
Brokerage receivables | 20,883 | 17,576 |
Financial assets at fair value not held for trading | 63,754 | 59,408 |
Total financial assets measured at fair value through profit or loss | 351,463 | 335,127 |
Financial assets measured at fair value through other comprehensive income | 2,233 | 2,239 |
Investments in associates | 983 | 1,101 |
Property, equipment and software | 11,044 | 11,316 |
Goodwill and intangible assets | 6,265 | 6,267 |
Deferred tax assets | 9,244 | 9,354 |
Other non-financial assets | 8,377 | 9,652 |
Total assets | 1,156,016 | 1,105,436 |
Liabilities | ||
Amounts due to banks | 16,720 | 11,596 |
Payables from securities financing transactions measured at amortized cost | 5,782 | 4,202 |
Cash collateral payables on derivative instruments | 34,886 | 36,436 |
Customer deposits | 555,673 | 527,171 |
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 |
Debt issued measured at amortized cost | 69,784 | 59,499 |
Other financial liabilities measured at amortized cost | 12,713 | 10,391 |
Total financial liabilities measured at amortized cost | 762,840 | 705,442 |
Financial liabilities at fair value held for trading | 31,712 | 29,515 |
Derivative financial instruments | 140,707 | 154,906 |
Brokerage payables designated at fair value | 42,275 | 45,085 |
Debt issued designated at fair value | 86,341 | 71,842 |
Other financial liabilities designated at fair value | 27,366 | 32,033 |
Total financial liabilities measured at fair value through profit or loss | 328,401 | 333,382 |
Provisions | 2,524 | 3,183 |
Other non-financial liabilities | 6,682 | 6,489 |
Total liabilities | 1,100,448 | 1,048,496 |
Equity | ||
Share capital | 386 | 338 |
Share premium | 24,638 | 24,648 |
Retained earnings | 28,235 | 31,746 |
Other comprehensive income recognized directly in equity, net of tax | 1,974 | (133) |
Equity attributable to shareholders | 55,234 | 56,598 |
Equity attributable to non-controlling interests | 335 | 342 |
Total equity | 55,569 | 56,940 |
Total liabilities and equity | $ 1,156,016 | $ 1,105,436 |
Consolidated Statement of Chang
Consolidated Statement of Changes in Equity - USD ($) $ in Millions | Total | Share capital | Share premium | Retained earnings | Other comprehensive income recognized directly in equity, net of tax | of which: foreign currency translation | of which: financial assets at fair value through other comprehensive income | of which: cash flow hedges | Total equity attributable to shareholders | Non-controlling interests |
Balance at Dec. 31, 2020 | $ 58,073 | $ 338 | $ 24,580 | $ 25,251 | $ 7,585 | $ 5,126 | $ 151 | $ 2,321 | $ 57,754 | $ 319 |
Premium on shares issued and warrants exercised | (7) | (7) | (7) | |||||||
Tax (expense) / benefit | (102) | (102) | (102) | |||||||
Dividends | (4,542) | (4,539) | (4,539) | (4) | ||||||
Translation effects recognized directly in retained earnings | 0 | 18 | (18) | 0 | (18) | 0 | ||||
Share of changes in retained earnings of associates and joint ventures | 1 | 1 | 1 | |||||||
New consolidations / (deconsolidations) and other increases / (decreases) | 193 | 182 | 182 | 12 | ||||||
Total comprehensive income for the year | 4,826 | 7,180 | (2,368) | (510) | (157) | (1,675) | 4,813 | 13 | ||
of which: net profit / (loss) | 7,061 | 7,032 | 7,032 | 29 | ||||||
of which: OCI, net of tax | (2,235) | 148 | (2,368) | (510) | (157) | (1,675) | (2,220) | (16) | ||
Balance at Dec. 31, 2021 | 58,442 | 338 | 24,653 | 27,912 | 5,200 | 4,617 | (7) | 628 | 58,102 | 340 |
Premium on shares issued and warrants exercised | (14) | (14) | (14) | |||||||
Tax (expense) / benefit | 5 | 5 | 5 | |||||||
Dividends | (4,209) | (4,200) | (4,200) | (9) | ||||||
Translation effects recognized directly in retained earnings | 0 | 69 | (69) | 0 | (69) | 0 | ||||
Share of changes in retained earnings of associates and joint ventures | 0 | 0 | 0 | |||||||
New consolidations / (deconsolidations) and other increases / (decreases) | (3) | 4 | 3 | (3) | (3) | 4 | (7) | |||
Total comprehensive income for the year | 2,719 | 7,961 | (5,260) | (519) | 6 | (4,793) | 2,701 | 18 | ||
of which: net profit / (loss) | 7,116 | 7,084 | 7,084 | 32 | ||||||
of which: OCI, net of tax | (4,396) | 877 | (5,260) | (519) | 6 | (4,793) | (4,383) | (14) | ||
Equity attributable to shareholders at the end of the period at Dec. 31, 2022 | 56,598 | |||||||||
Balance at Dec. 31, 2022 | 56,940 | 338 | 24,648 | 31,746 | (133) | 4,098 | (4) | (4,234) | 56,598 | 342 |
Equity attributable to non-controlling interests | 342 | |||||||||
Premium on shares issued and warrants exercised | (19) | (19) | (19) | |||||||
Tax (expense) / benefit | 12 | 12 | 12 | |||||||
Dividends | (6,004) | (6,000) | (6,000) | (4) | ||||||
Translation effects recognized directly in retained earnings | 0 | 127 | (127) | 0 | (127) | 0 | ||||
Share of changes in retained earnings of associates and joint ventures | (1) | (1) | (1) | |||||||
Share capital currency change | 0 | 48 | (48) | 0 | ||||||
New consolidations / (deconsolidations) and other increases / (decreases) | 15 | 45 | 0 | 45 | (31) | |||||
Total comprehensive income for the year | 4,625 | 2,363 | 2,235 | 849 | 5 | 1,400 | 4,598 | 27 | ||
of which: net profit / (loss) | 3,315 | 3,290 | 3,290 | 25 | ||||||
of which: OCI, net of tax | 1,311 | (927) | 2,235 | 849 | 5 | 1,400 | 1,308 | 2 | ||
Equity attributable to shareholders at the end of the period at Dec. 31, 2023 | 55,234 | |||||||||
Balance at Dec. 31, 2023 | 55,569 | $ 386 | $ 24,638 | $ 28,235 | $ 1,974 | $ 4,947 | $ 1 | $ (2,961) | $ 55,234 | $ 335 |
Equity attributable to non-controlling interests | $ 335 |
Consolidated Statement of Cha_2
Consolidated Statement of Changes in Equity (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
New consolidations / (deconsolidations) and other increases / (decreases) | $ 15 | $ (3) | $ 193 |
Share premium | |||
New consolidations / (deconsolidations) and other increases / (decreases) | 45 | 4 | 182 |
Retained earnings | |||
New consolidations / (deconsolidations) and other increases / (decreases) | 0 | 3 | |
Other comprehensive income recognized directly in equity, net of tax | |||
New consolidations / (deconsolidations) and other increases / (decreases) | (3) | ||
of which: financial assets at fair value through other comprehensive income | |||
New consolidations / (deconsolidations) and other increases / (decreases) | (3) | ||
Total equity attributable to shareholders | |||
New consolidations / (deconsolidations) and other increases / (decreases) | 45 | 4 | 182 |
Non-controlling interests | |||
New consolidations / (deconsolidations) and other increases / (decreases) | $ (31) | $ (7) | $ 12 |
Share information and earnings
Share information and earnings per share - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Shares issued | |||
Balance at the beginning of the year | 3,858,408,466 | ||
Balance at the end of the year | 3,858,408,466 | 3,858,408,466 | |
Basic and diluted earnings | |||
Net profit / (loss) attributable to shareholders | $ 3,290 | $ 7,084 | $ 7,032 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flow from / (used in) operating activities | |||
Net profit / (loss) | $ 3,315 | $ 7,116 | $ 7,061 |
Non-cash items included in net profit and other adjustments: | |||
Depreciation, amortization and impairment of non-financial assets | 2,238 | 1,845 | 1,875 |
Credit loss expense / (release) | 143 | 29 | (148) |
Share of net (profit) / loss of associates and joint ventures and impairment related to associates | 163 | (32) | (105) |
Deferred tax expense / (benefit) | (222) | 491 | 432 |
Net loss / (gain) from investing activities | (225) | (1,515) | (230) |
Net loss / (gain) from financing activities | 4,919 | (16,587) | 100 |
Other net adjustments | (10,383) | 5,792 | 3,790 |
Net change in operating assets and liabilities: | |||
Amounts due from banks and amounts due to banks | (10,093) | (1,088) | 2,148 |
Receivables from securities financing transactions measured at amortized cost | (4,993) | 5,690 | (1,565) |
Payables from securities financing transactions measured at amortized cost | 1,543 | (1,247) | (751) |
Cash collateral on derivative instruments | 1,162 | 73 | (3,311) |
Loans and advances to customers | 3,707 | 1,653 | (26,943) |
Customer deposits | 6,521 | (9,409) | 29,349 |
Financial assets and liabilities at fair value held for trading and derivative financial instruments | (16,017) | 8,173 | (10,635) |
Brokerage receivables and payables | (6,101) | 6,019 | 8,115 |
Financial assets at fair value not held for trading and other financial assets and liabilities | (4,661) | 5,557 | 19,793 |
Provisions and other non-financial assets and liabilities | 2,325 | (437) | 2,617 |
Income taxes paid, net of refunds | (1,541) | (1,495) | (1,026) |
Net cash flow from / (used in) operating activities | (28,202) | 10,630 | 30,563 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (4) | (3) | (1) |
Disposal of subsidiaries, associates and intangible assets | 109 | 1,729 | 593 |
Purchase of property, equipment and software | (1,283) | (1,478) | (1,581) |
Disposal of property, equipment and software | 33 | 161 | 295 |
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income | 30 | (699) | (750) |
Purchase of debt securities measured at amortized cost | (14,244) | (30,792) | (4,922) |
Disposal and redemption of debt securities measured at amortized cost | 10,435 | 18,799 | 4,507 |
Net cash flow from / (used in) investing activities | (4,924) | (12,283) | (1,860) |
Cash flow from / (used in) financing activities | |||
Net issuance (repayment) of short-term debt measured at amortized cost | 7,181 | (12,249) | (3,093) |
Distributions paid on UBS AG shares | (6,000) | (4,200) | (4,539) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 104,551 | 79,457 | 98,619 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (85,541) | (67,670) | (79,799) |
Net cash flows from other financing activities | (501) | (595) | (261) |
Net cash flow from / (used in) financing activities | 19,690 | (5,257) | 10,927 |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 195,200 | 207,755 | 173,430 |
Net cash flow from / (used in) operating, investing and financing activities | (13,435) | (6,911) | 39,630 |
Effects of exchange rate differences on cash and cash equivalents | 8,704 | (5,645) | (5,306) |
Cash and cash equivalents at the end of the year | 190,469 | 195,200 | 207,755 |
of which: cash and balances at central banks | 171,723 | 169,363 | 192,706 |
of which: loans and advances to banks | 12,078 | 13,329 | 13,822 |
of which: money market paper | 6,668 | 12,508 | 1,227 |
Net cash flow from / (used in) operating activities includes: | |||
Interest received in cash | 32,576 | 15,730 | 11,170 |
Interest paid in cash | 26,711 | 8,315 | 4,802 |
Dividends on equity investments, investment funds and associates received in cash | $ 2,241 | $ 1,907 | $ 2,531 |
Consolidated Statement ot Cash
Consolidated Statement ot Cash Flows (Parenthetical) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Statement Of Cash Flows [Line Items] | |||
Restricted cash and cash equivalents | $ 4,553 | $ 4,253 | $ 3,408 |
Money market paper in financial assets at fair value not held for trading | 6,345 | 6,048 | 1,066 |
Money market paper in other financial assets measured at amortized cost | 295 | 6,459 | 141 |
Money market paper in financial assets at fair value held for trading | $ 29 | $ 2 | $ 20 |
Changes in liabilities arising
Changes in liabilities arising from financing activities - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | $ 26,191 | $ (461) | |
Non-cash changes | 10,764 | (24,225) | |
of which: foreign currency translation | 3,467 | (5,036) | |
of which: fair value changes | 5,461 | (12,629) | |
of which: hedge accounting and other effects | 1,836 | (6,560) | |
Balance | 227,923 | 190,968 | $ 215,655 |
Debt issued measured at amortized cost | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | 7,979 | (19,390) | |
Non-cash changes | 2,306 | (3,543) | |
of which: foreign currency translation | 1,718 | (2,233) | |
of which: hedge accounting and other effects | 588 | (1,310) | |
Balance | 69,784 | 59,499 | 82,432 |
of which: short-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | 7,181 | (12,249) | |
Non-cash changes | 428 | (1,173) | |
of which: foreign currency translation | 428 | (1,173) | |
Balance | 37,285 | 29,676 | 43,098 |
of which: long-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | 798 | (7,141) | |
Non-cash changes | 1,878 | (2,370) | |
of which: foreign currency translation | 1,290 | (1,061) | |
of which: hedge accounting and other effects | 588 | (1,310) | |
Balance | 32,499 | 29,823 | 39,334 |
Debt issued designated at fair value | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | 8,433 | 13,277 | |
Non-cash changes | 6,066 | (12,895) | |
of which: foreign currency translation | 1,033 | (1,405) | |
of which: fair value changes | 5,033 | (11,490) | |
Balance | 86,341 | 71,842 | 71,460 |
Over-the-counter debt instruments | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | (122) | (251) | |
Non-cash changes | 4 | (193) | |
of which: foreign currency translation | (50) | (113) | |
of which: fair value changes | 53 | (80) | |
Balance | 1,566 | 1,684 | 2,128 |
Funding from UBS Group AG | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items] | |||
Cash flows | 9,901 | 5,903 | |
Non-cash changes | 2,389 | (7,595) | |
of which: foreign currency translation | 766 | (1,285) | |
of which: fair value changes | 374 | (1,060) | |
of which: hedge accounting and other effects | 1,249 | (5,250) | |
Balance | $ 70,232 | $ 57,943 | $ 59,635 |
Summary of material accounting
Summary of material accounting policies - Material accounting policies | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Material Accounting Policy Information [Line Items] | |
Material accounting policies | a) Material accounting policies This Note describes (the Financial authorized for issue by the Board of Directors Basis of accounting The International Accounting Standards Board (the IASB), Disclosures marked as audited in the “Risk, capital, liquidity an integral part of the Financial Statements. These disclosures relate to requirements under IFRS 7, Financial Instruments: Disclosures , and IAS 1, Presentation of Financial Statements , and are not repeated in this section. The stated in Note 1b. Critical accounting estimates and judgments Preparation of these Financial Statements under affect reported amounts of assets, liabilities, time they are made. Such estimates and which encompass historical updating them as necessary. Changes in those may differ significantly from UBS AG’s estimates, which could The following Statements: – expected credit loss measurement (refer to item 2g in this Note – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 10 in this – post-employment benefit plans (refer to item 5 in – goodwill (refer to item 9 in this Note and to Note – consolidation of structured entities (refer to item 1 in this Note 1) Consolidation The Financial Statements include the financial statements of UBS AG and its subsidiaries, presented as a single economic entity; intercompany including (ii) exposure to the entity‘s variable returns; Consideration is given the current ability to direct the relevant activities of an entity when Subsidiaries, when control ceases. Control, or the lack thereof, is reassessed if facts and circumstances to one or more elements required to establish that control Business combinations are is measured at the non-controlling interest’s proportionate › Refer to Note 28 for more information Critical accounting estimates and judgments Each individual entity is assessed for consolidation in line with the aforementioned consolidation principles. The assessment of requires involvement is unique for each entity, there is no uniform consolidation outcome by entity. may not. When carrying out the consolidation assessment, judgment is exercised considering all and activities of the investee, as well as the › Refer to Note 28 for more information 2) Financial instruments a. Recognition UBS AG generally recognizes However, (applying settlement date accounting to all standard purchases UBS AG retirement benefit criteria are Financial Statements. Client cash balances associated with derivatives clearing if, through contractual balances. b. Classification, measurement and presentation Financial assets Where the contractual (SPPI) on within a business model that has an objective of holding financial assets to collect contractual cash flows, or at fair value through other contractual cash flows and selling financial assets. All other those managed on a fair value basis, except for derivatives designated in certain hedge accounting relationships item 2j in this Note for more information). Business model assessment and contractual cash flow characteristics UBS AG determines particular business objective at the time an asset is recognized In assessing asset instrument. This assessment includes contractual (ESG) triggers. Financial liabilities Financial liabilities measured at amortized cost Financial liabilities Debt issued Funding from Group AG measured at amortized cost . The latter includes contingent capital instruments issued to UBS Group to November 2023 that contain contractual provisions under either a specified common equity tier 1 (CET1) ratio breach or a determination by the Swiss Financial Market Supervisory Authority (FINMA) that a viability event has occurred. Such contractual provisions are not derivatives, as the underlying is deemed contractual equity the debt is issued in Share premium separately from the amortized cost debt host. When the legal bail-in mechanism for write-down of issued debt instruments, it does not affect the accounting classification If a debt were to be written down or converted into equity in a future period, it would be partially or fully derecognized, with statement. Financial liabilities measured at fair value through profit or UBS AG designates certain issued debt instruments that such financial instruments the cash Financial instruments instruments. Measurement and presentation After initial IFRS 9, as described in the table below. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – amounts due from banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d in this Note; – ECL and reversals; and – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, see below in this table. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities held as HQLA. Measured at fair value, reported in Other comprehensive income , net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized recognized in the income statement: – interest income, which is accounted for in accordance with item 2d in this Note; – ECL and reversals; and – FX translation gains and losses. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short- term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded derivatives (ETD) and over-the-counter (OTC)-cleared derivatives that are legally settled on basis or economically net settled on a daily basis, are presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other Financial assets mandatorily measured at FVTPL that not held for trading include: – certain structured instruments, certain commercial loans, and receivables from securities financing transactions that are managed on a fair value basis; – loans managed on a fair value basis, hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity instruments; – assets held under unit-linked investment contracts. Classification, measurement and presentation Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – sweep deposits; – payables – non-structured debt issued; – subordinated debt; – commercial paper and certificates of deposit; – obligations against funding from UBS Group AG; – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Interest income generated from client deposits derecognized pursuant to certain deposit sweep is presented within Net interest income from financial instruments measured at fair value through and other . Measured at FVTPL Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS AG has third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes UBS AG’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis economically net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL Financial liabilities designated – issued hybrid debt instruments, linked, credit-linked and rates-linked bonds or notes; – issued debt instruments managed on a fair basis; – obligations against funding from UBS Group AG managed on a fair value basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. c. Loan commitments and financial guarantees Loan commitments commitments Financial guarantee contracts are contracts that require UBS AG to make specified payments to reimburse an incurred loss because a specified debtor debt instrument. d. Interest income and expense Interest calculating the effective interest rate (the EIR) for financial instruments (other than UBS AG estimates future with However, applying the EIR credit loss allowance. Upfront fees, including fees on loan commitments not measured at fair value where a loan is expected to be issued, and direct costs are and recognized over the expected life of the instrument Fees related to loan commitments does not same effective yield for comparable risk as other participants, are included in Net fee and commission income recognized over the life of the commitment or when syndication › Refer to item 3 in this Note for more information Interest expense expense, except when interest rates are negative, › Refer to item 2b in this Note and Note 3 e. Derecognition Financial assets UBS AG substantially all the risks and rewards of the asset or a significant part of the risks and rewards combined with a practical ability to sell or pledge the asset. Where transferred evidenced financial determined by the extent to which it is exposed to changes › Refer to Note 22 for more information Financial liabilities UBS AG derecognizes discharged, canceled or expires. When an existing financial liability is exchanged for a new one from the same lender on substantially derecognized income statement. Certain OTC derivative counterparties on a daily basis represents a legal or economic settlement, › Refer to Note 21 for more information f. Fair value of financial instruments UBS AG measurement date between market market. › Refer to Note 20 for more information Critical accounting estimates and judgments The use of valuation techniques, modeling assumptions and estimates of significant unobservable inputs participants would consider in estimating fair value, UBS AG’s governance arising from changing significant unobservable › Refer to Note 20 for more information g. Allowances and provisions for expected credit losses ECL are receivables, undrawn master credit before UBS AG can take credit risk Recognition of expected credit losses ECL are recognized on the following basis. – Stage 1 instruments: Maximum 12-month ECL ECL that would result occurring. – Stage 2 instruments: Lifetime ECL are to events over the no longer observed, the instrument will move back to stage – Stage 3 instruments: the occurrence Credit-impaired exposures they are expected to be fully recoverable through collateral – Changes in lifetime ECL since initial recognition are also PCI financial counterparty; All or part of a claim written off are generally credited to Credit loss expense / (release) . ECL are recognized in the income statement in Credit loss expense / (release) . A corresponding ECL allowance is reported as a decrease assets that Other comprehensive . For presented in Provisions. Default and credit impairment UBS AG applies a single definition of counterparty classified as defaulted based on quantitative › Refer to the “Risk management and control” section of this Measurement of expected credit losses IFRS 9 ECL reflect The method (LGD) and on the materiality of approach is applied that are point-in-time(PIT)-based material portfolios, PDs independent. For the based (A-IRB) framework and Pillar 2 stress loss models. Adjustments have been made to these models and IFRS 9-related models have been developed that consider the complexity, structure and that PDs and LGDs used in the ECL calculation are PIT-based, as opposed to the corresponding Basel III through-the-cycle (TTC) validation and oversight processes. Probability of default: PD represents the probability the probability of default determined for the next 12 months and a lifetime PD represents the remaining lifetime industry and information. Exposure at default: EAD represents an estimate of considering expected repayments, interest payments and accruals, are considered through and the characteristics of the respective portfolios. Loss given default: LGD represents an estimate expected proceedings commonly expressed Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination especially To accommodate represented by risks, and for for economic or changes in the nature and severity of the underlying scenario The determined weights constitute not that the chosen particular narratives with the related Macroeconomic and other factors The range and historical information availability of purposes, UBS AG period, to cycle-neutral PD and LGD for longer-term Factors relevant taken into account, with specific focus on Switzerland and For calculation: – gross domestic product (GDP) growth rates, given their significant – unemployment rates, given their significant effect on private – house price indices, given their significant effect on mortgage – interest rates, given their significant effect on counterparties’ – consumer price and economic stability; and – equity indices, given that they are an important factor Scenario generation, review process and governance A team of economists, with involvement from a broad range The scenarios, IFRS 9 Scenario and Group may not be capable allowance. The framework, ratifies the decisions taken by the ECL Management › Refer to Note 19 for more information ECL measurement period The period for which to commitments and for which UBS AG has an obligation to extend credit. Additionally, some financial instruments include both an on-demand loan and a revocable undrawn commitment, where the contractual cancellation right does not limit UBS client has to estimate have a defined managed as one portfolio level, with applied for credit card limits, to credit risk. Customary master credit commitments. negative indicators. The risk Larger UBS AG has reviews measurement period from the reporting date which UBS AG from the respective reporting date. Significant increase in credit risk Financial instruments subject maximum 12 since initial recognition of the financial instrument, applying both Primarily, UBS AG assesses changes in forward-looking and scenario-weighted lifetime PD of an – at the reporting date; and – at inception of the instrument. If, based on and the instrument is transferred to stage 2 with lifetime The threshold for those financial asset PIT applied are defined on a more granular level by interpolating SICR thresholds Internal rating at origination of the instrument Rating downgrades / SICR trigger 0–3 3 4–8 2 9–13 1 › Refer to the “Risk management and control” section of this Irrespective of increased for an instrument if contractual payments specifically the Swiss instruments are transferred before a and Global reclassified to stage 3, a one-year period is applied before Additionally, economic conditions, counterparties may be moved to a watch list, which is used as a secondary qualitative indicator for an sharing the same credit risk characteristics to take account In general, the overall SICR determination process does not certain monitoring processes stage 3 position. In exceptional cases, an individual adjustment and a transfer into stage 2 may be made to take account of specific facts. Credit risk different requirements are instrument-specific, such that maturing loans in stage 2 will migrate to stage 1 upon renewal irrespective of the risk-based determine what risk-mitigating actions may be warranted. › Refer to the “Risk management and control” section of this Critical accounting estimates and judgments The calculation of ECL requires timing and the amount of ECL recognized. Determination of a significant increase in IFRS 9 does not include a definition of what constitutes an Management Forum has been established to Scenarios, scenario weights and macroeconomic ECL reflect forward-looking Scenario Sounding and to determine whether any additional post-model ECL measurement period Lifetime ECL are generally callable master credit applied for credit card limits, capped at 12 months for Modeling and post-model adjustments A number of affect ECL. The models are governed by UBS AG’s model validation controls ECL Management Forum and endorsed by the A sensitivity analysis covering key macroeconomic › Refer to Note 19 for more information h. Restructured and modified financial assets When payment default is expected, in financial difficulties that extension of maturity, › Refer to the “Risk management and control” section of this Modifications result in an or as part of a credit financial asset being derecognition, any difference between gross carrying amount of the given financial asset is recognized i. Offsetting UBS AG presents financial assets and liabilities on its recognized simultaneously. transactions with various counterparties, exchanges and clearing houses. In simultaneously, emphasis is all credit and liquidity exposure between the counterparties. This condition precludes offsetting substantial amounts of UBS AG’s financial assets arrangements. Repurchase arrangements the settlement and payables in a single settlement process or cycle. › Refer to Note 21 for more information j. Hedge accounting UBS AG applies hedge accounting requirements of are met. Voluntary discontinuation of Fair value hedges of interest rate risk related to The amount hedging instrument. Fair value hedges of FX risk related to debt instruments The fair value change of the hedged item attributable item and foreign currency basis spread of cross-currency swaps designated as and accounted Other Equity . amounts are released to the income Discontinuation of fair value hedges Discontinuations for reasons which method. If the hedged item is derecognized, the unamortized fair value adjustment or deferred is recognized immediately in the income statement Cash flow hedges of forecast transactions Fair value gains or repricing Other Equity Interest from financial Interest expense affect profit transactions statement. Hedges of net investments in foreign operations Gains or losses Other comprehensive income Equity , while any gains (for example, the disposal of the foreign Equity the entity is reclassified to Other income . Interest Rate Benchmark Reform UBS AG replaced with would continue to with little or by alternative risk-free interest Amendments to IFRS 9, IAS 39, and IFRS 16 (Interest Rate Benchmark Reform – Phase 2) , where applicable . 3) Fee and commission income and expenses UBS AG earns fee income from the diverse range of services it provides to its clients. Fee income can be divided into two broad clients’ assets, custody services deal-contingent merger and acquisitions UBS AG recognizes fees earned from PIT services requires services to be provided Consideration nature considered to include a the client, e.g., management significant judgment in allocating the consideration received PIT services where the amount of revenue is known when the performance obligation is met. Fixed-over-time fees are recognized on a straight-line to customer’s performance related to contingencies beyond UBS AG’s control until such UBS AG’s fees are generally earned from component or term nature of such contracts, any significant contract assets or liabilities. UBS AG presents expenses primarily in that revenues, which are generally Total revenues Fee and commission expense , and those to Operating expenses . For its specific directly offset against the associated income collected from the given › Refer to Note 4 for more information, including the 4) Share-based and other deferred compensation plans UBS AG recognizes expenses for deferred compensation awards over the period that the service to affected by restructuring programs or mutually agreed termination provisions, recognition of such expense is accelerated to the who compensation expense is grant date. Share-based compensation plans UBS Group AG is the to employees share-based payment transactions. UBS AG recognizes the fair value of UBS Group inherent in the award, market conditions, and non-vesting conditions. For equity-settled awards, incremental estimate of performance conditions. For equity-settled relate to a service or performance condition) do not result For cash-settled recognized equals the cash distributed. Other deferred compensation plans Compensation depending on expected to be paid under the equals the cash or the fair value of respective financial › Refer to Note 27 for more information 5) Post-employment benefit plans Defined benefit plans Defined benefit plans specify an amount of benefit factors, the present value of the of the Other comprehensive income . If the fair value of the plan’s assets is higher than the present value of the defined benefit obligation, the recognition of form of obligation or employer, and Critical accounting estimates and judgments The net defined benefit determined significantly alter the defined rate, expected movements in each significant assumption for › Refer to Note 26 for more information Defined contribution plans A benefits sufficient Compensation expense is generally in the year of contribution. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in future payments is available. 6) Income taxes UBS AG is subject business operations. UBS AG’s provision for income taxes is composed of current and deferred taxes. Current income taxes represent taxes to be paid or refunded for the current period or previous periods Deferred tax assets amounts and periods. DTAs may also arise measured using reporting period and that will be in effect when such differences DTAs are recognized differences can extent that there are sufficient taxable temporary differences or there is convincing other evidence that sufficient taxable profit will be available against which the unused tax losses Deferred and current tax to the be settled net or realized simultaneously. Current and deferred taxes are recognized as income tax benefit or expense and deferred taxes recognized in relation to: (i) amount of goodwill arising from the acquisition); (ii) unrealized gains or losses on at defined benefit through (v) above are recognized in Other comprehensive income Equity . UBS AG reflects the considered probable by value methods, the uncertainty will be resolved. Critical accounting estimates and judgments Tax laws are complex, the performance of remaining tax loss carry-forward period, and its future profitability and business plan forecasts is inherently subjective Forecasts are required to prove there is sufficient future profitability income statement. In addition, judgment is the resolution of any income tax-related appeals and litigation. › Refer to Note 8 for more information 7) Investments in associates Interests in entities where UBS AG has significant influence does accounting. Typically, of an entity’s voting rights. Investments or decreased after the date of acquisition impairment losses. carrying amount of the investment in the associate exceeds › Refer to Note 28 for more information 8) Property, equipment and software Property, development costs are capitalized benefits calculated on a straight-line basis over an asset’s estimated Property, alongside goodwill and intangible assets as assets property that has a that would be currently required by a market participant to replace the service capacity of the asset. If such assets are no longer used, they are tested individually for impairment. › Refer to Note 11 for more information 9) Goodwill Goodwill represents liabilities of of whether there An impairment charge cash-generating-unit. Critical accounting estimates and judgments UBS AG‘s methodology for goodwill impairment available to shareholders (typically estimated Standards, in order to reflect facts and circumstances specific to a cash-generating growth rate. Earnings available to shareholders are estimated on the basis of forecast results, which are part of the business plan approved by the BoD. The discount rates and management. The key assumptions used to determine the recoverable amounts of each cash-generating unit are tested for sensitivity by changes to those assumptions. › Refer to Notes 2 and 12 for more information 10) Provisions and contingent liabilities Provisions are Provisions, Contingent Liabilities and Contingent , when: (i) UBS AG has is probable that of the obligation can be made. The benefits. change the scope of the business Provisions accordance with measurement principles set out in item 4 in this Note. In addition, UBS AG presents expected credit loss allowances within Provisions credit line. IAS 37 provisions at the balance sheet date. When conditions required to recognize a provision are not met, a contingent liability is disclosed, unless the likelihood of an outflow events, Critical accounting estimates and judgments Recognition of provisions often involves significant judgment in assessing the existence of an obligation that results from past events and in probability, the timing and the amount of any outflows of resources. This is particularly the case for litigation, regulatory and similar matters, which, due to their nature, are subject to many uncertainties, The amount of any provision matter. Management regularly reviews all the available information regarding such matters, including legal advice, to assess whether the recognition criteria provisions have been satisfied and to determine the › Refer to Note 17 for more information 11) Foreign currency translation Transactions spot exchange FVOCI, and closing exchange rate. Translation Other net income from fair value through profit or loss . Non-monetary items measured at historical cost are translated Upon at the closing exchange rate on the balance sheet date, are translated at the Equity and UBS AG no Share historic average rate and the spot rate Share premium. amounts recognized Other comprehensive are translated at Retained earnings . › Refer to Note 32 for more information |
Summary of material accountin_2
Summary of material accounting policies - Changes in accounting policies, comparability and adjustments | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Material Changes In Accounting Policies [Line Items] | |
Changes in accounting policies, comparability and other adjustments | Note 1 b) Changes in accounting policies, comparability and New or amended accounting standards IFRS 17, Insurance Contracts Effective Insurance , requirements for contractual rights held. The adoption any market. Amendments to IAS 12, Income Taxes In May 2023, the IASB issued amendments to IAS 12, Income Taxes , in relation to top-up taxes on income under Anti-Base Erosion the Pillar Two Certain countries in which UBS which introduced a tax with effect from 1 January 2024 and UBS AG’s worldwide operations with effect from 1 January 2025. Moreover, it is such legislation in 2024. The amendments to IAS be statements. An assessment substantively reporting and, also, This assessment with corporate Consequently, UBS AG legislation. |
Summary of material accountin_3
Summary of material accounting policies - IFRS Accounting Standards and Interpretations to be adopted and other changes | 12 Months Ended |
Dec. 31, 2023 | |
Description of Expected Impact of Initial Application of New Standards or Interpretations [Line Items] | |
IFRS Accounting Standards and Interpretations to be adopted in 2024 and later and other changes | c) IFRS Accounting Standards and Interpretations Other amendments to IFRS Accounting Standards The IASB has issued later. |
Segment reporting
Segment reporting | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Operating Segments [Line Items] | |
Disclosure Of Entitys Reportable Segments Explanatory | Note 2a UBS AG’s Corporate Banking, supported Group Items, the five business divisions reflect – Global Wealth ranges from investment management and banking products and services. – Personal retirement, financing, channels. – Asset Management across intermediaries and wealth management clients. – The Investment Bank to services, facilitating clients raising debt derivatives trading across equities and fixed income, and – Non-core and Legacy in Group Functions as not strategic in light of the acquisition of the Credit Suisse – Our Group functions are by the support and control functions are allocated to as Group Items (which Governance, Office, Group Sustainability and Impact, and Chief Strategy Financial information about reports to the Executive Board, Operating Segments . UBS AG’s determine reportable segments are carried out at internally agreed rates and are segments. several immaterial, as the majority of the Interest income earned average attributed equity and currency composition. Assets and and invested with Group functions, and the net interest Segment internal reporting to management. If one operating segment is involved in operating segment associated transaction principles. Non-current assets than benefits. USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group Items 1 UBS AG For the year ended 31 December 2023 Net interest income 5,436 3,128 (39) (2,612) 25 (1,372) 4,566 Non-interest income 13,194 2,158 2,108 10,371 34 1,244 29,109 Total revenues 18,631 5,285 2,069 7,759 59 (128) 33,675 Credit loss expense / (release) 25 50 (1) 67 1 1 143 Operating expenses 14,900 2,889 1,706 7,588 1,010 919 29,011 Operating profit / (loss) before tax 3,705 2,346 364 104 (952) (1,048) 4,521 Tax expense / (benefit) 1,206 Net profit / (loss) 3,315 Additional information Total assets 369,176 257,068 19,662 381,023 13,845 115,242 1,156,016 Additions to non-current assets 666 219 70 445 0 0 1,400 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group 1 UBS AG For the year ended 31 December 2022 Net interest income 5,274 2,192 (19) (241) 1 (690) 6,517 Non-interest income 13,689 2,113 2,980 2 8,958 236 423 28,398 Total revenues 18,963 4,304 2,961 8,717 237 (267) 34,915 Credit loss expense / (release) 0 39 0 (12) 2 0 29 Operating expenses 14,069 2,475 1,565 6,890 104 823 25,927 Operating profit / (loss) before tax 4,894 1,790 1,396 1,839 131 (1,091) 8,960 Tax expense / (benefit) 1,844 Net profit / (loss) 7,116 Additional information Total assets 388,624 235,330 16,971 391,495 13,367 59,649 1,105,436 Additions to non-current assets 42 13 1 33 0 1,773 1,862 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group Items 1 UBS AG For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (11) (215) 6,605 Non-interest income 15,175 2,144 2,632 8,978 70 224 29,222 Total revenues 19,419 4,264 2,617 9,459 60 9 35,828 Credit loss expense / (release) (29) (86) 1 (34) 0 0 (148) Operating expenses 14,743 2,623 1,593 6,902 138 1,014 27,012 Operating profit / (loss) before tax 4,706 1,726 1,023 2,592 (78) (1,005) 8,964 Tax expense / (benefit) 1,903 Net profit / (loss) 7,061 Additional information Total assets 3 395,235 225,425 25,202 346,641 25,153 98,488 1,116,145 Additions to non-current assets 56 16 1 30 0 1,689 1,791 1 As of or for the year ended 31 December 2023, Non-core and Legacy (previously reported within Group Functions) became a separate reportable segment and Group Functions has been renamed Group Items. Prior periods have been revised to reflect these changes. 848 m gain in Asset Management related to the sale of refined the methodology applied to allocate balance sheet assets allocated to business divisions would have been USD 26 bn higher, of which USD 14 bn would have related to the Investment Bank. The allocation of total revenues to these and its performance be reasonable, and may allocation methodology are management with the mandate are managed at a Group level. These revenues are included Global The geographic analysis For the year ended 31 December 2023 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 13.3 39 8.6 47 Asia Pacific 5.2 15 1.2 7 Europe, Middle East and Africa (excluding Switzerland) 6.1 18 2.6 14 Switzerland 9.2 27 5.9 32 Global (0.1) 0 0.0 0 Total 33.7 100 18.3 100 For the year ended 31 December 2022 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 13.8 40 9.0 48 Asia Pacific 5.6 16 1.5 8 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.6 14 Switzerland 7.7 22 5.6 30 Global 0.8 2 0.0 0 Total 34.9 100 18.7 100 For the year ended 31 December 2021 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 14.5 40 9.0 47 Asia Pacific 6.5 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.6 13 Switzerland 7.8 22 6.3 33 Global 0.1 0 0.0 0 Total 35.8 100 19.3 100 1 Predominantly related to the US. |
Net interest income and other n
Net interest income and other net income from fair value changes on financial instruments | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss [Line Items] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Explanatory | Note 3 profit or loss For the year ended USD m 31.12.23 31.12.22 31.12.21 Net interest income from financial instruments measured 1,765 1,410 1,437 Other net income from financial instruments measured 1 9,934 7,493 5,844 Total net income from financial instruments measured at fair value through profit or loss and 11,698 8,903 7,281 Net interest income Interest income from loans and deposits 2 19,637 9,634 6,489 Interest income from securities financing transactions measured 3 3,450 1,378 513 Interest income from other financial instruments measured 1,152 545 284 Interest income from debt instruments measured at fair 103 74 115 Interest resulting from derivative instruments designated as cash (1,898) 173 1,133 Total interest income from financial instruments measured at amortized cost and fair 22,444 11,803 8,534 Interest expense on loans and deposits 4 14,977 4,488 1,655 Interest expense on securities financing transactions measured 5 1,714 1,089 1,102 Interest expense on debt issued 2,855 1,031 512 Interest expense on lease liabilities 97 88 98 Total interest expense from financial instruments measured at amortized cost 19,643 6,696 3,366 Total net interest income from financial instruments measured at amortized cost and fair 2,801 5,108 5,168 Total net interest income from financial instruments measured at fair value through profit or loss 1,765 1,410 1,437 Total net interest income 4,566 6,517 6,605 1 Includes net losses from financial liabilities 4,065 m (net gains of USD 17,036 m in 2022 and net losses 6,457 m in 2021). This complementary financial liabilities designated at fair value excludes transactions into the respective liabilities designated at fair value included net 2,045 m (net gains of USD 4,112 m and net losses of USD 2,068 m in 2022 and 2021, respectively) from notes issued by UBS AG’s Asset Management business. These gains / on the financial assets hedging the unit-linked investment contracts, which are not disclosed as part of Net gains / (losses) from financial liabilities designated at fair value. and balances at central banks, amounts due from banks and customers, and cash collateral receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits, and collateral payables on derivative instruments. due to banks, cash collateral payables on derivative instruments, customer deposits, and funding from UBS Group AG measured at amortized cost, as well as negative interest on cash and balances at central banks, amounts due from banks, and cash collateral receivables on derivative instruments. |
Net fee and commission income
Net fee and commission income | 12 Months Ended |
Dec. 31, 2023 | |
Net fee And Commission Income [Line Items] | |
Disclosure Of Fee And Commission Income Expense Explanatory | Note 4 For the year ended USD m 31.12.23 31.12.22 31.12.21 Underwriting fees 637 633 1,512 M&A and corporate finance fees 669 804 1,102 Brokerage fees 3,323 3,487 4,383 Investment fund fees 4,730 4,942 5,790 Portfolio management and related services 9,091 9,059 9,762 Other 1,950 1,921 1,874 Total fee and commission income 1 20,399 20,846 24,422 of which: recurring 14,008 14,229 15,410 of which: transaction-based 6,320 6,550 8,743 of which: performance-based 71 68 269 Fee and commission expense 1,790 1,823 1,985 Net fee and commission income 18,610 19,023 22,438 1 For the 12,687 m for Global 1,840 m for Personal 2,723 m for Asset Management, USD 3,153 m for the Investment Bank, USD 7 m for Non-core and Legacy and negative USD 11 m for Group Items (for the year ended 31 December 2022: USD 12,990 m for Global Wealth Management, USD 1,657 m for 2,840 m for 3,350 m for 0 m for 10 m for ended 31 December 2021: USD 14,545 m for Global Wealth 1,645 m for Personal 3,337 m for Asset Management, 4,863 m for the Investment 0 m for Non-core and Legacy and USD 33 m for Group Items). For the year ended 31 December Functions has been renamed Group Items. Prior periods have been revised to reflect these changes. |
Other income
Other income | 12 Months Ended |
Dec. 31, 2023 | |
Other Income [Line Items] | |
Disclosure Of Other Operating Income Explanatory | Note 5 For the year ended USD m 31.12.23 31.12.22 31.12.21 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 24 148 (11) Net gains / (losses) from disposals of investments in associates 0 844 2 41 Share of net profits of associates and joint ventures (163) 3 32 105 Total (138) 1,024 134 Net gains / (losses) from disposals of financial assets measured (1) (1) 9 Income from properties 4 18 20 22 Net gains / (losses) from properties held for sale 8 71 100 5 Income from shared services provided to UBS Group AG or its subsidiaries 568 460 451 Other 6 112 308 7 224 8 Total other income 566 1,882 941 1 Includes foreign exchange gains / (losses) reclassified and disposals of 848 m gain related 255 m share of impairment losses reflected in the SIX Group profit 191 m reported in Personal 64 m reported in Global Wealth Management. third parties. 21 m related to the repurchase of UBS AG‘s 23 m in 2022 and a loss of USD 17 m in 2021). 133 m gain on the sale of UBS AG’s domestic wealth 111 m (with the remaining amount disclosed within Net gains / (losses) from acquisitions and disposals of subsidiaries) and income of USD 111 m related to a legacy litigation settlement and a legacy bankruptcy claim. 100 m from the sale of UBS AG’s domestic wealth management business in Austria. |
Personnel expenses
Personnel expenses | 12 Months Ended |
Dec. 31, 2023 | |
Personnel Expenses [Line Items] | |
Disclosure Of Employee Benefits Explanatory | Note 6 For the year ended USD m 31.12.23 31.12.22 31.12.21 Salaries 1 5,898 5,528 5,723 Variable compensation 2 7,669 7,636 7,973 of which: performance awards 2,841 2,910 2,916 of which: financial advisors 3 4,549 4,508 4,860 of which: other 279 217 196 Contractors 98 119 142 Social security 835 730 762 Post-employment benefit plans 4 579 555 582 of which: defined benefit plans 259 256 280 of which: defined contribution plans 320 299 303 Other personnel expenses 576 513 479 Total personnel expenses 15,655 15,080 15,661 1 Includes role-based approach. It also information. Includes curtailment 3 m for the 13 m; for the 49 m), which represent a reduction in the defined benefit obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. Personnel expenses increased by USD 575 m to USD 15,655 m and included integration-related expenses 626 m. |
General and administrative expe
General and administrative expenses | 12 Months Ended |
Dec. 31, 2023 | |
General And Administrative Expenses [Line Items] | |
Disclosure Of General And Administrative Expense Explanatory | Note 7 For the year ended USD m 31.12.23 31.12.22 31.12.21 Outsourcing costs 478 451 426 Technology costs 558 502 490 Consulting, legal and audit fees 650 494 465 Real estate and logistics costs 679 507 530 Market data services 400 367 367 Marketing and communication 209 195 171 Travel and entertainment 205 156 66 Litigation, regulatory and similar matters 1 816 348 910 Other 7,123 5,981 6,051 of which: shared services costs charged by UBS Group AG or its subsidiaries 6,203 5,264 5,321 Total general and administrative expenses 11,118 9,001 9,476 1 Reflects the net increase, including recoveries from third parties, in provisions for litigation, General 2,117 m 11,118 m, expenses of USD 491 m, largely reflected in higher consulting and |
Income taxes
Income taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Taxes [Line Items] | |
Disclosure Of Income Tax Explanatory | Note 8 For the year ended USD m 31.12.23 31.12.22 31.12.21 Tax expense / (benefit) Swiss Current 810 664 614 Deferred 39 (22) 26 Total Swiss 849 642 640 Non-Swiss Current 618 689 857 Deferred (262) 513 406 Total non-Swiss 356 1,202 1,263 Total income tax expense / (benefit) recognized in the income statement 1,206 1,844 1,903 Income tax recognized in the income statement The Swiss current tax expenses related to taxable profits The non-Swiss 100 m in tax (CAMT) and USD 518 m in respect of other taxable profits of non-Swiss subsidiaries The non-Swiss net 274 m in respect tax assets (DTAs) that resulted awards due to an increase in the Group’s share price during the year. In addition, the net deferred tax benefit included a benefit 100 m in benefits were partly offset by a net deferred tax expense of USD 112 m that primarily related to the amortization of DTAs previously recognized in relation to tax losses carried forward Excluding any potential any material jurisdictional 24 %. For the year ended USD m 31.12.23 31.12.22 31.12.21 Operating profit / (loss) before tax 4,521 8,960 8,964 of which: Swiss 3,174 4,052 2,983 of which: non-Swiss 1,347 4,907 5,981 Income taxes at Swiss tax rate of 18.5 % for 2023, 18 % for 2022 and 18.5 % for 2021 836 1,613 1,658 Increase / (decrease) resulting from: Non-Swiss tax rates differing from Swiss tax rate (43) 267 217 Tax effects of losses not recognized 71 74 124 Previously unrecognized tax losses now utilized (401) (217) (179) Non-taxable and lower-taxed income (165) (316) (252) Non-deductible expenses and additional taxable income 1,017 414 487 Adjustments related to prior years, current tax (15) (33) (38) Adjustments related to prior years, deferred tax 10 19 (3) Change in deferred tax recognition (273) (217) (341) Adjustments to deferred tax balances arising from changes 0 0 (1) Other items 169 240 230 Income tax expense / (benefit) 1,206 1,844 1,903 The components of statements and the amounts calculated at the Swiss tax rate, Component Description Non-Swiss tax rates differing from the Swiss tax rate To the extent that UBS AG profits or losses arise outside Switzerland, the applicable local Swiss tax rate. This item reflects, for such profits, an adjustment rate to the tax expense that would arise at the from the tax benefit that would arise at the Swiss rate. Tax effects of losses not recognized This item relates to tax losses of entities arising in the in relation to those losses. Therefore, the tax benefit calculated above is reversed. Previously unrecognized tax losses now utilized This item relates to taxable profits of the year that are offset by tax losses previously recorded. Consequently, no current tax or deferred tax expense arises in relation to those taxable the tax expense Non-taxable and lower- taxed income This item relates to tax deductions for the year in profits that are either not taxable or are taxable at a lower rate of made for tax purposes, which are not reflected in the Non-deductible expenses and additional taxable income This item relates to additional taxable income for is recognized for tax purposes by an entity but is well as expenses for the year that are non-deductible locations). Adjustments related to prior years, This item relates to adjustments to current tax expense for tax authorities in an amount that differs from the amount Adjustments related to prior years, tax This item relates to adjustments to deferred tax positions recognized and the amount of the tax loss agreed with recognized as DTAs in the accounts). Change in deferred tax recognition This item relates to changes in DTAs, including changes in DTAs previously recognized resulting from reassessments of expected future taxable profits. It also includes changes recognized. Adjustments to deferred tax balances arising from changes in tax rates This item relates to remeasurements of DTAs and liabilities recognized due to changes of changing the future tax saving that is expected from tax of DTAs recognized or, alternatively, differences and therefore the deferred tax liability. Other items Other items include other differences between profits or losses benefit, including movements in provisions for uncertain Income tax recognized directly in equity A net tax expense of USD 288 m was recognized in Other comprehensive income 1,095 m) and a net tax benefit of USD 12 m was recognized in Share premium 5 m). Deferred tax assets and liabilities UBS AG has temporary differences, as well as deferred tax liabilities in respect of taxable temporary differences, as shown in below. management related tax loss carry-forwards and deductible The recognition of DTAs is opportunities are available that would Deferred tax joint arrangements, temporary difference, and it is probable that such will not reverse in 2023, this exception was not considered to apply to any USD m 31.12.23 31.12.22 Deferred tax assets 1 Gross Valuation allowance Recognized Gross Valuation allowance Recognized Tax loss carry-forwards 11,453 (8,496) 2,957 12,708 (8,720) 3,988 Unused tax credits 95 0 95 0 0 0 Temporary differences 6,771 (579) 6,192 5,774 (408) 5,365 of which: related to real estate costs capitalized for US purposes 2,703 0 2,703 2,485 0 2,485 of which: related to compensation and benefits 1,457 (205) 1,252 1,169 (175) 993 of which: related to cash flow hedges 619 0 619 947 0 947 of which: other 1,992 (374) 1,618 1,173 (233) 940 Total deferred tax assets 18,319 (9,076) 9,244 2 18,482 (9,128) 9,354 2 of which: related to the US 8,505 8,294 of which: related to other locations 739 1,060 Deferred tax liabilities Total deferred tax liabilities 162 233 1 After offset of DTLs, as applicable. 408 m (31 December 2022: USD 471 m) in respect of entities that incurred losses in either the current or preceding year. In general, US federal tax losses incurred prior losses incurred after that date of the either 25% or 50% carry-forwards that state and local tax purposes. Unrecognized tax loss carry-forwards USD m 31.12.23 31.12.22 Within 1 year 192 231 From 2 to 5 years 10,278 2,184 From 6 to 10 years 2,708 11,106 From 11 to 20 years 1,199 1,610 No expiry 16,252 16,960 Total 30,630 32,091 of which: related to the US 1 12,354 13,350 of which: related to the UK 14,333 14,332 of which: related to other locations 3,943 4,409 1 Related to UBS AG’s US branch. |
Financial assets at amortized c
Financial assets at amortized cost and other positions in scope of expected credit loss measurement | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Provision Matrix [Line Items] | |
Disclosure Of Provision Matrix Explanatory | Balance sheet notes Note 9 The tables credit loss (ECL on shared risk characteristics and on the table below. › Refer to Note 19 for more information about expected Segment Segment description Description of credit risk sensitivity Business division Private clients with mortgages Lending to private clients secured by owner-occupied real estate and personal account overdrafts of those clients Sensitive to the interest rate environment, unemployment levels, real estate collateral values and other regional aspects – Personal & Corporate Banking – Global Wealth Management Real estate financing Rental or income-producing real estate financing to private and corporate clients secured by real estate Sensitive to unemployment interest rate environment, real estate collateral values and other regional aspects – Personal & Corporate Banking – Global Wealth Management – Investment Bank Large corporate clients Lending to large corporate and multi- national clients Sensitive to GDP developments, unemployment levels, seasonality, business cycles and collateral values (diverse collateral, and other collateral types) – Personal & Corporate Banking – Investment Bank SME clients Lending to small and medium-sized corporate clients Sensitive to GDP developments, unemployment levels, the interest rate environment and, to some extent, seasonality, values (diverse collateral, estate and other collateral types) – Personal & Corporate Banking Lombard Loans secured by pledges of marketable securities, guarantees and other forms of collateral (including concentration in hedge funds, private equity and unlisted equities), as well as unsecured recourse lending Sensitive to equity and debt markets (e.g., changes in collateral values) – Global Wealth Management Credit cards Credit card solutions in Switzerland and the US Sensitive to unemployment levels – Personal & Corporate Banking – Global Wealth Management Commodity trade finance Working capital financing of commodity traders, generally extended on a self- liquidating transactional basis Sensitive primarily to the strength of individual transaction structures and collateral values (price volatility of commodities), debt service is directly linked to the shipments financed – Personal & Corporate Banking Financial intermediaries and hedge funds Lending to financial institutions and pension funds, including exposures to broker-dealers and clearing houses Sensitive to GDP development, the interest rate environment, price and volatility risks in financial markets, and regulatory and political risk – Personal & Corporate Banking – Investment Bank › Refer to Note 19f for more details regarding sensitivity The tables certain non-financial instruments that are USD m 31.12.23 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 171,806 171,788 18 0 (26) 0 (26) 0 Amounts due from banks 28,206 28,191 14 0 (7) (6) (1) 0 Receivables from securities financing transactions measured at amortized 74,128 74,128 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 32,300 32,300 0 0 0 0 0 0 Loans and advances to customers 405,633 385,493 18,131 2,009 (935) (173) (185) (577) of which: Private clients with mortgages 174,400 163,617 9,955 828 (156) (39) (89) (28) of which: Real estate financing 54,305 50,252 4,038 15 (46) (20) (25) (1) of which: Large corporate clients 14,431 12,594 1,331 506 (241) (34) (32) (174) of which: SME clients 12,694 10,662 1,524 508 (262) (34) (24) (204) of which: Lombard 117,924 117,874 0 50 (22) (5) 0 (17) of which: Credit cards 2,041 1,564 438 39 (42) (6) (11) (24) of which: Commodity trade finance 2,889 2,873 12 4 (119) (7) 0 (111) Other financial assets measured at amortized cost 54,334 53,882 312 141 (87) (16) (5) (66) of which: Loans to financial advisors 2,615 2,422 79 114 (49) (4) (1) (44) Total financial assets measured at amortized cost 766,407 745,782 18,475 2,150 (1,057) (197) (217) (643) Financial assets measured at fair value through other comprehensive income 2,233 2,233 0 0 0 0 0 0 Total on-balance sheet financial assets within the scope of ECL requirements 768,640 748,015 18,475 2,150 (1,057) (197) (217) (643) Total exposure ECL provisions Off-balance sheet (within the scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 33,211 32,332 761 118 (40) (14) (7) (19) of which: Large corporate clients 3,624 3,051 486 87 (10) (3) (2) (6) of which: SME clients 1,506 1,299 177 31 (7) (1) (1) (5) of which: Financial intermediaries and hedge funds 22,549 22,504 46 0 (12) (8) (3) 0 of which: Lombard 3,009 3,009 0 0 (1) 0 0 (1) of which: Commodity trade finance 1,811 1,803 8 0 (1) (1) 0 0 Irrevocable loan commitments 44,018 42,085 1,878 56 (95) (55) (38) (2) of which: Large corporate clients 26,096 24,444 1,622 30 (76) (45) (28) (2) Forward starting reverse repurchase and securities borrowing agreements 10,373 10,373 0 0 0 0 0 0 Committed unconditionally revocable credit lines 47,421 45,452 1,913 56 (49) (39) (10) 0 of which: Real estate financing 9,439 8,854 585 0 (4) (3) (1) 0 of which: Large corporate clients 5,110 4,951 151 8 (6) (4) (3) 0 of which: SME clients 5,408 5,188 191 29 (21) (17) (3) 0 of which: Lombard 8,964 8,964 0 1 0 0 0 0 of which: Credit cards 10,458 9,932 522 4 (10) (8) (2) 0 of which: Commodity trade finance 537 537 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 4,183 4,169 11 4 (4) (3) 0 0 Total off-balance sheet financial instruments and credit lines 139,206 134,410 4,562 234 (188) (111) (56) (21) Total allowances and provisions (1,244) (308) (272) (664) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL USD m 31.12.22 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 169,445 169,402 44 0 (12) 0 (12) 0 Amounts due from banks 14,671 14,670 1 0 (6) (5) (1) 0 Receivables from securities financing transactions measured at amortized 67,814 67,814 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 35,033 35,033 0 0 0 0 0 0 Loans and advances to customers 390,027 372,903 15,587 1,538 (783) (129) (180) (474) of which: Private clients with mortgages 156,930 147,651 8,579 699 (161) (27) (107) (28) of which: Real estate financing 46,470 43,112 3,349 9 (41) (17) (23) 0 of which: Large corporate clients 12,226 10,733 1,189 303 (130) (24) (14) (92) of which: SME clients 13,903 12,211 1,342 351 (251) (26) (22) (203) of which: Lombard 132,287 132,196 0 91 (26) (9) 0 (17) of which: Credit cards 1,834 1,420 382 31 (36) (7) (10) (19) of which: Commodity trade finance 3,272 3,261 0 11 (96) (6) 0 (90) Other financial assets measured at amortized cost 53,389 52,829 413 147 (86) (17) (6) (63) of which: Loans to financial advisors 2,611 2,357 128 126 (59) (7) (2) (51) Total financial assets measured at amortized cost 730,379 712,651 16,044 1,685 (890) (154) (199) (537) Financial assets measured at fair value through other comprehensive income 2,239 2,239 0 0 0 0 0 0 Total on-balance sheet financial assets within the scope of ECL requirements 732,618 714,889 16,044 1,685 (890) (154) (199) (537) Total exposure ECL provisions Off-balance sheet (within the scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 22,167 19,805 2,254 108 (48) (13) (9) (26) of which: Large corporate clients 3,663 2,883 721 58 (26) (2) (3) (21) of which: SME clients 1,337 1,124 164 49 (5) (1) (1) (3) of which: Financial intermediaries and hedge funds 11,833 10,513 1,320 0 (12) (8) (4) 0 of which: Lombard 2,376 2,376 0 1 (1) 0 0 (1) of which: Commodity trade finance 2,121 2,121 0 0 (1) (1) 0 0 Irrevocable loan commitments 39,996 37,531 2,341 124 (111) (59) (52) 0 of which: Large corporate clients 23,611 21,488 2,024 99 (93) (49) (45) 0 Forward starting reverse repurchase and securities borrowing agreements 3,801 3,801 0 0 0 0 0 0 Committed unconditionally revocable credit lines 43,677 41,809 1,833 36 (40) (32) (8) 0 of which: Real estate financing 8,711 8,528 183 0 (6) (6) 0 0 of which: Large corporate clients 4,578 4,304 268 5 (4) (1) (2) 0 of which: SME clients 4,723 4,442 256 26 (19) (16) (3) 0 of which: Lombard 7,855 7,854 0 1 0 0 0 0 of which: Credit cards 9,390 8,900 487 3 (7) (5) (2) 0 of which: Commodity trade finance 327 327 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 4,696 4,600 94 2 (2) (2) 0 0 Total off-balance sheet financial instruments and credit lines 114,337 107,545 6,522 270 (201) (106) (69) (26) Total allowances and provisions (1,091) (260) (267) (564) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL Coverage ratios are carrying amount Loans and Loans to financial advisors . These ratios are influenced by the following key factors: – Lombard loans are generally secured with marketable securities in portfolios that are, as a rule, highly diversified, strict lending policies that are intended to ensure that – mortgage loans low loan-to-value ratios and strong debt service capabilities; – the amount of unsecured retail lending (including credit cards) – lending in Switzerland includes government-backed COVID-19 loans; – contractual Lombard lending between two one and two years with related loan commitments up to – write-offs of or forgiven, reduces the coverage ratios. The total 22 1 point higher than on 10 with 31 December 2022; the stage 3 ratio was 22 %, materially unchanged compared with 31 December 31.12.23 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 174,555 163,656 10,044 856 9 2 88 7 326 Real estate financing 54,351 50,272 4,063 16 9 4 61 8 594 Total real estate lending 228,906 213,928 14,107 872 9 3 81 8 331 Large corporate clients 14,671 12,628 1,363 680 164 27 237 48 2,558 SME clients 12,956 10,696 1,548 712 202 32 155 47 2,861 Total corporate lending 27,627 23,324 2,911 1,392 182 29 193 48 2,714 Lombard 117,946 117,879 0 67 2 0 0 0 2,487 Credit cards 2,083 1,571 449 63 200 40 253 87 3,801 Commodity trade finance 3,008 2,881 12 115 394 25 62 25 9,676 Other loans and advances to customers 26,997 26,083 837 77 18 10 44 11 2,379 Loans to financial advisors 2,665 2,426 80 159 185 17 122 20 2,793 Total other lending 152,699 150,840 1,378 481 18 3 117 4 4,462 Total 1 409,232 388,092 18,396 2,744 24 5 101 9 2,263 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 6,801 6,560 226 15 8 7 29 8 40 Real estate financing 10,662 10,064 599 0 6 5 22 6 0 Total real estate lending 17,463 16,624 824 15 6 6 24 6 40 Large corporate clients 34,829 32,446 2,259 125 27 16 147 25 628 SME clients 7,872 7,337 456 80 47 29 230 41 626 Total corporate lending 42,702 39,782 2,715 205 30 18 161 28 627 Lombard 13,609 13,609 0 1 1 1 0 1 0 Credit cards 10,458 9,932 522 4 10 8 35 10 0 Commodity trade finance 2,354 2,346 8 0 4 4 36 4 0 Financial intermediaries and hedge funds 25,378 25,148 230 0 5 4 157 5 0 Other off-balance sheet commitments 16,869 16,596 264 9 12 5 170 8 0 Total other lending 68,668 67,630 1,024 14 7 4 97 6 5,921 Total 2 128,833 124,037 4,562 234 15 9 122 13 908 Total on- and off-balance sheet 3 538,065 512,129 22,958 2,978 22 6 105 10 2,157 1 Includes Loans repurchase and securities borrowing agreements. 31.12.22 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 157,091 147,678 8,686 727 10 2 123 9 381 Real estate financing 46,511 43,129 3,372 9 9 4 70 9 232 Total real estate lending 203,602 190,807 12,059 736 10 2 108 9 379 Large corporate clients 12,356 10,757 1,204 395 105 22 120 32 2,325 SME clients 14,154 12,237 1,364 553 177 22 161 36 3,664 Total corporate lending 26,510 22,994 2,567 949 144 22 142 34 3,106 Lombard 132,313 132,205 0 108 2 1 0 1 1,580 Credit cards 1,869 1,427 393 50 190 46 256 91 3,779 Commodity trade finance 3,367 3,266 0 101 285 18 0 18 8,901 Other loans and advances to customers 23,149 22,333 748 68 18 6 38 7 3,769 Loans to financial advisors 2,670 2,364 130 176 221 28 124 33 2,870 Total other lending 163,368 161,595 1,270 503 16 3 114 3 4,016 Total 1 393,480 375,396 15,896 2,188 21 4 114 8 2,398 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 6,535 6,296 236 3 5 4 18 4 1,183 Real estate financing 10,054 9,779 275 0 6 7 0 6 0 Total real estate lending 16,589 16,075 511 3 6 6 2 6 1,288 Large corporate clients 32,126 28,950 3,013 163 38 18 165 32 1,263 SME clients 7,122 6,525 499 98 47 30 214 43 304 Total corporate lending 39,247 35,475 3,513 260 40 20 172 34 903 Lombard 12,919 12,918 0 1 2 1 0 1 0 Credit cards 9,390 8,900 487 3 7 5 36 7 0 Commodity trade finance 2,459 2,459 0 0 3 3 0 3 0 Financial intermediaries and hedge funds 18,128 16,464 1,664 0 7 6 25 7 0 Other off-balance sheet commitments 11,803 11,454 346 3 11 8 68 9 0 Total other lending 54,700 52,195 2,498 7 6 5 33 6 0 Total 2 110,537 103,745 6,522 270 18 10 106 16 980 Total on- and off-balance sheet 3 504,016 479,140 22,418 2,458 21 5 112 10 2,242 1 Includes Loans repurchase and securities borrowing agreements. |
Derivative instruments
Derivative instruments | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Derivative Financial Instruments [Line Items] | |
Disclosure Of Derivative Financial Instruments Explanatory | Note 10 Overview Over-the-counter (OTC) derivative Association (ISDA) and settlement through clearing houses, adopted, under derivatives. Regulators variation margins on certain OTC derivative contracts, which may Exchange-traded derivatives (ETD) are standardized in terms of their amounts and sold changes in value and, consequently, reduced credit risk. Most of UBS AG’s and marketing of derivative products risks. Market-making aims to offer prices to other market participants with the aim of generating revenues based on spread and volume. UBS AG also uses various derivative instruments for hedging purposes. › Refer to Notes 15 and 20 for more information about › Refer to Note 25 for more information about derivatives Risks of derivative instruments The derivative financial assets shown on the however, UBS AG’s credit exposure in its derivatives business with that counterparty. This is hand, replacement values can increase over time (potential future exposure), while, on the other hand, exposure may be mitigated by entering into master netting agreements and bilateral collateral arrangements. Both the exposure measures used internally factors. › Refer to Note 21 for more information about derivative permitted under enforceable netting arrangements › Refer to the “Risk management and control” section of this instruments Derivative instruments 31.12.23 31.12.22 USD bn Derivative financial assets Derivative financial liabilities Notional amounts related to derivative financial assets and liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Derivative financial liabilities Notional amounts related to derivative financial assets and liabilities 2,3 Other notional amounts 2,4 Interest rate 35.3 32.8 2,471.7 13,749.0 39.8 37.5 2,080.3 11,255.4 of which: forwards (OTC) 1 0.1 0.0 114.0 1,061.4 0.2 0.0 72.3 792.7 of which: swaps (OTC) 23.0 18.2 788.0 11,884.1 25.2 19.8 607.1 9,728.6 of which: options (OTC) 12.1 14.4 1,569.4 14.2 17.5 1,392.5 of which: futures (ETD) 707.4 606.3 of which: options (ETD) 0.0 0.0 0.2 96.1 0.0 0.0 8.3 127.7 Credit derivatives 1.8 1.6 93.1 1.0 1.2 73.9 of which: credit default swaps (OTC) 1.6 1.5 91.4 0.9 1.0 71.0 of which: total return swaps (OTC) 0.0 0.1 0.7 0.1 0.2 1.2 Foreign exchange 65.4 71.7 6,367.1 179.6 85.5 88.5 6,080.1 40.1 of which: forwards (OTC) 15.6 18.9 1,881.7 26.5 28.6 1,763.8 of which: swaps (OTC) 43.5 46.7 3,587.2 178.7 49.6 50.4 3,233.0 38.4 of which: options (OTC) 6.2 6.1 892.6 9.3 9.2 1,073.2 Equity / index 27.3 32.9 1,191.1 84.3 22.2 26.1 885.8 63.4 of which: swaps (OTC) 6.0 8.9 263.4 5.3 6.6 217.4 of which: options (OTC) 2.8 5.9 193.4 2.8 4.4 140.6 of which: futures (ETD) 77.3 52.2 of which: options (ETD) 10.3 10.0 732.7 6.9 9.0 8.1 526.7 11.2 of which: client-cleared transactions (ETD) 8.1 8 5.1 7.0 Commodities 1.6 1.3 128.6 15.5 1.4 1.4 132.3 17.6 of which: swaps (OTC) 0.7 0.5 44.8 0.5 0.7 38.5 of which: options (OTC) 0.6 0.3 38.4 0.4 0.3 29.1 of which: futures (ETD) 13.0 16.4 of which: forwards (ETD) 0.0 0.0 31.5 0.0 0.0 47.7 of which: client-cleared transactions (ETD) 0.2 0.3 0.2 0.3 Other 5 0.3 0.4 86.0 0.2 0.1 49.7 Total derivative instruments, based on IFRS netting 6 131.7 140.7 10,337.6 14,028.4 150.1 154.9 9,302.1 11,376.5 1 Includes certain where derivative financial instruments are presented on a net basis on the balance sheet, the amounts of client-cleared ETD and OTC transactions through central clearing counterparties are not disclosed, as they have a significantly different risk profile. cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented instruments and Cash collateral payables on purchases and sales of non-derivative financial instruments assets and liabilities are presented net on the balance sheet if UBS AG default, bankruptcy or insolvency of the entity and all of on netting arrangements. On 51 % (31 December 2022: 46 %) mature 30 % (31 December 2022: 32 %) within one to 19 % (31 December 2022: 22 %) after five years. Notional amounts of interest rate contracts cleared through either a central counterparty settled or economically Other notional amounts are categorized into maturity Other notional 2.5 trn compared mainly reflecting inflation. |
Property, equipment and softwar
Property, equipment and software | 12 Months Ended |
Dec. 31, 2023 | |
Property Equipment And Software [Line Items] | |
Disclosure of property, equipment and software [text block] | Note 11 At historical cost less accumulated depreciation USD m Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2023 3 2022 3 Historical cost Balance at the beginning of the year 10,352 4,275 9,220 1,046 24,893 24,542 Additions 106 96 81 1,110 1,393 1,859 Disposals / write-offs 4 (299) (63) (1,087) 0 (1,449) (414) Reclassifications 550 0 1,390 (1,561) 378 (894) Foreign currency translation 653 71 185 45 954 (200) Balance at the end of the year 11,362 4,379 9,789 640 26,169 24,893 Accumulated depreciation Balance at the beginning of the year 6,697 1,638 5,242 0 13,577 12,830 Depreciation 457 446 1,070 0 1,974 1,819 Impairment 5 15 0 223 0 238 2 Disposals / write-offs 4 (296) (62) (1,087) 0 (1,445) (410) Reclassifications 207 0 (2) 0 206 (566) Foreign currency translation 439 36 101 0 576 (99) Balance at the end of the year 7,520 2,058 5,548 0 15,126 13,577 Net book value Net book value at the beginning of the year 3,655 2,637 3,978 1,046 11,316 11,712 Net book value at the end of the year 3,842 2,321 4,241 640 6 11,044 11,316 1 Includes leasehold improvements and IT hardware. in relation to real 594 m (2022: USD 589 m). Interest expense on Interest expense from financial were no material gains or losses arising from sale-and-leaseback and other non-current assets held amount based on a value-in-use approach was determined to be zero. 415 m related to software and USD 224 m related to Owned properties and equipment. |
Goodwill and intangible assets
Goodwill and intangible assets | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Goodwill And Intangible Assets [Line Items] | |
Disclosure Of Intangible Assets And Goodwill Explanatory | Note 12 Introduction UBS AG performs an impairment test on its goodwill assets UBS AG considers Asset Management, level at which the that a Inc. in 2000, which mainly affected the Americas portion the Management International (consisting of EMEA, Asia Pacific and Global). The impairment with the based on their value in use. An impairment As 6.0 bn, 3.7 bn carried by 1.2 bn was Switzerland and International CGU, and USD 1.1 bn was carried by Asset Management. Based on the impairment testing methodology described below, UBS AG CGUs were not impaired. For each 31 December performed as of 31 December 2023. Methodology for goodwill impairment testing The recoverable that consider features of sum of adjusted for the effect of the capital period. The the third-year For period was extended from three to five years (with a planning product capabilities and offerings years did not trigger, The framework, denominator (both their framework management assumptions. Attributed equity considered a reasonable applied in the respective CGU. Assumptions Valuation applicable. The available to shareholders in years one to three, to changes in the discount rates and to changes in the long-term growth rate. The applied Earnings available approved by the Board of Directors. The quantitative and qualitative inputs from both internal and external analysts and the view of management. They also take into account term growth rates are determined at the regional level based Key reasonably possible change to 20 %, the discount rates 1.5 0.75 points. Under all scenarios, or International, and Asset Management. If the estimated earnings attributable to Asset Management may become impaired in the impairment of and, expected on UBS AG’s capital ratios. Discount and growth rates Discount rates Growth rates In % 31.12.23 31.12.22 31.12.23 31.12.22 Global Wealth Management Americas 9.5 10.5 3.8 3.8 Global Wealth Management Switzerland and International 9.5 9.4 3.4 3.6 Asset Management 9.0 9.5 3.3 3.4 USD m Goodwill Intangible assets 1 2023 2022 Historical cost Balance at the beginning of the year 6,043 1,598 7,641 7,739 Additions 0 6 6 0 Disposals 2 (10) (30) (40) (22) Foreign currency translation 10 28 38 (76) Balance at the end of the year 6,043 1,602 7,645 7,641 Accumulated amortization and impairment Balance at the beginning of the year 0 1,374 1,374 1,360 Amortization 26 26 26 Impairment / (reversal of impairment) 0 0 0 (1) Disposals 2 0 (30) (30) 0 Foreign currency translation 0 9 9 (11) Balance at the end of the year 0 1,379 1,379 1,374 Net book value at the end of the year 6,043 223 6,265 6,267 of which: Global Wealth Management Americas 3,712 36 3,748 3,740 of which: Global Wealth Management Switzerland and International 1,182 52 1,233 1,225 of which: Asset Management 1,149 0 1,149 1,167 of which: Investment Bank 0 135 135 135 1 Intangible assets mainly include customer relationships, contractual rights and the fully amortized branch network intangible asset recognized in connection with the acquisition of PaineWebber Group, Inc. in 2000. 2 Reflects the derecognition of goodwill allocated to business and intangible assets held by entities that have been disposed of. The table below presents estimated aggregated USD m Intangible assets Estimated aggregated amortization expenses for: 2024 27 2025 26 2026 26 2027 25 2028 19 Thereafter 98 Not amortized due to indefinite useful life 2 Total 223 |
Other financial and non-financi
Other financial and non-financial assets | 12 Months Ended |
Dec. 31, 2023 | |
Other Financial And Non Financial Assets [Line Items] | |
Other Financial And Non Financial Assets Explanatory [textblock] | Note 13 a) Other financial assets measured at amortized cost USD m 31.12.23 31.12.22 Debt securities 43,245 44,594 Loans to financial advisors 2,615 2,611 Fee- and commission-related receivables 1,883 1,803 Finance lease receivables 1,427 1,314 Settlement and clearing accounts 311 1,174 Accrued interest income 2,004 1,276 Other 2,849 1 618 Total other financial assets measured at amortized cost 54,334 53,389 1 Predominantly includes cash collateral provided to exchanges and clearing houses to secure securities trading activity through Effective from 1 April through other comprehensive income with a fair value of USD 6.9 bn (the Portfolio) to Other financial assets measured at amortized cost. The Portfolio’s cumulative fair value losses of USD 449 m pre-tax and USD 333 m post-tax, previously recognized in Other comprehensive , reclassification date, so that a value 7.4 bn as Portfolio mortgage-backed securities, held as a direct result impacted UBS Bank the business, years preceding the reclassification date, UBS Bank USA’s deposit base cash balances, with a number of new products being launched, additional lending and a broader range of customer and the announcement the contractual assets mature, requiring a reclassification of the Portfolio b) Other non-financial assets USD m 31.12.23 31.12.22 Precious metals and other physical commodities 4,426 4,471 Deposits and collateral provided in connection with litigation, 1 1,379 2,205 Prepaid expenses 1,062 709 VAT, 746 1,405 Properties and other non-current assets held for sale 105 279 Other 660 583 Total other non-financial assets 8,377 9,652 1 Refer to Note 17 for more information. |
Customer deposits
Customer deposits | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Due To Banks And Customers [Line Items] | |
Disclosure of due to banks and customers [text block] | Note 14 a) Customer deposits USD m 31.12.23 31.12.22 Demand deposits 146,163 182,307 Retail savings / deposits 152,683 149,310 Sweep deposits 41,045 69,223 Time deposits 1 215,782 126,331 Total customer deposits 555,673 527,171 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf of its clients. Customer deposits increased mainly due to net inflows into time deposit products, partly continued to shift funds from Demand and Sweep b) Funding from UBS Group AG measured at amortized USD m 31.12.23 31.12.22 Debt contributing to total loss-absorbing capacity (TLAC) 51,102 42,073 Debt eligible as high-trigger loss-absorbing additional tier 11,286 10,654 Debt eligible as low-trigger loss-absorbing additional 1,212 1,187 Other 1 3,682 2,232 Total funding from UBS Group AG measured at amortized cost 2,3 67,282 56,147 1 Includes debt not eligible as TLAC having of redemption. debt obligations that are since 1.1.2020. UBS AG uses interest rate and foreign exchange derivatives to at amortized cost. In 1a and Note 25. Funding from UBS Group AG measured at amortized cost 3.2 bn as of 31 December 2023 and a decrease of USD 5.1 bn as of 31 December 2022, reflecting changes Of the Total funding from UBS 65.6 bn pays a fixed interest rate and USD 1.7 bn pays a floating rate of interest. › Refer to Note 23 for maturity information |
Debt issued designated at fair
Debt issued designated at fair value | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Financial Liabilities [Line Items] | |
Disclosure Of Financial Instruments Designated At Fair Value Through Profit Or Loss Explanatory | Note 15 USD m 31.12.23 31.12.22 Issued debt instruments Equity-linked 1 46,269 41,901 Rates-linked 16,880 16,276 Credit-linked 4,506 2,170 Fixed-rate 14,295 6,538 Commodity-linked 3,704 4,294 Other 687 663 Total debt issued designated at fair value 86,341 71,842 of which: issued by UBS AG with original maturity greater than one 2 73,544 57,750 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2022: 100 %). |
Debt issued held at amortized c
Debt issued held at amortized cost | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Financial Liabilities [Line Items] | |
Disclosure Of Debt Securities Explanatory | Note 16 USD m 31.12.23 31.12.22 Short-term debt 1 37,285 29,676 Senior unsecured debt 18,450 17,892 of which: issued by UBS AG with original maturity greater than one 18,446 17,892 Covered bonds 1,006 0 Subordinated debt 3,008 2,968 of which: eligible as low-trigger loss-absorbing tier 2 capital 0 2,422 of which: eligible as non-Basel III-compliant tier 2 capital 538 536 Debt issued through the Swiss central mortgage institutions 10,035 8,962 Long-term debt 2 32,499 29,823 Total debt issued measured at amortized cost 3,4 69,784 59,499 1 Debt with an original contractual maturity classification of debt presented. 100 % of the balance was unsecured as of 31 December 2023. UBS AG uses interest rate and foreign exchange derivatives to at amortized cost. In 1a and Note Debt issued measured at amortized cost 0.4 bn as of 31 December 2023 and a decrease of USD 1.0 bn as of 31 December 2022, reflecting changes Subordinated debt consists other instruments outstanding as of 31 December 2023 pay a › Refer to Note 23 for maturity information |
Provisions
Provisions | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Other Provisions [Line Items] | |
Disclosure Of Provisions Explanatory | Note 17 a) Provisions The table below presents an overview of total provisions. USD m 31.12.23 31.12.22 Provisions other than provisions for expected credit losses 2,336 2,982 Provisions for expected credit losses 1 188 201 Total provisions 2,524 3,183 1 Refer to Note 9 for more information about ECL provisions recognized for off-balance sheet financial instruments and credit lines. The following table presents additional information for USD m Litigation, regulatory and similar matters 1 Restructuring 2 Real estate 3 Other 4 Total 2023 Balance at the beginning of the year 2,586 98 122 175 2,982 Increase in provisions recognized in the income statement 866 234 8 41 1,148 Release of provisions recognized in the income statement (47) (13) 0 (17) (77) Provisions used in conformity with designated purpose (1,642) (114) (12) (27) (1,795) Foreign currency translation and other movements 48 4 18 10 79 Balance at the end of the year 1,810 209 135 181 2,336 1 Consists of provisions for losses resulting from legal, liability and compliance risks. 146 m of provisions for onerous contracts related to real estate as of 31 December 2023 (31 December 2022: USD 28 m) and USD 64 m of personnel-related restructuring provisions as of 31 December 70 m). 4 Mainly includes provisions related to employee benefits and operational risks. Restructuring provisions relate to onerous contracts and personnel-related provisions. Onerous contracts for property are recognized maintenance, provisions are natural estimated costs. Information about provisions is included in Note 17b. There are no material contingent |
Litigation, regulatory and simi
Litigation, regulatory and similar matters | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | |
Disclosure Of Contingent Liabilities Explanatory | b) Litigation, regulatory and similar matters UBS operates in disputes and litigation, arbitration, and regulatory to UBS AG and / or one or more of its subsidiaries, as applicable. Such predict, agreement. continuing to contest inherent in which provisions have against it when, legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required, and the amount claims that have not yet been asserted similar asserted claims. If any of those conditions is not met, such matters result in contingent liabilities. If the amount of an probable. Accordingly, no provision is established even if the potential outflow of resources could be issuance of financial example, the developments provide evidence of conditions that existed at the end of the reporting period), are adjusting events period. Specific considers to reputational and other where available and appropriate in order to assist users in considering In the case of certain matters below, we no such statement. seriously our position with other parties in the matter because it would reveal reliably estimable that preclude provision, either: (a) we have that fact believes an outflow of resources to be probable and reliably estimable. With respect to certain litigation, regulatory and similar matters for which we have established provisions, we are able to estimate the expected for which over the relevant time periods. The aggregate amount provisioned for litigation, regulatory and similar matters table in Note 17a similar matters as a class of contingent liabilities. Doing so would require UBS to provide speculative legal assessments as to claims are at early stages of adjudication, or as to which alleged damages have not been quantified by the claimants. Although UBS therefore similar remote substantially exceeds the level of current provisions. Litigation, regulatory and or conviction UBS to obtain waivers of regulatory disqualifications to maintain certain operations, limit, suspend or terminate UBS’s participation in termination of licenses, authorizations or participations, could The risk of loss associated with of determining capital requirements. Information concerning our capital requirements and the calculation of operational risk for this purpose is included in the “Capital, liquidity Provisions for litigation, regulatory and similar matters 1 USD m Global Wealth Manage- ment Personal & Corporate Banking Asset Manage- ment Investment Bank Non-core and Legacy 2 Group 2 Total 2023 Balance at the beginning of the year 1,182 159 8 308 771 158 2,586 Increase in provisions recognized in the income statement 113 0 5 81 665 2 866 Release of provisions recognized in the income statement (7) (9) 0 (2) 0 (29) (47) Provisions used in conformity with designated purpose (98) 0 (1) (106) (1,435) (1) (1,642) Foreign currency translation and other movements 31 6 0 5 4 1 48 Balance at the end of the year 1,220 156 12 286 4 132 1,810 1 Provisions, if any, Global Wealth Management and Personal & Corporate Banking. Provisions, of 2023, Non-core and Legacy represents a separate reportable segment and Group Functions has been renamed Group Items. 1. Inquiries regarding cross-border wealth management businesses Tax and regulatory authorities in a number of employees located in their UBS and other financial institutions. Since 2013, UBS (France) S.A., UBS AG and certain former employees have been under investigation in to UBS’s cross-border business with French clients. In connection with this investigation, the UBS AG to provide bail (“ caution ”) of EUR 1.1 bn. In 2019, the court territory unlawful solicitation 3.7 bn on UBS AG and UBS (France) S.A. and 800 m of civil damages to the Appeal took place in March 2021. In December and aggravated 3.75 m, the EUR 1 bn, and awarded civil 800 m. UBS appealed the Court. regarding unlawful solicitation and aggravated of EUR 1 bn, the 3.75 m and the 800 m of civil been remanded to the EUR 800 m of civil damages to UBS AG. Our balance sheet the applicable accounting standard. As in the case of other matters for which we have established provisions, outflow information and accordingly may ultimately have recognized. 2. Madoff In relation to the Bernard L. Madoff Investment Securities LLC (BMIS) investment (now UBS Europe SE, Luxembourg branch) and certain other UBS of regulators, Surveillance du substantially all assets of which direct or documentation manager, In 2009 and 2010, certain individuals, 2.1 bn, which includes amounts that the funds may be held liable A large number of alleged beneficiaries have filed claims against UBS entities (and non-UBS entities) for purported losses relating to the Madoff fraud. The majority of these in Supreme Court has dismissed a further appeal in one of In the US, the BMIS Trustee one of the offshore funds. The total amount 2 bn. In 2014, except 125 m preference payments. In 2016, the of Appeals reversed a petition further proceedings. 3. Foreign exchange, LIBOR and benchmark rates, and other Foreign concerning investigations, Commission. jurisdictions in businesses. Foreign exchange-related civil litigation: jurisdictions transactions with any of transactions with on such 141 m and cooperation to the filed individual competition laws and unjust enrichment. UBS and the other In 2015, a and businesses their own end use. defendants’ summary judgment motion, dismissing the case. LIBOR regarding potential improper attempts by UBS, times. investigating jurisdictions, including the with settlement with WEKO, as the Secretariat of WEKO has asserted LIBOR and other the federal interest rate benchmark-based derivatives. asserting losses related adjustable investments certain benchmark interest rates, including USD LIBOR, Euroyen TIBOR, Yen LIBOR, EURIBOR, CHF LIBOR, GBP LIBOR and seek unspecified compensatory and other damages under USD LIBOR class and individual In 2013 and 2015, in whole or in part, certain state common Circuit affirmed proceedings. The defendants. Separately, in individual plaintiffs’ claims and motions for class to appeal that was conspired monopolized defendants’ motion to complaint. complaint. appealed the 2024. Other benchmark class actions in the US: Yen – standing grounds. amended complaint focused the against the remaining defendant in the district court. CHF LIBOR filed an amended the Second Circuit granted the parties’ joint motion Plaintiffs filed a third amended in January 2023. EURIBOR for lack of personal jurisdiction. Plaintiffs have appealed. GBP LIBOR Government bonds: on behalf filed in 2017 in the US District Court for the Southern District of New York alleging that to, and under the granted in 2021. the court granted defendants’ district government bonds. In 2021, antitrust rules in 2007–2011 relating 172 m. UBS is appealing the amount of the fine. With respect to our balance the applicable accounting standard. As in the case of other matters outflow information and accordingly may ultimately have recognized. 4. Swiss retrocessions The Federal Supreme Court of Switzerland for distributing third-party and intra-group investment funds and structured products must be disclosed and surrendered to clients who have entered a supervisory note to and has notified all potentially affected clients. The Supreme Court decision has resulted, and continues to result, in a number of client requests for potentially account when assessing these cases include, among other things, the existence of a discretionary or not the client documentation contained a valid waiver Our amount that UBS on client requests and matters for which determined substantially greater (or may be less) than the provision that |
Other financial and non-finan_2
Other financial and non-financial liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Other Financial And Non Financial Liabilities [Line Items] | |
Other Financial And Non Financial Liabilities Explanatory | Note 18 a) Other financial liabilities measured at amortized USD m 31.12.23 31.12.22 Other accrued expenses 1,613 1,564 Accrued interest expenses 4,186 2,008 Settlement and clearing accounts 1,314 1,060 Lease liabilities 2,904 3,211 Other 2,695 2,549 Total other financial liabilities measured at amortized cost 12,713 10,391 b) Other financial liabilities designated at fair value USD m 31.12.23 31.12.22 Financial liabilities related to unit-linked investment contracts 15,922 13,221 Securities financing transactions 6,927 15,333 Over-the-counter debt instruments and other 1,566 1,684 Funding from UBS Group AG 1 2,950 1,796 Total other financial liabilities designated at fair value 27,366 32,033 1 The Funding from UBS Group AG consists in right of payment to all other present and future non-subordinated obligations of the respective issuing entity. c) Other non-financial liabilities USD m 31.12.23 31.12.22 Compensation-related liabilities 4,526 4,424 of which: financial advisor compensation plans 1,472 1,463 of which: other compensation plans 1,955 2,023 of which: net defined benefit liability 487 449 of which: other compensation-related liabilities 1 611 490 Current tax liabilities 932 1,044 Deferred tax liabilities 162 233 VAT, 712 472 Deferred income 276 233 Other 74 84 Total other non-financial liabilities 6,682 6,489 1 Includes liabilities for payroll taxes and untaken vacation. |
Expected credit loss measuremen
Expected credit loss measurement | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Provision Matrix [Line Items] | |
Disclosure Of Financial Assets Explanatory | Note 19 a) Expected credit losses in the period Total net credit loss expenses were USD 143 m in 2023, reflecting net credit loss expenses of USD 23 m related to stage 1 and 2 positions and net credit loss expenses of 120 m related to credit-impaired › Refer to Note 19b for more information regarding changes to expected post-model adjustments Stage 3 120 m USD 56 m 37 m 27 m Management. Credit loss expense / (release) Performing positions Credit-impaired positions USD m Stages 1 and 2 Stage 3 Total For the year ended 31.12.23 Global Wealth Management (2) 27 25 Personal & Corporate Banking 13 37 50 Asset Management 0 (1) (1) Investment Bank 11 56 67 Non-core and Legacy 0 1 1 Group Items 1 1 0 1 Total 23 120 143 For the year ended 31.12.22 Global Wealth Management (5) 5 0 Personal & Corporate Banking 27 12 39 Asset Management 0 0 0 Investment Bank 6 (18) (12) Non-core and Legacy 0 2 2 Group Items 1 0 0 0 Total 29 0 29 For the year ended 31.12.21 Global Wealth Management (28) (1) (29) Personal & Corporate Banking (62) (24) (86) Asset Management 0 1 1 Investment Bank (34) 0 (34) Non-core and Legacy 0 0 0 Group Items 1 0 0 0 Total (123) (25) (148) 1 Starting with the third quarter of 2023, Non-core and Legacy became a separate reportable segment and Group Functions has been renamed Group Items. Prior periods have been restated to reflect these changes. b) Changes to Refer to weights and Governance Comprehensive scenario updates and weights, model outputs Model changes During 2023, the model review and enhancement default (LGD) and credit conversion 27 m increase in ECL allowances. This includes an increase 16 m Large corporate , 12 m increase in Personal Large corporate SME clients. Scenario and During 2023, the scenarios and related macroeconomic factors were updated from considering changed the economic outlook during the year: interest rates Baseline : the for Oxford Economics growth slows to high, though falling inflation, 2023 levels. optimistic outlook Mild debt crisis scenario : The first hypothetical downside scenario is the mild debt crisis scenario. At the beginning of the second quarter of 2023 with the mild debt crisis should be rebalanced by reintroducing assumptions solvency and liquidity concerns cause a global economy Stagflationary geopolitical crisis scenario: The second scenario and was updated in 2023 escalation commodity prices and further disruptions are forced assumptions in the scenario had a substantive impact on model-based ECL allowances Switzerland and the mortgages. Refer Asset price The upside tensions across monetary lead to significantly. The table below details the key assumptions for the four scenarios Scenario weights and post-model adjustments The scenario weights did not change during 2023, but the replace one of in early 2023, 15 %, unchanged for the stagflationary geopolitical crisis, baseline and asset price inflation scenarios, i.e., 25 %, 60 % and 0 %, respectively. However, unquantifiable risks continue to be relevant, as the the world economy from relates supportable their implications for credit risk portfolios, cannot comprehensively reflect such extraordinary events, such as a pandemic or gauging these risks and applying model parameters that management continued to also apply post-model adjustments. Total 580 m adjustments of 133 m (31 December 131 m). Overlays geopolitical situation. Economic scenarios and weights applied Assigned weights in % ECL scenario 31.12.23 31.12.22 Asset price inflation 0.0 0.0 Baseline 60.0 60.0 Mild debt crisis 15.0 0.0 Stagflationary geopolitical crisis 25.0 25.0 Global crisis 0.0 15.0 Scenario assumptions One year Three years cumulative 31.12.23 Asset price inflation Baseline Mild debt crisis Stagflationary geopolitical crisis Asset price inflation Baseline Mild debt crisis Stagflationary geopolitical crisis Real GDP growth (% change) United States 4.0 0.1 (1.6) (4.8) 9.1 4.4 0.6 (4.4) Eurozone 3.0 0.5 (1.7) (5.6) 6.2 2.9 (0.1) (5.7) Switzerland 3.0 1.4 (1.2) (4.8) 6.6 4.4 0.3 (4.9) Consumer price index (% change) United States 2.5 2.3 (0.1) 10.0 8.1 7.1 2.3 15.8 Eurozone 2.3 2.0 (0.2) 9.6 7.4 6.1 1.8 14.8 Switzerland 2.1 1.5 (0.4) 5.8 6.2 4.3 0.8 10.7 Unemployment rate (end-of-period level, %) United States 3.0 4.4 6.3 9.2 3.0 4.4 7.7 11.8 Eurozone 6.0 6.9 8.2 10.6 6.0 6.8 9.0 11.8 Switzerland 1.6 2.3 2.9 4.1 1.5 2.3 3.8 5.0 Fixed income: 10-year government bonds (change in yields, basis points) USD 13 (82) (215) 270 37 (78) (155) 245 EUR 20 (90) (185) 225 58 (78) (140) 195 CHF 25 (41) (73) 195 63 (34) (28) 180 Equity indices (% change) S&P 500 20.0 15.3 (26.6) (51.5) 51.7 28.1 (12.2) (45.6) EuroStoxx 50 20.0 12.0 (26.4) (51.6) 46.6 22.9 (16.6) (47.2) SPI 15.0 4.6 (24.5) (51.6) 39.2 15.9 (11.2) (47.2) Swiss real estate (% change) Single-Family Homes 6.6 (1.5) (4.4) (18.5) 14.0 0.8 (3.0) (28.6) Other real estate (% change) United States (S&P / Case–Shiller) 8.1 0.6 (8.6) (20.0) 19.7 5.8 (5.2) (30.2) Eurozone (House Price Index) 7.0 0.6 (5.9) (8.4) 15.4 6.4 (5.2) (12.9) Scenario assumptions One year Three years cumulative 31.12.22 Asset price inflation Baseline Stagflationary geopolitical crisis Global crisis Asset price inflation Baseline Stagflationary geopolitical crisis Global crisis Real GDP growth (% change) United States 4.0 (0.3) (4.8) (6.4) 9.1 3.2 (4.4) (1.8) Eurozone 3.0 0.6 (5.6) (8.5) 6.2 2.5 (5.7) (8.3) Switzerland 3.0 0.7 (4.8) (6.7) 6.6 3.5 (4.9) (3.7) Consumer price index (% change) United States 2.5 2.6 10.0 (0.5) 8.1 6.5 15.8 1.2 Eurozone 2.3 5.0 9.6 (0.7) 7.4 9.6 14.8 (0.7) Switzerland 2.1 1.6 5.8 (1.8) 6.2 3.9 10.7 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 9.2 10.0 3.0 5.3 11.8 9.4 Eurozone 6.0 7.0 10.9 11.9 6.0 7.1 12.2 13.0 Switzerland 1.7 2.3 4.3 4.4 1.5 2.6 5.1 4.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 25 (6) 235 (326) 70 (13) 205 (291) EUR 20 48 250 (271) 58 45 220 (247) CHF 25 46 220 (210) 63 57 205 (160) Equity indices (% change) S&P 500 20.0 7.4 (51.5) (50.0) 51.7 22.8 (45.6) (27.9) EuroStoxx 50 17.0 17.2 (51.6) (50.0) 42.9 29.2 (47.2) (39.3) SPI 14.0 5.6 (51.6) (46.0) 37.9 19.3 (47.2) (32.9) Swiss real estate (% change) Single-Family Homes 6.6 1.1 (16.7) (19.9) 14.0 2.3 (32.9) (23.9) Other real estate (% change) United States (S&P / Case–Shiller) 7.8 (4.5) (12.8) (19.3) 19.1 (0.6) (35.8) (32.7) Eurozone (House Price Index) 7.0 (2.7) (8.4) (8.9) 15.4 2.0 (14.7) (17.5) c) Development of ECL allowances and provisions The ECL allowances and provisions recognized – the effect of selecting and updating forward-looking scenarios – origination of new instruments during the period; – the effect of for the remaining lifetime decreases (all other factors remaining – derecognition of instruments in the period; – change in individual asset quality of instruments; – movements between stages 1 and 2; – movements from stages 1 and 2 to stage 3 (credit-impaired status) to 100% (or vice versa); – changes in models or updates to model parameters; – write-off; and – foreign exchange translations for assets denominated in The instruments and credit lines factors listed above. Development of ECL allowances and USD m Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2022 (1,091) (260) (267) (564) Net movement from new and derecognized transactions 1 (11) (27) 9 7 of which: Private clients with mortgages (5) (8) 3 0 of which: Real estate financing (2) (4) 3 0 of which: Large corporate clients 2 (8) 3 7 of which: SME clients (3) (3) 0 0 of which: Other (4) (4) 0 0 (1) (1) 0 0 0 0 0 0 Remeasurements with stage transfers 2 (140) 8 (7) (142) of which: Private clients with mortgages 3 1 3 (1) of which: Real estate financing (2) 2 (5) 0 of which: Large corporate clients (76) 3 (3) (76) of which: SME clients (56) 1 (1) (55) of which: Other (10) 1 0 (11) 0 0 1 0 1 0 0 0 Remeasurements without stage transfers 3 35 7 14 14 of which: Private clients with mortgages 5 (5) 14 (3) of which: Real estate financing 5 2 3 (1) of which: Large corporate clients 15 13 10 (8) of which: SME clients 44 (1) 1 44 of which: Other (34) (2) (14) (18) (15) 0 (15) (7) 1 0 (8) Model changes 4 (27) (18) (9) 0 Movements with profit or loss impact 5 (143) (30) 7 (120) Movements without profit or loss impact (write-off, FX and other) 6 (10) (18) (13) 21 Balance as of 31 December 2023 (1,244) (308) (272) (664) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. and methodology changes. uncollectible or forgiven and movements in foreign exchange rates. Movements with 23 m: – Net movement 27 m stage 9 m stage releases: Stage 1 expenses are primarily effect is spread across other lending segments. Stage 2 in Personal & Corporate Banking and Global Wealth Management. – Remeasurements with stage transfers 8 m releases in 7 m expenses in includes the transfer of a few large corporate and real estate stage 1 and related but generally higher expenses in stage – Remeasurements without stage transfers 7 m and stage 2 releases of USD 14 m. These releases of USD 21 m relate to large corporate lending 23 m) and real estate lending (USD 14 m), substantially due to scenario effects, partly offset by expenses to a single 15 m). – Model changes : refer to Note 19b for more information. Movements without : Stages 31 m, almost FX. Stage 21 m, driven 48 m, partly write-offs / recoveries of USD 69 m. Development of ECL allowances and USD m Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2021 (1,165) (282) (220) (662) Net movement from new and derecognized transactions 1 (7) (21) 16 (2) of which: Private clients with mortgages (6) (6) 0 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients 8 (1) 11 (2) of which: SME clients (1) (1) 0 0 of which: Other (6) (8) 3 0 0 (2) 2 0 0 0 0 0 Remeasurements with stage transfers 2 (65) 20 (39) (46) of which: Private clients with mortgages (10) 3 (12) 0 of which: Real estate financing 7 (1) 8 0 of which: Large corporate clients (33) 16 (28) (21) of which: SME clients (23) 2 (2) (22) of which: Other (6) 1 (4) (3) 0 0 0 0 1 2 (1) 0 Remeasurements without stage transfers 3 13 (8) (27) 48 of which: Private clients with mortgages (12) 5 (18) 1 of which: Real estate financing 13 3 10 0 of which: Large corporate clients 32 (11) 2 41 of which: SME clients (6) (10) (9) 14 of which: Other (15) 5 (12) (8) (8) 0 (8) (3) 3 (1) (6) Model changes 4 30 29 1 0 Movements with profit or loss impact 5 (29) 20 (49) 0 Movements without profit or loss impact (write-off, FX and other) 6 104 3 1 99 Balance as of 31 December 2022 (1,091) (260) (267) (564) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. and methodology changes. uncollectible or forgiven and movements in foreign exchange rates. As explained in Note 1a, the assessment of a significant increase in credit risk (an and quantitative primary assessment considers changes in PD based on rating analyses and economic into consideration days past due. ECL stage 2 (“significant deterioration USD m Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On- and off-balance sheet (272) (197) (23) (53) of which: Private clients with mortgages (89) (69) 0 (21) of which: Real estate financing (26) (21) 0 (5) of which: Large corporate clients (66) (48) (15) (2) of which: SME clients (38) (23) (5) (9) of which: Financial intermediaries and hedge funds (4) (4) 0 0 of which: Loans to financial advisors (1) 0 0 (1) of which: Credit cards (13) (13) of which: Other (33) (31) (2) (1) d) Maximum exposure to credit risk The tables and instruments. The maximum exposure sheet subject to credit risk collateral is presented at fair enhancements, capped at section of this respects from the requirements of IFRS Accounting Standards. Maximum exposure to credit risk 31.12.23 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD bn Maximum exposure to credit risk Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 171.8 171.8 Amounts due from banks 4 28.2 0.2 4.8 0.1 23.1 Receivables from securities financing transactions measured at amortized cost 74.1 0.0 70.7 2.8 0.7 Cash collateral receivables on derivative instruments 5,6 32.3 22.8 9.5 Loans and advances to customers 405.6 31.4 105.2 222.7 24.9 2.8 18.7 Other financial assets measured at amortized cost 54.3 0.1 0.8 0.0 1.5 51.9 Total financial assets measured at amortized cost 766.4 31.5 176.8 222.7 33.9 22.8 0.0 2.9 275.7 Financial assets measured at fair value through other comprehensive income – debt 2.2 2.2 Total maximum exposure to credit risk reflected on the balance sheet within the scope of ECL 768.6 31.5 176.8 222.7 33.9 22.8 0.0 2.9 277.9 Guarantees 7 33.2 1.6 19.8 0.2 1.8 2.0 7.8 Irrevocable loan commitments 43.9 0.2 2.0 1.8 8.9 0.0 1.0 30.0 Forward starting reverse repurchase and securities borrowing agreements 10.4 10.4 0.0 Committed unconditionally revocable credit lines 47.4 0.5 9.1 7.1 5.1 0.6 25.1 Total maximum exposure to credit risk not reflected on the balance sheet within the scope of ECL 134.8 2.3 41.3 9.0 15.7 0.0 0.0 3.5 62.9 31.12.22 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD bn Maximum exposure to credit risk Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 169.4 169.4 Amounts due from banks 4 14.7 0.0 0.1 14.6 Receivables from securities financing transactions measured at amortized cost 67.8 0.0 64.5 2.4 0.9 Cash collateral receivables on derivative instruments 5,6 35.0 22.9 12.1 Loans and advances to customers 390.0 36.1 115.9 197.8 19.6 3.0 17.6 Other financial assets measured at amortized cost 53.4 0.1 0.5 0.0 1.3 51.4 Total financial assets measured at amortized cost 730.4 36.2 181.0 197.9 23.4 22.9 0.0 3.0 266.1 Financial assets measured at fair value through other comprehensive income – debt 2.2 2.2 Total maximum exposure to credit risk reflected on the balance sheet within the scope of ECL 732.6 36.2 181.0 197.9 23.4 22.9 0.0 3.0 268.3 Guarantees 7 22.1 1.2 9.3 0.1 2.0 1.8 7.7 Irrevocable loan commitments 39.9 0.2 3.1 1.3 6.5 0.1 1.0 27.8 Forward starting reverse repurchase and securities borrowing agreements 3.8 3.8 0.0 Committed unconditionally revocable credit lines 43.6 0.2 8.2 6.0 6.2 0.5 22.5 Total maximum exposure to credit risk not reflected on the balance sheet within the scope of ECL 109.4 1.6 24.4 7.5 14.7 0.0 0.1 3.3 58.0 1 Of which: USD 1,637 m for 31 December 2023 1,372 m) relates to total credit-impaired 105 m for 31 December 2023 2022: USD 113 m) to total off-balance sheet financial instruments and instruments, real estate and with funded and unfunded elements, the partners, inventory, mortgage loans, gold borne by those clients. on behalf of clients who retain the associated credit risk. 7 Guarantees collateralized by equity and debt instruments include certain overnight repurchase and the Fixed Income Clearing Corporation minimizes its liability under remote. e) Financial assets subject to credit risk by rating category The table rating system and probability of default of individual counterparties, allowances. › Refer to the “Risk management and control” section of this Financial assets subject to credit risk by rating USD m 31.12.23 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 171,573 215 0 0 43 0 171,832 (26) 171,806 of which: stage 1 171,573 215 0 0 0 0 171,788 0 171,788 of which: stage 2 0 0 0 0 43 0 43 (26) 18 Amounts due from banks 811 25,095 1,359 463 485 0 28,213 (7) 28,206 of which: stage 1 811 25,095 1,354 462 476 0 28,198 (6) 28,191 of which: stage 2 0 0 5 1 9 0 15 (1) 14 of which: stage 3 0 0 0 0 0 0 0 0 0 Receivables from securities financing transactions 36,689 15,958 6,073 14,319 1,091 0 74,130 (2) 74,128 of which: stage 1 36,689 15,958 6,073 14,319 1,091 0 74,130 (2) 74,128 Cash collateral receivables on derivative instruments 8,009 13,575 6,423 4,095 198 0 32,300 0 32,300 of which: stage 1 8,009 13,575 6,423 4,095 198 0 32,300 0 32,300 Loans and advances to customers 5,993 196,897 82,867 89,738 28,486 2,586 406,568 (935) 405,633 of which: stage 1 5,993 195,590 80,534 82,633 20,916 0 385,666 (173) 385,493 of which: stage 2 0 1,307 2,333 7,106 7,570 0 18,316 (185) 18,131 of which: stage 3 0 0 0 0 0 2,586 2,586 (577) 2,009 Other financial assets measured at amortized cost 25,727 20,541 678 6,770 499 206 54,421 (87) 54,334 of which: stage 1 25,727 20,539 659 6,619 353 0 53,897 (16) 53,882 of which: stage 2 0 2 19 151 146 0 317 (5) 312 of which: stage 3 0 0 0 0 0 206 206 (66) 141 Total financial assets measured at amortized cost 248,802 272,281 97,400 115,386 30,802 2,792 767,462 (1,057) 766,407 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 1,222 850 0 161 0 0 2,233 0 2,233 Total on-balance sheet financial instruments 250,024 273,131 97,400 115,547 30,802 2,792 769,696 (1,057) 768,640 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and Off-balance sheet positions subject to expected USD m 31.12.23 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off- balance sheet exposure (maximum exposure to credit risk) ECL provision Off-balance sheet financial instruments Guarantees 17,771 7,306 4,268 2,800 948 118 33,211 (40) of which: stage 1 17,771 7,267 4,219 2,301 774 0 32,332 (14) of which: stage 2 0 39 49 499 174 0 761 (7) of which: stage 3 0 0 0 0 0 118 118 (19) Irrevocable loan commitments 1,720 13,920 9,834 11,142 7,345 56 44,018 (95) of which: stage 1 1,720 13,920 9,781 10,845 5,818 0 42,085 (55) of which: stage 2 0 0 53 298 1,527 0 1,878 (38) of which: stage 3 0 0 0 0 0 56 56 (2) Forward starting reverse repurchase and securities borrowing agreements 10,152 2 84 135 0 0 10,373 0 Total off-balance sheet financial instruments 29,643 21,228 14,186 14,077 8,293 174 87,601 (134) Credit lines Committed unconditionally revocable credit lines 2,604 17,303 10,893 11,950 4,616 56 47,421 (49) of which: stage 1 2,604 16,903 10,553 11,452 3,941 0 45,452 (39) of which: stage 2 0 400 341 497 675 0 1,913 (10) of which: stage 3 0 0 0 0 0 56 56 0 Irrevocable committed prolongation of existing loans 4 1,803 1,045 826 501 4 4,183 (4) of which: stage 1 4 1,803 1,045 824 493 0 4,169 (3) of which: stage 2 0 0 0 2 9 0 11 0 of which: stage 3 0 0 0 0 0 4 4 0 Total credit lines 2,609 19,105 11,939 12,776 5,117 59 51,604 (53) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management Financial assets subject to credit risk by rating USD m 31.12.22 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 168,525 877 0 0 56 0 169,457 (12) 169,445 of which: stage 1 168,525 877 0 0 0 0 169,402 0 169,402 of which: stage 2 0 0 0 0 56 0 56 (12) 44 Amounts due from banks 862 11,150 832 996 837 0 14,676 (6) 14,671 of which: stage 1 862 11,150 832 996 836 0 14,675 (5) 14,670 of which: stage 2 0 0 0 0 1 0 1 (1) 1 of which: stage 3 0 0 0 0 0 0 0 0 0 Receivables from securities financing transactions measured at amortized cost 27,158 15,860 8,870 15,207 721 0 67,816 (2) 67,814 of which: stage 1 27,158 15,860 8,870 15,207 721 0 67,816 (2) 67,814 Cash collateral receivables on derivative instruments 10,613 12,978 7,138 4,157 147 0 35,034 0 35,033 of which: stage 1 10,613 12,978 7,138 4,157 147 0 35,034 0 35,033 Loans and advances to customers 6,491 216,824 68,444 76,147 20,891 2,012 390,810 (783) 390,027 of which: stage 1 6,491 215,332 66,202 69,450 15,557 0 373,032 (129) 372,903 of which: stage 2 0 1,493 2,242 6,698 5,334 0 15,767 (180) 15,587 of which: stage 3 0 0 0 0 0 2,012 2,012 (474) 1,538 Other financial assets measured at amortized cost 29,011 16,649 447 6,708 450 210 53,475 (86) 53,389 of which: stage 1 29,011 16,646 427 6,426 336 0 52,846 (17) 52,829 of which: stage 2 0 2 20 283 114 0 419 (6) 413 of which: stage 3 0 0 0 0 0 210 210 (63) 147 Total financial assets measured at amortized cost 242,660 274,337 85,731 103,216 23,102 2,222 731,269 (890) 730,379 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 1,307 840 0 92 0 0 2,239 0 2,239 Total on-balance sheet financial instruments 243,966 275,178 85,731 103,308 23,102 2,222 733,508 (890) 732,618 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and Off-balance sheet positions subject to expected USD m 31.12.22 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off- balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 7,252 5,961 4,772 3,049 1,025 108 22,167 (48) of which: stage 1 7,252 5,917 3,812 2,229 596 0 19,805 (13) of which: stage 2 0 44 960 821 429 0 2,254 (9) of which: stage 3 0 0 0 0 0 108 108 (26) Irrevocable loan commitments 1,770 14,912 6,986 10,097 6,107 124 39,996 (111) of which: stage 1 1,770 14,789 6,818 9,625 4,529 0 37,531 (59) of which: stage 2 0 123 168 472 1,578 0 2,341 (52) of which: stage 3 0 0 0 0 0 124 124 0 Forward starting reverse repurchase and securities borrowing agreements 2,781 2 11 1,007 0 0 3,801 0 Total off-balance sheet financial instruments 11,803 20,874 11,769 14,153 7,132 233 65,964 (159) Credit lines Committed unconditionally revocable credit lines 2,288 16,483 9,247 11,885 3,739 36 43,677 (40) of which: stage 1 2,288 15,777 8,960 11,355 3,429 0 41,809 (32) of which: stage 2 0 705 287 531 310 0 1,833 (8) of which: stage 3 0 0 0 0 0 36 36 0 Irrevocable committed prolongation of existing loans 7 1,939 1,489 868 392 2 4,696 (2) of which: stage 1 7 1,938 1,411 864 380 0 4,600 (2) of which: stage 2 0 1 78 4 11 0 94 0 of which: stage 3 0 0 0 0 0 2 2 0 Total credit lines 2,295 18,421 10,736 12,753 4,131 37 48,373 (42) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and f) Sensitivity information As outlined in Note 1a, ECL estimates involve significant uncertainties ECL models The models applied to determine point-in-time PD and LGD rely on market and statistical data, which has been found to each of the ECL reporting segments to such factors are summarized Sustainability and climate risk Sustainability exposure to physical risks in locations likely to be impacted in credit current PD models could be risk scenario in addition rationale probability weight assessment given the paucity of Instead, UBS AG focuses transition risk is deemed to a downward revision of the counterparty individual contribution to ECLs. At the climate risk may and financial institutions. Initial tests were based on a set of assumptions presented by external parties (such as the Bank of England), and complemented by internally derived climate pathway scenarios. Such analysis undertaken during 2022, and reassessed during 2023, concluded that the counterparties are not expected to be significantly impacted by physical or transition risks, loan book has also shown over information estate financing, given the long lead times for investments As a result of the aforementioned factors, it was assessed that the magnitude of any impact of sustainability and climate risk on adjustment was made in this regard. › Refer to “UBS AG consolidated supplemental disclosures core loan book Forward-looking scenarios Depending on the directions under low growth and falling key risk drivers of a given credit portfolio. As forecasting of individual parameters macroeconomy. compensatory effects in other macroeconomic unchanged. Potential effect on stage 1 and stage 2 positions USD m 100% Baseline 100% Stagflationary geopolitical crisis 100% Mild Debt Crisis Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (3) (104) (3) (14) +0.50% 3 125 6 17 +1.00% 7 274 14 42 Unemployment rate (absolute change) –1.00% (4) (142) (6) (20) –0.50% (2) (76) (3) (11) +0.50% 2 89 3 13 +1.00% 5 188 7 26 Real GDP growth (relative change) –2.00% 10 27 11 14 –1.00% 6 13 6 8 +1.00% (3) (12) (6) (6) +2.00% (5) (22) (7) (10) House Price Index (relative change) –5.00% 16 174 25 46 –2.50% 8 84 12 21 +2.50% (7) (76) (9) (18) +5.00% (11) (149) (19) (34) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 4 10 8 6 –5.00% 2 5 3 2 +5.00% (2) (5) (3) (2) +10.00% (3) (8) (5) (4) Sensitivities macroeconomic alternative changes portfolios and disclosed for each scenario. The forecasting horizon is limited to three years, with a model-based mean reversion of PD and LGD assumed thereafter. Changes to these timelines may have an effect on ECLs: will lead to different annualized lifetime PD and average LGD estimations. This is currently not deemed to be UBS, as a large horizon. Scenario weights and stage allocation Potential effect on stage 1 and stage 2 positions Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Asset price inflation 100% Stagflationary geopolitical crisis 100% Mild debt crisis Weighted average USD m, except where indicated Segmentation Private clients with mortgages (133) (43) (10) (521) (63) (368) Real estate financing (52) (34) (21) (200) (36) (125) Large corporate clients (152) (108) (53) (252) (146) (234) SME clients (103) (85) (57) (186) (96) (164) Other segments (140) (126) (78) (162) (151) (302) Total (580) (396) (219) (1,322) (492) (1,193) Potential effect on stage 1 and stage 2 positions Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Asset price inflation 100% Stagflationary geopolitical crisis 100% Global crisis Weighted average USD m, except where indicated Segmentation Private clients with mortgages (136) (25) (13) (523) (184) (473) Real estate financing (43) (26) (22) (176) (30) (126) Large corporate clients (136) (97) (84) (199) (174) (235) SME clients (86) (67) (66) (162) (97) (153) Other segments (125) (114) (111) (145) (153) (281) Total (526) (329) (295) (1,204) (638) (1,267) Scenario weights ECL is sensitive to changing scenario weights, in particular if narratives and parameters are the baseline scenario, highlighting the non-linearity of credit As shown 396 m (31 2022: 329 m) 580 m (31 526 m) baseline scenario . The weighted-average ECL therefore amounted 146 % (31 December 2022: 160 %) of the baseline value. The effects of weighting each of the four scenarios 100% Stage allocation and SICR The determination of the SICR trigger will have a direct effect on ECLs, as more or scenario. The allowances and provisions for stage 1 and stage 1,193 m, if all non-impaired positions across the portfolio with actual stage 1 and 2 allowances and provisions of USD 580 m as of 31 December 2023. Maturity profile The maturity into stage short. Lending to years. Real estate lending is generally between two and three years in Switzerland, with long-dated maturities in the US. Lombard-lending features. A agreements, which drawings under such agreements with a fixed of 12 months in stage 1; (ii) for unused credit lines and all drawings that UBS generally applies a 12-month maturity from the reporting date, given the credit review policies, which require either continuous monitoring of key indicators and behavioral patterns for smaller positions or an annual formal review for any other limit. The ECLs for these products are sensitive |
Fair value measurement
Fair value measurement | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Fair Value Measurement [Line Items] | |
Disclosure Of Fair Value Measurement Explanatory | Note 20 a) Valuation principles All financial and non-financial fair transparency used to measure fair value may fall within different the hierarchy within which an instrument is classified in its entirety is based on the lowest level input the position’s fair value measurement: – Level 1 – quoted prices (unadjusted) in active markets – Level 2 – valuation techniques for which all significant inputs – Level 3 – valuation techniques for which significant inputs Fair values are determined using quoted the valuation including model, liquidity, credit which would nevertheless particular valuation technique fair value applies valuation adjustments conditions are met, UBS AG similar and offsetting risk exposures on the basis of the › Refer to Note 20d for more information b) Valuation governance UBS AG’s fair value safeguards that New products and control functions. Responsibility with the business divisions. Fair divisions. Independent price verification is performed by Finance through benchmarking the business divisions’ fair estimates controls are valuation models are used to Risk Control pricing. As estimates of fair value to align with independent market › Refer to Note 20d for more information c) Fair value hierarchy The table at product types their classification within the fair value hierarchy. During 2023, assets and liabilities that were transferred from Level 2 to for the entire reporting approach to testing for observability as part of Suisse. This methodological change enhances Application of the new methodology as of 31 December 2022 would have resulted in USD 1.3 bn lower Level 3 liabilities (as of 31 December 2023 the balance of affected liabilities in Level 3 was USD 1.9 bn), with an offsetting impact to Level 2 liabilities. Determination of fair values from quoted market 1 31.12.23 31.12.22 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 115,345 17,936 1,817 135,098 96,263 10,284 1,488 108,034 of which: Equity instruments 99,510 721 140 100,372 83,095 789 126 84,010 of which: Government bills / bonds 6,843 2,195 14 9,052 5,496 950 18 6,464 of which: Investment fund units 8,008 1,082 9 9,098 6,673 596 61 7,330 of which: Corporate and municipal bonds 982 11,956 648 13,586 976 6,509 541 8,026 of which: Loans 0 1,870 904 2,775 0 1,179 628 1,807 of which: Asset-backed securities 3 111 101 215 22 261 114 397 Derivative financial instruments 593 129,871 1,264 131,728 769 147,876 1,464 150,109 of which: Foreign exchange 317 65,070 0 65,387 575 84,882 2 85,459 of which: Interest rate 0 35,028 284 35,311 0 39,345 460 39,805 of which: Equity / index 0 26,649 667 27,317 1 21,542 653 22,195 of which: Credit 0 1,452 301 1,752 0 719 318 1,038 of which: Commodities 0 1,627 12 1,639 0 1,334 30 1,365 Brokerage receivables 0 20,883 0 20,883 0 17,576 0 17,576 Financial assets at fair value not held for trading 29,529 30,124 4,101 63,754 26,572 29,110 3,725 59,408 of which: Financial assets for unit-linked investment contracts 15,814 0 0 15,814 13,071 1 0 13,072 of which: Corporate and municipal bonds 62 16,716 215 16,994 35 14,101 230 14,366 of which: Government bills / bonds 13,262 3,332 0 16,594 13,103 3,638 0 16,741 of which: Loans 0 4,172 1,254 5,426 0 3,602 736 4,337 of which: Securities financing transactions 0 5,541 4 5,545 0 7,590 114 7,704 of which: Auction rate securities 0 0 1,208 1,208 0 0 1,326 1,326 of which: Investment fund units 367 233 205 804 307 178 190 675 of which: Equity instruments 24 0 1,088 1,112 57 0 792 849 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 68 2,165 0 2,233 57 2,182 0 2,239 of which: Commercial paper and certificates of deposit 0 1,948 0 1,948 0 1,878 0 1,878 of which: Corporate and municipal bonds 68 207 0 276 57 278 0 335 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 4,426 0 0 4,426 4,471 0 0 4,471 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 2 0 0 17 17 0 0 21 21 Total assets measured at fair value 149,962 200,979 7,198 358,139 128,132 207,028 6,698 341,858 Determination of fair values from quoted market 1 31.12.23 31.12.22 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,451 6,110 151 31,712 23,578 5,823 114 29,515 of which: Equity instruments 16,310 236 87 16,632 16,521 352 78 16,951 of which: Corporate and municipal bonds 28 4,893 58 4,979 36 4,643 27 4,707 of which: Government bills / bonds 8,320 806 0 9,126 5,880 706 1 6,587 of which: Investment fund units 794 117 4 915 1,141 84 3 1,229 Derivative financial instruments 716 136,833 3,158 140,707 640 152,582 1,684 154,906 of which: Foreign exchange 400 71,322 21 71,743 587 87,897 24 88,508 of which: Interest rate 0 32,656 107 32,763 0 37,429 116 37,545 of which: Equity / index 0 30,209 2,717 32,926 0 24,963 1,184 26,148 of which: Credit 0 1,341 273 1,614 0 920 279 1,199 of which: Commodities 0 1,271 20 1,291 0 1,309 52 1,361 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 42,275 0 42,275 0 45,085 0 45,085 Debt issued designated at fair value 0 78,509 7,832 86,341 0 62,603 9,240 71,842 Other financial liabilities designated at fair value 0 25,069 2,297 27,366 0 30,055 1,978 32,033 of which: Financial liabilities related to unit-linked investment contracts 0 15,922 0 15,922 0 13,221 0 13,221 of which: Securities financing transactions 0 6,927 0 6,927 0 15,333 0 15,333 of which: Funding from UBS Group AG 0 1,327 1,623 2,950 0 508 1,287 1,796 of which: Over-the-counter debt instruments and other 0 892 674 1,566 0 993 691 1,684 Total liabilities measured at fair value 26,167 288,796 13,438 328,401 24,219 296,148 13,015 333,382 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are measured at the Valuation techniques UBS AG instruments that are value of expected cash flows, relative value Discounted future cash flows from that profiles to using an observed models. techniques and models. Relative adjustments Option referenced probability-weighted expected curve modeling formula or other mathematical techniques (e.g., binomial tree Where available, valuation techniques use may be derived other observable market data. or analogous of current market conditions and valuation approaches. For consensus pricing services and relevant and the also standard within credit exchange rates, levels used by UBS AG incorporate the funding and credit characteristics Financial instruments excluding derivatives: valuation and classification in the fair value hierarchy Product Valuation and classification in the fair value hierarchy Government bills and bonds Valuation – Generally valued using prices obtained directly – Instruments not priced directly using active-market data are valued using discounted cash flow valuation techniques that incorporate market data Fair value hierarchy – Generally traded in active markets with prices that can be obtained directly from these markets, in classification as Level 1, while the remaining Corporate and municipal bonds Valuation – Generally adjusted for seniority, maturity and liquidity. – When prices are incorporating the credit spread of the – For convertible bond model. Fair value hierarchy – Generally classified as Level 1 or Level 2, depending – Level 3 instruments have no suitable pricing information Traded loans and loans measured at fair value Valuation – Valued directly – Where no derived from debt instruments in comparable entities a credit default swap and interest approach based on rating agency guidelines. Fair value hierarchy – Instruments with suitably deep and liquid pricing – Positions requiring the depth, are classified as Level 3. Investment fund units Valuation – Predominantly exchange-traded, prices are not available, fair value may be measured Fair value hierarchy – Listed units classification, while other positions are classified – Positions for classified as Level 3. Asset-backed securities (ABS) Valuation – For liquid securities, the levels between the time of trading and the time of valuation. Less liquid instruments are measured using discounted expected Fair value hierarchy – Residential generally classified as data is not available, they are classified as Level Auction rate securities (ARS) Valuation – ARS emanating from the note coupon, credit risk attributable to the underlying closed-end fund investments, liquidity risk as a function of the level of trading volume in these perpetual instruments that require an assumption Fair value hierarchy – Granular and liquid pricing information is generally not available for ARS. As a result, these securities are classified as Level 3. Equity instruments Valuation – Listed equity instruments are generally valued – Unlisted equity holdings, including private and are deemed to be impaired. Fair value hierarchy – The majority of readily and regularly available, resulting in Level – Equity securities less actively traded will be Financial assets for unit-linked investment contracts Valuation – The majority of assets are listed on exchanges Fair value hierarchy – Most assets are classified as Level 1 if actively traded, – Instruments for which prices are not readily available Securities financing transactions Valuation – These instruments are valued using discounted expected cash flow techniques. The discount rate applied is based on funding curves that are relevant Fair value hierarchy – Collateral funding curves for these are classified as Level 2. – Where the positions are classified as Level 3. Brokerage receivables and payables Valuation – Fair value is determined based on the value of Fair value hierarchy – Due to their on-demand nature, these receivables Product Valuation and classification in the fair value hierarchy Financial liabilities related to unit- linked investment contracts Valuation – The fair corresponding assets. Fair value hierarchy – The actively traded and are therefore classified Precious metals and other physical commodities Valuation – Physical assets are valued using the spot rate Fair value hierarchy – Generally traded in classification as Level 1. Debt issued designated at fair value Valuation – The risk management and the valuation approaches for these instruments are closely aligned with the equivalent component are the same as the relevant valuation Fair value hierarchy – The observability is closely aligned with the equivalent Commercial paper and certificates of deposit Valuation – Generally valued using or similar issuers over the underlying currency Fair value hierarchy – Due to the short-dated nature of classified as Level 2. Derivative instruments: valuation and classification The curves used associated with the relevant collateral arrangement for the instrument across collateralized derivatives are the cheapest eligible currency for the respective Uncollateralized and equivalent) partially collateralized (DVAs) and credit risk, UBS AG’s own credit risk, and funding costs › Refer to Note 10 for more information about derivative Derivative product Valuation and classification in the fair value hierarchy Interest rate contracts Valuation – Interest rate swap contracts flows using curves used to estimate future index curve models using interest rates associated with interest rate swap rates, forward rate agreement rates, short-term interest rate futures prices, spreads and inflation swap rates. – Interest rate option contracts include interest rate yield curves, inflation curves, – When the maturity quotes are observable for last observable point using standard assumptions parameter to represent a suitable proxy for that Fair value hierarchy – The majority of interest inputs for yield curve models are generally traded – Options are to active-market options and more exotic products. – Interest rate swap observable quotes. – Exotic options for market data are classified as Level 3. Credit derivative contracts Valuation – Credit derivative spreads, upfront pricing points and implied recovery rates. Where a derivative credit spread is not directly available, it may be derived from the price of – Asset-backed credit security with an adjustment to reflect Fair value hierarchy – Single-entity and recovery rates name(s) are not actively traded instruments, these contracts are classified – Asset-backed distributed across Level 2 and Level 3. Derivative product Valuation and classification in the fair value hierarchy Foreign exchange contracts Valuation – Open spot foreign exchange (FX) contracts are – Forward FX contracts are valued using the FX spot rate adjusted for forward pricing points observed from standard market-based sources. – Over-the-counter (OTC) FX The models used for shorter-dated options (i.e., those used for additional consideration of interest rate and FX – The valuation for observed FX volatilities for all relevant FX pairs. Fair value hierarchy – The therefore such FX contracts are generally classified – A significant proportion of from standard market contracts traded in Equity / index contracts Valuation – Equity forward models. The key inputs to the models are stock (which are implied discounted using market-standard discounted cash flow models using a rate that reflects the appropriate funding rate for they are related equity. – Equity option contracts are valued described between discounted appropriate funding rate not volatility data, or the equivalent data for Fair value hierarchy – As inputs are significant proportion of equity forward contracts – Equity option positions for which inputs are derived observable markets are also classified correlation inputs are not observable. Commodity contracts Valuation – Commodity forward forward levels on standard instruments. – Commodity commodity forward level for the volatility of the underlying or between different commodities or commodity Fair value hierarchy – Individual market data is available. d) Valuation adjustments and other items The output As a result, in estimating fair value, to reflect close-out costs, credit exposure, model-driven valuation uncertainty, benefits, trading restrictions and other factors. Deferred day-1 profit or loss reserves For new based on observable market data, the financial instrument is initially recognized at the transaction price. The transaction price may differ from the fair value obtained using initially recognized in the income statement. Deferred day-1 profit or loss Other net income from financial through profit the transaction is closed out. The table below summarizes the changes in deferred day-1 Deferred day-1 profit or loss reserves USD m 2023 2022 2021 Reserve balance at the beginning of the year 422 418 269 Profit / (loss) deferred on new transactions 250 299 459 (Profit) / loss recognized in the income statement (275) (295) (308) Foreign currency translation 0 0 (2) Reserve balance at the end of the year 397 422 418 Own credit Own credit risk relevant for valuation purposes by UBS AG’s counterparties Changes in recognized Other Retained statement statement, as UBS AG does not hedge changes in own credit. Own credit is estimated using own credit adjustment (OCA) curves, which incorporate observable market data, market-observed secondary prices for UBS’s debt own credit consists of changes in fair value that are attributable to the change in UBS effect of changes in decay and associated cumulative unrealized change since initial recognition. › Refer to Note 15 for more information about debt Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD m 31.12.23 31.12.22 31.12.21 Recognized during the period: Realized gain / (loss) 8 1 (14) Unrealized gain / (loss) (869) 866 60 Total gain / (loss), before tax (861) 867 46 USD m 31.12.23 31.12.22 31.12.21 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (312) 556 (315) of which: debt issued designated at fair value (208) 289 (144) of which: other financial liabilities designated at fair value (105) 266 (172) Credit valuation adjustments In classified as Financial assets at inherent counterparty credit risk of that counterparty, applicable collateral or netting arrangements, break Funding valuation adjustments FVAs receivables and payables derivative cash flows from the ARR to OCA using the CVA An FVA is also applied to collateralized Debit valuation adjustments A DVA is estimated to incorporate own credit in the valuation of derivatives where an FVA is not already recognized. The DVA calculation all exposures market movements and UBS AG’s credit default Other valuation adjustments Instruments that are measured as to ensure consistent valuation the overall market transactions and other relevant sources and Uncertainties through the use of model valuations produced directly and market inputs used, these assess these uncertainties. Model reserves pricing services and other relevant sources. Balance sheet valuation adjustments As of USD m 31.12.23 31.12.22 Credit valuation adjustments 1 (37) (33) Funding and debit valuation adjustments (82) (46) Other valuation adjustments (730) (839) of which: liquidity (308) (311) of which: model uncertainty (423) (529) 1 Amounts do not include reserves against defaulted counterparties. e) Level 3 instruments: valuation techniques and inputs The table below presents fair value, unobservable, and a range of values for those unobservable inputs. The range of does not reflect the level of uncertainty regarding a particular input or an assessment of the reasonableness of UBS AG’s estimates and assumptions, but rather the different underlying characteristics of the relevant assets and liabilities held by UBS AG. The the instruments held at each balance sheet date. Furthermore, the ranges of unobservable inputs may financial institutions, reflecting the diversity of the products Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.23 31.12.22 USD bn 31.12.23 31.12.22 31.12.23 31.12.22 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 0.8 0.1 0.0 Relative value to market comparable Bond price equivalent 9 114 93 14 112 85 points Discounted expected cash flows Discount margin 491 491 412 412 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.3 1.7 0.0 0.0 Relative value to market comparable Loan price equivalent 6 101 98 30 100 97 points Discounted expected cash flows Credit spread 200 275 252 200 200 200 basis points Market comparable and securitization model Credit spread 162 1,849 318 145 1,350 322 basis points Auction rate securities 1.2 1.3 Discounted expected cash flows Credit spread 135 205 150 115 196 144 basis points Investment fund units 3 0.2 0.3 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 1.2 0.9 0.1 0.1 Relative value to market comparable Price Debt issued designated at fair value 4 7.8 9.2 Other financial liabilities designated at fair value 2.3 2.0 Discounted expected cash flows Funding spread 51 201 23 175 basis points Derivative financial instruments Interest rate 0.3 0.5 0.1 0.1 Option model Volatility of interest rates 84 112 75 143 basis points Credit 0.3 0.3 0.3 0.3 Discounted expected cash flows Credit spreads 1 306 9 565 basis points Bond price equivalent 2 242 3 277 points Equity / index 0.7 0.7 2.7 1.2 Option model Equity dividend yields 0 14 0 20 % Volatility of equity stocks, equity and other indices 4 104 4 120 % Equity-to-FX correlation (40) 70 (29) 84 % Equity-to-equity correlation 13 100 (25) 100 % 1 The ranges most non-derivative financial instruments and were designated at fair value and Derivative financial instruments, as this would not be meaningful. issued designated at fair value primarily consists of UBS AG structured notes, which include variable maturity all of which have embedded derivative parameters that are considered to be unobservable. The equivalent Significant unobservable inputs in Level 3 positions This section potential effect that between observable and unobservable inputs have not Input Description Bond price equivalent – Where market prices are similar instruments. Factors considered when selecting comparable instruments include credit quality, maturity and industry of the issuer. Fair value may be measured either by a direct price comparison or yield (either as an outright yield or as a spread – For corporate and municipal bonds, the fair value. Bonds priced or measurement date. – For credit derivatives, the bond price range converted to an equivalent yield or credit Loan price equivalent – Where market prices are observable pricing data for similar instruments. Factors considered when selecting comparable instruments include industry segment, comparison or reference issuances of a similar credit quality used to measure fair value for loans classified as Level 3. Loans priced at 0 distressed to the repaid in full. Credit spread – Valuation models for many credit derivatives is a reflection of the in relation in terms of by credit default swaps nature and direction benchmark against which the spread is calculated. A wider credit spread represents decreasing creditworthiness. The range represents a diverse set of underlyings, with upper end of the range representing greater Discount margin – The discount margin (DM) spread represents the discount rates applied to present market return required index (e.g., Secured Overnight Financing Rate the DM in isolation would result in a higher – The high schedule. This indicates that the market is pricing being captured by better-quality instruments. Funding spread – Structured financing transactions collateral for the an estimate of where UBS AG can source and deploy secured funding with counterparties funding spreads are expressed – A small proportion of structured debt instruments and non-structured fixed-rate bonds within financial liabilities designated at fair value had an exposure to funding Volatility – Volatility measures a higher number reflects a more volatile key input into instrument. The contract is a long or short position. In most cases, the fair value of an and is reduced market option prices (referred to as which represents the effect of pricing options – Volatilities of low interest rates may have significantly different implied volatilities. Input Description Correlation – Correlation measures the –100% associated with a movement of the other variable in the same direction) and –100% implies that correlated direction). The effect of correlation valued, reflecting the range of different payoff Equity dividend yields – The derivation of a forward price contracts and for measuring fair forward price is based on a combination relevant funding of the share price, with yield and timing represent equity forward price. f) Level 3 instruments: sensitivity to changes in unobservable The table below summarizes of change fair value significantly, and the estimated effect thereof. The table below does not represent the estimated effect of stress Furthermore, direct the valuation uncertainty. Sensitivity data is estimated market participants, variation fair value used in valuations are not always precisely in the middle Sensitivity data Diversification would an overall sensitivity that would that the diversification benefit is not significant to this analysis. Sensitivity of fair value measurements to changes 1 31.12.23 31.12.22 USD m Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans measured at fair value, loan commitments and guarantees 22 2 (29) 2 19 (12) Securities financing transactions 24 (24) 33 (37) Auction rate securities 67 (21) 46 (46) Asset-backed securities 25 (22) 27 (27) Equity instruments 189 (178) 183 (161) Interest rate derivatives, net 27 (18) 18 (12) Credit derivatives, net 2 (5) 3 (4) Foreign exchange derivatives, net 5 (4) 10 (5) Equity / index derivatives, net 358 (285) 361 (330) Other 62 (62) 39 (62) Total 781 (648) 738 (696) 1 Sensitivity of issued and over-the-counter debt instruments is reported with the equivalent derivative g) Level 3 instruments: movements during the period The table below presents recurring basis. value hierarchy, of limited unobservable liabilities had been transferred at the beginning of the Movements of Level 3 instruments USD bn Balance at the beginning of the period Net gains / losses included in compre- hensive income 1 of which: related to instruments held at the end of the period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance at the end of the period For the twelve months ended 31 December 2023 2 Financial assets at fair value held for trading 1.5 (0.1) (0.1) 0.4 (0.8) 0.8 0.0 0.2 (0.3) 0.0 1.8 of which: Equity instruments 0.1 (0.1) (0.1) 0.0 (0.1) 0.0 0.0 0.2 (0.0) 0.0 0.1 of which: Corporate and municipal bonds 0.5 (0.0) (0.0) 0.4 (0.3) 0.0 0.0 0.0 (0.0) 0.0 0.6 of which: Loans 0.6 (0.1) (0.1) 0.1 (0.4) 0.8 0.0 0.0 (0.2) 0.0 0.9 Derivative financial instruments – assets 1.5 (0.3) (0.3) 0.0 (0.0) 0.7 (0.5) 0.1 (0.3) 0.0 1.3 of which: Interest rate 0.5 0.0 (0.0) 0.0 0.0 0.1 (0.2) 0.0 (0.1) (0.0) 0.3 of which: Equity / index 0.7 (0.2) (0.2) 0.0 0.0 0.6 (0.1) 0.0 (0.2) 0.0 0.7 of which: Credit 0.3 (0.1) (0.1) 0.0 0.0 0.1 (0.1) 0.1 (0.0) 0.0 0.3 Financial assets at fair value not held for trading 3.7 0.2 0.2 0.8 (0.7) 0.0 (0.0) 0.1 (0.1) 0.0 4.1 of which: Loans 0.7 0.3 0.3 0.3 (0.0) 0.0 (0.0) 0.1 (0.1) (0.0) 1.3 of which: Auction rate securities 1.3 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.0 0.0 1.2 of which: Equity instruments 0.8 0.1 0.0 0.4 (0.2) 0.0 0.0 0.1 0.0 0.0 1.1 Derivative financial instruments – liabilities 1.7 0.3 0.3 0.0 (0.0) 1.9 (0.6) 0.0 (0.2) 0.0 3.2 of which: Interest rate 0.1 0.0 0.0 0.0 0.0 0.0 (0.1) 0.0 (0.0) 0.0 0.1 of which: Equity / index 1.2 0.3 0.3 0.0 0.0 1.8 (0.4) 0.0 (0.2) 0.0 2.7 of which: Credit 0.3 (0.0) 0.0 0.0 0.0 0.1 0.0 0.0 (0.1) (0.0) 0.3 Debt issued designated at fair value 9.2 0.4 0.3 0.0 0.0 3.5 (3.2) 0.5 (2.6) 0.0 7.8 Other financial liabilities designated at fair value 2.0 0.3 0.4 0.0 0.0 0.2 (0.2) 0.0 (0.0) 0.0 2.3 For the twelve months ended 31 December 2022 Financial assets at fair value held for trading 2.3 (0.3) (0.3) 0.3 (1.8) 0.5 0.0 0.7 (0.3) (0.0) 1.5 of which: Investment fund units 0.0 (0.0) (0.0) 0.0 (0.0) 0.0 0.0 0.1 (0.0) (0.0) 0.1 of which: Corporate and municipal bonds 0.6 (0.0) (0.0) 0.3 (0.6) 0.0 0.0 0.4 (0.0) (0.0) 0.5 of which: Loans 1.4 (0.1) (0.1) 0.0 (1.1) 0.5 0.0 0.0 (0.2) 0.0 0.6 Derivative financial instruments – assets 1.1 0.6 0.3 0.0 0.0 0.4 (0.7) 0.1 (0.0) (0.0) 1.5 of which: Interest rate 0.5 0.3 0.3 0.0 0.0 0.0 (0.2) 0.0 (0.1) (0.0) 0.5 of which: Equity / index 0.4 0.2 0.1 0.0 0.0 0.4 (0.3) 0.1 (0.0) (0.0) 0.7 of which: Credit 0.2 0.1 (0.1) 0.0 0.0 0.0 (0.2) 0.0 0.1 0.0 0.3 Financial assets at fair value not held for trading 4.2 0.1 0.1 0.7 (1.2) 0.1 (0.0) 0.2 (0.3) (0.0) 3.7 of which: Loans 0.9 (0.0) (0.0) 0.4 (0.4) 0.1 0.0 0.1 (0.3) (0.0) 0.7 of which: Auction rate securities 1.6 0.1 0.0 0.0 (0.3) 0.0 0.0 0.0 0.0 0.0 1.3 of which: Equity instruments 0.7 0.0 0.0 0.1 (0.1) 0.0 0.0 0.1 0.0 (0.0) 0.8 Derivative financial instruments – liabilities 2.2 (0.8) (0.4) 0.0 0.0 1.1 (0.9) 0.3 (0.2) (0.1) 1.7 of which: Interest rate 0.3 (0.3) (0.0) 0.0 0.0 0.1 (0.0) 0.0 (0.0) (0.0) 0.1 of which: Equity / index 1.5 (0.4) (0.3) 0.0 0.0 0.8 (0.7) 0.1 (0.2) (0.0) 1.2 of which: Credit 0.3 (0.1) (0.0) 0.0 0.0 0.1 (0.1) 0.1 (0.0) (0.0) 0.3 Debt issued designated at fair value 11.9 (1.3) (0.9) 0.0 0.0 4.7 (3.1) 0.7 (3.3) (0.3) 9.2 Other financial liabilities designated at fair value 3.2 (1.0) (1.0) 0.0 0.0 0.0 (0.1) 0.1 (0.2) (0.0) 2.0 1 Net gains / losses included in comprehensive income are recognized in Net interest income and Other net income from financial instruments measured at fair value through profit or loss in the Income statement, and also in 7.2 bn (31 December 2022: USD 6.7 bn). Total Level 3 liabilities as of 31 December 2023 were USD 13.4 bn (31 December 2022: USD 13.0 bn). h) Maximum exposure to credit risk for financial instruments The tables below provide UBS AG’s maximum exposure to credit risk for financial instruments measured at fair value the respective collateral and other credit The maximum exposure sheet subject to credit risk collateral is presented at fair enhancements, capped at section of this respects from the requirements of IFRS Accounting Standards. Maximum exposure to credit risk 31.12.23 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD bn Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 25.6 25.6 Derivative financial instruments 4 131.7 5.1 117.6 9.1 Brokerage receivables 20.9 20.5 0.4 Financial assets at fair value not held for trading – debt instruments 5 46.0 10.2 35.8 Total financial assets measured at fair value 224.3 0.0 35.8 0.0 0.0 117.6 0.0 0.0 70.9 Guarantees 0.1 0.1 0.0 31.12.22 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD bn Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 16.7 16.7 Derivative financial instruments 4 150.1 5.9 133.5 10.7 Brokerage receivables 17.6 17.3 0.3 Financial assets at fair value not held for trading – debt instruments 5 44.8 11.4 33.4 Total financial assets measured at fair value 229.2 0.0 34.6 0.0 0.0 133.5 0.0 0.0 61.2 Guarantees 0.2 0.2 0.0 1 The maximum exposure to loss not considered as these positions are generally managed under the market risk framework. not recognized collateralized by equity and debt instruments consisted of structured loans and reverse repurchase and securities borrowing agreements. i) Financial instruments not measured at fair value The table below provides the estimated fair values of financial Financial instruments not measured at fair value 31.12.23 31.12.22 Carrying amount Fair value Carrying amount Fair value USD bn Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets Cash and balances at central banks 171.8 171.7 0.0 0.1 0.0 171.8 169.4 169.4 0.1 0.0 0.0 169.4 Amounts due from banks 28.2 12.5 0.0 15.4 0.2 28.2 14.7 13.9 0.0 0.7 0.0 14.6 Receivables from securities financing transactions measured at amortized cost 74.1 68.7 0.0 3.9 1.5 74.1 67.8 64.3 0.0 1.8 1.7 67.8 Cash collateral receivables on derivative instruments 32.3 32.3 0.0 0.0 0.0 32.3 35.0 35.0 0.0 0.0 0.0 35.0 Loans and advances to customers 405.6 131.8 0.0 44.3 220.4 396.5 390.0 136.9 0.0 45.9 195.0 377.7 Other financial assets measured at amortized cost 54.3 9.0 12.8 29.6 2.6 54.1 53.4 13.0 10.3 25.1 2.5 51.0 Liabilities Amounts due to banks 16.7 8.8 0.0 8.0 0.0 16.7 11.6 8.9 0.0 2.7 0.0 11.6 Payables from securities financing transactions measured at amortized cost 5.8 5.1 0.0 0.4 0.4 5.8 4.2 3.5 0.0 0.7 0.0 4.2 Cash collateral payables on derivative instruments 34.9 34.9 0.0 0.0 0.0 34.9 36.4 36.4 0.0 0.0 0.0 36.4 Customer deposits 555.7 482.1 0.0 74.5 0.0 556.6 527.2 493.0 0.0 33.9 0.0 526.9 Funding from UBS Group AG measured at amortized cost 67.3 3.3 0.0 64.4 0.0 67.7 56.1 2.0 0.0 53.7 0.0 55.7 Debt issued measured at amortized cost 69.8 18.1 0.0 51.7 0.0 69.8 59.5 13.4 0.0 45.5 0.0 58.9 Other financial liabilities measured at amortized cost 2 9.8 9.8 0.0 0. |
Offsetting financial assets and
Offsetting financial assets and financial liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Offsetting Financial Assets And Financial Liabilities [Line Items] | |
Disclosure Of Offsetting Of Financial Assets And Financial Liabilities Explanatory | Note 21 UBS AG repurchase exchange-traded derivatives. These netting agreements set counterparties to the transaction are unable to fulfill The tables below netting exposures for these financial instruments. UBS AG arrangements. Therefore, the net risk exposure. Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.23, USD bn Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions measured at amortized cost 69.2 (12.2) 56.9 (1.5) (55.2) 0.3 17.2 17.5 74.1 Derivative financial instruments 128.8 (2.5) 126.3 (99.3) (23.4) 3.7 5.4 9.1 131.7 Cash collateral receivables on derivative instruments 1 31.5 0.0 31.5 (20.4) (2.5) 8.7 0.8 9.5 32.3 Financial assets at fair value not held for trading 96.3 (89.6) 6.7 (1.8) (4.9) 0.0 57.1 57.1 63.8 of which: reverse repurchase agreements 95.1 (89.6) 5.5 (1.8) (3.7) 0.0 0.0 0.0 5.5 Total assets 325.7 (104.3) 221.4 (122.9) (85.9) 12.6 80.5 93.1 301.9 As of 31.12.22, USD bn Receivables from securities financing transactions measured at amortized cost 60.8 (11.1) 49.6 (3.0) (46.4) 0.3 18.2 18.5 67.8 Derivative financial instruments 147.4 (2.5) 144.9 (110.9) (28.5) 5.5 5.2 10.7 150.1 Cash collateral receivables on derivative instruments 1 33.5 0.0 33.5 (20.9) (1.9) 10.6 1.5 12.1 35.0 Financial assets at fair value not held for trading 85.6 (76.8) 8.7 (1.5) (7.3) 0.0 50.7 50.7 59.4 of which: reverse repurchase agreements 84.4 (76.8) 7.6 (1.5) (6.1) 0.0 0.1 0.1 7.7 Total assets 327.2 (90.4) 236.8 (136.3) (84.1) 16.4 75.6 92.0 312.4 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross from securities financing transactions “Payables from securities financing transactions measured at amortized cost” and “Other financial liabilities designated at fair value” lines the amounts of financial instruments and cash collateral presented have been capped so as not to exceed the net amount of financial assets presented on the balance sheet; i.e., over-collateralization, where is not reflected in the table. Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.23, USD bn Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions measured at amortized cost 16.1 (12.1) 4.0 (0.8) (3.2) 0.0 1.8 1.8 5.8 Derivative financial instruments 135.9 (2.5) 133.5 (99.3) (24.5) 9.7 7.2 16.9 140.7 Cash collateral payables on derivative instruments 1 33.5 0.0 33.5 (17.2) (3.4) 12.9 1.4 14.3 34.9 Other financial liabilities designated at fair value 97.1 (89.8) 7.3 (2.5) (4.8) 0.0 20.1 20.1 27.4 of which: repurchase agreements 96.7 (89.8) 6.9 (2.5) (4.4) 0.0 0.0 0.0 6.9 Total liabilities 282.6 (104.3) 178.3 (119.7) (36.0) 22.5 30.4 53.0 208.7 As of 31.12.22, USD bn Payables from securities financing transactions measured at amortized cost 14.1 (11.1) 3.0 (1.3) (1.8) 0.0 1.2 1.2 4.2 Derivative financial instruments 150.3 (2.5) 147.8 (110.9) (26.2) 10.7 7.1 17.8 154.9 Cash collateral payables on derivative instruments 1 34.9 0.0 34.9 (20.0) (1.9) 13.0 1.6 14.5 36.4 Other financial liabilities designated at fair value 92.5 (76.9) 15.6 (3.2) (12.4) 0.0 16.4 16.4 32.0 of which: repurchase agreements 92.1 (76.9) 15.3 (3.2) (12.1) 0.0 0.1 0.1 15.3 Total liabilities 291.7 (90.4) 201.3 (135.3) (42.3) 23.7 26.3 49.9 227.6 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the “Netting with gross measured at amortized financing transactions measured at amortized cost” instruments and cash collateral presented have been capped so as not to exceed the net amount of financial liabilities presented on the balance sheet; table. |
Restricted financial assets
Restricted financial assets | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Restricted Financial Assets [Line Items] | |
Restricted Assets Disclosure [Text Block] | Note 22 This Note 22c) and financial assets that are received a) Restricted financial assets Restricted other assets that are otherwise explicitly restricted Financial relation to mortgage loans, Loan Banks USD 2.0 bn as of 31 December 2023 could be withdrawn or used for future liabilities or covered breaching existing collateral 3.1 bn). Existing liabilities central mortgage institutions 15.4 bn as of 31 December 2023 (31 December 2022: USD 9.0 bn). Repurchase securities depending on agreement to repurchase is generally in excess of the cash borrowed. Other restricted financial investment contracts to back related liabilities to the policy holders and assets held in certain jurisdictions to comply with explicit minimum local asset restricted financial comply with local asset maintenance requirements, for Restricted financial assets USD m 31.12.23 31.12.22 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties Financial assets pledged as collateral Cash and balances at central banks 1 709 Financial assets at fair value held for trading 76,579 44,524 57,435 36,742 Loans and advances to customers 28,105 15,195 Financial assets at fair value not held for trading 3,099 2,110 1,509 1,220 Debt securities classified as Other financial assets measured 7,043 6,299 3,432 2,685 Total financial assets pledged as collateral 115,535 77,571 Other restricted financial assets Amounts due from banks 2,543 3,689 Financial assets at fair value held for trading 169 162 Cash collateral receivables on derivative instruments 4,685 5,155 Loans and advances to customers 28 1,127 Other financial assets measured at amortized cost 3,334 2 815 Financial assets at fair value not held for trading 17,844 14,090 Financial assets measured at fair value through other comprehensive 1,846 1,842 Other 249 44 Total other restricted financial assets 30,698 26,924 Total financial assets pledged and other restricted financial assets 3 146,233 104,495 1 Assets pledged to the depositor protection system in Switzerland following new requirements that became effective in 2023. to secure (31 December 2023: USD 9.7 bn; 31 December 2022: USD 5.9 bn). In requirements that affect authorities also may Board’s Comprehensive Capital Analysis and make distributions of capital based on the results of those Supervisory subsidiaries. Non-regulated subsidiaries are generally can requirements. In 4.7 bn requirements as of 31 December 2023 (31 4.4 bn). |
Transferred financial assets th
Transferred financial assets that are not derecognized in their entirety | 12 Months Ended |
Dec. 31, 2023 | |
Transferred Financial Assets That Are Not Derecognized In Their Entirety [Line Items] | |
Disclosure Of Transfers Of Financial Assets Explanatory | b) Transferred financial assets that are not derecognized The recognition in full, as well as recognized Transferred financial assets subject to continued recognition in full USD m 31.12.23 31.12.22 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 44,524 23,374 36,742 16,470 Financial assets at fair value not held for trading that may be sold or repledged counterparties 2,110 1,976 1,220 1,050 Debt securities classified as Other financial assets measured sold or repledged by counterparties 6,299 5,928 2,685 2,302 Total financial assets transferred 52,933 31,278 40,647 19,822 Transactions in which financial assets are transferred but continue to be sheet include securities lending with counterparties subject to UBS AG’s normal credit › Refer to Note 1a item 2e for more information about repurchase Financial assets at and received and other financial asset transfers. For 0 % 15 % transferred transferred assets. The In securities securities received nor the obligation to return them are recognized on UBS AG’s balance sheet, as the risks and rewards of repledged in another transaction, this is not considered to Other financial asset transfers primarily include carrying amount on a specific collateral pledged and the associated liability. Transferred financial assets that are not subject UBS AG’s continuing involvement were not material as of |
Transferred financial assets _2
Transferred financial assets that are derecognized in their entirety with continuing involvement | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Transferred Financial Assets [Line Items] | |
Disclosure Of Continuing Involvement In Derecognised Financial Assets Explanatory | c) Transferred financial assets that are derecognized Continuing involvement in the particular transfer connection with the transfer. The fair 2023 and positions in securitization vehicles that have been fully marked |
Off-balance sheet assets receiv
Off-balance sheet assets received | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Off-balance Sheet Assets Received [Line Items] | |
Disclosure Of Off Balance Sheet Assets Received Text Block | d) Off-balance sheet assets received The table below presents assets received from third parties that can be sold or repledged and that are not recognized on the balance sheet but that are held as collateral, including Off-balance sheet assets received USD m 31.12.23 31.12.22 Fair value of assets received that can be sold or repledged 489,476 434,023 of which: sold or repledged 357,020 331,805 1 Includes securities services. 16.0 bn; 31 December 2022: USD 9.9 bn) placed with central banks related to undrawn settlement purposes for which there are no associated liabilities or contingent liabilities. |
Maturity analysis of financial
Maturity analysis of financial liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Measurement Categories Credit Risk And Maturity Analysis Of Financial Instruments [Line Items] | |
Measurement categories, credit risk and maturity analysis of financial instruments [text block] | Note 23 a) Maturity analysis of carrying amounts of assets and The table sheet includes the effect based on the earliest date on which a third party Derivative financial instruments Due within 1 month Assets held to hedge unit-linked investment contracts Financial assets at fair value not ) are Due within under unit-linked investment contracts (presented within Other financial liabilities designated at fair value ). Other financial assets Perpetual / Not applicable counterparty contracts are presented in the Perpetual / Not applicable Non-financial assets Perpetual / column. 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Assets Total financial assets measured at amortized cost 416.2 25.6 47.6 105.2 77.8 94.0 766.4 Amounts due from banks 12.0 0.5 5.4 10.0 0.2 0.1 28.2 Loans and advances to customers 135.5 12.1 33.3 89.4 61.4 74.0 405.6 Other financial assets measured at amortized cost 7.4 1.6 4.2 5.1 16.1 19.9 54.3 Total financial assets measured at fair value through profit or loss 312.5 6.7 7.8 7.4 11.8 3.4 1.9 351.5 Financial assets at fair value not held for trading 24.8 6.7 7.8 7.4 11.8 3.4 1.9 63.8 Financial assets measured at fair value through other comprehensive income 0.1 1.1 1.0 0.1 0.0 0.0 2.2 Total non-financial assets 6.6 0.2 1.2 0.4 27.5 35.9 Total assets 735.4 33.4 56.5 112.7 90.8 97.8 29.5 1,156.0 Liabilities Total financial liabilities measured at amortized cost 497.1 65.1 81.1 30.3 49.6 27.1 12.5 762.8 Customer deposits 433.2 48.9 49.6 15.3 8.4 0.3 555.7 Funding from UBS Group AG measured at amortized cost 2.5 0.8 8.2 24.3 19.0 12.5 67.3 Debt issued measured at amortized cost 6.4 11.7 26.8 6.3 11.8 6.8 69.8 of which: non-subordinated 6.4 11.7 24.3 6.0 11.6 6.8 66.8 of which: subordinated 2.5 0.3 0.2 3.0 Total financial liabilities measured at fair value through profit or loss 1 250.1 11.4 22.6 23.3 8.3 12.7 328.4 Debt issued designated at fair value 13.1 11.3 21.8 23.0 8.0 9.1 86.3 Total non-financial liabilities 5.2 2.8 0.5 9.2 Total liabilities 752.5 79.3 103.8 53.7 58.3 39.9 13.0 1,100.4 Guarantees, loan commitments and forward starting transactions 2 Irrevocable loan commitments 43.0 0.5 0.4 0.0 0.0 44.0 Guarantees 33.4 33.4 Forward starting reverse repurchase and securities borrowing agreements 10.4 10.4 Irrevocable committed prolongation of existing loans 2.0 0.8 1.3 0.0 0.0 4.2 Total 88.8 1.4 1.8 0.0 0.0 91.9 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Assets Total financial assets measured at amortized cost 425.2 28.7 34.5 78.8 70.5 92.8 730.4 Amounts due from banks 13.3 0.6 0.6 0.0 0.0 0.1 14.7 Loans and advances to customers 141.9 16.3 28.3 74.9 55.6 73.0 390.0 Other financial assets measured at amortized cost 8.8 4.2 2.8 3.0 14.8 19.7 53.4 Total financial assets measured at fair value through profit or loss 300.4 10.0 7.8 3.6 9.9 2.0 1.5 335.1 Financial assets at fair value not held for trading 24.6 10.0 7.8 3.6 9.9 2.0 1.5 59.4 Financial assets measured at fair value through other comprehensive income 0.3 0.9 0.9 0.1 0.0 0.0 2.2 Total non-financial assets 7.1 0.2 2.0 0.4 28.0 37.7 Total assets 732.9 39.5 43.4 82.4 82.4 95.1 29.6 1,105.4 Liabilities Total financial liabilities measured at amortized cost 524.3 40.2 49.6 20.7 35.2 23.5 11.8 705.4 Customer deposits 464.5 28.5 23.8 7.7 2.3 0.3 527.2 Funding from UBS Group AG measured at amortized cost 2.0 4.8 21.2 16.3 11.8 56.1 Debt issued measured at amortized cost 4.6 8.8 23.3 7.2 10.0 5.7 59.5 of which: non-subordinated 4.6 8.8 23.3 4.8 9.5 5.7 56.5 of which: subordinated 2.4 0.5 3.0 Total financial liabilities measured at fair value through profit or loss 1 265.9 13.8 16.3 19.6 7.3 10.5 333.4 Debt issued designated at fair value 9.3 12.3 15.9 19.3 6.9 8.2 71.8 Total non-financial liabilities 6.7 2.6 0.5 9.7 Total liabilities 796.9 56.5 65.9 40.4 42.5 34.0 12.3 1,048.5 Guarantees, loan commitments and forward starting transactions 2 Irrevocable loan commitments 39.3 0.3 0.4 0.0 40.0 Guarantees 22.4 22.4 Forward starting reverse repurchase and securities borrowing agreements 3.8 3.8 Irrevocable committed prolongation of existing loans 4.7 4.7 Total 70.1 0.3 0.4 0.0 70.9 1 As of 31 December through profit or loss agreements, measured at information. b) Maturity analysis of financial liabilities on an undiscounted The table below provides principal and liabilities are based on the earliest date on trading liabilities, Due within 1 , as this provides a conservative reflection of the nature of these trading activities. The residual contractual extend over significantly longer periods. 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.2 2.6 3.9 0.3 4.4 0.0 17.4 Payables from securities financing transactions 4.0 1.1 0.7 5.8 Cash collateral payables on derivative instruments 34.9 34.9 Customer deposits 433.5 49.7 51.6 16.9 9.8 0.3 561.8 Funding from UBS Group AG measured at amortized cost 2 2.8 1.7 1.7 11.0 31.9 24.1 12.9 86.1 Debt issued measured at amortized cost 6.4 11.9 27.4 7.0 12.8 8.1 73.6 Other financial liabilities measured at amortized cost 6.2 0.1 0.4 0.5 1.1 1.1 9.4 0.0 0.1 0.4 0.5 1.1 1.1 3.3 Total financial liabilities measured at amortized cost 494.1 67.0 85.7 35.6 60.1 33.6 12.9 789.1 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 140.7 140.7 Brokerage payables designated at fair value 42.3 42.3 Debt issued designated at fair value 6 13.1 11.8 22.5 25.7 8.1 11.8 93.0 Other financial liabilities designated at fair value 22.1 0.1 0.8 0.3 0.3 7.2 30.8 Total financial liabilities measured at fair value through profit or loss 249.9 11.9 23.3 26.0 8.4 19.0 338.4 Total 744.0 78.9 109.0 61.6 68.5 52.6 12.9 1,127.5 Guarantees, loan commitments and forward starting transactions Irrevocable loan commitments 7 43.0 0.5 0.4 0.0 0.0 44.0 Guarantees 33.4 33.4 Forward starting reverse repurchase and securities borrowing agreements 7 10.4 10.4 Irrevocable committed prolongation of existing loans 2.0 0.8 1.3 0.0 0.0 4.2 Total 88.8 1.4 1.8 0.0 0.0 91.9 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.3 2.6 1.9 0.3 0.6 0.0 11.7 Payables from securities financing transactions 3.3 0.3 0.4 0.3 0.0 4.4 Cash collateral payables on derivative instruments 36.4 36.4 Customer deposits 464.6 28.8 24.5 8.2 2.6 0.3 529.0 Funding from UBS Group AG measured at amortized cost 2 2.2 0.6 1.2 6.8 27.6 21.2 12.7 72.3 Debt issued measured at amortized cost 4.6 8.9 23.7 7.8 10.8 6.9 62.8 Other financial liabilities measured at amortized cost 5.6 0.1 0.4 0.5 1.2 1.3 9.2 0.1 0.1 0.4 0.5 1.2 1.3 3.7 Total financial liabilities measured at amortized cost 523.1 41.2 52.2 24.0 42.8 29.8 12.7 725.8 Financial liabilities at fair value held for trading 3,4 29.5 29.5 Derivative financial instruments 3,5 154.9 154.9 Brokerage payables designated at fair value 45.1 45.1 Debt issued designated at fair value 6 9.4 12.4 16.0 19.7 7.1 12.3 76.8 Other financial liabilities designated at fair value 27.1 1.4 0.4 0.4 0.5 5.0 34.8 Total financial liabilities measured at fair value through profit or loss 266.0 13.8 16.4 20.0 7.5 17.3 341.1 Total 789.2 55.0 68.6 44.0 50.3 47.1 12.7 1,066.9 Guarantees, loan commitments and forward starting transactions Irrevocable loan commitments 7 39.3 0.3 0.4 0.0 40.0 Guarantees 22.4 22.4 Forward starting reverse repurchase and securities borrowing agreements 7 3.8 3.8 Irrevocable committed prolongation of existing loans 4.7 4.7 Total 70.1 0.3 0.4 0.0 70.9 1 Except for financial liabilities at payments. cash flows 29.9 bn due (31 December 2022: USD 27.8 bn), USD 1.8 bn due between 1 1.7 bn) and USD 0 bn due between 1 0 bn). 52 m (31 December 2022: USD 46 m) related to fair contractual committed amount of USD 65.2 bn (31 December 2022: USD 34.4 bn) is presented in Note 10 under notional amounts. to the applicable interest rate prevailing as of loan commitments and forward starting reverse repurchase agreements measured at fair value (see footnote 5). |
Interest rate benchmark reform
Interest rate benchmark reform | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Interest Rate Benchmark Reform [Line Items] | |
Disclosure of how entity is managing transition to alternative benchmark rates, its progress at reporting date and risks to which it is exposed arising from financial instruments because of transition [text block] | Note 24 During 2023, UBS AG largely completed the transition of the USD London Interbank Offered Rate (LIBOR) contracts. The transition of the 9 bn as of 31 December Overnight Financing LIBOR rates, i.e., rates. In August June 2022 2023, the transition of these USD LIBOR-linked derivatives had been The 31 December 2023 given transition has largely completed as noted 31.12.22 1 Measure USD LIBOR benchmark rates Carrying value of non-derivative financial instruments Total non-derivative financial assets USD m 14,269 2 Total non-derivative financial liabilities USD m 1,138 3 Trade count of derivative financial instruments Total derivative financial instruments Trade count 32,006 4 Off-balance sheet exposures Total irrevocable loan commitments USD m 4,606 5 1 As of 31 December 2022, non-USD balances and trade counts were minimal. 1 bn of loans related to revolving multi-currency credit lines, USD LIBOR. The remaining balances as of 31 December 2022 primarily related to US mortgages and corporate LIBOR, with transition dependent upon the actions of respective issuers. 2,000 30 June 2023. No further contractual fixing is required for these contracts. 3 bn of loan commitments that can be drawn in different currencies; however, efforts remained open as of 31 December 2022. In addition, as of 31 December 2023 2 bn equivalent of yen- and US funding from UBS Group based reference rates robust advance of any rate resets. |
Hedge accounting
Hedge accounting | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Hedge Accounting [Line Items] | |
Disclosure Of General Hedge Accounting Explanatory | Note 25 Derivatives designated in hedge accounting relationships UBS AG applies hedge risk related to net investments in foreign › Refer to “Market risk” in the “Risk management and how they are managed by UBS AG Hedging instruments and hedged risk Interest rate swaps are in benchmark change in the fair value of the hedged position in transaction Cross-currency foreign exchange swaps in foreign operations. In both cases the hedged risk arises solely from The notional of the designated hedging instruments matches the rate determined based on the swap sensitivity. Note 25 Hedged items and hedge designation Fair value hedges of interest rate risk related to Fair associated with held, customer swaps that either pay fixed and receive floating cash flows or that receive fixed and pay floating cash flows. The floating future cash flows Funds Rate (EFFR), Swiss (ESTR), Average Rate (TONA) and Singapore Cash flow hedges of forecast transactions UBS AG hedges are expected timing of future and interest UBS AG, which is hedged with interest rate swaps, the maximum maturity of which is risk exposures traded and designated, or are terminated resulting Fair value hedges of foreign exchange risk related to issued Debt instruments denominated in currencies other than the US dollar are designated in fair value hedges of spot foreign exchange economically designations also involve impact consolidated profit or loss. Hedges of net investments in foreign operations UBS AG applies hedge accounting for certain net investments in and associates. and new designations are made to reflect Economic relationship between hedged item and hedging The economic relationship analysis instrument, a quantitative respective terms is also performed. Sources of hedge ineffectiveness In different curves to date of the hedging derivative. In hedges of foreign hedging instruments and items. In hedges of net investments in foreign operations, ineffectiveness is unlikely unless the hedged net assets fall below the designated hedged amount. the foreign operation, where the currency basis may cause ineffectiveness. Hedge ineffectiveness from financial instruments Other net income from financial instruments measured at fair value Derivatives not designated in hedge accounting relationships Non-hedge-accounted Other income from financial instruments , even when held as an or to exchange contracts acting as economic hedges, which are Net interest income. All hedges: designated hedging instruments As of or for the year ended 31.12.23 USD m Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 114,618 0 0 2,203 (2,195) 8 Cash flow hedges 83,333 3 0 (35) 57 22 Foreign exchange risk Fair value hedges 2 33,877 468 291 132 (151) (19) Hedges of net investments in foreign operations 13,260 3 455 (910) 912 3 As of or for the year ended 31.12.22 USD m Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 92,415 0 0 (5,195) 5,169 (27) Cash flow hedges 75,304 2 5 (5,813) 5,760 (53) Foreign exchange risk Fair value hedges 2 20,566 845 3 (1,088) 1,105 18 Hedges of net investments in foreign operations 13,844 7 528 318 (319) (1) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. Fair value hedges: designated hedged items 1 USD m 31.12.23 31.12.22 Interest rate risk FX risk Interest rate risk FX risk Loans and advances to customers Carrying amount of designated loans 15,296 14,270 of which: accumulated amount of fair value hedge adjustment (508) (1,249) of which: accumulated amount of fair value hedge adjustment subject portion of the portfolio that ceased to be part of hedge (179) (51) Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 6,333 4,577 (109) (180) Customer deposits Carrying amount of Customer deposits 8,972 50 Funding from UBS Group AG Carrying amount of designated debt instruments 63,760 17,693 57,250 14,828 (3,174) (5,055) Debt issued measured at amortized cost Carrying amount of designated debt issued 15,243 4,636 11,279 5,737 (412) (1,002) 1 In addition, as of 31 December 12 bn of intragroup debt instruments on these instruments impact consolidated profit or loss. No such designations were in place as of 31 December 2022. Fair value hedges: profile of the timing of the 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 6 12 62 35 115 Cross-currency swaps 1 2 2 22 7 34 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 4 10 53 26 92 Cross-currency swaps 0 1 2 12 5 21 Cash flow hedge reserve on a pre-tax basis USD m 31.12.23 31.12.22 Amounts related to hedge relationships for which hedge (2,349) (4,692) Amounts related to hedge relationships for which hedge (1,331) (540) Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis (3,680) (5,232) Foreign currency translation reserve on a pre-tax basis USD m 31.12.23 31.12.22 Amounts related to hedge relationships for which hedge (690) 250 Amounts related to hedge relationships for which hedge 266 266 Total other comprehensive income recognized directly in equity related to hedging instruments basis (424) 515 Interest rate benchmark reform In 2023, Interest (Amendments IFRS 7) , published by Singapore dollars respectively. the London Clearing House), with hedge relationships Interest Rate Benchmark Reform – Phase 2 (Amendments . Cash flow and replaced with new ARR designations in May As of 31 December 2023, cessation date of in such hedge relationships as of 31 December 2022. Hedges of net investments in foreign operations are not › Refer to Note 1a item 2j for more information interest rate benchmark reform › Refer to Note 24 for more information about the transition Hedging instruments referencing LIBOR 31.12.22 Carrying amount USD m Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 20,383 0 0 Cash flow hedges 2,179 0 0 |
Post-employment benefit plans
Post-employment benefit plans | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Post-employment Benefit Plans [Line Items] | |
Post-employment benefit plans [text block] | Note 26 a) Defined benefit plans UBS AG has and practices. on the specific plan rules. Swiss pension plan In 2017, directly covering Solutions AG and UBS pension asset Solutions AG based on the aggregated UBS Swiss pension plan The responsibilities of the minimum benefit requirements under Savings contributions to the UBS Swiss age of 6.5 % and 27.5 % of base salary 2.8 % and 9 % of savings contributions paid by them, 2.5 % and 13.5 % of the contributory base salary 0 % and 9 % of the contributory UBS AG also pays risk contributions that are used to fund The plan offers to members at the 65 lump sum payment. Participants 58 , but they can also continue employment 70 . Employees can purchases of benefits to fund early retirement benefits. The pension amount the transferred participant’s determined by the Pension Foundation Board at the end Although the UBS for as a defined benefit plan the participants’ retirement savings accounts and the payment An actuarial valuation in accordance with Swiss pension law is performed regularly. this basis occur, the Pension Foundation Board is required to take the necessary measures to ensure that full funding can be 10 underfunded on situation, the risk is 50 % funding ratio in accordance with Swiss pension law of 119.2 % (31 December 2022: 119.0 %). The regulations relating Board based on a medium- and long-term balance between assets and liabilities. As measurement basis, as the fair value 3,585 m (31 December 2022: USD 4,418 m). However, a surplus is only recognized on the balance sheet to the extent that it does not estimated 31 December 2023 and 31 December benefit asset was recognized on the balance sheet. The regular employer contributions to the UBS Swiss pension 315 m. UK pension plan The UBS UK price inflation, subject 60 65 . The plan provides guaranteed lifetime pension more participate in the UBS UK defined contribution plan. The governance responsibility plan between expected and actual longevity. In established to was USD 260 m (31 December 292 m) and and other financial the event of UBS AG’s insolvency or not paying a required funding In 2023, UBS AG 19 m to the 5 m). The employer contributions to the UBS UK 19 m, subject to regular funding reviews the year. US defined benefit plans There are two main 65 . Both plans were closed to more than 20 years One of salary in a retirement that is linked to the average yield on one-year US government bonds. For the other UBS defined benefit plan, retirement benefits accrue based on the benefits can take a lump sum payment As required under the governance of the plans. Each plan’s both plans are invested in diversified portfolios of financial assets. The employer contributions to the UBS US defined benefit 12 m. German pension plans There are two major unfunded UBS defined 65 paid directly savings account. interest at a rate of 5 %. The plan has been closed to new entrants, and all participants younger than the age of 55 as of June related to guaranteed interest rate 6 % for amounts accrued 4 % for amounts accrued of 0.9 % for amounts accrued pay increased in line with price inflation. In June 2021, UBS AG implemented a investment returns 0 %. The June 2018 and for all eligible active participants younger of salary in a retirement savings account. The employer contributions to the UBS German defined benefit 14 m. Financial information by plan The tables defined benefit plans, as well as an analysis of amounts Other comprehensive incom e. Defined benefit plans USD m Swiss plan UK plan US and German plans Total 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Defined benefit obligation at the beginning of the year 12,539 15,480 2,166 4,105 1,375 1,740 16,080 21,324 Current service cost 236 240 0 0 5 5 241 244 Interest expense 287 195 109 67 61 35 457 297 Plan participant contributions 163 154 0 0 0 0 163 154 Remeasurements 1,901 (2,424) 96 (1,474) 33 (267) 2,031 (4,165) of which: actuarial (gains) / losses due to changes in demographic 45 2 (75) (6) (2) 1 (31) (3) of which: actuarial (gains) / losses due to changes in financial 1,168 (2,653) 36 (1,575) 37 (279) 1,241 (4,506) of which: experience (gains) / losses 1 688 226 135 107 (3) 11 820 344 Past service cost related to plan amendments 0 0 0 0 0 0 0 0 Curtailments (3) (13) 0 0 0 0 (3) (13) Benefit payments (662) (796) (107) (123) (110) (111) (880) (1,030) Other movements 0 (5) 0 0 0 0 0 (5) Foreign currency translation 1,288 (291) 114 (408) 9 (28) 1,411 (727) Defined benefit obligation at the end of the year 15,748 12,539 2,379 2,166 1,373 1,375 19,500 16,080 of which: amounts owed to active members 9,336 7,103 73 65 209 169 9,618 7,336 of which: amounts owed to deferred members 0 0 950 656 527 528 1,478 1,184 of which: amounts owed to retirees 6,412 5,436 1,356 1,445 636 678 8,404 7,560 of which: funded plans 15,748 12,539 2,379 2,166 979 1,011 19,106 15,717 of which: unfunded plans 0 0 0 0 394 363 394 363 Fair value of plan assets at the beginning of the year 16,957 19,196 2,488 4,297 1,039 1,329 20,484 24,821 Return on plan assets excluding interest income 513 (1,942) 65 (1,312) 26 (223) 603 (3,476) Interest income 393 274 126 70 48 31 568 376 Employer contributions 290 401 19 5 17 16 327 422 Plan participant contributions 163 154 0 0 0 0 163 154 Benefit payments (662) (796) (107) (123) (110) (111) (880) (1,030) Administration expenses, taxes and premiums paid (8) (7) 0 0 (4) (3) (12) (11) Other movements 2 (1) 0 0 0 0 2 (1) Foreign currency translation 1,685 (322) 130 (450) 0 0 1,815 (772) Fair value of plan assets at the end of the year 19,333 16,957 2,720 2,488 1,017 1,039 23,070 20,484 Surplus / (deficit) 3,585 4,418 341 321 (356) (335) 3,570 4,404 Asset ceiling effect at the beginning of the year 4,418 3,716 0 0 0 0 4,418 3,716 Interest expense on asset ceiling effect 102 77 0 0 0 0 102 77 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect (1,332) 656 0 0 0 0 (1,332) 656 Foreign currency translation 397 (31) 0 0 0 0 397 (31) Asset ceiling effect at the end of the year 3,585 4,418 0 0 0 0 3,585 4,418 Net defined benefit asset / (liability) of major plans 0 0 341 321 (356) (335) (15) (14) Net defined benefit asset / (liability) of remaining plans (90) (80) Total net defined benefit asset / (liability) (105) (94) of which: Net defined benefit asset 383 355 of which: Net defined benefit liability 2 (487) (449) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD m Swiss plan UK plan US and German plans Total For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Current service cost 236 240 0 0 5 5 241 244 Interest expense related to defined benefit obligation 287 195 109 67 61 35 457 297 Interest income related to plan assets (393) (274) (126) (70) (48) (31) (568) (376) Interest expense on asset ceiling effect 102 77 0 0 0 0 102 77 Administration expenses, taxes and premiums paid 8 7 0 0 4 3 12 11 Past service cost related to plan amendments 0 0 0 0 0 0 0 0 Curtailments (3) (13) 0 0 0 0 (3) (13) Net periodic expenses recognized in net profit for major plans 236 230 (17) (3) 22 12 241 239 Net periodic expenses recognized in net profit for remaining plans 2 19 17 Total net periodic expenses recognized in net profit 259 256 1 Refer to Note 6. The table below provides information about the duration Swiss plan UK plan US and German plans 1 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Duration of the defined benefit obligation (in years) 14.1 13.4 14.5 13.7 7.8 7.9 Maturity analysis of benefits expected to be paid USD m Benefits expected to be paid within 12 months 811 702 137 107 133 123 Benefits expected to be paid between 1 and 3 years 1,627 1,445 256 234 235 232 Benefits expected to be paid between 3 and 6 years 2,552 2,183 415 384 336 335 Benefits expected to be paid between 6 and 11 years 4,233 3,751 721 667 502 502 Benefits expected to be paid between 11 and 16 years 3,878 3,519 723 667 376 388 Benefits expected to be paid in more than 16 years 13,751 13,243 2,703 2,570 417 516 1 The duration of the defined benefit obligation represents a weighted average across US and Actuarial assumptions The jurisdiction in discount rate. The discount currency actuarial assumptions used in calculating the DBO to determine › Refer to Note 1a item 5 for a description The tables below show the significant actuarial assumptions Significant actuarial assumptions of plans Swiss plan UK plan US plans German plans In % 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Discount rate 1.48 2.34 4.79 5.02 4.72 1 4.92 1 3.28 3.81 Rate of pension increase 0.00 0.00 3.00 3.08 0.00 0.00 2.10 2.20 Rate of interest credit on retirement savings 2.48 3.39 0.00 0.00 6.28 2 5.73 2 0.00 0.00 1 Represents weighted average across US pension plans. Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.23 31.12.22 31.12.23 31.12.22 Switzerland BVG 2020 G with CMI 2022 projections 1 21.8 21.7 23.5 23.4 UK S3PA with CMI 2022 projections 2 22.2 23.5 23.4 24.6 USA Pri-2012 with MP-2021 projection scale 22.0 22.0 23.4 23.3 Germany Dr. K. Heubeck 2018 G 20.8 20.6 23.5 23.4 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.23 31.12.22 31.12.23 31.12.22 Switzerland BVG 2020 G with CMI 2022 projections 1 23.5 23.5 25.1 25.1 UK S3PA with CMI 2022 projections 2 24.0 25.0 25.7 26.4 USA Pri-2012 with MP-2021 projection scale 23.5 23.4 24.8 24.8 Germany Dr. K. Heubeck 2018 G 24.2 24.0 26.4 26.3 1 In 2022, BVG 2020 G with CMI 2021 projections was used. Sensitivity analysis of significant actuarial assumptions The table have been affected date. deemed sensitivities may not be linear. Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss plan UK plan US and German plans USD m 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Discount rate Increase by 50 basis points (857) (641) (164) (141) (50) (51) Decrease by 50 basis points 973 723 183 157 54 55 Rate of pension increase Increase by 50 basis points 639 487 137 127 4 4 Decrease by 50 basis points – 2 – 2 (129) (118) (4) (3) Rate of interest credit on retirement savings Increase by 50 basis points 144 106 – 3 – 3 9 9 Decrease by 50 basis points (144) (106) – 3 – 3 (8) (8) Life expectancy Increase in longevity by one additional year 416 304 78 65 39 39 1 The sensitivity analyses are based on a change in one increase was 0 % as of 31 December 2023 and as of 31 December 2022, a downward change in assumption assumption is not applicable. Fair value of plan assets The tables below plans. Composition and fair value of plan assets Swiss defined benefit plan 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 62 0 62 0 183 0 183 1 Real estate / property Domestic 0 2,426 2,426 13 0 2,130 2,130 13 Foreign 0 576 576 3 0 517 517 3 Investment funds Equity Domestic 489 0 489 3 418 0 418 2 Foreign 3,283 1,244 4,526 23 2,794 1,222 4,017 24 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 13 2,117 0 2,117 12 Foreign, AAA to BBB– 4,073 0 4,073 21 3,395 0 3,395 20 Foreign, below BBB– 668 0 668 3 598 0 598 4 Real estate Foreign 0 45 45 0 0 0 0 0 Other 1,094 1,910 3,004 16 867 1,997 2,864 17 Other investments 378 481 859 4 351 367 718 4 Total fair value of plan assets 12,652 6,681 19,333 100 10,724 6,233 16,957 100 31.12.23 31.12.22 Total fair value of plan assets 19,333 16,957 of which: 2 Bank accounts at UBS Group AG 69 189 UBS Group AG debt instruments 116 28 UBS Group AG shares 26 15 Securities lent to UBS Group AG 3 467 489 Property occupied by UBS Group AG 61 51 Derivative financial instruments, counterparty UBS Group AG 3 302 43 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s rating classification. positions disclosed 3 Securities lent to UBS AG and derivative of collateral, derivative financial instruments amounted to negative USD 19 m as of 31 December 2023 (31 December 2022: negative USD 5 m). Composition and fair value of plan assets UK defined benefit plan 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents (27) 0 (27) (1) 104 0 104 4 Bonds 1 Domestic, AAA to BBB– 2,375 0 2,375 87 1,729 0 1,729 69 Foreign, AAA to BBB– 357 0 357 13 297 0 297 12 Foreign, below BBB– 0 0 0 0 7 0 7 0 Investment funds Equity Domestic 9 3 12 0 19 3 22 1 Foreign 234 0 234 9 366 0 366 15 Bonds 1 Domestic, AAA to BBB– 310 38 348 13 367 90 457 18 Domestic, below BBB– 6 0 6 0 1 0 1 0 Foreign, AAA to BBB– 97 0 97 4 90 0 90 4 Foreign, below BBB– 93 0 93 3 114 0 114 5 Real estate Domestic 61 0 61 2 64 0 64 3 Foreign 4 12 16 1 6 31 36 1 Other 64 0 64 2 (280) 0 (280) (11) Repurchase agreements (947) 0 (947) (35) (612) 0 (612) (25) Other investments 15 16 31 1 66 27 94 4 Total fair value of plan assets 2,652 69 2,720 100 2,336 151 2,488 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s US and German defined benefit plans 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 4 0 4 0 7 0 7 1 Equity Domestic 54 0 54 5 55 0 55 5 Foreign 23 0 23 2 24 0 24 2 Bonds 1 Domestic, AAA to BBB– 308 0 308 30 359 0 359 35 Domestic, below BBB– 3 0 3 0 4 0 4 0 Foreign, AAA to BBB– 51 0 51 5 74 0 74 7 Foreign, below BBB– 2 0 2 0 3 0 3 0 Investment funds Equity Domestic 25 0 25 2 27 0 27 3 Foreign 43 0 43 4 33 0 33 3 Bonds 1 Domestic, AAA to BBB– 271 0 271 27 266 0 266 26 Domestic, below BBB– 172 0 172 17 109 0 109 10 Foreign, AAA to BBB– 4 0 4 0 2 0 2 0 Foreign, below BBB– 6 0 6 1 5 0 5 0 Real estate Domestic 0 9 9 1 0 11 11 1 Other 49 0 49 5 54 0 54 5 Other investments (8) 1 (7) (1) 5 1 6 1 Total fair value of plan assets 1,007 10 1,017 100 1,027 12 1,039 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s b) Defined contribution plans UBS AG sponsors obligation is limited to its contributions made matching contributions. USD 320 m in 2023 and USD 299 m in 2022. › Refer to Note 6 for more information c) Related-party disclosure UBS AG UBS AG is limited to, trading, do not 20 m in services 20 m). employment benefit plans held USD 396 m in UBS Group AG shares (31 December 253 m). › Refer to the “Composition and fair value of UBS AG and UBS Group AG instruments held Other comprehensive income – gains / (losses) on defined benefit plans USD m Swiss plan UK plan US and German plans Total For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Remeasurement of defined benefit obligation (1,901) 2,424 (96) 1,474 (33) 267 (2,031) 4,165 of which: change in discount rate assumption (1,332) 3,078 (69) 1,451 (33) 317 (1,434) 4,846 of which: change in rate of pension increase assumption 0 0 34 123 1 (5) 34 118 of which: change in rate of interest credit on retirement savings 207 (408) 0 0 (9) (82) 198 (490) of which: change in life expectancy 0 0 75 5 0 (1) 75 4 of which: change in other actuarial assumptions (88) (19) 0 1 5 48 (83) 30 of which: experience gains / (losses) 1 (688) (226) (135) (107) 3 (11) (820) (344) Return on plan assets excluding interest income 513 (1,942) 65 (1,312) 26 (223) 603 (3,476) Asset ceiling effect excluding interest expense and foreign currency 1,332 (656) 0 0 0 0 1,332 (656) Total gains / (losses) recognized in other comprehensive income for major plans (56) (173) (31) 162 (8) 43 (95) 32 Total gains / (losses) recognized in other comprehensive income for remaining plans (8) 8 Total gains / (losses) recognized in other comprehensive income 2 (103) 40 1 Experience (gains) / occurred. |
Employee benefits_ variable com
Employee benefits: variable compensation | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Equity Participation And Other Compensation Plans [Line Items] | |
Employee benefits: variable compensation [text block] | Note 27 a) Plans offered UBS has (GEB) members and other employees with the interests Share-based awards are granted paid in notional shares or cash. Awards are settled by delivering UBS shares at vesting, except in jurisdictions permitted for legal or tax reasons. Deferred employment with UBS. These compensation plans are also designed to meet provisions employees of UBS AG, the Group AG to UBS AG. For the purpose of this Note, refere The most significant deferred compensation plans › Refer to Note 1a Mandatory deferred compensation plans Long-Term Incentive Plan The Long-Term Group (i.e., GEB members and selected senior management). The number of notional shares delivered at vesting depends on two equally weighted year compares Important three period for selected senior management. Equity Ownership Plan / Fund Ownership Plan The Equity Ownership Plan are subject to deferral requirements. Certain Asset Plan or FOP, previously delivered depends on the value of the underlying investment Deferred Contingent Capital Plan The deferral requirements. discretion of UBS, can be settled in cash or a perpetual, marketable AT1 capital instrument. DCCP awards generally bear notional forfeited if a the risk of insolvency, the public capital ratio falls 20 % of DCCP year during the vesting period. Financial advisor variable compensation In line with market practice for US wealth management businesses, the compensation for US financial advisors in Global Wealth Management approach based on production. Cash Compensable production is generally based on transaction revenue and investment advisory fees and may reflect further adjustments. The percentage rate generally varies based Financial period. The annual deferred compensation amount reflects Cash compensation and carelessness, or failure to comply with the firm’s rules, standards, practices and / or policies, and / or applicable laws and regulations. Financial supporting the transition of related to compensation commitments with financial advisors vesting requirements. b) Effect on the income statement Effect on the income statement for the financial year and The table recognized in the financial year ended in the income statement for 2024 2023 performance unvested share average period of 2.6 Variable compensation Expenses recognized in 2023 Expenses deferred to 2024 and later 1 USD m Related to the 2023 performance year Related to prior performance years Total Related to the 2023 performance year Related to prior performance years Total Non-deferred cash 1,884 (36) 1,848 0 0 0 Deferred compensation awards 356 637 993 537 731 1,268 of which: Equity Ownership Plan 95 319 415 180 235 416 of which: Deferred Contingent Capital Plan 124 233 357 216 436 652 of which: Long-Term Incentive Plan 121 39 160 112 33 145 of which: Fund Ownership Plan 15 45 61 28 27 55 Variable compensation – performance awards 2,240 601 2,841 537 731 1,268 Variable compensation – financial advisors 2 3,761 788 4,549 1,236 3,300 4,536 of which: non-deferred cash 3,440 (4) 3,436 0 0 0 of which: deferred share-based awards 110 87 197 113 209 321 of which: deferred cash-based awards 169 245 414 301 1,029 1,331 of which: compensation commitments with recruited financial 42 459 501 822 2,062 2,884 Variable compensation – other 3 168 111 279 224 214 438 Total variable compensation 6,169 1,500 7,669 4 1,997 4,245 6,242 1 Estimate as awards and is based on that are subject to vesting requirements. 4 Includes USD 818 m in expenses related to share-based compensation 575 m; other variable compensation: USD 46 m; financial advisor compensation: USD 197 m). A further USD 135 m in expenses related to share-based compensation 4 m related to role-based allowances; 109 m; other personnel expenses: USD 22 m related to the Equity Plus Plan). Variable compensation (continued) Expenses recognized in 2022 Expenses deferred to 2023 and later 1 USD m Related to the 2022 performance year Related to prior performance years Total Related to the 2022 performance year Related to prior performance years Total Non-deferred cash 2,012 (9) 2,003 0 0 0 Deferred compensation awards 346 561 907 582 730 1,312 of which: Equity Ownership Plan 191 225 416 294 240 534 of which: Deferred Contingent Capital Plan 123 211 334 238 395 634 of which: Long-Term Incentive Plan 11 30 41 30 40 70 of which: Fund Ownership Plan 21 95 116 20 54 74 Variable compensation – performance awards 2,358 552 2,910 582 730 1,312 Variable compensation – financial advisors 2 3,799 709 4,508 1,290 2,652 3,942 of which: non-deferred cash 3,481 0 3,481 0 0 0 of which: deferred share-based awards 104 62 166 122 180 302 of which: deferred cash-based awards 185 215 400 588 636 1,224 of which: compensation commitments with recruited financial 29 432 461 580 1,836 2,416 Variable compensation – other 3 146 72 217 230 189 419 Total variable compensation 6,304 1,332 7,636 4 2,101 3,571 5,672 1 Estimate as awards and is based on that are subject to vesting requirements. 4 Includes USD 680 m in expenses related to share-based compensation (performance awards: USD 457 m; other variable compensation: USD 56 m; financial advisor compensation: USD 166 m). A further USD 80 m in expenses related to 4 m related to 57 m; other expenses: USD 19 m related to the Equity Plus Plan). Variable compensation (continued) Expenses recognized in 2021 Expenses deferred to 2022 and later 1 USD m Related to the 2021 performance year Related to prior performance years Total Related to the 2021 performance year Related to prior performance years Total Non-deferred cash 2,136 (8) 2,128 0 0 0 Deferred compensation awards 389 399 788 767 606 1,373 of which: Equity Ownership Plan 175 174 350 374 180 553 of which: Deferred Contingent Capital Plan 134 151 285 290 318 608 of which: Long-Term Incentive Plan 51 17 69 48 32 79 of which: Fund Ownership Plan 29 55 84 56 77 133 Variable compensation – performance awards 2,525 391 2,916 767 606 1,373 Variable compensation – financial advisors 2 4,175 685 4,860 1,097 2,323 3,419 of which: non-deferred cash 3,858 (6) 3,853 0 0 0 of which: deferred share-based awards 106 51 157 123 146 269 of which: deferred cash-based awards 170 202 372 311 495 806 of which: compensation commitments with recruited financial 41 438 479 662 1,682 2,344 Variable compensation – other 3 163 33 196 210 178 388 Total variable compensation 6,863 1,109 7,973 4 2,074 3,107 5,181 1 Estimate as of 31 compensable revenues and firm tenure using vesting requirements. USD 631 m in expenses related to share-based compensation 419 m; other variable compensation: USD 56 m; financial advisor compensation: USD 157 m). A further USD 77 m in expenses related to share-based 5 m related to 59 m; other personnel USD 13 m related to the Equity Plus Plan). c) Outstanding share-based compensation awards Share and performance share awards Movements in 2022 are provided in the table below. Movements in outstanding share-based compensation Number of shares 2023 Weighted average grant date fair value (USD) Number of shares 2022 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 614,428 17 295,921 15 Awarded during the year 279,310 20 358,424 19 Distributed during the year (132,770) 15 (37,994) 14 Forfeited during the year (4,043) 19 (1,923) 15 Outstanding, at the end of the year 756,925 19 614,428 17 of which: shares vested for accounting purposes 217,420 174,329 The 31 December 2022 was USD 14 m and USD 7 m, respectively. d) Valuation UBS share awards UBS measures compensation expense the SIX market conditions, where is discounted on at-the-money European without dividend between the grant date and distribution. |
Interests in subsidiaries
Interests in subsidiaries | 12 Months Ended |
Dec. 31, 2023 | |
Interests In Subsidiaries [Line Items] | |
Disclosure Of Interests In Subsidiaries Explanatory | Note 28 a) Interests in subsidiaries UBS AG to UBS AG’s and IFRS 12, Swiss regulations and the rules of the US Securities Individually significant subsidiaries The table below lists UBS AG’s individually significant subsidiaries as of 31 December 2023. Unless otherwise stated, the subsidiaries listed below of ownership interest held is equal to the voting The through a including in the UK, in a number of EU Member the currency of the legally registered office. Individually significant subsidiaries of 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Items USD 2,900.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Items USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct 1,000 2,900,000,000 . USD 100,000 1,283,000,000 . Other subsidiaries The table below to requirements set by the SEC. Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 153.8 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Items USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.7 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 2,841.6 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. Consolidated structured entities Consolidated vehicles. UBS AG has no individually significant subsidiaries that In 2023 and 2022, UBS support to when UBS future. resulted in UBS AG controlling the SE during the reporting |
Interests in associates and joi
Interests in associates and joint ventures | 12 Months Ended |
Dec. 31, 2023 | |
Interests In Associates And Joint Ventures [Line Items] | |
Disclosure of interests in associates and joint ventures [text block] | Note 28 b) Interests in associates and joint ventures As of Also, there were no significant restrictions on the ability of associates or joint ventures to transfer funds to UBS AG or its subsidiaries as cash dividends or or joint ventures of UBS AG. Investments in associates and joint ventures USD m 2023 2022 Carrying amount at the beginning of the year 1,101 1,243 Additions 1 3 Reclassifications 0 (44) Share of comprehensive income (180) (41) of which: share of net profit / (loss) 1 (163) 32 of which: share of other comprehensive income 2 (17) (73) Share of changes in retained earnings (1) 0 Dividends received (35) (31) Foreign currency translation 97 (30) Carrying amount at the end of the year 983 1,101 of which: associates 980 1,098 of which: SIX Group AG, Zurich 3 826 954 of which: other associates 154 144 of which: joint ventures 3 3 1 For 2023, consists of negative USD 163 m from associates (for 2022, consists of USD 27 m from associates and USD 5 m from joint ventures). 17 m from associates (for 2022, consists of negative USD 73 m from associates). 17 %. UBS AG is represented on the Board of Directors. |
Interests in unconsolidated str
Interests in unconsolidated structured entities | 12 Months Ended |
Dec. 31, 2023 | |
Interests In Unconsolidated Structured Entities [Line Items] | |
Disclosure Of Unconsolidated Structured Entities Explanatory | c) Unconsolidated structured entities UBS AG is considered to in establishing that 2023, securitization vehicles, client vehicles and certain 2023 because it did not control them. Interests in unconsolidated structured entities The table below total assets held by the SEs in which UBS had an interest parties, for which the carrying amount of UBS’s interest As a interests clearly government-sponsored entities included within Group Treasury’s HQLA absorb significant risk and third-party funding vehicles of large multi-nationals have been excluded as they are no longer considered changes, UBS AG does not disclose any interest in other vehicles Sponsored unconsolidated structured entities in which UBS During 2023 and 2022, UBS AG did not earn material income from have an interest at year-end. During 2023 and in the year. UBS AG perspective 0.5 bn 0.5 bn, (2022: 1 bn 3 bn, investors invested and redeemed market movements, resulted in a total closing net asset value 44 bn (31 December 2022: USD 38 bn). 31.12.23 USD m, except where indicated Securitization vehicles 1 Client Vehicles sponsored by UBS 2 Investment funds Total Maximum exposure to loss 3 Financial assets at fair value held for trading 88 37 7,413 7,538 7,538 Derivative financial instruments 2 147 66 215 215 Loans and advances to customers 0 0 200 200 200 Financial assets at fair value not held for trading 0 0 143 143 143 Financial assets measured at fair value through other comprehensive income 0 0 0 0 0 Other financial assets measured at amortized cost 188 0 0 188 438 Total assets 278 185 7,821 8,285 8,534 Derivative financial instruments 1 8 590 598 2 Total liabilities 1 8 590 598 2 Assets held by the unconsolidated structured entities in which UBS AG had an interest (USD bn) 17 4 2 5 118 6 31.12.22 USD m, except where indicated Securitization vehicles 1,2 Client Vehicles sponsored by UBS 2 Investment funds Total Maximum exposure to loss 3 Financial assets at fair value held for trading 263 2 5,884 6,149 6,149 Derivative financial instruments 3 160 115 278 278 Loans and advances to customers 0 0 119 119 119 Financial assets at fair value not held for trading 0 0 108 108 108 Financial assets measured at fair value through other comprehensive income 0 0 0 0 0 Other financial assets measured at amortized cost 0 0 2 3 252 Total assets 266 162 6,228 6,657 6,907 Derivative financial instruments 1 35 763 798 2 Total liabilities 1 35 763 798 2 Assets held by the unconsolidated structured entities in which UBS AG had an interest (USD bn) 39 4 2 5 95 6 1 Includes securities issued by securitization structured entities sponsored by both UBS regulatory requirements and are not party funding vehicles of large multi-nationals have been excluded, with prior periods restated. The restatement resulted in a 852 m and a decrease in interests in client vehicles of USD 5,057 m as of 31 December 2022. There was a corresponding decrease 11 bn and a decrease in assets held by client vehicles in which UBS has an interest of USD 105 bn as of 31 December 2022. credit enhancements. amount of UBS’s interests in the investment funds not sponsored by UBS. UBS AG letters generally equal to the market movements. amount, adjusted for losses already incurred, representing the The including unconsolidated SE or risk-reducing effects of collateral or In contractually obligated to do so, nor does UBS AG currently In 2023 movements Other , which were generally hedged with sponsored funds. Interests in securitization vehicles As securitization vehicles that relate to financing, The numbers outlined in the table Pillar 3 ubs.com/investors, synthetic interest Standards carrying amount within and (iii) different classification of vehicles viewed as sponsored › Refer to the 31 December 2023 Pillar 3 Report, ubs.com/investors, for more information Interests in client vehicles sponsored by UBS UBS-sponsored exposures. Such vehicles entity with the investor’s intended investment objective, As of relate to financing, secondary market and derivative Interests in investment funds Investment funds have a collective does not have a substantive effect have substantive voting or similar rights. UBS AG holds interests in a number structured product various pooled investment funds and receives fees based, in whole or in part, on the net asset value of the fund and / or the performance of the fund. The specific fee structure is determined based on various market fund’s nature and the represent an the performance fund’s assets and / or from the fund’s assets. by 356 bn 336 bn 31 December 2023 and 31 December 2022, respectively, and have been excluded from the table above. UBS AG have any material exposure to loss from these interests as |
Changes in organization and acq
Changes in organization and acquisitions and disposals of subsidiaries and businesses | 12 Months Ended |
Dec. 31, 2023 | |
Changes In Organisation And Disposals [Line Items] | |
Disclosure of changes in organisation and disposals [text block] | Note 29 Disposals of subsidiaries and businesses Sale of UBS Hana Asset Management Co., Ltd. In the fourth quarter of 2023, UBS AG completed the sale of its 51 % stake in UBS Hana Asset Management Co., Ltd. to Hana Securities. 23 m (net translation loss) in Asset Management which was recognized Other income . Changes in organization Legal structure integration In December 2023, the Board of Directors of UBS Group AG approved the merger of UBS AG and Credit Suisse AG, and both entities entered into a and is expected to occur by the end of the second quarter UBS also expects and the planned merger of UBS Switzerland AG and Credit |
Related parties
Related parties | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Related Parties [Line Items] | |
Disclosure Of Related Party Explanatory | Note 30 Related parties of UBS AG are: – entities UBS Group (including Credit Suisse subsidiaries from the date – associates UBS Group); – joint another party); – post-employment benefit plans for the benefit of UBS AG’s employees – key management personnel and close family members of – entities over which key management personnel or their significant influence. Key management personnel are those persons having authority the activities of the Group, directly or indirectly. the Executive Board Board (the GEB) of UBS Group AG to a) Remuneration of key management personnel The retirement. Total table below. Remuneration of key management USD m, except where indicated 31.12.23 31.12.22 31.12.21 Base salaries and other cash payments 1 35 26 30 Incentive awards – cash 2 24 16 17 Annual incentive award under DCCP 36 23 26 Employer’s contributions to retirement benefit plans 3 2 2 Benefits in kind, fringe benefits (at market value) 1 1 1 Share-based compensation 3 63 42 45 Total 162 110 122 Total (CHF m) 4 147 106 112 1 May include role-based allowances in line with market practice is based on composed of LTIP US dollar amounts translated at the applicable performance award currency exchange rates (2023: USD 0.91 ; 2022: USD / CHF 0.96 ; 2021: USD / CHF 0.92 ). The independent members of AG, and thus are not entitled to benefits upon termination of their service on the BoD. Payments to these individuals for their 11.7 m 10.6 m) 11.1 m (CHF 10.7 m) in 2022 and USD 7.5 m (CHF 6.9 m) in 2021. b) Equity holdings of key management personnel Equity holdings of key management personnel 1 31.12.23 31.12.22 Number of UBS Group AG shares held by members of the 2 5,121,564 2,443,580 1 No options were held in provisions. Of the share totals above, no shares were held by close family members of key management personnel on 31 December 2023 and 31 December 2022. by 31 December 2023, no member of the BoD AG. c) Loans, advances, mortgages and deposit balances The non-independent ordinary including interest rates and unfavorable features for the firm. Independent BoD members are granted loans and mortgages in the ordinary course of business at general market conditions. Outstanding balances with key management personnel were Loans, advances and mortgages to key management 1 USD m, except where indicated 2023 2022 Balance at the beginning of the year 28 28 Balance at the end of the year 2 55 28 Balance at the end of the year (CHF m) 2, 3 46 26 1 All loans are secured loans. 14 m (CHF 12 m) unused uncommitted credit facilities as of 31 December 2023 and no unused uncommitted credit facilities as of 31 December 2022. amounts disclosed represent the respective US dollar amounts translated at the relevant year-end In 21 m 18 m) 31 December 2023. d) Other related-party transactions with entities controlled In 2023 and 2022, UBS AG did not enter into transactions with entities, close 31 December Furthermore, in did not therefore also received no fees. e) Transactions with associates and joint ventures Loans to and outstanding receivables from associates USD m 2023 2022 Carrying amount at the beginning of the year 217 251 Additions 664 402 Reductions (716) (438) Foreign currency translation 18 1 Carrying amount at the end of the year 183 217 of which: unsecured loans and receivables 174 209 Other transactions with associates and As of or for the year ended USD m 31.12.23 31.12.22 Payments to associates and joint ventures for goods and services 155 138 Fees received for services provided to associates and joint ventures 10 4 Liabilities to associates and joint ventures 103 90 Commitments and contingent liabilities to associates 8 7 Refer to Note 28 for an overview of investments f) Receivables and payables from / to UBS Group AG USD m 31.12.23 31.12.22 Receivables Amounts due from banks 1 14,752 0 Cash collateral receivables on derivative instruments 312 1 Loans and advances to customers 4,889 2,807 Other financial assets measured at amortized cost 232 147 Financial assets at fair value held for trading 325 146 Derivative financial instruments 3,031 1 Payables Amounts due to banks 364 0 Cash collateral payables on derivative instruments 1,447 0 Customer deposits 3,069 2,119 Funding from UBS Group AG measured at amortized cost 67,282 56,147 Other financial liabilities measured at amortized cost 2,574 1,985 Derivative financial instruments 2,032 0 Other financial liabilities designated at fair value 2 2,995 1,796 1 Reflects funding provided to Credit Suisse. |
Invested assets and net new mon
Invested assets and net new money | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Invested Assets And Net New Money [Line Items] | |
Disclosure Of Invested Assets And Net New Money Explanatory | Note 31 The following including net new money, Invested assets Invested assets consist of all include managed fiduciary deposits, time deposits, savings accounts, and held management and transactional purposes, does not offer deposits from third-party banks for Discretionary assets are defined the client ultimately sold results independently providing a service to their respective clients, Net new money Net new money in a reporting less those withdrawn by existing clients and clients who terminated Net new determined at net new money inflows. excluded from net new money, Reclassifications between invested generally treated as net new imposed regulation reported as Other effects . The Investment Bank does not track Investment Bank already with UBS AG. In 2023 UBS AG has money and accounting applied to resulting in an increase to 24 bn and an increase 2022 of USD 8 bn, all relating to Asset Management. Invested assets and net new money As of or for the year ended USD bn 31.12.23 31.12.22 1 Fund assets managed by UBS 429 390 Discretionary assets 1,674 1,464 Other invested assets 2,402 2,127 Total invested assets 2 4,505 3,981 of which: double counts 411 340 Net new money 2 112 76 1 Comparative figures have been restated to include net new money and invested assets from associates. Development of invested assets USD bn 31.12.23 31.12.22 1 Total invested assets at the beginning of the year 2 3,981 4,614 Net new money 112 76 Market movements 3 379 (596) Foreign currency translation 69 (74) Other effects (37) (40) of which: acquisitions / (divestments) (25) (19) Total invested assets at the end of the year 2 4,505 3,981 1 Comparative figures have been restated to include net new money and invested assets from associates. |
Currency translation rates
Currency translation rates | 12 Months Ended |
Dec. 31, 2023 | |
Foreign Exchange Rates [Line Items] | |
Disclosure Of Effect Of Changes In Foreign Exchange Rates Explanatory | Note 32 The operations with a functional currency other than the Closing exchange rate Average rate 1 As of For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.21 1 CHF 1.19 1.08 1.11 1.05 1.09 1 EUR 1.10 1.07 1.08 1.05 1.18 1 GBP 1.28 1.21 1.25 1.23 1.37 100 JPY 0.71 0.76 0.71 0.76 0.91 1 Monthly income statement items of twelve month-end rates, weighted according to the income and expense may deviate from the weighted average rates for UBS AG. |
Main differences between IFRS a
Main differences between IFRS and Swiss GAAP | 12 Months Ended |
Dec. 31, 2023 | |
Main Differences Between IFRS And Swiss GAAP [Line Items] | |
Disclosure of main differences between IFRS and Swiss GAAP [text block] | Note 33 The consolidated financial statements of UBS AG are prepared in accordance with IFRS Accounting Standards. The Swiss Financial Accounting Standards and Swiss “Accounting – banks” recognition and FINMA governing true and fair view financial statement reporting 1. Consolidation Under GAAP controlled but investments measured at the lower of cost or market 2. Classification and measurement of financial assets Under comprehensive model within which the instruments are accounted for in cost, even form of securities for sale, and equity instruments with no permanent Financial investments at the lower of gains or Other income from ordinary activities. Equity Non-consolidated investments recorded in the Impairment of investments Reversals of impairments up to the original cost amount and realized gains or losses upon disposal of the investment are recorded as Extraordinary income / Extraordinary expenses . 3. Fair value option applied to financial liabilities Under IFRS Instruments for which the fair value option is applied are accounted for at FVTPL. The attributable to Other comprehensive Retained earnings . The fair value option is applied primarily to issued structured certain payables under repurchase agreements and cash collateral on securities lending agreements, amounts due under unit-linked investment contracts, and brokerage Under Swiss contract and fair value Net trading income . 4. Allowances and provisions for credit losses Swiss GAAP permit use on an expected credit loss (ECL) model. UBS has chosen to the ECL scope of both frameworks, IFRS Accounting Standards For the small residual IFRS Accounting Standards due to classification differences, – For exposures for which Pillar 1 internal ratings-based models are applied to measure credit risk, ECL is determined by the regulatory expected loss (EL), with an the next control” – For exposures for portfolio approach for the entire portfolio. 5. Hedge accounting Under IFRS Accounting portion of statement when hedged item attributable to the hedged risk is reflected in the measurement of the hedged item and is recognized in the income statement portion of the fair value change of a derivative on the balance sheet as Other assets Other liabilities . The carrying amount of the hedged item designated in fair value hedges is not adjusted for fair value changes attributable 6. Goodwill and intangible assets Under IFRS Accounting Standards, impairment. Intangible Under Swiss GAAP, five years, unless a longer useful life, which may 10 annually for impairment. 7. Post-employment benefit plans Swiss GAAP plans, with the election made on a plan-by-plan basis. UBS has elected to and Swiss statements. The are hybrid in benefit plans include savings, which are not considered under the used to determine the defined high-quality corporate bonds of the market in the respective pension plan country. The discount rate used in accordance with Swiss GAAP (i.e., the technical interest rate) is determined by the Pension Foundation Board based on the expected returns of the Board’s investment strategy. For defined benefit plans, IFRS Accounting Standards be recognized elected, changes GAAP. Swiss GAAP require statement. Swiss GAAP in accordance from pension asset required to contribute to the reduction of a pension deficit 8. Leasing Under (RoU) asset RoU asset liability unsecured borrowing prepayments, initial direct costs, any is depreciated over the shorter of the lease term or the Under underlying assets, are are recognized on General and basis over the lease term, which commences with control of the physical use of the asset. Lease incentives are treated as a reduction of rental expense and recognized on a consistent 9. Netting of derivative assets and liabilities Under IFRS Accounting Standards are (i) existence enforceable, counterparties; simultaneously. Under Swiss GAAP, are enforceable in the event of default, bankruptcy Note 33 10. Negative interest Under IFRS Accounting interest presented assets is presented 11. Extraordinary income and expense Certain non-recurring of participations, fixed and intangible as extraordinary items under Swiss GAAP. |
Supplemental guarantor informat
Supplemental guarantor information required under SEC regulations | 12 Months Ended |
Dec. 31, 2023 | |
Supplemental Guarantor Information [Line Items] | |
Condensed Financial Information Of Parent Company Only Disclosure [Text Block] | Note 34 Joint liability of UBS Switzerland AG In 2015, the Personal & Corporate Banking from terms of the asset transfer agreement, existing on issued by UBS AG. To guarantor. The 1.0 bn USD 3.3 bn as of 31 December 2023. The extinguishments, fair value movements and foreign currency effects. Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2023 Interest income from financial instruments measured at fair value through other comprehensive income 11,181 7,229 9,057 (5,022) 22,444 Interest expense from financial instruments measured at (14,797) (3,055) (7,699) 5,907 (19,643) Net interest income from financial instruments measured profit or loss and other 891 785 952 (864) 1,765 Net interest income (2,725) 4,959 2,310 22 4,566 Other net income from financial instruments measured profit or loss 7,879 1,031 1,105 (81) 9,934 Fee and commission income 2,581 5,067 13,350 (598) 20,399 Fee and commission expense (705) (456) (1,214) 585 (1,790) Net fee and commission income 1,876 4,611 12,136 (13) 18,610 Other income 2,994 228 1,542 (4,198) 566 Total revenues 10,023 10,829 17,092 (4,269) 33,675 Credit loss expense / (release) 18 57 31 37 143 Personnel expenses 3,356 2,201 10,097 0 15,655 General and administrative expenses 3,951 3,840 6,155 (2,828) 11,118 Depreciation, amortization and impairment of non-financial 888 411 1,048 (109) 2,238 Operating expenses 8,195 6,452 17,301 (2,937) 29,011 Operating profit / (loss) before tax 1,810 4,320 (240) (1,370) 4,521 Tax expense / (benefit) 251 779 224 (48) 1,206 Net profit / (loss) 1,559 3,540 (463) (1,321) 3,315 Net profit / (loss) attributable to non-controlling interests 0 0 25 0 25 Net profit / (loss) attributable to shareholders 1,559 3,540 (488) (1,321) 3,290 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2023 Comprehensive income attributable to shareholders Net profit / (loss) 1,559 3,540 (488) (1,321) 3,290 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 79 1,523 222 (975) 849 Financial assets measured at fair value through other comprehensive income, net of tax 3 4 1 0 5 Cash flow hedges, net of tax 707 679 23 (9) 1,400 Cost of hedging, net of tax (19) 0 (19) Total other comprehensive income that may be reclassified to the income statement, net of tax 771 2,202 245 (984) 2,235 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (82) (36) (19) 0 (136) Own credit on financial liabilities designated at fair value, net of tax (790) (790) Total other comprehensive income that will not be reclassified to the income statement, net of tax (872) (36) (19) 0 (927) Total other comprehensive income (101) 2,167 226 (984) 1,308 Total comprehensive income attributable to shareholders 1,458 5,707 (262) (2,305) 4,598 Total comprehensive income attributable to non-controlling interests 27 27 Total comprehensive income 1,458 5,707 (235) (2,305) 4,625 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2023 Assets Cash and balances at central banks 49,620 87,044 35,142 171,806 Amounts due from banks 61,579 6,241 16,696 (56,311) 28,206 Receivables from securities financing transactions measured at amortized cost 61,116 63 37,022 (24,073) 74,128 Cash collateral receivables on derivative instruments 34,048 1,640 9,124 (12,512) 32,300 Loans and advances to customers 91,940 255,205 93,581 (35,093) 405,633 Other financial assets measured at amortized cost 24,403 9,149 23,429 (2,647) 54,334 Total financial assets measured at amortized cost 322,705 359,343 214,995 (130,636) 766,407 Financial assets at fair value held for trading 121,947 101 14,463 (1,412) 135,098 of which: assets pledged as collateral that may be sold or repledged by counterparties 51,325 0 5,930 (12,731) 44,524 Derivative financial instruments 126,916 5,845 40,190 (41,223) 131,728 Brokerage receivables 12,924 7,959 0 20,883 Financial assets at fair value not held for trading 46,658 10,022 29,688 (22,613) 63,754 Total financial assets measured at fair value through profit or loss 308,444 15,968 92,300 (65,249) 351,463 Financial assets measured at fair value through other comprehensive income 1,957 276 2,233 Investments in subsidiaries and associates 52,134 37 2 (51,190) 983 Property, equipment and software 5,842 1,798 3,687 (284) 11,044 Goodwill and intangible assets 212 5,974 79 6,265 Deferred tax assets 1,488 147 7,633 (24) 9,244 Other non-financial assets 5,366 1,748 1,256 7 8,377 Total assets 698,149 379,042 326,124 (247,298) 1,156,016 Liabilities Amounts due to banks 55,680 44,170 58,769 (141,898) 16,720 Payables from securities financing transactions measured at amortized cost 14,329 336 15,288 (24,171) 5,782 Cash collateral payables on derivative instruments 35,148 1,076 11,091 (12,430) 34,886 Customer deposits 108,279 293,133 118,168 36,094 555,673 Funding from UBS Group AG measured at amortized cost 67,282 67,282 Debt issued measured at amortized cost 58,729 11,042 12 0 69,784 Other financial liabilities measured at amortized cost 6,589 2,974 6,147 (2,997) 12,713 Total financial liabilities measured at amortized cost 346,036 352,731 209,475 (145,402) 762,840 Financial liabilities at fair value held for trading 27,280 248 5,508 (1,325) 31,712 Derivative financial instruments 135,272 6,223 40,436 (41,225) 140,707 Brokerage payables designated at fair value 30,724 11,552 0 42,275 Debt issued designated at fair value 85,424 986 (69) 86,341 Other financial liabilities designated at fair value 14,392 21,081 (8,107) 27,366 Total financial liabilities measured at fair value through profit or loss 293,092 6,471 79,564 (50,726) 328,401 Provisions 1,903 208 413 (1) 2,524 Other non-financial liabilities 1,572 1,377 3,688 46 6,682 Total liabilities 642,602 360,788 293,140 (196,083) 1,100,448 Equity attributable to shareholders 55,546 18,254 32,649 (51,215) 55,234 Equity attributable to non-controlling interests 335 0 335 Total equity 55,546 18,254 32,984 (51,215) 55,569 Total liabilities and equity 698,149 379,042 326,124 (247,298) 1,156,016 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2023 Net cash flow from / (used in) operating activities (23,275) (3,041) (1,886) (28,202) Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (1) (3) (4) Disposal of subsidiaries, associates and intangible assets 2 109 109 Purchase of property, equipment and software (427) (287) (569) (1,283) Disposal of property, equipment and software 33 33 Net (purchase) / redemption of financial assets measured income 15 15 30 Purchase of debt securities measured at amortized cost (9,561) (1,431) (3,251) (14,244) Disposal and redemption of debt securities measured at amortized 4,890 1,625 3,920 10,435 Net cash flow from / (used in) investing activities (4,942) (94) 112 (4,924) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) 7,138 (1) 44 7,181 Distributions paid on UBS AG shares (6,000) (6,000) Issuance of debt designated at fair value and long-term debt measured 3 101,956 2,007 588 104,551 Repayment of debt designated at fair value and long-term debt measured 3 (84,366) (1,017) (159) (85,541) Net cash flows from other financing activities (249) (251) (501) Net activity related to group internal capital transactions and dividends 3,698 (2,944) (754) 0 Net cash flow from / (used in) financing activities 22,177 (1,954) (532) 19,690 Total cash flow Cash and cash equivalents at the beginning of the year 63,608 86,232 45,359 195,200 Net cash flow from / (used in) operating, investing and financing (6,040) (5,089) (2,306) (13,435) Effects of exchange rate differences on cash and cash equivalents 591 7,860 253 8,704 Cash and cash equivalents at the end of the year 4 58,159 89,003 43,307 190,469 of which: cash and balances at central banks 4 49,537 87,044 35,142 171,723 of which: amounts due from banks 4 2,763 1,448 7,866 12,078 of which: money market paper 4,5 5,858 511 299 6,668 1 Cash flows generally represent a third-party associates. 4,553 m of cash and cash equivalents were restricted. included in the balance sheet under Financial assets at fair value not held for trading, Other financial assets measured at amortized Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2022 Interest income from financial instruments measured at fair value through other comprehensive income 4,824 3,894 4,661 (1,575) 11,803 Interest expense from financial instruments measured at (5,449) (736) (2,604) 2,093 (6,696) Net interest income from financial instruments measured profit or loss and other 881 546 431 (449) 1,410 Net interest income 257 3,704 2,488 68 6,517 Other net income from financial instruments measured profit or loss 5,541 900 940 112 7,493 Fee and commission income 2,875 4,865 13,766 (660) 20,846 Fee and commission expense (684) (464) (1,327) 652 (1,823) Net fee and commission income 2,191 4,401 12,439 (8) 19,023 Other income 6,732 203 3,329 (8,382) 1,882 Total revenues 14,721 9,208 19,197 (8,210) 34,915 Credit loss expense / (release) (17) 50 (3) (1) 29 Personnel expenses 3,251 1,995 9,835 0 15,080 General and administrative expenses 3,374 3,258 5,029 (2,660) 9,001 Depreciation, amortization and impairment of non-financial 871 340 744 (109) 1,845 Operating expenses 7,496 5,592 15,607 (2,769) 25,927 Operating profit / (loss) before tax 7,242 3,566 3,592 (5,440) 8,960 Tax expense / (benefit) (28) 638 1,083 151 1,844 Net profit / (loss) 7,270 2,928 2,509 (5,592) 7,116 Net profit / (loss) attributable to non-controlling interests 0 0 32 0 32 Net profit / (loss) attributable to shareholders 7,270 2,928 2,477 (5,592) 7,084 1 Amounts presented for UBS AG under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated statement USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2022 Comprehensive income attributable to shareholders Net profit / (loss) 7,270 2,928 2,477 (5,592) 7,084 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (114) (197) (506) 298 (519) Financial assets measured at fair value through other comprehensive income, net of tax 3 (3) 0 9 0 6 Cash flow hedges, net of tax (2,791) (1,359) (631) (12) (4,793) Cost of hedging, net of tax 45 45 Total other comprehensive income that may be reclassified to the income statement, net of tax (2,863) (1,555) (1,128) 286 (5,260) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (112) 23 0 81 Own credit on financial liabilities designated at fair value, net of tax 796 796 Total other comprehensive income that will not be reclassified to the income statement, net of tax 966 (112) 23 0 877 Total other comprehensive income (1,897) (1,667) (1,104) 286 (4,383) Total comprehensive income attributable to shareholders 5,373 1,261 1,373 (5,306) 2,701 Total comprehensive income attributable to non-controlling interests 18 18 Total comprehensive income 5,373 1,261 1,391 (5,306) 2,719 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2022 Assets Cash and balances at central banks 48,689 84,465 36,291 0 169,445 Amounts due from banks 39,691 6,357 19,063 (50,441) 14,671 Receivables from securities financing transactions measured at amortized cost 51,493 903 34,110 (18,691) 67,814 Cash collateral receivables on derivative instruments 35,594 1,221 10,074 (11,856) 35,033 Loans and advances to customers 90,168 229,861 101,231 (31,233) 390,027 Other financial assets measured at amortized cost 24,005 9,532 21,880 (2,029) 53,389 Total financial assets measured at amortized cost 289,641 332,339 222,649 (114,250) 730,379 Financial assets at fair value held for trading 95,810 173 13,899 (1,848) 108,034 of which: assets pledged as collateral that may be sold or repledged by counterparties 41,056 0 5,578 (9,892) 36,742 Derivative financial instruments 149,447 5,925 35,106 (40,368) 150,109 Brokerage receivables 9,763 0 7,814 0 17,576 Financial assets at fair value not held for trading 45,302 4,354 26,843 (17,091) 59,408 Total financial assets measured at fair value through profit or loss 300,321 10,453 83,661 (59,308) 335,127 Financial assets measured at fair value through other comprehensive income 1,953 0 286 0 2,239 Investments in subsidiaries and associates 54,323 33 0 (53,255) 1,101 Property, equipment and software 5,852 1,654 4,077 (267) 11,316 Goodwill and intangible assets 213 0 6,050 5 6,267 Deferred tax assets 1,624 276 7,470 (16) 9,354 Other non-financial assets 6,930 1,768 951 4 9,652 Total assets 660,856 346,522 325,144 (227,087) 1,105,436 Liabilities Amounts due to banks 41,395 37,123 51,555 (118,477) 11,596 Payables from securities financing transactions measured at amortized cost 9,425 247 13,303 (18,774) 4,202 Cash collateral payables on derivative instruments 35,528 1,518 11,191 (11,800) 36,436 Customer deposits 98,628 273,316 132,619 22,608 527,171 Funding from UBS Group AG measured at amortized cost 56,147 0 0 56,147 Debt issued measured at amortized cost 50,706 8,965 1 (173) 59,499 Other financial liabilities measured at amortized cost 4,903 2,221 5,554 (2,287) 10,391 Total financial liabilities measured at amortized cost 296,733 323,391 214,222 (128,903) 705,442 Financial liabilities at fair value held for trading 25,059 183 5,843 (1,570) 29,515 Derivative financial instruments 153,778 6,177 35,314 (40,363) 154,906 Brokerage payables designated at fair value 32,346 0 12,746 (7) 45,085 Debt issued designated at fair value 71,444 0 508 (110) 71,842 Other financial liabilities designated at fair value 17,888 0 17,074 (2,928) 32,033 Total financial liabilities measured at fair value through profit or loss 300,514 6,360 71,484 (44,977) 333,382 Provisions 1,904 239 1,041 (2) 3,183 Other non-financial liabilities 1,630 1,019 3,742 98 6,489 Total liabilities 600,782 331,009 290,490 (173,785) 1,048,496 Equity attributable to shareholders 60,075 15,513 34,313 (53,303) 56,598 Equity attributable to non-controlling interests 342 0 342 Total equity 60,075 15,513 34,655 (53,303) 56,940 Total liabilities and equity 660,856 346,522 325,144 (227,087) 1,105,436 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2022 Net cash flow from / (used in) operating activities 17,286 (1,165) (5,491) 10,630 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (3) (3) Disposal of subsidiaries, associates and intangible assets 2 157 453 1,120 1,729 Purchase of property, equipment and software (562) (292) (624) (1,478) Disposal of property, equipment and software 161 161 Net (purchase) / redemption of financial assets measured income (943) 244 (699) Purchase of debt securities measured at amortized cost (22,602) (2,690) (5,500) (30,792) Disposal and redemption of debt securities measured at amortized 14,442 870 3,487 18,799 Net cash flow from / (used in) investing activities (9,346) (1,663) (1,274) (12,283) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (12,215) (3) (31) (12,249) Distributions paid on UBS AG shares (4,200) (4,200) Issuance of debt designated at fair value and long-term debt measured 3 78,866 550 41 79,457 Repayment of debt designated at fair value and long-term debt measured 3 (66,526) (860) (284) (67,670) Net cash flows from other financing activities (258) (337) (595) Net activity related to group internal capital transactions and dividends 5,217 (2,088) (3,128) 0 Net cash flow from / (used in) financing activities 884 (2,401) (3,740) (5,257) Total cash flow Cash and cash equivalents at the beginning of the year 57,895 92,799 57,061 207,755 Net cash flow from / (used in) operating, investing and financing 8,824 (5,229) (10,505) (6,911) Effects of exchange rate differences on cash and cash equivalents (3,111) (1,338) (1,196) (5,645) Cash and cash equivalents at the end of the year 4 63,608 86,232 45,359 195,200 of which: cash and balances at central banks 4 48,607 84,465 36,291 169,363 of which: amounts due from banks 4 2,957 1,550 8,821 13,329 of which: money market paper 4,5 12,044 216 248 12,508 1 Cash flows generally represent sales of: UBS AG’s shareholding investments administration 4 Balances with an original maturity 4,253 m of cash and cash equivalents held for trading, Financial assets measured at fair value through other comprehensive income, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Interest income from financial instruments measured at fair value through other comprehensive income 3,130 3,652 2,456 (703) 8,534 Interest expense from financial instruments measured at (2,847) (520) (1,024) 1,025 (3,366) Net interest income from financial instruments measured profit or loss and other 1,229 254 228 (274) 1,437 Net interest income 1,512 3,386 1,660 48 6,605 Other net income from financial instruments measured profit or loss 3,751 807 1,369 (83) 5,844 Fee and commission income 3,837 5,204 16,151 (770) 24,422 Fee and commission expense (810) (481) (1,450) 755 (1,985) Net fee and commission income 3,027 4,723 14,702 (14) 22,438 Other income 7,555 221 1,560 (8,396) 941 Total revenues 15,845 9,137 19,291 (8,445) 35,828 Credit loss expense / (release) (65) (98) (10) 24 (148) Personnel expenses 3,401 2,098 10,161 1 15,661 General and administrative expenses 4,255 3,442 4,474 (2,696) 9,476 Depreciation, amortization and impairment of non-financial 949 285 755 (114) 1,875 Operating expenses 8,605 5,825 15,390 (2,809) 27,012 Operating profit / (loss) before tax 7,305 3,409 3,910 (5,660) 8,964 Tax expense / (benefit) 203 622 1,090 (11) 1,903 Net profit / (loss) 7,102 2,788 2,820 (5,649) 7,061 Net profit / (loss) attributable to non-controlling interests 0 0 29 0 29 Net profit / (loss) attributable to shareholders 7,102 2,788 2,792 (5,649) 7,032 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Comprehensive income attributable to shareholders Net profit / (loss) 7,102 2,788 2,792 (5,649) 7,032 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (1) (419) (607) 517 (510) Financial assets measured at fair value through other comprehensive income, net of tax 0 (157) 0 (157) Cash flow hedges, net of tax (1,129) (279) (250) (17) (1,675) Cost of hedging, net of tax (26) (26) Total other comprehensive income that may be reclassified to the income statement, net of tax (1,155) (699) (1,014) 500 (2,368) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (135) 67 0 102 Own credit on financial liabilities designated at fair value, net of tax 46 46 Total other comprehensive income that will not be reclassified to the income statement, net of tax 217 (135) 67 0 148 Total other comprehensive income (939) (834) (947) 500 (2,220) Total comprehensive income attributable to shareholders 6,163 1,954 1,845 (5,149) 4,813 Total comprehensive income attributable to non-controlling interests 13 13 Total comprehensive income 6,163 1,954 1,858 (5,149) 4,826 1 Amounts presented for UBS AG under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2021 Net cash flow from / (used in) operating activities 5,714 2,131 22,718 30,563 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (1) (1) Disposal of subsidiaries, associates and intangible assets 2 16 0 577 593 Purchase of property, equipment and software (656) (276) (650) (1,581) Disposal of property, equipment and software 294 1 295 Net (purchase) / redemption of financial assets measured income (817) 67 (750) Purchase of debt securities measured at amortized cost (1,840) (45) (3,038) (4,922) Disposal and redemption of debt securities measured at amortized 1,033 817 2,658 4,507 Net cash flow from / (used in) investing activities (1,970) 495 (385) (1,860) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (3,073) (21) 0 (3,093) Distributions paid on UBS AG shares (4,539) (4,539) Issuance of debt designated at fair value and long-term debt measured 3 97,250 1,177 193 98,619 Repayment of debt designated at fair value and long-term debt measured 3 (78,385) (1,093) (320) (79,799) Net cash flows from other financing activities (280) 20 (261) Net activity related to group internal capital transactions and dividends 5,240 (537) (4,702) 0 Net cash flow from / (used in) financing activities 16,212 (475) (4,811) 10,927 Total cash flow Cash and cash equivalents at the beginning of the year 39,400 93,342 40,689 173,430 Net cash flow from / (used in) operating, investing and financing 19,957 2,151 17,523 39,630 Effects of exchange rate differences on cash and cash equivalents (1,462) (2,693) (1,151) (5,306) Cash and cash equivalents at the end of the year 4 57,895 92,799 57,061 207,755 of which: cash and balances at central banks 4 53,729 91,031 47,946 192,706 of which: amounts due from banks 4 3,258 1,588 8,975 13,822 of which: money market paper 4,5 908 179 139 1,227 1 Cash flows generally represent sale of the minority stake in Clearstream Fund Centre AG and dividends received from USD 3,408 m of cash and cash equivalents were restricted. other comprehensive income, Financial assets at fair value not held for trading and Other financial |
MD&A - Risk management and cont
MD&A - Risk management and control | 12 Months Ended |
Dec. 31, 2023 | |
MDA Risk Management And Control [Line Items] | |
Disclosure Of Financial Risk Management Explanatory | Credit risk: the risk of loss resulting from the failure of a client or counterparty contractual obligations toward UBS AG. risk. Settlement risk: security versus cash) where we must deliver without we will receive the consideration. Loan underwriting risk: that are intended for further distribution. Step-in risk: entity that is facing stress in the absence of, or in such support. Market risk market variables. Market variables include observable rates, equity prices, credit spreads and commodity (including that may be unobservable or only indirectly observable, includes issuer risk and investment risk. Issuer risk: the risk of loss that would occur if an issuer to securities or derivatives referencing the issuer was subject to Investment risk: Liquidity risk: unexpected current and forecast cash flows and collateral operations or the financial condition of the Funding risk: the market on an unsecured (or even secured) basis at proposed commitments, i.e., the risk that UBS AG’s firm’s current business and desired strategy. We apply a concentrations. Risks that are include generally developed by dedicated units within control Risk concentrations may exist where one or several positions within in potential impact is a critical component of our risk management For financial risks, we consider a number of elements, such and the sensitivity of positions to changes in the underlying risk factors. Also of the markets risk-mitigating factors. This includes an the hedge might be traded. Particular risk is defined as a positive correlation between the size of the exposure and the likelihood of a loss. Risk on risk is when a position and its risk mitigation can be impacted by the same For non-financial risks, risk concentrations may result from, for example, a single operational risk issue that is large on its own (i.e., it has or related risk issues that may link together to create Risk Governance, and assessed to do that emerge in a stressed environment differ markedly from those Main sources of credit risk – Global Wealth Management credit risk hedge fund from derivatives trading. – A substantial secured therefore depends on the performance of the Swiss economy and – The Derivatives trading and securities financing are and give rise to temporary concentrated exposure. – Credit risk and derivatives, and residual exposures to securitized products. Overview of measurement, monitoring and management – Credit risk exposure at default (EAD) and loss given default (LGD). Limits are established for individual counterparties and groups of approved by the Board of Directors and divisional CROs, based on risk exposure amounts, internal credit rating – Limits apply not only to the current outstanding exposure of traded products. The Investment Bank monitoring, measurement and limit framework distinguishes between held to maturity (take-and-hold exposures) and those intended – We use models to derive portfolio credit risk measures of expected loss, statistical loss and stress loss at firm-wide and business division levels, and to establish portfolio limits. – Credit risk concentrations can arise if clients are engaged or have affected by changes in economic, political or other conditions. To avoid credit risk concentrations, we establish limits / operational exposure, country risk and specific product exposures. Counterparty credit SFTs, out basis. over the with frameworks are also used to control overall exposure to specific sectors. to senior management. Trading in OTC derivatives are not used, we have clearly defined under bilateral allow for initial margin is taken to cover some or all taken collateral agreements securities government debt or other margining uncleared OTC margining counterparties, resulting in lower close-out risk over time. UBS AG actively hedging. UBS AG uses a scoring model as part of a modifying Swiss mortgage loans. The model’s two key factors The value assigned to each purchase valuation. UBS AG similarly applies underwriting guidelines loan portfolio, taking mortgage types, such type, loan size, and 45 80 %. In addition to LTV, also part of our underwriting guidelines. A risk limit framework is applied to set segments, such to senior set up to mortgage underwriting and documentation requirements. For underwriting guidelines with regions, the underwriting guidelines a stressed for commercial real repayment strategy property 30 % to 70 %, depending on the type supported by personal guarantees of stress scenarios to ensure that exposures remain within predefined Lombard loans are financial securities are primarily transferable securities, such as approved security provides Lending values securities are calculated to cover a possible adverse change in market value over a given close-out period and confidence level. Less Concentration and correlation risks across collateral posted across counterparties. Targeted securities, issuers or issuer groups, industry sectors, countries, regions or currencies may result in higher risk and reduced liquidity. In UBS AG instruments to actively or portfolios and, for CCR, the profit or loss effect We have strict guidelines when monitoring hedges credit protection also creates credit protection relevant counterparties, this includes loan. reported to UBS portfolio. Exposures to individual counterparties are measured using three generally accepted parameters: PD, EAD and LGD. For a given credit facility, the product of these three parameters results basis for the advanced internal ratings-based credit risk measures of EL, statistical loss and stress loss. Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa2 CCC+ to CCC CCC+ to CCC 13 >17 Caa3 to C CCC- to C CCC- to C Counterparty is in default Default Defaulted D D In line with the due; (ii) it is subject to restructuring proceedings, where tenor, to payment; or (iv) there is other evidence that payment Default and credit-impaired UBS AG uses a purposes. defaulted when days for certain exposures in private presumption application of the 90-day criterion would not accurately reflect as defaulted when: bankruptcy, insolvency proceedings restructured on preferential terms (forbearance); or there is other evidence that payment obligations will not be without recourse when due. If as defaulted. An identified carrying amount following a risk event of the issuer or originated with a defaulted counterparty. Once a financial asset is classified as defaulted / credit impaired past due credit-restructured, and there is transfer back to stages 1 or 2 can be triggered. However, If payment default is difficulties that we would otherwise rates, forbearance measure takes Forbearance supersede the preferential conditions, our risk tolerance. Contractual conditions are within our usual risk tolerance, are not considered Main sources of market risk Market risks arise from both trading and non-trading – Trading market trading for core and Legacy and our municipal securities trading business – Non-trading market personal banking and lending in our wealth management Banking business division, – Group Treasury assumes market risks the Group’s liquidity and funding profile, including high-quality – Equity and defined benefit pension schemes. Overview of measurement, monitoring and management techniques – Market business lines, reflecting the nature and magnitude of the – Management value-at-risk (VaR) measures exposures under and some by Market and Treasury Risk Control functions. – Our primary portfolio measures of market risk are liquidity-adjusted stress are approved by the Board of Directors (the BoD). – These measures are Our trading businesses are subject and volatility, quality. – Trading transaction expiries or changes not generally seek to distinguish in the trading portfolio between Issuer risk is controlled by limits applied at the business division level based on jump-to-zero measures, which estimate maximum default exposure (the default event loss assuming – Non-trading management of consolidated capital activity. Our CRO Treasury function applies a holistic risk framework, setting the appetite for treasury-related risk-taking activities across UBS AG. and the sensitivity BoD to balance the effect of foreign exchange movements ratio. Non-trading interest rate and foreign exchange risks are included in firm-wide statistical and stress which flow into our risk appetite framework. Equity and debt investments are management and Risk Control stress-testing metrics. VaR (holding period) at an established level of confidence. VaR assumes no change in UBS AG’s trading time horizon. UBS AG developed VaR model, which simulates returns over the holding period to, and commodity, simulation approach. UBS AG uses an unweighted five-year look-back window. for equity good-quality historical data. simulates idiosyncratic returns through in such a way that systematic and residual risk are consistently captured. When modeling risk factor returns, we consider the stationarity properties of the historical time series of risk the logarithmic returns. Risk factor return distributions are updated Risk factor office systems, enabling us to capture material non-linear UBS AG uses a single (RWA), purposes, risk limits are 95 % confidence level with period, aligned to the way we consider the risks associated with our trading activities. The regulatory measure of market risk 99 % confidence returns. Additionally, the portfolio populations VaR positions. For instead under the securitization approach for regulatory We also regulatory 99 %). For SVaR, period from 1 January 2007 to the present. SVaR is computed Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of UBS AG business divisions and Group Items by general market risk type 1 For the year ended 31.12.23 USD m Equity Interest rates Credit spreads Foreign exchange Commodities Min. 3 9 3 1 1 Max. 19 21 19 10 10 Average 9 12 6 2 3 31.12.23 11 18 7 2 3 Total management VaR 7 25 15 19 Average (per business division and risk type) Global Wealth Management 1 2 1 2 0 1 2 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 5 23 14 18 9 12 5 2 3 Non-core and Legacy 1 2 1 1 0 1 1 0 0 Group Items 3 6 4 4 1 3 3 1 0 Diversification effect 2,3 (6) (6) (1) (4) (4) (1) 0 For the year ended 31.12.22 4 USD m Equity Interest rates Credit spreads Foreign exchange Commodities Min. 2 8 4 2 2 Max. 17 18 9 11 7 Average 6 10 5 3 3 31.12.22 6 10 4 3 3 Total management VaR 6 18 11 9 Average (per business division and risk type) Global Wealth Management 1 2 1 1 0 1 1 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 6 17 10 8 6 9 5 3 3 Group Functions (including Non-core and Legacy Portfolio) 3 5 4 5 1 4 3 1 0 Diversification effect 2,3 (5) (5) (1) (3) (4) (1) 0 1 Statistics at individual levels may not be summed to deduce the corresponding aggregate figures. business line or risk type, being driven time series, rendering invalid the simple summation of figures to arrive at the aggregate total. 3 As the minima and acquisition UBS values as the risk profile compared with UBS AG does not materially differ. Actual realized market risk losses may differ – VaR is calibrated to a specified level of confidence and – The capture market risk of positions that cannot be closed out – In portfolios. – Effects sensitivities, calculations. – The choice of a quickly as time. Similarly, after periods for a period of time influenced by the length of the historical SVaR is longer datasets for a financial crisis is to use that data. This approach UBS AG recognizes that of metrics with material completeness of risk our comprehensive stress testing framework. We also have a framework to identify and quantify potential risks as risks not in VaR. The framework underpins these potential No material changes were made to the UBS AG VaR IRRBB arises Financial assets at fair issued measured at these positions may affect treatment. UBS AG’s Wealth Management and Personal & Corporate Banking, as well hedges in Corporate Banking interest rate different sources The residual accounting. Short-term with external interest rate swaps are designated in fair value hedge accounting Risk management and governance IRRBB is measured using several metrics, the most – EVE sensitivity accounting treatment. e.g., VaR and stress scenarios, as well as the regulatory interest rate scenarios. These are measured and reported daily. The regulatory IRRBB It excludes the sensitivity from additional tier 1 (AT1) capital instruments (as per modeled interest rate shock scenarios to its banking book positions – Net horizon, which we implied forward rates and assuming constant business The sensitivities are measured and reported monthly. UBS AG actively manages NII exposure at consolidated and significant legal entity levels. The independent governance. › Refer to “Risk measurement” in this section for Key modeling assumptions The cash margins and Our external issuances are discounted using UBS’s senior debt curve, and date. NII balance sheet structure and volumes, and considers The average repricing to protect by simulating and applying a real-world market rate UBS AG uses an and consolidated. macroeconomic regulatory prepayment and early redemption penalties. The EVE sensitivity 28.1 m as of 31 December 2023, 25.0 m as of 31 December USD 4.8 m from AT1 The majority of our modeled 22.4 m (31 December 19.6 m) assigned estate, with the aim of generating a 15.8 m and USD 5.6 m are attributable to the US dollar and the Swiss franc portfolios, respectively 14.0 m and USD 4.8 m, respectively). In addition The “Parallel change in EVE of negative USD 5.3 bn, or 9.3 %, of our tier 1 capital (31 December 2022: negative USD 4.6 bn, or 8.4 %), which is well below the 15 % threshold as per the BCBS banking book. The immediate effect on UBS AG’s tier 1 capital in the “Parallel up” scenario a decrease of 0.5 bn, or 0.9 % (31 December 0.4 bn, or 0.7 %), reflecting the of our banking book have a positive effect on NII, assuming a constant balance UBS AG also applies granular internal interest rate shock book’s specific risk profile. Net interest income sensitivity The main NII We IRRBB. This with various shocks of –200 and +200 basis points under the assumption Interest rate risk – banking book 31.12.23 USD m Effect on EVE 1 Effect on EVE 1 Scenarios CHF EUR GBP USD Other Total Additional tier 1 (AT1) capital instruments Total +1 bp (4.3) (0.7) 0.0 (23.1) 0.1 (28.1) 4.8 (23.3) Parallel up 2 (608.9) (142.9) 2.2 (4,522.3) (15.0) (5,287.0) 888.3 (4,398.7) Parallel down 2 686.1 150.0 (11.8) 4,593.2 17.1 5,434.5 (1,028.0) 4,406.6 Steepener 3 (335.2) (16.0) (13.1) (973.6) (23.0) (1,361.0) 95.9 (1,265.1) Flattener 4 214.1 (6.8) 12.3 (94.1) 17.5 142.9 104.7 247.6 Short-term up 5 (38.5) (48.4) 13.4 (1,909.8) 7.1 (1,976.3) 477.4 (1,498.9) Short-term down 6 42.9 49.8 (14.3) 2,036.8 (10.0) 2,105.3 (498.9) 1,606.4 31.12.22 USD m Effect on EVE 1 Effect on EVE 1 Scenarios CHF EUR GBP USD Other Total Additional tier 1 (AT1) capital instruments Total +1 bp (4.1) (0.6) 0.1 (20.4) (0.1) (25.0) 3.4 (21.5) Parallel up 2 (576.5) (111.6) 33.4 (3,936.5) (26.3) (4,617.2) 652.5 (3,964.7) Parallel down 2 644.2 142.2 (45.7) 4,066.1 21.9 4,828.5 (702.8) 4,125.7 Steepener 3 (256.7) (93.2) (28.2) (1,026.7) (3.3) (1,408.2) (47.3) (1,455.5) Flattener 4 144.7 75.4 32.7 95.4 (2.6) 345.8 191.1 536.9 Short-term up 5 (84.1) 37.1 42.4 (1,514.7) (13.9) (1,532.9) 440.8 (1,092.2) Short-term down 6 88.1 (36.1) (42.6) 1,654.0 13.4 1,676.6 (457.8) 1,218.8 1 Economic value increase. UBS companies, investments in technology companies via them at required by agreement to buy, The investments are generally intended For these reasons, However, such equity investments are subject to a different by business management senior management. They are also included appetite framework. As of 2.9 bn, of 1.9 bn was classified as Financial assets at fair value not held for 1.0 bn as Investments in associates . Debt investments classified 31 December 2023 were measured categorized as money market instruments and debt securities primarily held for statutory, The risk control framework applied to comprehensive exposures may be included They are also included in our Debt instruments value of USD 2.2 bn as of 31 December 2023, compared with USD 2.2 bn as of 31 December 2022. |
MD&A - Capital management
MD&A - Capital management | 12 Months Ended |
Dec. 31, 2023 | |
MDA Capital Management [Line Items] | |
Disclosure Of Objectives Policies And Processes For Managing Capital Explanatory | An adequate level of internal assessment and regulatory requirements Reconciliation of equity under IFRS Accounting Standards to Swiss SRB common equity tier 1 capital USD m 31.12.23 31.12.22 Total equity under IFRS Accounting Standards 55,569 56,940 Equity attributable to non-controlling interests (335) (342) Defined benefit plans, net of tax (336) (311) Deferred tax assets recognized for tax loss carry-forwards (3,004) (4,077) Deferred tax assets for unused tax credits (97) Deferred tax assets on temporary differences, excess over threshold (1,233) (262) Goodwill, net of tax 1 (5,750) (5,754) Intangible assets, net of tax (146) (150) Expected losses on advanced internal ratings-based portfolio less provisions (532) (471) Unrealized (gains) / losses from cash flow hedges, net of tax 2,961 4,234 Own credit related to (gains) / losses on financial liabilities 313 (523) Own credit related to (gains) / losses on derivative financial instruments (63) (105) Prudential valuation adjustments (177) (201) Accruals for dividends to shareholders (3,000) (6,000) Other (39) (51) Total common equity tier 1 capital 44,130 42,929 1 Includes goodwill related to significant investments in financial institutions of USD 20 m as of 31 December 2023 (31 December 2022: USD 20 m) presented on the balance sheet line Investments in associates. CET1 capital mainly consists of: share capital; share premium, which primarily consists of additional paid-in capital related to capital is provided capital” table. CET1 1.2 bn 44.1 bn before tax of USD 4.5 bn, with associated current tax expenses of USD 1.4 bn, positive foreign currency translation effects of USD 0.9 bn and a 0.2 bn in eligible dividend accruals of USD 3.0 bn. Loss-absorbing AT1 capital 0.7 bn to USD 12.5 bn, mainly driven by two 3.5 bn and positive interest risk hedge, foreign currency translation and other effects. These increases were partly offset by a USD 2.5 bn AT1 capital instrument that ceased to be eligible of the instrument. In addition, high-trigger loss-absorbing AT1 1.1 bn equivalent previously on lent from the Group to UBS AG were transferred to Credit Total 7.5 bn to 54.5 bn as of included USD 53.9 bn of TLAC-eligible |
Summary of material accountin_4
Summary of material accounting policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Material Accounting Policies Descriptions [Line Items] | |
Basis of accounting | Basis of accounting The International Accounting Standards Board (the IASB), Disclosures marked as audited in the “Risk, capital, liquidity an integral part of the Financial Statements. These disclosures relate to requirements under IFRS 7, Financial Instruments: Disclosures , and IAS 1, Presentation of Financial Statements , and are not repeated in this section. The stated in Note 1b. |
Critical accounting estimates and judgments | Critical accounting estimates and judgments Preparation of these Financial Statements under affect reported amounts of assets, liabilities, time they are made. Such estimates and which encompass historical updating them as necessary. Changes in those may differ significantly from UBS AG’s estimates, which could The following Statements: – expected credit loss measurement (refer to item 2g in this Note – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 10 in this – post-employment benefit plans (refer to item 5 in – goodwill (refer to item 9 in this Note and to Note – consolidation of structured entities (refer to item 1 in this Note |
Consolidation and related policies | 1) Consolidation The Financial Statements include the financial statements of UBS AG and its subsidiaries, presented as a single economic entity; intercompany including (ii) exposure to the entity‘s variable returns; Consideration is given the current ability to direct the relevant activities of an entity when Subsidiaries, when control ceases. Control, or the lack thereof, is reassessed if facts and circumstances to one or more elements required to establish that control Business combinations are is measured at the non-controlling interest’s proportionate Critical accounting estimates and judgments Each individual entity is assessed for consolidation in line with the aforementioned consolidation principles. The assessment of requires involvement is unique for each entity, there is no uniform consolidation outcome by entity. may not. When carrying out the consolidation assessment, judgment is exercised considering all and activities of the investee, as well as the |
Financial instruments | 2) Financial instruments a. Recognition UBS AG generally recognizes However, (applying settlement date accounting to all standard purchases UBS AG retirement benefit criteria are Financial Statements. Client cash balances associated with derivatives clearing if, through contractual balances. b. Classification, measurement and presentation Financial assets Where the contractual (SPPI) on within a business model that has an objective of holding financial assets to collect contractual cash flows, or at fair value through other contractual cash flows and selling financial assets. All other those managed on a fair value basis, except for derivatives designated in certain hedge accounting relationships item 2j in this Note for more information). Business model assessment and contractual cash flow characteristics UBS AG determines particular business objective at the time an asset is recognized In assessing asset instrument. This assessment includes contractual (ESG) triggers. Financial liabilities Financial liabilities measured at amortized cost Financial liabilities Debt issued Funding from Group AG measured at amortized cost . The latter includes contingent capital instruments issued to UBS Group to November 2023 that contain contractual provisions under either a specified common equity tier 1 (CET1) ratio breach or a determination by the Swiss Financial Market Supervisory Authority (FINMA) that a viability event has occurred. Such contractual provisions are not derivatives, as the underlying is deemed contractual equity the debt is issued in Share premium separately from the amortized cost debt host. When the legal bail-in mechanism for write-down of issued debt instruments, it does not affect the accounting classification If a debt were to be written down or converted into equity in a future period, it would be partially or fully derecognized, with statement. Financial liabilities measured at fair value through profit or UBS AG designates certain issued debt instruments that such financial instruments the cash Financial instruments instruments. Measurement and presentation After initial IFRS 9, as described in the table below. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – amounts due from banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d in this Note; – ECL and reversals; and – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, see below in this table. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities held as HQLA. Measured at fair value, reported in Other comprehensive income , net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized recognized in the income statement: – interest income, which is accounted for in accordance with item 2d in this Note; – ECL and reversals; and – FX translation gains and losses. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short- term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded derivatives (ETD) and over-the-counter (OTC)-cleared derivatives that are legally settled on basis or economically net settled on a daily basis, are presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other Financial assets mandatorily measured at FVTPL that not held for trading include: – certain structured instruments, certain commercial loans, and receivables from securities financing transactions that are managed on a fair value basis; – loans managed on a fair value basis, hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity instruments; – assets held under unit-linked investment contracts. Classification, measurement and presentation Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – sweep deposits; – payables – non-structured debt issued; – subordinated debt; – commercial paper and certificates of deposit; – obligations against funding from UBS Group AG; – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Interest income generated from client deposits derecognized pursuant to certain deposit sweep is presented within Net interest income from financial instruments measured at fair value through and other . Measured at FVTPL Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS AG has third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes UBS AG’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis economically net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL Financial liabilities designated – issued hybrid debt instruments, linked, credit-linked and rates-linked bonds or notes; – issued debt instruments managed on a fair basis; – obligations against funding from UBS Group AG managed on a fair value basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. |
Loan commitments | Loan commitments commitments |
Financial guarantee contracts | Financial guarantee contracts are contracts that require UBS AG to make specified payments to reimburse an incurred loss because a specified debtor debt instrument. |
Interest income and expense | d. Interest income and expense Interest calculating the effective interest rate (the EIR) for financial instruments (other than UBS AG estimates future with However, applying the EIR credit loss allowance. Upfront fees, including fees on loan commitments not measured at fair value where a loan is expected to be issued, and direct costs are and recognized over the expected life of the instrument Fees related to loan commitments does not same effective yield for comparable risk as other participants, are included in Net fee and commission income recognized over the life of the commitment or when syndication Interest expense expense, except when interest rates are negative, |
Derecognition | e. Derecognition Financial assets UBS AG substantially all the risks and rewards of the asset or a significant part of the risks and rewards combined with a practical ability to sell or pledge the asset. Where transferred evidenced financial determined by the extent to which it is exposed to changes Financial liabilities UBS AG derecognizes discharged, canceled or expires. When an existing financial liability is exchanged for a new one from the same lender on substantially derecognized income statement. Certain OTC derivative counterparties on a daily basis represents a legal or economic settlement, |
Fair value of financial instruments | f. Fair value of financial instruments UBS AG measurement date between market market. Critical accounting estimates and judgments The use of valuation techniques, modeling assumptions and estimates of significant unobservable inputs participants would consider in estimating fair value, UBS AG’s governance arising from changing significant unobservable |
Allowances and provisions for expected credit losses | g. Allowances and provisions for expected credit losses ECL are receivables, undrawn master credit before UBS AG can take credit risk Recognition of expected credit losses ECL are recognized on the following basis. – Stage 1 instruments: Maximum 12-month ECL ECL that would result occurring. – Stage 2 instruments: Lifetime ECL are to events over the no longer observed, the instrument will move back to stage – Stage 3 instruments: the occurrence Credit-impaired exposures they are expected to be fully recoverable through collateral – Changes in lifetime ECL since initial recognition are also PCI financial counterparty; All or part of a claim written off are generally credited to Credit loss expense / (release) . ECL are recognized in the income statement in Credit loss expense / (release) . A corresponding ECL allowance is reported as a decrease assets that Other comprehensive . For presented in Provisions. Default and credit impairment UBS AG applies a single definition of counterparty classified as defaulted based on quantitative Measurement of expected credit losses IFRS 9 ECL reflect The method (LGD) and on the materiality of approach is applied that are point-in-time(PIT)-based material portfolios, PDs independent. For the based (A-IRB) framework and Pillar 2 stress loss models. Adjustments have been made to these models and IFRS 9-related models have been developed that consider the complexity, structure and that PDs and LGDs used in the ECL calculation are PIT-based, as opposed to the corresponding Basel III through-the-cycle (TTC) validation and oversight processes. Probability of default: PD represents the probability the probability of default determined for the next 12 months and a lifetime PD represents the remaining lifetime industry and information. Exposure at default: EAD represents an estimate of considering expected repayments, interest payments and accruals, are considered through and the characteristics of the respective portfolios. Loss given default: LGD represents an estimate expected proceedings commonly expressed Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination especially To accommodate represented by risks, and for for economic or changes in the nature and severity of the underlying scenario The determined weights constitute not that the chosen particular narratives with the related Macroeconomic and other factors The range and historical information availability of purposes, UBS AG period, to cycle-neutral PD and LGD for longer-term Factors relevant taken into account, with specific focus on Switzerland and For calculation: – gross domestic product (GDP) growth rates, given their significant – unemployment rates, given their significant effect on private – house price indices, given their significant effect on mortgage – interest rates, given their significant effect on counterparties’ – consumer price and economic stability; and – equity indices, given that they are an important factor Scenario generation, review process and governance A team of economists, with involvement from a broad range The scenarios, IFRS 9 Scenario and Group may not be capable allowance. The framework, ratifies the decisions taken by the ECL Management ECL measurement period The period for which to commitments and for which UBS AG has an obligation to extend credit. Additionally, some financial instruments include both an on-demand loan and a revocable undrawn commitment, where the contractual cancellation right does not limit UBS client has to estimate have a defined managed as one portfolio level, with applied for credit card limits, to credit risk. Customary master credit commitments. negative indicators. The risk Larger UBS AG has reviews measurement period from the reporting date which UBS AG from the respective reporting date. Significant increase in credit risk Financial instruments subject maximum 12 since initial recognition of the financial instrument, applying both Primarily, UBS AG assesses changes in forward-looking and scenario-weighted lifetime PD of an – at the reporting date; and – at inception of the instrument. If, based on and the instrument is transferred to stage 2 with lifetime The threshold for those financial asset PIT applied are defined on a more granular level by interpolating SICR thresholds Internal rating at origination of the instrument Rating downgrades / SICR trigger 0–3 3 4–8 2 9–13 1 Irrespective of increased for an instrument if contractual payments specifically the Swiss instruments are transferred before a and Global reclassified to stage 3, a one-year period is applied before Additionally, economic conditions, counterparties may be moved to a watch list, which is used as a secondary qualitative indicator for an sharing the same credit risk characteristics to take account In general, the overall SICR determination process does not certain monitoring processes stage 3 position. In exceptional cases, an individual adjustment and a transfer into stage 2 may be made to take account of specific facts. Credit risk different requirements are instrument-specific, such that maturing loans in stage 2 will migrate to stage 1 upon renewal irrespective of the risk-based determine what risk-mitigating actions may be warranted. Critical accounting estimates and judgments The calculation of ECL requires timing and the amount of ECL recognized. Determination of a significant increase in IFRS 9 does not include a definition of what constitutes an Management Forum has been established to Scenarios, scenario weights and macroeconomic ECL reflect forward-looking Scenario Sounding and to determine whether any additional post-model ECL measurement period Lifetime ECL are generally callable master credit applied for credit card limits, capped at 12 months for Modeling and post-model adjustments A number of affect ECL. The models are governed by UBS AG’s model validation controls ECL Management Forum and endorsed by the A sensitivity analysis covering key macroeconomic |
Restructured and modified financial assets | h. Restructured and modified financial assets When payment default is expected, in financial difficulties that extension of maturity, Modifications result in an or as part of a credit financial asset being derecognition, any difference between gross carrying amount of the given financial asset is recognized |
Offsetting | i. Offsetting UBS AG presents financial assets and liabilities on its recognized simultaneously. transactions with various counterparties, exchanges and clearing houses. In simultaneously, emphasis is all credit and liquidity exposure between the counterparties. This condition precludes offsetting substantial amounts of UBS AG’s financial assets arrangements. Repurchase arrangements the settlement and payables in a single settlement process or cycle. |
Hedge accounting | j. Hedge accounting UBS AG applies hedge accounting requirements of are met. Voluntary discontinuation of Fair value hedges of interest rate risk related to The amount hedging instrument. Fair value hedges of FX risk related to debt instruments The fair value change of the hedged item attributable item and foreign currency basis spread of cross-currency swaps designated as and accounted Other Equity . amounts are released to the income Discontinuation of fair value hedges Discontinuations for reasons which method. If the hedged item is derecognized, the unamortized fair value adjustment or deferred is recognized immediately in the income statement Cash flow hedges of forecast transactions Fair value gains or repricing Other Equity Interest from financial Interest expense affect profit transactions statement. Hedges of net investments in foreign operations Gains or losses Other comprehensive income Equity , while any gains (for example, the disposal of the foreign Equity the entity is reclassified to Other income . Interest Rate Benchmark Reform UBS AG replaced with would continue to with little or by alternative risk-free interest Amendments to IFRS 9, IAS 39, and IFRS 16 (Interest Rate Benchmark Reform – Phase 2) , where applicable . |
Fee and commission income and expenses | 3) Fee and commission income and expenses UBS AG earns fee income from the diverse range of services it provides to its clients. Fee income can be divided into two broad clients’ assets, custody services deal-contingent merger and acquisitions UBS AG recognizes fees earned from PIT services requires services to be provided Consideration nature considered to include a the client, e.g., management significant judgment in allocating the consideration received PIT services where the amount of revenue is known when the performance obligation is met. Fixed-over-time fees are recognized on a straight-line to customer’s performance related to contingencies beyond UBS AG’s control until such UBS AG’s fees are generally earned from component or term nature of such contracts, any significant contract assets or liabilities. UBS AG presents expenses primarily in that revenues, which are generally Total revenues Fee and commission expense , and those to Operating expenses . For its specific directly offset against the associated income collected from the given |
Share-based and other deferred compensation plans | 4) Share-based and other deferred compensation plans UBS AG recognizes expenses for deferred compensation awards over the period that the service to affected by restructuring programs or mutually agreed termination provisions, recognition of such expense is accelerated to the who compensation expense is grant date. Share-based compensation plans UBS Group AG is the to employees share-based payment transactions. UBS AG recognizes the fair value of UBS Group inherent in the award, market conditions, and non-vesting conditions. For equity-settled awards, incremental estimate of performance conditions. For equity-settled relate to a service or performance condition) do not result For cash-settled recognized equals the cash distributed. Other deferred compensation plans Compensation depending on expected to be paid under the equals the cash or the fair value of respective financial |
Post-employment benefit plans | 5) Post-employment benefit plans Defined benefit plans Defined benefit plans specify an amount of benefit factors, the present value of the of the Other comprehensive income . If the fair value of the plan’s assets is higher than the present value of the defined benefit obligation, the recognition of form of obligation or employer, and Critical accounting estimates and judgments The net defined benefit determined significantly alter the defined rate, expected movements in each significant assumption for Defined contribution plans A benefits sufficient Compensation expense is generally in the year of contribution. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in future payments is available. |
Income taxes | 6) Income taxes UBS AG is subject business operations. UBS AG’s provision for income taxes is composed of current and deferred taxes. Current income taxes represent taxes to be paid or refunded for the current period or previous periods Deferred tax assets amounts and periods. DTAs may also arise measured using reporting period and that will be in effect when such differences DTAs are recognized differences can extent that there are sufficient taxable temporary differences or there is convincing other evidence that sufficient taxable profit will be available against which the unused tax losses Deferred and current tax to the be settled net or realized simultaneously. Current and deferred taxes are recognized as income tax benefit or expense and deferred taxes recognized in relation to: (i) amount of goodwill arising from the acquisition); (ii) unrealized gains or losses on at defined benefit through (v) above are recognized in Other comprehensive income Equity . UBS AG reflects the considered probable by value methods, the uncertainty will be resolved. Critical accounting estimates and judgments Tax laws are complex, the performance of remaining tax loss carry-forward period, and its future profitability and business plan forecasts is inherently subjective Forecasts are required to prove there is sufficient future profitability income statement. In addition, judgment is the resolution of any income tax-related appeals and litigation. |
Investment in associates | 7) Investments in associates Interests in entities where UBS AG has significant influence does accounting. Typically, of an entity’s voting rights. Investments or decreased after the date of acquisition impairment losses. carrying amount of the investment in the associate exceeds |
Property, equipment and software | 8) Property, equipment and software Property, development costs are capitalized benefits calculated on a straight-line basis over an asset’s estimated Property, alongside goodwill and intangible assets as assets property that has a that would be currently required by a market participant to replace the service capacity of the asset. If such assets are no longer used, they are tested individually for impairment. |
Goodwill | 9) Goodwill Goodwill represents liabilities of of whether there An impairment charge cash-generating-unit. Critical accounting estimates and judgments UBS AG‘s methodology for goodwill impairment available to shareholders (typically estimated Standards, in order to reflect facts and circumstances specific to a cash-generating growth rate. Earnings available to shareholders are estimated on the basis of forecast results, which are part of the business plan approved by the BoD. The discount rates and management. The key assumptions used to determine the recoverable amounts of each cash-generating unit are tested for sensitivity by changes to those assumptions. |
Provisions and contingent liabilities | 10) Provisions and contingent liabilities Provisions are Provisions, Contingent Liabilities and Contingent , when: (i) UBS AG has is probable that of the obligation can be made. The benefits. change the scope of the business Provisions accordance with measurement principles set out in item 4 in this Note. In addition, UBS AG presents expected credit loss allowances within Provisions credit line. IAS 37 provisions at the balance sheet date. When conditions required to recognize a provision are not met, a contingent liability is disclosed, unless the likelihood of an outflow events, Critical accounting estimates and judgments Recognition of provisions often involves significant judgment in assessing the existence of an obligation that results from past events and in probability, the timing and the amount of any outflows of resources. This is particularly the case for litigation, regulatory and similar matters, which, due to their nature, are subject to many uncertainties, The amount of any provision matter. Management regularly reviews all the available information regarding such matters, including legal advice, to assess whether the recognition criteria provisions have been satisfied and to determine the |
Foreign currency translation | 11) Foreign currency translation Transactions spot exchange FVOCI, and closing exchange rate. Translation Other net income from fair value through profit or loss . Non-monetary items measured at historical cost are translated Upon at the closing exchange rate on the balance sheet date, are translated at the Equity and UBS AG no Share historic average rate and the spot rate Share premium. amounts recognized Other comprehensive are translated at Retained earnings . |
Segment reporting (Tables)
Segment reporting (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Operating Segments [Line Items] | |
Disclosure Of Operating Segments Explanatory | USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group Items 1 UBS AG For the year ended 31 December 2023 Net interest income 5,436 3,128 (39) (2,612) 25 (1,372) 4,566 Non-interest income 13,194 2,158 2,108 10,371 34 1,244 29,109 Total revenues 18,631 5,285 2,069 7,759 59 (128) 33,675 Credit loss expense / (release) 25 50 (1) 67 1 1 143 Operating expenses 14,900 2,889 1,706 7,588 1,010 919 29,011 Operating profit / (loss) before tax 3,705 2,346 364 104 (952) (1,048) 4,521 Tax expense / (benefit) 1,206 Net profit / (loss) 3,315 Additional information Total assets 369,176 257,068 19,662 381,023 13,845 115,242 1,156,016 Additions to non-current assets 666 219 70 445 0 0 1,400 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group 1 UBS AG For the year ended 31 December 2022 Net interest income 5,274 2,192 (19) (241) 1 (690) 6,517 Non-interest income 13,689 2,113 2,980 2 8,958 236 423 28,398 Total revenues 18,963 4,304 2,961 8,717 237 (267) 34,915 Credit loss expense / (release) 0 39 0 (12) 2 0 29 Operating expenses 14,069 2,475 1,565 6,890 104 823 25,927 Operating profit / (loss) before tax 4,894 1,790 1,396 1,839 131 (1,091) 8,960 Tax expense / (benefit) 1,844 Net profit / (loss) 7,116 Additional information Total assets 388,624 235,330 16,971 391,495 13,367 59,649 1,105,436 Additions to non-current assets 42 13 1 33 0 1,773 1,862 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy 1 Group Items 1 UBS AG For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (11) (215) 6,605 Non-interest income 15,175 2,144 2,632 8,978 70 224 29,222 Total revenues 19,419 4,264 2,617 9,459 60 9 35,828 Credit loss expense / (release) (29) (86) 1 (34) 0 0 (148) Operating expenses 14,743 2,623 1,593 6,902 138 1,014 27,012 Operating profit / (loss) before tax 4,706 1,726 1,023 2,592 (78) (1,005) 8,964 Tax expense / (benefit) 1,903 Net profit / (loss) 7,061 Additional information Total assets 3 395,235 225,425 25,202 346,641 25,153 98,488 1,116,145 Additions to non-current assets 56 16 1 30 0 1,689 1,791 1 As of or for the year ended 31 December 2023, Non-core and Legacy (previously reported within Group Functions) became a separate reportable segment and Group Functions has been renamed Group Items. Prior periods have been revised to reflect these changes. 848 m gain in Asset Management related to the sale of refined the methodology applied to allocate balance sheet assets allocated to business divisions would have been USD 26 bn higher, of which USD 14 bn would have related to the Investment Bank. |
Disclosure Of Geographical Areas Explanatory | For the year ended 31 December 2023 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 13.3 39 8.6 47 Asia Pacific 5.2 15 1.2 7 Europe, Middle East and Africa (excluding Switzerland) 6.1 18 2.6 14 Switzerland 9.2 27 5.9 32 Global (0.1) 0 0.0 0 Total 33.7 100 18.3 100 For the year ended 31 December 2022 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 13.8 40 9.0 48 Asia Pacific 5.6 16 1.5 8 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.6 14 Switzerland 7.7 22 5.6 30 Global 0.8 2 0.0 0 Total 34.9 100 18.7 100 For the year ended 31 December 2021 Total revenues Total non-current assets USD bn Share % USD bn Share % Americas 1 14.5 40 9.0 47 Asia Pacific 6.5 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.6 13 Switzerland 7.8 22 6.3 33 Global 0.1 0 0.0 0 Total 35.8 100 19.3 100 1 Predominantly related to the US. |
Net interest income and other i
Net interest income and other income from fair value changes on financial instruments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Tables [Line Items] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Tables Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Net interest income from financial instruments measured 1,765 1,410 1,437 Other net income from financial instruments measured 1 9,934 7,493 5,844 Total net income from financial instruments measured at fair value through profit or loss and 11,698 8,903 7,281 Net interest income Interest income from loans and deposits 2 19,637 9,634 6,489 Interest income from securities financing transactions measured 3 3,450 1,378 513 Interest income from other financial instruments measured 1,152 545 284 Interest income from debt instruments measured at fair 103 74 115 Interest resulting from derivative instruments designated as cash (1,898) 173 1,133 Total interest income from financial instruments measured at amortized cost and fair 22,444 11,803 8,534 Interest expense on loans and deposits 4 14,977 4,488 1,655 Interest expense on securities financing transactions measured 5 1,714 1,089 1,102 Interest expense on debt issued 2,855 1,031 512 Interest expense on lease liabilities 97 88 98 Total interest expense from financial instruments measured at amortized cost 19,643 6,696 3,366 Total net interest income from financial instruments measured at amortized cost and fair 2,801 5,108 5,168 Total net interest income from financial instruments measured at fair value through profit or loss 1,765 1,410 1,437 Total net interest income 4,566 6,517 6,605 1 Includes net losses from financial liabilities 4,065 m (net gains of USD 17,036 m in 2022 and net losses 6,457 m in 2021). This complementary financial liabilities designated at fair value excludes transactions into the respective liabilities designated at fair value included net 2,045 m (net gains of USD 4,112 m and net losses of USD 2,068 m in 2022 and 2021, respectively) from notes issued by UBS AG’s Asset Management business. These gains / on the financial assets hedging the unit-linked investment contracts, which are not disclosed as part of Net gains / (losses) from financial liabilities designated at fair value. and balances at central banks, amounts due from banks and customers, and cash collateral receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits, and collateral payables on derivative instruments. due to banks, cash collateral payables on derivative instruments, customer deposits, and funding from UBS Group AG measured at amortized cost, as well as negative interest on cash and balances at central banks, amounts due from banks, and cash collateral receivables on derivative instruments. |
Net fee and commission income (
Net fee and commission income (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Net fee And Commission Income Tables [Line Items] | |
Disclosure Of Fee And Commission Income Expense Tables Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Underwriting fees 637 633 1,512 M&A and corporate finance fees 669 804 1,102 Brokerage fees 3,323 3,487 4,383 Investment fund fees 4,730 4,942 5,790 Portfolio management and related services 9,091 9,059 9,762 Other 1,950 1,921 1,874 Total fee and commission income 1 20,399 20,846 24,422 of which: recurring 14,008 14,229 15,410 of which: transaction-based 6,320 6,550 8,743 of which: performance-based 71 68 269 Fee and commission expense 1,790 1,823 1,985 Net fee and commission income 18,610 19,023 22,438 1 For the 12,687 m for Global 1,840 m for Personal 2,723 m for Asset Management, USD 3,153 m for the Investment Bank, USD 7 m for Non-core and Legacy and negative USD 11 m for Group Items (for the year ended 31 December 2022: USD 12,990 m for Global Wealth Management, USD 1,657 m for 2,840 m for 3,350 m for 0 m for 10 m for ended 31 December 2021: USD 14,545 m for Global Wealth 1,645 m for Personal 3,337 m for Asset Management, 4,863 m for the Investment 0 m for Non-core and Legacy and USD 33 m for Group Items). For the year ended 31 December Functions has been renamed Group Items. Prior periods have been revised to reflect these changes. |
Other income (Tables)
Other income (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other Income Tables [Line Items] | |
Disclosure Of Other Operating Income Tables Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 24 148 (11) Net gains / (losses) from disposals of investments in associates 0 844 2 41 Share of net profits of associates and joint ventures (163) 3 32 105 Total (138) 1,024 134 Net gains / (losses) from disposals of financial assets measured (1) (1) 9 Income from properties 4 18 20 22 Net gains / (losses) from properties held for sale 8 71 100 5 Income from shared services provided to UBS Group AG or its subsidiaries 568 460 451 Other 6 112 308 7 224 8 Total other income 566 1,882 941 1 Includes foreign exchange gains / (losses) reclassified and disposals of 848 m gain related 255 m share of impairment losses reflected in the SIX Group profit 191 m reported in Personal 64 m reported in Global Wealth Management. third parties. 21 m related to the repurchase of UBS AG‘s 23 m in 2022 and a loss of USD 17 m in 2021). 133 m gain on the sale of UBS AG’s domestic wealth 111 m (with the remaining amount disclosed within Net gains / (losses) from acquisitions and disposals of subsidiaries) and income of USD 111 m related to a legacy litigation settlement and a legacy bankruptcy claim. 100 m from the sale of UBS AG’s domestic wealth management business in Austria. |
Personnel expenses (Tables)
Personnel expenses (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Personnel Expenses Tables [Line Items] | |
Disclosure Of Employee Benefits Tables Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Salaries 1 5,898 5,528 5,723 Variable compensation 2 7,669 7,636 7,973 of which: performance awards 2,841 2,910 2,916 of which: financial advisors 3 4,549 4,508 4,860 of which: other 279 217 196 Contractors 98 119 142 Social security 835 730 762 Post-employment benefit plans 4 579 555 582 of which: defined benefit plans 259 256 280 of which: defined contribution plans 320 299 303 Other personnel expenses 576 513 479 Total personnel expenses 15,655 15,080 15,661 1 Includes role-based approach. It also information. Includes curtailment 3 m for the 13 m; for the 49 m), which represent a reduction in the defined benefit obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. |
General and administrative ex_2
General and administrative expenses (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
General And Administrative Expenses Tables [Line Items] | |
Disclosure Of General And Administrative Expense Tables Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Outsourcing costs 478 451 426 Technology costs 558 502 490 Consulting, legal and audit fees 650 494 465 Real estate and logistics costs 679 507 530 Market data services 400 367 367 Marketing and communication 209 195 171 Travel and entertainment 205 156 66 Litigation, regulatory and similar matters 1 816 348 910 Other 7,123 5,981 6,051 of which: shared services costs charged by UBS Group AG or its subsidiaries 6,203 5,264 5,321 Total general and administrative expenses 11,118 9,001 9,476 1 Reflects the net increase, including recoveries from third parties, in provisions for litigation, |
Income taxes (Tables)
Income taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Income Taxes Tables [Line Items] | |
Disclosure of tax expense/(benefit) recognized and its relationship with accounting profit [text block] | For the year ended USD m 31.12.23 31.12.22 31.12.21 Tax expense / (benefit) Swiss Current 810 664 614 Deferred 39 (22) 26 Total Swiss 849 642 640 Non-Swiss Current 618 689 857 Deferred (262) 513 406 Total non-Swiss 356 1,202 1,263 Total income tax expense / (benefit) recognized in the income statement 1,206 1,844 1,903 |
Disclosure Of Details Of Major Components Of Tax Expense Income Explanatory | For the year ended USD m 31.12.23 31.12.22 31.12.21 Operating profit / (loss) before tax 4,521 8,960 8,964 of which: Swiss 3,174 4,052 2,983 of which: non-Swiss 1,347 4,907 5,981 Income taxes at Swiss tax rate of 18.5 % for 2023, 18 % for 2022 and 18.5 % for 2021 836 1,613 1,658 Increase / (decrease) resulting from: Non-Swiss tax rates differing from Swiss tax rate (43) 267 217 Tax effects of losses not recognized 71 74 124 Previously unrecognized tax losses now utilized (401) (217) (179) Non-taxable and lower-taxed income (165) (316) (252) Non-deductible expenses and additional taxable income 1,017 414 487 Adjustments related to prior years, current tax (15) (33) (38) Adjustments related to prior years, deferred tax 10 19 (3) Change in deferred tax recognition (273) (217) (341) Adjustments to deferred tax balances arising from changes 0 0 (1) Other items 169 240 230 Income tax expense / (benefit) 1,206 1,844 1,903 |
Disclosure Of Total Recognized And Unrecognized Deferred Tax Assets And Deferred Tax Liabilities Explanatory | USD m 31.12.23 31.12.22 Deferred tax assets 1 Gross Valuation allowance Recognized Gross Valuation allowance Recognized Tax loss carry-forwards 11,453 (8,496) 2,957 12,708 (8,720) 3,988 Unused tax credits 95 0 95 0 0 0 Temporary differences 6,771 (579) 6,192 5,774 (408) 5,365 of which: related to real estate costs capitalized for US purposes 2,703 0 2,703 2,485 0 2,485 of which: related to compensation and benefits 1,457 (205) 1,252 1,169 (175) 993 of which: related to cash flow hedges 619 0 619 947 0 947 of which: other 1,992 (374) 1,618 1,173 (233) 940 Total deferred tax assets 18,319 (9,076) 9,244 2 18,482 (9,128) 9,354 2 of which: related to the US 8,505 8,294 of which: related to other locations 739 1,060 Deferred tax liabilities Total deferred tax liabilities 162 233 1 After offset of DTLs, as applicable. 408 m (31 December 2022: USD 471 m) in respect of entities that incurred losses in either the current or preceding year. |
Disclosure Of Expiry Of Unused Tax Losses Explanatory | Unrecognized tax loss carry-forwards USD m 31.12.23 31.12.22 Within 1 year 192 231 From 2 to 5 years 10,278 2,184 From 6 to 10 years 2,708 11,106 From 11 to 20 years 1,199 1,610 No expiry 16,252 16,960 Total 30,630 32,091 of which: related to the US 1 12,354 13,350 of which: related to the UK 14,333 14,332 of which: related to other locations 3,943 4,409 1 Related to UBS AG’s US branch. |
Financial assets at amortized_2
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Financial Assets [Line Item] | |
Disclosure Of Credit Risk Exposure Explanatory | USD m 31.12.23 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 171,806 171,788 18 0 (26) 0 (26) 0 Amounts due from banks 28,206 28,191 14 0 (7) (6) (1) 0 Receivables from securities financing transactions measured at amortized 74,128 74,128 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 32,300 32,300 0 0 0 0 0 0 Loans and advances to customers 405,633 385,493 18,131 2,009 (935) (173) (185) (577) of which: Private clients with mortgages 174,400 163,617 9,955 828 (156) (39) (89) (28) of which: Real estate financing 54,305 50,252 4,038 15 (46) (20) (25) (1) of which: Large corporate clients 14,431 12,594 1,331 506 (241) (34) (32) (174) of which: SME clients 12,694 10,662 1,524 508 (262) (34) (24) (204) of which: Lombard 117,924 117,874 0 50 (22) (5) 0 (17) of which: Credit cards 2,041 1,564 438 39 (42) (6) (11) (24) of which: Commodity trade finance 2,889 2,873 12 4 (119) (7) 0 (111) Other financial assets measured at amortized cost 54,334 53,882 312 141 (87) (16) (5) (66) of which: Loans to financial advisors 2,615 2,422 79 114 (49) (4) (1) (44) Total financial assets measured at amortized cost 766,407 745,782 18,475 2,150 (1,057) (197) (217) (643) Financial assets measured at fair value through other comprehensive income 2,233 2,233 0 0 0 0 0 0 Total on-balance sheet financial assets within the scope of ECL requirements 768,640 748,015 18,475 2,150 (1,057) (197) (217) (643) Total exposure ECL provisions Off-balance sheet (within the scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 33,211 32,332 761 118 (40) (14) (7) (19) of which: Large corporate clients 3,624 3,051 486 87 (10) (3) (2) (6) of which: SME clients 1,506 1,299 177 31 (7) (1) (1) (5) of which: Financial intermediaries and hedge funds 22,549 22,504 46 0 (12) (8) (3) 0 of which: Lombard 3,009 3,009 0 0 (1) 0 0 (1) of which: Commodity trade finance 1,811 1,803 8 0 (1) (1) 0 0 Irrevocable loan commitments 44,018 42,085 1,878 56 (95) (55) (38) (2) of which: Large corporate clients 26,096 24,444 1,622 30 (76) (45) (28) (2) Forward starting reverse repurchase and securities borrowing agreements 10,373 10,373 0 0 0 0 0 0 Committed unconditionally revocable credit lines 47,421 45,452 1,913 56 (49) (39) (10) 0 of which: Real estate financing 9,439 8,854 585 0 (4) (3) (1) 0 of which: Large corporate clients 5,110 4,951 151 8 (6) (4) (3) 0 of which: SME clients 5,408 5,188 191 29 (21) (17) (3) 0 of which: Lombard 8,964 8,964 0 1 0 0 0 0 of which: Credit cards 10,458 9,932 522 4 (10) (8) (2) 0 of which: Commodity trade finance 537 537 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 4,183 4,169 11 4 (4) (3) 0 0 Total off-balance sheet financial instruments and credit lines 139,206 134,410 4,562 234 (188) (111) (56) (21) Total allowances and provisions (1,244) (308) (272) (664) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL USD m 31.12.22 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 169,445 169,402 44 0 (12) 0 (12) 0 Amounts due from banks 14,671 14,670 1 0 (6) (5) (1) 0 Receivables from securities financing transactions measured at amortized 67,814 67,814 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 35,033 35,033 0 0 0 0 0 0 Loans and advances to customers 390,027 372,903 15,587 1,538 (783) (129) (180) (474) of which: Private clients with mortgages 156,930 147,651 8,579 699 (161) (27) (107) (28) of which: Real estate financing 46,470 43,112 3,349 9 (41) (17) (23) 0 of which: Large corporate clients 12,226 10,733 1,189 303 (130) (24) (14) (92) of which: SME clients 13,903 12,211 1,342 351 (251) (26) (22) (203) of which: Lombard 132,287 132,196 0 91 (26) (9) 0 (17) of which: Credit cards 1,834 1,420 382 31 (36) (7) (10) (19) of which: Commodity trade finance 3,272 3,261 0 11 (96) (6) 0 (90) Other financial assets measured at amortized cost 53,389 52,829 413 147 (86) (17) (6) (63) of which: Loans to financial advisors 2,611 2,357 128 126 (59) (7) (2) (51) Total financial assets measured at amortized cost 730,379 712,651 16,044 1,685 (890) (154) (199) (537) Financial assets measured at fair value through other comprehensive income 2,239 2,239 0 0 0 0 0 0 Total on-balance sheet financial assets within the scope of ECL requirements 732,618 714,889 16,044 1,685 (890) (154) (199) (537) Total exposure ECL provisions Off-balance sheet (within the scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 22,167 19,805 2,254 108 (48) (13) (9) (26) of which: Large corporate clients 3,663 2,883 721 58 (26) (2) (3) (21) of which: SME clients 1,337 1,124 164 49 (5) (1) (1) (3) of which: Financial intermediaries and hedge funds 11,833 10,513 1,320 0 (12) (8) (4) 0 of which: Lombard 2,376 2,376 0 1 (1) 0 0 (1) of which: Commodity trade finance 2,121 2,121 0 0 (1) (1) 0 0 Irrevocable loan commitments 39,996 37,531 2,341 124 (111) (59) (52) 0 of which: Large corporate clients 23,611 21,488 2,024 99 (93) (49) (45) 0 Forward starting reverse repurchase and securities borrowing agreements 3,801 3,801 0 0 0 0 0 0 Committed unconditionally revocable credit lines 43,677 41,809 1,833 36 (40) (32) (8) 0 of which: Real estate financing 8,711 8,528 183 0 (6) (6) 0 0 of which: Large corporate clients 4,578 4,304 268 5 (4) (1) (2) 0 of which: SME clients 4,723 4,442 256 26 (19) (16) (3) 0 of which: Lombard 7,855 7,854 0 1 0 0 0 0 of which: Credit cards 9,390 8,900 487 3 (7) (5) (2) 0 of which: Commodity trade finance 327 327 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 4,696 4,600 94 2 (2) (2) 0 0 Total off-balance sheet financial instruments and credit lines 114,337 107,545 6,522 270 (201) (106) (69) (26) Total allowances and provisions (1,091) (260) (267) (564) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL |
Disclosure Of Coverage Ratios Explanatory | 31.12.23 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 174,555 163,656 10,044 856 9 2 88 7 326 Real estate financing 54,351 50,272 4,063 16 9 4 61 8 594 Total real estate lending 228,906 213,928 14,107 872 9 3 81 8 331 Large corporate clients 14,671 12,628 1,363 680 164 27 237 48 2,558 SME clients 12,956 10,696 1,548 712 202 32 155 47 2,861 Total corporate lending 27,627 23,324 2,911 1,392 182 29 193 48 2,714 Lombard 117,946 117,879 0 67 2 0 0 0 2,487 Credit cards 2,083 1,571 449 63 200 40 253 87 3,801 Commodity trade finance 3,008 2,881 12 115 394 25 62 25 9,676 Other loans and advances to customers 26,997 26,083 837 77 18 10 44 11 2,379 Loans to financial advisors 2,665 2,426 80 159 185 17 122 20 2,793 Total other lending 152,699 150,840 1,378 481 18 3 117 4 4,462 Total 1 409,232 388,092 18,396 2,744 24 5 101 9 2,263 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 6,801 6,560 226 15 8 7 29 8 40 Real estate financing 10,662 10,064 599 0 6 5 22 6 0 Total real estate lending 17,463 16,624 824 15 6 6 24 6 40 Large corporate clients 34,829 32,446 2,259 125 27 16 147 25 628 SME clients 7,872 7,337 456 80 47 29 230 41 626 Total corporate lending 42,702 39,782 2,715 205 30 18 161 28 627 Lombard 13,609 13,609 0 1 1 1 0 1 0 Credit cards 10,458 9,932 522 4 10 8 35 10 0 Commodity trade finance 2,354 2,346 8 0 4 4 36 4 0 Financial intermediaries and hedge funds 25,378 25,148 230 0 5 4 157 5 0 Other off-balance sheet commitments 16,869 16,596 264 9 12 5 170 8 0 Total other lending 68,668 67,630 1,024 14 7 4 97 6 5,921 Total 2 128,833 124,037 4,562 234 15 9 122 13 908 Total on- and off-balance sheet 3 538,065 512,129 22,958 2,978 22 6 105 10 2,157 1 Includes Loans repurchase and securities borrowing agreements. 31.12.22 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 157,091 147,678 8,686 727 10 2 123 9 381 Real estate financing 46,511 43,129 3,372 9 9 4 70 9 232 Total real estate lending 203,602 190,807 12,059 736 10 2 108 9 379 Large corporate clients 12,356 10,757 1,204 395 105 22 120 32 2,325 SME clients 14,154 12,237 1,364 553 177 22 161 36 3,664 Total corporate lending 26,510 22,994 2,567 949 144 22 142 34 3,106 Lombard 132,313 132,205 0 108 2 1 0 1 1,580 Credit cards 1,869 1,427 393 50 190 46 256 91 3,779 Commodity trade finance 3,367 3,266 0 101 285 18 0 18 8,901 Other loans and advances to customers 23,149 22,333 748 68 18 6 38 7 3,769 Loans to financial advisors 2,670 2,364 130 176 221 28 124 33 2,870 Total other lending 163,368 161,595 1,270 503 16 3 114 3 4,016 Total 1 393,480 375,396 15,896 2,188 21 4 114 8 2,398 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 1&2 Stage 3 Private clients with mortgages 6,535 6,296 236 3 5 4 18 4 1,183 Real estate financing 10,054 9,779 275 0 6 7 0 6 0 Total real estate lending 16,589 16,075 511 3 6 6 2 6 1,288 Large corporate clients 32,126 28,950 3,013 163 38 18 165 32 1,263 SME clients 7,122 6,525 499 98 47 30 214 43 304 Total corporate lending 39,247 35,475 3,513 260 40 20 172 34 903 Lombard 12,919 12,918 0 1 2 1 0 1 0 Credit cards 9,390 8,900 487 3 7 5 36 7 0 Commodity trade finance 2,459 2,459 0 0 3 3 0 3 0 Financial intermediaries and hedge funds 18,128 16,464 1,664 0 7 6 25 7 0 Other off-balance sheet commitments 11,803 11,454 346 3 11 8 68 9 0 Total other lending 54,700 52,195 2,498 7 6 5 33 6 0 Total 2 110,537 103,745 6,522 270 18 10 106 16 980 Total on- and off-balance sheet 3 504,016 479,140 22,418 2,458 21 5 112 10 2,242 1 Includes Loans repurchase and securities borrowing agreements. |
Derivative instruments (Tables)
Derivative instruments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Derivative Financial Assets And Liabilities [Line Items] | |
Disclosure Of Derivative Financial Assets And Liabilities Explanatory | 31.12.23 31.12.22 USD bn Derivative financial assets Derivative financial liabilities Notional amounts related to derivative financial assets and liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Derivative financial liabilities Notional amounts related to derivative financial assets and liabilities 2,3 Other notional amounts 2,4 Interest rate 35.3 32.8 2,471.7 13,749.0 39.8 37.5 2,080.3 11,255.4 of which: forwards (OTC) 1 0.1 0.0 114.0 1,061.4 0.2 0.0 72.3 792.7 of which: swaps (OTC) 23.0 18.2 788.0 11,884.1 25.2 19.8 607.1 9,728.6 of which: options (OTC) 12.1 14.4 1,569.4 14.2 17.5 1,392.5 of which: futures (ETD) 707.4 606.3 of which: options (ETD) 0.0 0.0 0.2 96.1 0.0 0.0 8.3 127.7 Credit derivatives 1.8 1.6 93.1 1.0 1.2 73.9 of which: credit default swaps (OTC) 1.6 1.5 91.4 0.9 1.0 71.0 of which: total return swaps (OTC) 0.0 0.1 0.7 0.1 0.2 1.2 Foreign exchange 65.4 71.7 6,367.1 179.6 85.5 88.5 6,080.1 40.1 of which: forwards (OTC) 15.6 18.9 1,881.7 26.5 28.6 1,763.8 of which: swaps (OTC) 43.5 46.7 3,587.2 178.7 49.6 50.4 3,233.0 38.4 of which: options (OTC) 6.2 6.1 892.6 9.3 9.2 1,073.2 Equity / index 27.3 32.9 1,191.1 84.3 22.2 26.1 885.8 63.4 of which: swaps (OTC) 6.0 8.9 263.4 5.3 6.6 217.4 of which: options (OTC) 2.8 5.9 193.4 2.8 4.4 140.6 of which: futures (ETD) 77.3 52.2 of which: options (ETD) 10.3 10.0 732.7 6.9 9.0 8.1 526.7 11.2 of which: client-cleared transactions (ETD) 8.1 8 5.1 7.0 Commodities 1.6 1.3 128.6 15.5 1.4 1.4 132.3 17.6 of which: swaps (OTC) 0.7 0.5 44.8 0.5 0.7 38.5 of which: options (OTC) 0.6 0.3 38.4 0.4 0.3 29.1 of which: futures (ETD) 13.0 16.4 of which: forwards (ETD) 0.0 0.0 31.5 0.0 0.0 47.7 of which: client-cleared transactions (ETD) 0.2 0.3 0.2 0.3 Other 5 0.3 0.4 86.0 0.2 0.1 49.7 Total derivative instruments, based on IFRS netting 6 131.7 140.7 10,337.6 14,028.4 150.1 154.9 9,302.1 11,376.5 1 Includes certain where derivative financial instruments are presented on a net basis on the balance sheet, the amounts of client-cleared ETD and OTC transactions through central clearing counterparties are not disclosed, as they have a significantly different risk profile. cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented instruments and Cash collateral payables on purchases and sales of non-derivative financial instruments assets and liabilities are presented net on the balance sheet if UBS AG default, bankruptcy or insolvency of the entity and all of on netting arrangements. |
Property, equipment and softw_2
Property, equipment and software (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes Property Equipment And Software Tables [Line Items] | |
Disclosure Of Property Equipment Software Tables Explanatory | At historical cost less accumulated depreciation USD m Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2023 3 2022 3 Historical cost Balance at the beginning of the year 10,352 4,275 9,220 1,046 24,893 24,542 Additions 106 96 81 1,110 1,393 1,859 Disposals / write-offs 4 (299) (63) (1,087) 0 (1,449) (414) Reclassifications 550 0 1,390 (1,561) 378 (894) Foreign currency translation 653 71 185 45 954 (200) Balance at the end of the year 11,362 4,379 9,789 640 26,169 24,893 Accumulated depreciation Balance at the beginning of the year 6,697 1,638 5,242 0 13,577 12,830 Depreciation 457 446 1,070 0 1,974 1,819 Impairment 5 15 0 223 0 238 2 Disposals / write-offs 4 (296) (62) (1,087) 0 (1,445) (410) Reclassifications 207 0 (2) 0 206 (566) Foreign currency translation 439 36 101 0 576 (99) Balance at the end of the year 7,520 2,058 5,548 0 15,126 13,577 Net book value Net book value at the beginning of the year 3,655 2,637 3,978 1,046 11,316 11,712 Net book value at the end of the year 3,842 2,321 4,241 640 6 11,044 11,316 1 Includes leasehold improvements and IT hardware. in relation to real 594 m (2022: USD 589 m). Interest expense on Interest expense from financial were no material gains or losses arising from sale-and-leaseback and other non-current assets held amount based on a value-in-use approach was determined to be zero. 415 m related to software and USD 224 m related to Owned properties and equipment. |
Goodwill and intangible assets
Goodwill and intangible assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes Goodwill And Intangible Assets Tables [Line Items] | |
Disclosure of information for cashgenerating unit with significant amount of goodwill explanatory | Discount and growth rates Discount rates Growth rates In % 31.12.23 31.12.22 31.12.23 31.12.22 Global Wealth Management Americas 9.5 10.5 3.8 3.8 Global Wealth Management Switzerland and International 9.5 9.4 3.4 3.6 Asset Management 9.0 9.5 3.3 3.4 |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill Explanatory | USD m Goodwill Intangible assets 1 2023 2022 Historical cost Balance at the beginning of the year 6,043 1,598 7,641 7,739 Additions 0 6 6 0 Disposals 2 (10) (30) (40) (22) Foreign currency translation 10 28 38 (76) Balance at the end of the year 6,043 1,602 7,645 7,641 Accumulated amortization and impairment Balance at the beginning of the year 0 1,374 1,374 1,360 Amortization 26 26 26 Impairment / (reversal of impairment) 0 0 0 (1) Disposals 2 0 (30) (30) 0 Foreign currency translation 0 9 9 (11) Balance at the end of the year 0 1,379 1,379 1,374 Net book value at the end of the year 6,043 223 6,265 6,267 of which: Global Wealth Management Americas 3,712 36 3,748 3,740 of which: Global Wealth Management Switzerland and International 1,182 52 1,233 1,225 of which: Asset Management 1,149 0 1,149 1,167 of which: Investment Bank 0 135 135 135 1 Intangible assets mainly include customer relationships, contractual rights and the fully amortized branch network intangible asset recognized in connection with the acquisition of PaineWebber Group, Inc. in 2000. 2 Reflects the derecognition of goodwill allocated to business and intangible assets held by entities that have been disposed of. |
Disclosure Of Assets With Infinite Useful Lives And Finite Useful Lives Intangible Assets Future Amortization Expense Explanatory | USD m Intangible assets Estimated aggregated amortization expenses for: 2024 27 2025 26 2026 26 2027 25 2028 19 Thereafter 98 Not amortized due to indefinite useful life 2 Total 223 |
Other financial and non-finan_3
Other financial and non-financial assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other financial assets measured at amortized cost | |
DisclosureOf Other Assets Tables [Line Items] | |
Disclosure Of Other Assets Explanatory | USD m 31.12.23 31.12.22 Debt securities 43,245 44,594 Loans to financial advisors 2,615 2,611 Fee- and commission-related receivables 1,883 1,803 Finance lease receivables 1,427 1,314 Settlement and clearing accounts 311 1,174 Accrued interest income 2,004 1,276 Other 2,849 1 618 Total other financial assets measured at amortized cost 54,334 53,389 1 Predominantly includes cash collateral provided to exchanges and clearing houses to secure securities trading activity through |
Other non-financial assets | |
DisclosureOf Other Assets Tables [Line Items] | |
Disclosure Of Other Assets Explanatory | USD m 31.12.23 31.12.22 Precious metals and other physical commodities 4,426 4,471 Deposits and collateral provided in connection with litigation, 1 1,379 2,205 Prepaid expenses 1,062 709 VAT, 746 1,405 Properties and other non-current assets held for sale 105 279 Other 660 583 Total other non-financial assets 8,377 9,652 1 Refer to Note 17 for more information. |
Customer deposits (Tables)
Customer deposits (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Customer Deposits Note Tables [Line Items] | |
Disclosure Of Customer Deposits Explanatory | USD m 31.12.23 31.12.22 Demand deposits 146,163 182,307 Retail savings / deposits 152,683 149,310 Sweep deposits 41,045 69,223 Time deposits 1 215,782 126,331 Total customer deposits 555,673 527,171 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf of its clients. |
Funding From Group Explanatory | USD m 31.12.23 31.12.22 Debt contributing to total loss-absorbing capacity (TLAC) 51,102 42,073 Debt eligible as high-trigger loss-absorbing additional tier 11,286 10,654 Debt eligible as low-trigger loss-absorbing additional 1,212 1,187 Other 1 3,682 2,232 Total funding from UBS Group AG measured at amortized cost 2,3 67,282 56,147 1 Includes debt not eligible as TLAC having of redemption. debt obligations that are since 1.1.2020. |
Debt issued designated at fai_2
Debt issued designated at fair value (Table) | 12 Months Ended |
Dec. 31, 2023 | |
Debt issued designated at fair value | |
Disclosure Of Financial Liabilities [Line Items] | |
Disclosure Of Designated Financial Liabilities At Fair Value Through Profit Or Loss | USD m 31.12.23 31.12.22 Issued debt instruments Equity-linked 1 46,269 41,901 Rates-linked 16,880 16,276 Credit-linked 4,506 2,170 Fixed-rate 14,295 6,538 Commodity-linked 3,704 4,294 Other 687 663 Total debt issued designated at fair value 86,341 71,842 of which: issued by UBS AG with original maturity greater than one 2 73,544 57,750 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2022: 100 %). |
Debt issued measured at amortiz
Debt issued measured at amortized cost (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes And Debentures Issued [Member] | |
Disclosure Of Financial Liabilities [Line Items] | |
Disclosure Of Detailed Information About Borrowings Explanatory | USD m 31.12.23 31.12.22 Short-term debt 1 37,285 29,676 Senior unsecured debt 18,450 17,892 of which: issued by UBS AG with original maturity greater than one 18,446 17,892 Covered bonds 1,006 0 Subordinated debt 3,008 2,968 of which: eligible as low-trigger loss-absorbing tier 2 capital 0 2,422 of which: eligible as non-Basel III-compliant tier 2 capital 538 536 Debt issued through the Swiss central mortgage institutions 10,035 8,962 Long-term debt 2 32,499 29,823 Total debt issued measured at amortized cost 3,4 69,784 59,499 1 Debt with an original contractual maturity classification of debt presented. 100 % of the balance was unsecured as of 31 December 2023. |
Provisions and contingent liabi
Provisions and contingent liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Other Provisions [Line Items] | |
Total provisions recognized under both IAS 37 and IFRS 9 [textblock] | USD m 31.12.23 31.12.22 Provisions other than provisions for expected credit losses 2,336 2,982 Provisions for expected credit losses 1 188 201 Total provisions 2,524 3,183 1 Refer to Note 9 for more information about ECL provisions recognized for off-balance sheet financial instruments and credit lines. |
Total provisions with additional information [textblock] | USD m Litigation, regulatory and similar matters 1 Restructuring 2 Real estate 3 Other 4 Total 2023 Balance at the beginning of the year 2,586 98 122 175 2,982 Increase in provisions recognized in the income statement 866 234 8 41 1,148 Release of provisions recognized in the income statement (47) (13) 0 (17) (77) Provisions used in conformity with designated purpose (1,642) (114) (12) (27) (1,795) Foreign currency translation and other movements 48 4 18 10 79 Balance at the end of the year 1,810 209 135 181 2,336 1 Consists of provisions for losses resulting from legal, liability and compliance risks. 146 m of provisions for onerous contracts related to real estate as of 31 December 2023 (31 December 2022: USD 28 m) and USD 64 m of personnel-related restructuring provisions as of 31 December 70 m). 4 Mainly includes provisions related to employee benefits and operational risks. |
Disclosure of provisions for litigation, regulatory and similar matters [text block] | Provisions for litigation, regulatory and similar matters 1 USD m Global Wealth Manage- ment Personal & Corporate Banking Asset Manage- ment Investment Bank Non-core and Legacy 2 Group 2 Total 2023 Balance at the beginning of the year 1,182 159 8 308 771 158 2,586 Increase in provisions recognized in the income statement 113 0 5 81 665 2 866 Release of provisions recognized in the income statement (7) (9) 0 (2) 0 (29) (47) Provisions used in conformity with designated purpose (98) 0 (1) (106) (1,435) (1) (1,642) Foreign currency translation and other movements 31 6 0 5 4 1 48 Balance at the end of the year 1,220 156 12 286 4 132 1,810 1 Provisions, if any, Global Wealth Management and Personal & Corporate Banking. Provisions, of 2023, Non-core and Legacy represents a separate reportable segment and Group Functions has been renamed Group Items. |
Other liabilities (Tables)
Other liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Other Liabilities Tables [Line Items] | |
Disclosure Of Other Financial Liabilities Measured At Amortized Cost Explanatory | USD m 31.12.23 31.12.22 Other accrued expenses 1,613 1,564 Accrued interest expenses 4,186 2,008 Settlement and clearing accounts 1,314 1,060 Lease liabilities 2,904 3,211 Other 2,695 2,549 Total other financial liabilities measured at amortized cost 12,713 10,391 |
Disclosure Of Other Financial Liabilities Designated At Fair Value Explanatory | USD m 31.12.23 31.12.22 Financial liabilities related to unit-linked investment contracts 15,922 13,221 Securities financing transactions 6,927 15,333 Over-the-counter debt instruments and other 1,566 1,684 Funding from UBS Group AG 1 2,950 1,796 Total other financial liabilities designated at fair value 27,366 32,033 1 The Funding from UBS Group AG consists in right of payment to all other present and future non-subordinated obligations of the respective issuing entity. |
Disclosure Of Other Non Financial Liabilities Explanatory | USD m 31.12.23 31.12.22 Compensation-related liabilities 4,526 4,424 of which: financial advisor compensation plans 1,472 1,463 of which: other compensation plans 1,955 2,023 of which: net defined benefit liability 487 449 of which: other compensation-related liabilities 1 611 490 Current tax liabilities 932 1,044 Deferred tax liabilities 162 233 VAT, 712 472 Deferred income 276 233 Other 74 84 Total other non-financial liabilities 6,682 6,489 1 Includes liabilities for payroll taxes and untaken vacation. |
Expected credit loss measurem_2
Expected credit loss measurement (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Financial Assets [Line Item] | |
Disclosure Of Credit Loss Expense Recovery Explanatory | Credit loss expense / (release) Performing positions Credit-impaired positions USD m Stages 1 and 2 Stage 3 Total For the year ended 31.12.23 Global Wealth Management (2) 27 25 Personal & Corporate Banking 13 37 50 Asset Management 0 (1) (1) Investment Bank 11 56 67 Non-core and Legacy 0 1 1 Group Items 1 1 0 1 Total 23 120 143 For the year ended 31.12.22 Global Wealth Management (5) 5 0 Personal & Corporate Banking 27 12 39 Asset Management 0 0 0 Investment Bank 6 (18) (12) Non-core and Legacy 0 2 2 Group Items 1 0 0 0 Total 29 0 29 For the year ended 31.12.21 Global Wealth Management (28) (1) (29) Personal & Corporate Banking (62) (24) (86) Asset Management 0 1 1 Investment Bank (34) 0 (34) Non-core and Legacy 0 0 0 Group Items 1 0 0 0 Total (123) (25) (148) 1 Starting with the third quarter of 2023, Non-core and Legacy became a separate reportable segment and Group Functions has been renamed Group Items. Prior periods have been restated to reflect these changes. |
Disclosure Of Key Macro Economic Scenario Weights Explanatory | Economic scenarios and weights applied Assigned weights in % ECL scenario 31.12.23 31.12.22 Asset price inflation 0.0 0.0 Baseline 60.0 60.0 Mild debt crisis 15.0 0.0 Stagflationary geopolitical crisis 25.0 25.0 Global crisis 0.0 15.0 |
Disclosure Of Key Macro Economic Variables Explanatory | Scenario assumptions One year Three years cumulative 31.12.23 Asset price inflation Baseline Mild debt crisis Stagflationary geopolitical crisis Asset price inflation Baseline Mild debt crisis Stagflationary geopolitical crisis Real GDP growth (% change) United States 4.0 0.1 (1.6) (4.8) 9.1 4.4 0.6 (4.4) Eurozone 3.0 0.5 (1.7) (5.6) 6.2 2.9 (0.1) (5.7) Switzerland 3.0 1.4 (1.2) (4.8) 6.6 4.4 0.3 (4.9) Consumer price index (% change) United States 2.5 2.3 (0.1) 10.0 8.1 7.1 2.3 15.8 Eurozone 2.3 2.0 (0.2) 9.6 7.4 6.1 1.8 14.8 Switzerland 2.1 1.5 (0.4) 5.8 6.2 4.3 0.8 10.7 Unemployment rate (end-of-period level, %) United States 3.0 4.4 6.3 9.2 3.0 4.4 7.7 11.8 Eurozone 6.0 6.9 8.2 10.6 6.0 6.8 9.0 11.8 Switzerland 1.6 2.3 2.9 4.1 1.5 2.3 3.8 5.0 Fixed income: 10-year government bonds (change in yields, basis points) USD 13 (82) (215) 270 37 (78) (155) 245 EUR 20 (90) (185) 225 58 (78) (140) 195 CHF 25 (41) (73) 195 63 (34) (28) 180 Equity indices (% change) S&P 500 20.0 15.3 (26.6) (51.5) 51.7 28.1 (12.2) (45.6) EuroStoxx 50 20.0 12.0 (26.4) (51.6) 46.6 22.9 (16.6) (47.2) SPI 15.0 4.6 (24.5) (51.6) 39.2 15.9 (11.2) (47.2) Swiss real estate (% change) Single-Family Homes 6.6 (1.5) (4.4) (18.5) 14.0 0.8 (3.0) (28.6) Other real estate (% change) United States (S&P / Case–Shiller) 8.1 0.6 (8.6) (20.0) 19.7 5.8 (5.2) (30.2) Eurozone (House Price Index) 7.0 0.6 (5.9) (8.4) 15.4 6.4 (5.2) (12.9) Scenario assumptions One year Three years cumulative 31.12.22 Asset price inflation Baseline Stagflationary geopolitical crisis Global crisis Asset price inflation Baseline Stagflationary geopolitical crisis Global crisis Real GDP growth (% change) United States 4.0 (0.3) (4.8) (6.4) 9.1 3.2 (4.4) (1.8) Eurozone 3.0 0.6 (5.6) (8.5) 6.2 2.5 (5.7) (8.3) Switzerland 3.0 0.7 (4.8) (6.7) 6.6 3.5 (4.9) (3.7) Consumer price index (% change) United States 2.5 2.6 10.0 (0.5) 8.1 6.5 15.8 1.2 Eurozone 2.3 5.0 9.6 (0.7) 7.4 9.6 14.8 (0.7) Switzerland 2.1 1.6 5.8 (1.8) 6.2 3.9 10.7 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 9.2 10.0 3.0 5.3 11.8 9.4 Eurozone 6.0 7.0 10.9 11.9 6.0 7.1 12.2 13.0 Switzerland 1.7 2.3 4.3 4.4 1.5 2.6 5.1 4.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 25 (6) 235 (326) 70 (13) 205 (291) EUR 20 48 250 (271) 58 45 220 (247) CHF 25 46 220 (210) 63 57 205 (160) Equity indices (% change) S&P 500 20.0 7.4 (51.5) (50.0) 51.7 22.8 (45.6) (27.9) EuroStoxx 50 17.0 17.2 (51.6) (50.0) 42.9 29.2 (47.2) (39.3) SPI 14.0 5.6 (51.6) (46.0) 37.9 19.3 (47.2) (32.9) Swiss real estate (% change) Single-Family Homes 6.6 1.1 (16.7) (19.9) 14.0 2.3 (32.9) (23.9) Other real estate (% change) United States (S&P / Case–Shiller) 7.8 (4.5) (12.8) (19.3) 19.1 (0.6) (35.8) (32.7) Eurozone (House Price Index) 7.0 (2.7) (8.4) (8.9) 15.4 2.0 (14.7) (17.5) |
Disclosure Of Credit Risk Exposure Movement Explanatory | Development of ECL allowances and USD m Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2022 (1,091) (260) (267) (564) Net movement from new and derecognized transactions 1 (11) (27) 9 7 of which: Private clients with mortgages (5) (8) 3 0 of which: Real estate financing (2) (4) 3 0 of which: Large corporate clients 2 (8) 3 7 of which: SME clients (3) (3) 0 0 of which: Other (4) (4) 0 0 (1) (1) 0 0 0 0 0 0 Remeasurements with stage transfers 2 (140) 8 (7) (142) of which: Private clients with mortgages 3 1 3 (1) of which: Real estate financing (2) 2 (5) 0 of which: Large corporate clients (76) 3 (3) (76) of which: SME clients (56) 1 (1) (55) of which: Other (10) 1 0 (11) 0 0 1 0 1 0 0 0 Remeasurements without stage transfers 3 35 7 14 14 of which: Private clients with mortgages 5 (5) 14 (3) of which: Real estate financing 5 2 3 (1) of which: Large corporate clients 15 13 10 (8) of which: SME clients 44 (1) 1 44 of which: Other (34) (2) (14) (18) (15) 0 (15) (7) 1 0 (8) Model changes 4 (27) (18) (9) 0 Movements with profit or loss impact 5 (143) (30) 7 (120) Movements without profit or loss impact (write-off, FX and other) 6 (10) (18) (13) 21 Balance as of 31 December 2023 (1,244) (308) (272) (664) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. and methodology changes. uncollectible or forgiven and movements in foreign exchange rates. Development of ECL allowances and USD m Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2021 (1,165) (282) (220) (662) Net movement from new and derecognized transactions 1 (7) (21) 16 (2) of which: Private clients with mortgages (6) (6) 0 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients 8 (1) 11 (2) of which: SME clients (1) (1) 0 0 of which: Other (6) (8) 3 0 0 (2) 2 0 0 0 0 0 Remeasurements with stage transfers 2 (65) 20 (39) (46) of which: Private clients with mortgages (10) 3 (12) 0 of which: Real estate financing 7 (1) 8 0 of which: Large corporate clients (33) 16 (28) (21) of which: SME clients (23) 2 (2) (22) of which: Other (6) 1 (4) (3) 0 0 0 0 1 2 (1) 0 Remeasurements without stage transfers 3 13 (8) (27) 48 of which: Private clients with mortgages (12) 5 (18) 1 of which: Real estate financing 13 3 10 0 of which: Large corporate clients 32 (11) 2 41 of which: SME clients (6) (10) (9) 14 of which: Other (15) 5 (12) (8) (8) 0 (8) (3) 3 (1) (6) Model changes 4 30 29 1 0 Movements with profit or loss impact 5 (29) 20 (49) 0 Movements without profit or loss impact (write-off, FX and other) 6 104 3 1 99 Balance as of 31 December 2022 (1,091) (260) (267) (564) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. and methodology changes. uncollectible or forgiven and movements in foreign exchange rates. |
Disclosure Of Credit Risk Exposure Categories Explanatory | ECL stage 2 (“significant deterioration USD m Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On- and off-balance sheet (272) (197) (23) (53) of which: Private clients with mortgages (89) (69) 0 (21) of which: Real estate financing (26) (21) 0 (5) of which: Large corporate clients (66) (48) (15) (2) of which: SME clients (38) (23) (5) (9) of which: Financial intermediaries and hedge funds (4) (4) 0 0 of which: Loans to financial advisors (1) 0 0 (1) of which: Credit cards (13) (13) of which: Other (33) (31) (2) (1) |
Disclosure Of Maximum Exposure To Credit Risk Explanatory | Maximum exposure to credit risk 31.12.23 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD bn Maximum exposure to credit risk Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 171.8 171.8 Amounts due from banks 4 28.2 0.2 4.8 0.1 23.1 Receivables from securities financing transactions measured at amortized cost 74.1 0.0 70.7 2.8 0.7 Cash collateral receivables on derivative instruments 5,6 32.3 22.8 9.5 Loans and advances to customers 405.6 31.4 105.2 222.7 24.9 2.8 18.7 Other financial assets measured at amortized cost 54.3 0.1 0.8 0.0 1.5 51.9 Total financial assets measured at amortized cost 766.4 31.5 176.8 222.7 33.9 22.8 0.0 2.9 275.7 Financial assets measured at fair value through other comprehensive income – debt 2.2 2.2 Total maximum exposure to credit risk reflected on the balance sheet within the scope of ECL 768.6 31.5 176.8 222.7 33.9 22.8 0.0 2.9 277.9 Guarantees 7 33.2 1.6 19.8 0.2 1.8 2.0 7.8 Irrevocable loan commitments 43.9 0.2 2.0 1.8 8.9 0.0 1.0 30.0 Forward starting reverse repurchase and securities borrowing agreements 10.4 10.4 0.0 Committed unconditionally revocable credit lines 47.4 0.5 9.1 7.1 5.1 0.6 25.1 Total maximum exposure to credit risk not reflected on the balance sheet within the scope of ECL 134.8 2.3 41.3 9.0 15.7 0.0 0.0 3.5 62.9 31.12.22 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD bn Maximum exposure to credit risk Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 169.4 169.4 Amounts due from banks 4 14.7 0.0 0.1 14.6 Receivables from securities financing transactions measured at amortized cost 67.8 0.0 64.5 2.4 0.9 Cash collateral receivables on derivative instruments 5,6 35.0 22.9 12.1 Loans and advances to customers 390.0 36.1 115.9 197.8 19.6 3.0 17.6 Other financial assets measured at amortized cost 53.4 0.1 0.5 0.0 1.3 51.4 Total financial assets measured at amortized cost 730.4 36.2 181.0 197.9 23.4 22.9 0.0 3.0 266.1 Financial assets measured at fair value through other comprehensive income – debt 2.2 2.2 Total maximum exposure to credit risk reflected on the balance sheet within the scope of ECL 732.6 36.2 181.0 197.9 23.4 22.9 0.0 3.0 268.3 Guarantees 7 22.1 1.2 9.3 0.1 2.0 1.8 7.7 Irrevocable loan commitments 39.9 0.2 3.1 1.3 6.5 0.1 1.0 27.8 Forward starting reverse repurchase and securities borrowing agreements 3.8 3.8 0.0 Committed unconditionally revocable credit lines 43.6 0.2 8.2 6.0 6.2 0.5 22.5 Total maximum exposure to credit risk not reflected on the balance sheet within the scope of ECL 109.4 1.6 24.4 7.5 14.7 0.0 0.1 3.3 58.0 1 Of which: USD 1,637 m for 31 December 2023 1,372 m) relates to total credit-impaired 105 m for 31 December 2023 2022: USD 113 m) to total off-balance sheet financial instruments and instruments, real estate and with funded and unfunded elements, the partners, inventory, mortgage loans, gold borne by those clients. on behalf of clients who retain the associated credit risk. 7 Guarantees collateralized by equity and debt instruments include certain overnight repurchase and the Fixed Income Clearing Corporation minimizes its liability under remote. |
Disclosure Of Internal Credit Exposures Explanatory | Financial assets subject to credit risk by rating USD m 31.12.23 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 171,573 215 0 0 43 0 171,832 (26) 171,806 of which: stage 1 171,573 215 0 0 0 0 171,788 0 171,788 of which: stage 2 0 0 0 0 43 0 43 (26) 18 Amounts due from banks 811 25,095 1,359 463 485 0 28,213 (7) 28,206 of which: stage 1 811 25,095 1,354 462 476 0 28,198 (6) 28,191 of which: stage 2 0 0 5 1 9 0 15 (1) 14 of which: stage 3 0 0 0 0 0 0 0 0 0 Receivables from securities financing transactions 36,689 15,958 6,073 14,319 1,091 0 74,130 (2) 74,128 of which: stage 1 36,689 15,958 6,073 14,319 1,091 0 74,130 (2) 74,128 Cash collateral receivables on derivative instruments 8,009 13,575 6,423 4,095 198 0 32,300 0 32,300 of which: stage 1 8,009 13,575 6,423 4,095 198 0 32,300 0 32,300 Loans and advances to customers 5,993 196,897 82,867 89,738 28,486 2,586 406,568 (935) 405,633 of which: stage 1 5,993 195,590 80,534 82,633 20,916 0 385,666 (173) 385,493 of which: stage 2 0 1,307 2,333 7,106 7,570 0 18,316 (185) 18,131 of which: stage 3 0 0 0 0 0 2,586 2,586 (577) 2,009 Other financial assets measured at amortized cost 25,727 20,541 678 6,770 499 206 54,421 (87) 54,334 of which: stage 1 25,727 20,539 659 6,619 353 0 53,897 (16) 53,882 of which: stage 2 0 2 19 151 146 0 317 (5) 312 of which: stage 3 0 0 0 0 0 206 206 (66) 141 Total financial assets measured at amortized cost 248,802 272,281 97,400 115,386 30,802 2,792 767,462 (1,057) 766,407 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 1,222 850 0 161 0 0 2,233 0 2,233 Total on-balance sheet financial instruments 250,024 273,131 97,400 115,547 30,802 2,792 769,696 (1,057) 768,640 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and Financial assets subject to credit risk by rating USD m 31.12.22 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 168,525 877 0 0 56 0 169,457 (12) 169,445 of which: stage 1 168,525 877 0 0 0 0 169,402 0 169,402 of which: stage 2 0 0 0 0 56 0 56 (12) 44 Amounts due from banks 862 11,150 832 996 837 0 14,676 (6) 14,671 of which: stage 1 862 11,150 832 996 836 0 14,675 (5) 14,670 of which: stage 2 0 0 0 0 1 0 1 (1) 1 of which: stage 3 0 0 0 0 0 0 0 0 0 Receivables from securities financing transactions measured at amortized cost 27,158 15,860 8,870 15,207 721 0 67,816 (2) 67,814 of which: stage 1 27,158 15,860 8,870 15,207 721 0 67,816 (2) 67,814 Cash collateral receivables on derivative instruments 10,613 12,978 7,138 4,157 147 0 35,034 0 35,033 of which: stage 1 10,613 12,978 7,138 4,157 147 0 35,034 0 35,033 Loans and advances to customers 6,491 216,824 68,444 76,147 20,891 2,012 390,810 (783) 390,027 of which: stage 1 6,491 215,332 66,202 69,450 15,557 0 373,032 (129) 372,903 of which: stage 2 0 1,493 2,242 6,698 5,334 0 15,767 (180) 15,587 of which: stage 3 0 0 0 0 0 2,012 2,012 (474) 1,538 Other financial assets measured at amortized cost 29,011 16,649 447 6,708 450 210 53,475 (86) 53,389 of which: stage 1 29,011 16,646 427 6,426 336 0 52,846 (17) 52,829 of which: stage 2 0 2 20 283 114 0 419 (6) 413 of which: stage 3 0 0 0 0 0 210 210 (63) 147 Total financial assets measured at amortized cost 242,660 274,337 85,731 103,216 23,102 2,222 731,269 (890) 730,379 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 1,307 840 0 92 0 0 2,239 0 2,239 Total on-balance sheet financial instruments 243,966 275,178 85,731 103,308 23,102 2,222 733,508 (890) 732,618 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and |
Disclosure Of Off Balance Sheet Positions By Rating Category Explanatory | Off-balance sheet positions subject to expected USD m 31.12.23 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off- balance sheet exposure (maximum exposure to credit risk) ECL provision Off-balance sheet financial instruments Guarantees 17,771 7,306 4,268 2,800 948 118 33,211 (40) of which: stage 1 17,771 7,267 4,219 2,301 774 0 32,332 (14) of which: stage 2 0 39 49 499 174 0 761 (7) of which: stage 3 0 0 0 0 0 118 118 (19) Irrevocable loan commitments 1,720 13,920 9,834 11,142 7,345 56 44,018 (95) of which: stage 1 1,720 13,920 9,781 10,845 5,818 0 42,085 (55) of which: stage 2 0 0 53 298 1,527 0 1,878 (38) of which: stage 3 0 0 0 0 0 56 56 (2) Forward starting reverse repurchase and securities borrowing agreements 10,152 2 84 135 0 0 10,373 0 Total off-balance sheet financial instruments 29,643 21,228 14,186 14,077 8,293 174 87,601 (134) Credit lines Committed unconditionally revocable credit lines 2,604 17,303 10,893 11,950 4,616 56 47,421 (49) of which: stage 1 2,604 16,903 10,553 11,452 3,941 0 45,452 (39) of which: stage 2 0 400 341 497 675 0 1,913 (10) of which: stage 3 0 0 0 0 0 56 56 0 Irrevocable committed prolongation of existing loans 4 1,803 1,045 826 501 4 4,183 (4) of which: stage 1 4 1,803 1,045 824 493 0 4,169 (3) of which: stage 2 0 0 0 2 9 0 11 0 of which: stage 3 0 0 0 0 0 4 4 0 Total credit lines 2,609 19,105 11,939 12,776 5,117 59 51,604 (53) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management Off-balance sheet positions subject to expected USD m 31.12.22 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off- balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 7,252 5,961 4,772 3,049 1,025 108 22,167 (48) of which: stage 1 7,252 5,917 3,812 2,229 596 0 19,805 (13) of which: stage 2 0 44 960 821 429 0 2,254 (9) of which: stage 3 0 0 0 0 0 108 108 (26) Irrevocable loan commitments 1,770 14,912 6,986 10,097 6,107 124 39,996 (111) of which: stage 1 1,770 14,789 6,818 9,625 4,529 0 37,531 (59) of which: stage 2 0 123 168 472 1,578 0 2,341 (52) of which: stage 3 0 0 0 0 0 124 124 0 Forward starting reverse repurchase and securities borrowing agreements 2,781 2 11 1,007 0 0 3,801 0 Total off-balance sheet financial instruments 11,803 20,874 11,769 14,153 7,132 233 65,964 (159) Credit lines Committed unconditionally revocable credit lines 2,288 16,483 9,247 11,885 3,739 36 43,677 (40) of which: stage 1 2,288 15,777 8,960 11,355 3,429 0 41,809 (32) of which: stage 2 0 705 287 531 310 0 1,833 (8) of which: stage 3 0 0 0 0 0 36 36 0 Irrevocable committed prolongation of existing loans 7 1,939 1,489 868 392 2 4,696 (2) of which: stage 1 7 1,938 1,411 864 380 0 4,600 (2) of which: stage 2 0 1 78 4 11 0 94 0 of which: stage 3 0 0 0 0 0 2 2 0 Total credit lines 2,295 18,421 10,736 12,753 4,131 37 48,373 (42) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and |
Scenario Sensitivity Analysis Explanatory | Potential effect on stage 1 and stage 2 positions Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Asset price inflation 100% Stagflationary geopolitical crisis 100% Mild debt crisis Weighted average USD m, except where indicated Segmentation Private clients with mortgages (133) (43) (10) (521) (63) (368) Real estate financing (52) (34) (21) (200) (36) (125) Large corporate clients (152) (108) (53) (252) (146) (234) SME clients (103) (85) (57) (186) (96) (164) Other segments (140) (126) (78) (162) (151) (302) Total (580) (396) (219) (1,322) (492) (1,193) Potential effect on stage 1 and stage 2 positions Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Asset price inflation 100% Stagflationary geopolitical crisis 100% Global crisis Weighted average USD m, except where indicated Segmentation Private clients with mortgages (136) (25) (13) (523) (184) (473) Real estate financing (43) (26) (22) (176) (30) (126) Large corporate clients (136) (97) (84) (199) (174) (235) SME clients (86) (67) (66) (162) (97) (153) Other segments (125) (114) (111) (145) (153) (281) Total (526) (329) (295) (1,204) (638) (1,267) |
Scenario Sensitivity Analysis Calculation Change Explanatory | Potential effect on stage 1 and stage 2 positions USD m 100% Baseline 100% Stagflationary geopolitical crisis 100% Mild Debt Crisis Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (3) (104) (3) (14) +0.50% 3 125 6 17 +1.00% 7 274 14 42 Unemployment rate (absolute change) –1.00% (4) (142) (6) (20) –0.50% (2) (76) (3) (11) +0.50% 2 89 3 13 +1.00% 5 188 7 26 Real GDP growth (relative change) –2.00% 10 27 11 14 –1.00% 6 13 6 8 +1.00% (3) (12) (6) (6) +2.00% (5) (22) (7) (10) House Price Index (relative change) –5.00% 16 174 25 46 –2.50% 8 84 12 21 +2.50% (7) (76) (9) (18) +5.00% (11) (149) (19) (34) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 4 10 8 6 –5.00% 2 5 3 2 +5.00% (2) (5) (3) (2) +10.00% (3) (8) (5) (4) |
Fair value measurement (Tables)
Fair value measurement (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Measurement Tables [Line Items] | |
Disclosure Of Fair Value Measurement Of Assets Explanatory | Determination of fair values from quoted market 1 31.12.23 31.12.22 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 115,345 17,936 1,817 135,098 96,263 10,284 1,488 108,034 of which: Equity instruments 99,510 721 140 100,372 83,095 789 126 84,010 of which: Government bills / bonds 6,843 2,195 14 9,052 5,496 950 18 6,464 of which: Investment fund units 8,008 1,082 9 9,098 6,673 596 61 7,330 of which: Corporate and municipal bonds 982 11,956 648 13,586 976 6,509 541 8,026 of which: Loans 0 1,870 904 2,775 0 1,179 628 1,807 of which: Asset-backed securities 3 111 101 215 22 261 114 397 Derivative financial instruments 593 129,871 1,264 131,728 769 147,876 1,464 150,109 of which: Foreign exchange 317 65,070 0 65,387 575 84,882 2 85,459 of which: Interest rate 0 35,028 284 35,311 0 39,345 460 39,805 of which: Equity / index 0 26,649 667 27,317 1 21,542 653 22,195 of which: Credit 0 1,452 301 1,752 0 719 318 1,038 of which: Commodities 0 1,627 12 1,639 0 1,334 30 1,365 Brokerage receivables 0 20,883 0 20,883 0 17,576 0 17,576 Financial assets at fair value not held for trading 29,529 30,124 4,101 63,754 26,572 29,110 3,725 59,408 of which: Financial assets for unit-linked investment contracts 15,814 0 0 15,814 13,071 1 0 13,072 of which: Corporate and municipal bonds 62 16,716 215 16,994 35 14,101 230 14,366 of which: Government bills / bonds 13,262 3,332 0 16,594 13,103 3,638 0 16,741 of which: Loans 0 4,172 1,254 5,426 0 3,602 736 4,337 of which: Securities financing transactions 0 5,541 4 5,545 0 7,590 114 7,704 of which: Auction rate securities 0 0 1,208 1,208 0 0 1,326 1,326 of which: Investment fund units 367 233 205 804 307 178 190 675 of which: Equity instruments 24 0 1,088 1,112 57 0 792 849 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 68 2,165 0 2,233 57 2,182 0 2,239 of which: Commercial paper and certificates of deposit 0 1,948 0 1,948 0 1,878 0 1,878 of which: Corporate and municipal bonds 68 207 0 276 57 278 0 335 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 4,426 0 0 4,426 4,471 0 0 4,471 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 2 0 0 17 17 0 0 21 21 Total assets measured at fair value 149,962 200,979 7,198 358,139 128,132 207,028 6,698 341,858 |
Disclosure Of Fair Value Measurement Of Liabilities Explanatory | Determination of fair values from quoted market 1 31.12.23 31.12.22 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,451 6,110 151 31,712 23,578 5,823 114 29,515 of which: Equity instruments 16,310 236 87 16,632 16,521 352 78 16,951 of which: Corporate and municipal bonds 28 4,893 58 4,979 36 4,643 27 4,707 of which: Government bills / bonds 8,320 806 0 9,126 5,880 706 1 6,587 of which: Investment fund units 794 117 4 915 1,141 84 3 1,229 Derivative financial instruments 716 136,833 3,158 140,707 640 152,582 1,684 154,906 of which: Foreign exchange 400 71,322 21 71,743 587 87,897 24 88,508 of which: Interest rate 0 32,656 107 32,763 0 37,429 116 37,545 of which: Equity / index 0 30,209 2,717 32,926 0 24,963 1,184 26,148 of which: Credit 0 1,341 273 1,614 0 920 279 1,199 of which: Commodities 0 1,271 20 1,291 0 1,309 52 1,361 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 42,275 0 42,275 0 45,085 0 45,085 Debt issued designated at fair value 0 78,509 7,832 86,341 0 62,603 9,240 71,842 Other financial liabilities designated at fair value 0 25,069 2,297 27,366 0 30,055 1,978 32,033 of which: Financial liabilities related to unit-linked investment contracts 0 15,922 0 15,922 0 13,221 0 13,221 of which: Securities financing transactions 0 6,927 0 6,927 0 15,333 0 15,333 of which: Funding from UBS Group AG 0 1,327 1,623 2,950 0 508 1,287 1,796 of which: Over-the-counter debt instruments and other 0 892 674 1,566 0 993 691 1,684 Total liabilities measured at fair value 26,167 288,796 13,438 328,401 24,219 296,148 13,015 333,382 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are measured at the |
Disclosure Of Deferred Day-One Profit Or Loss Explanatory | Deferred day-1 profit or loss reserves USD m 2023 2022 2021 Reserve balance at the beginning of the year 422 418 269 Profit / (loss) deferred on new transactions 250 299 459 (Profit) / loss recognized in the income statement (275) (295) (308) Foreign currency translation 0 0 (2) Reserve balance at the end of the year 397 422 418 |
Disclosure Of Change In Fair Value Of Financial Liability Attributable To Change In Credit Risk Of Liability Explanatory | Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD m 31.12.23 31.12.22 31.12.21 Recognized during the period: Realized gain / (loss) 8 1 (14) Unrealized gain / (loss) (869) 866 60 Total gain / (loss), before tax (861) 867 46 USD m 31.12.23 31.12.22 31.12.21 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (312) 556 (315) of which: debt issued designated at fair value (208) 289 (144) of which: other financial liabilities designated at fair value (105) 266 (172) |
Disclosure Of Valuation Adjustments On Financial Instruments Explanatory | Balance sheet valuation adjustments As of USD m 31.12.23 31.12.22 Credit valuation adjustments 1 (37) (33) Funding and debit valuation adjustments (82) (46) Other valuation adjustments (730) (839) of which: liquidity (308) (311) of which: model uncertainty (423) (529) 1 Amounts do not include reserves against defaulted counterparties. |
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Of Assets And Liabilities Explanatory | Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.23 31.12.22 USD bn 31.12.23 31.12.22 31.12.23 31.12.22 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 0.8 0.1 0.0 Relative value to market comparable Bond price equivalent 9 114 93 14 112 85 points Discounted expected cash flows Discount margin 491 491 412 412 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.3 1.7 0.0 0.0 Relative value to market comparable Loan price equivalent 6 101 98 30 100 97 points Discounted expected cash flows Credit spread 200 275 252 200 200 200 basis points Market comparable and securitization model Credit spread 162 1,849 318 145 1,350 322 basis points Auction rate securities 1.2 1.3 Discounted expected cash flows Credit spread 135 205 150 115 196 144 basis points Investment fund units 3 0.2 0.3 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 1.2 0.9 0.1 0.1 Relative value to market comparable Price Debt issued designated at fair value 4 7.8 9.2 Other financial liabilities designated at fair value 2.3 2.0 Discounted expected cash flows Funding spread 51 201 23 175 basis points Derivative financial instruments Interest rate 0.3 0.5 0.1 0.1 Option model Volatility of interest rates 84 112 75 143 basis points Credit 0.3 0.3 0.3 0.3 Discounted expected cash flows Credit spreads 1 306 9 565 basis points Bond price equivalent 2 242 3 277 points Equity / index 0.7 0.7 2.7 1.2 Option model Equity dividend yields 0 14 0 20 % Volatility of equity stocks, equity and other indices 4 104 4 120 % Equity-to-FX correlation (40) 70 (29) 84 % Equity-to-equity correlation 13 100 (25) 100 % 1 The ranges most non-derivative financial instruments and were designated at fair value and Derivative financial instruments, as this would not be meaningful. issued designated at fair value primarily consists of UBS AG structured notes, which include variable maturity all of which have embedded derivative parameters that are considered to be unobservable. The equivalent |
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities Explanatory | Sensitivity of fair value measurements to changes 1 31.12.23 31.12.22 USD m Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans measured at fair value, loan commitments and guarantees 22 2 (29) 2 19 (12) Securities financing transactions 24 (24) 33 (37) Auction rate securities 67 (21) 46 (46) Asset-backed securities 25 (22) 27 (27) Equity instruments 189 (178) 183 (161) Interest rate derivatives, net 27 (18) 18 (12) Credit derivatives, net 2 (5) 3 (4) Foreign exchange derivatives, net 5 (4) 10 (5) Equity / index derivatives, net 358 (285) 361 (330) Other 62 (62) 39 (62) Total 781 (648) 738 (696) 1 Sensitivity of issued and over-the-counter debt instruments is reported with the equivalent derivative |
Disclosure Of Level 3 Of Fair Value Of Financial Instruments Explanatory | Movements of Level 3 instruments USD bn Balance at the beginning of the period Net gains / losses included in compre- hensive income 1 of which: related to instruments held at the end of the period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance at the end of the period For the twelve months ended 31 December 2023 2 Financial assets at fair value held for trading 1.5 (0.1) (0.1) 0.4 (0.8) 0.8 0.0 0.2 (0.3) 0.0 1.8 of which: Equity instruments 0.1 (0.1) (0.1) 0.0 (0.1) 0.0 0.0 0.2 (0.0) 0.0 0.1 of which: Corporate and municipal bonds 0.5 (0.0) (0.0) 0.4 (0.3) 0.0 0.0 0.0 (0.0) 0.0 0.6 of which: Loans 0.6 (0.1) (0.1) 0.1 (0.4) 0.8 0.0 0.0 (0.2) 0.0 0.9 Derivative financial instruments – assets 1.5 (0.3) (0.3) 0.0 (0.0) 0.7 (0.5) 0.1 (0.3) 0.0 1.3 of which: Interest rate 0.5 0.0 (0.0) 0.0 0.0 0.1 (0.2) 0.0 (0.1) (0.0) 0.3 of which: Equity / index 0.7 (0.2) (0.2) 0.0 0.0 0.6 (0.1) 0.0 (0.2) 0.0 0.7 of which: Credit 0.3 (0.1) (0.1) 0.0 0.0 0.1 (0.1) 0.1 (0.0) 0.0 0.3 Financial assets at fair value not held for trading 3.7 0.2 0.2 0.8 (0.7) 0.0 (0.0) 0.1 (0.1) 0.0 4.1 of which: Loans 0.7 0.3 0.3 0.3 (0.0) 0.0 (0.0) 0.1 (0.1) (0.0) 1.3 of which: Auction rate securities 1.3 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.0 0.0 1.2 of which: Equity instruments 0.8 0.1 0.0 0.4 (0.2) 0.0 0.0 0.1 0.0 0.0 1.1 Derivative financial instruments – liabilities 1.7 0.3 0.3 0.0 (0.0) 1.9 (0.6) 0.0 (0.2) 0.0 3.2 of which: Interest rate 0.1 0.0 0.0 0.0 0.0 0.0 (0.1) 0.0 (0.0) 0.0 0.1 of which: Equity / index 1.2 0.3 0.3 0.0 0.0 1.8 (0.4) 0.0 (0.2) 0.0 2.7 of which: Credit 0.3 (0.0) 0.0 0.0 0.0 0.1 0.0 0.0 (0.1) (0.0) 0.3 Debt issued designated at fair value 9.2 0.4 0.3 0.0 0.0 3.5 (3.2) 0.5 (2.6) 0.0 7.8 Other financial liabilities designated at fair value 2.0 0.3 0.4 0.0 0.0 0.2 (0.2) 0.0 (0.0) 0.0 2.3 For the twelve months ended 31 December 2022 Financial assets at fair value held for trading 2.3 (0.3) (0.3) 0.3 (1.8) 0.5 0.0 0.7 (0.3) (0.0) 1.5 of which: Investment fund units 0.0 (0.0) (0.0) 0.0 (0.0) 0.0 0.0 0.1 (0.0) (0.0) 0.1 of which: Corporate and municipal bonds 0.6 (0.0) (0.0) 0.3 (0.6) 0.0 0.0 0.4 (0.0) (0.0) 0.5 of which: Loans 1.4 (0.1) (0.1) 0.0 (1.1) 0.5 0.0 0.0 (0.2) 0.0 0.6 Derivative financial instruments – assets 1.1 0.6 0.3 0.0 0.0 0.4 (0.7) 0.1 (0.0) (0.0) 1.5 of which: Interest rate 0.5 0.3 0.3 0.0 0.0 0.0 (0.2) 0.0 (0.1) (0.0) 0.5 of which: Equity / index 0.4 0.2 0.1 0.0 0.0 0.4 (0.3) 0.1 (0.0) (0.0) 0.7 of which: Credit 0.2 0.1 (0.1) 0.0 0.0 0.0 (0.2) 0.0 0.1 0.0 0.3 Financial assets at fair value not held for trading 4.2 0.1 0.1 0.7 (1.2) 0.1 (0.0) 0.2 (0.3) (0.0) 3.7 of which: Loans 0.9 (0.0) (0.0) 0.4 (0.4) 0.1 0.0 0.1 (0.3) (0.0) 0.7 of which: Auction rate securities 1.6 0.1 0.0 0.0 (0.3) 0.0 0.0 0.0 0.0 0.0 1.3 of which: Equity instruments 0.7 0.0 0.0 0.1 (0.1) 0.0 0.0 0.1 0.0 (0.0) 0.8 Derivative financial instruments – liabilities 2.2 (0.8) (0.4) 0.0 0.0 1.1 (0.9) 0.3 (0.2) (0.1) 1.7 of which: Interest rate 0.3 (0.3) (0.0) 0.0 0.0 0.1 (0.0) 0.0 (0.0) (0.0) 0.1 of which: Equity / index 1.5 (0.4) (0.3) 0.0 0.0 0.8 (0.7) 0.1 (0.2) (0.0) 1.2 of which: Credit 0.3 (0.1) (0.0) 0.0 0.0 0.1 (0.1) 0.1 (0.0) (0.0) 0.3 Debt issued designated at fair value 11.9 (1.3) (0.9) 0.0 0.0 4.7 (3.1) 0.7 (3.3) (0.3) 9.2 Other financial liabilities designated at fair value 3.2 (1.0) (1.0) 0.0 0.0 0.0 (0.1) 0.1 (0.2) (0.0) 2.0 1 Net gains / losses included in comprehensive income are recognized in Net interest income and Other net income from financial instruments measured at fair value through profit or loss in the Income statement, and also in 7.2 bn (31 December 2022: USD 6.7 bn). Total Level 3 liabilities as of 31 December 2023 were USD 13.4 bn (31 December 2022: USD 13.0 bn). |
Disclosure Of Maximum Credit Risk Exposure Explanatory | Maximum exposure to credit risk 31.12.23 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD bn Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 25.6 25.6 Derivative financial instruments 4 131.7 5.1 117.6 9.1 Brokerage receivables 20.9 20.5 0.4 Financial assets at fair value not held for trading – debt instruments 5 46.0 10.2 35.8 Total financial assets measured at fair value 224.3 0.0 35.8 0.0 0.0 117.6 0.0 0.0 70.9 Guarantees 0.1 0.1 0.0 31.12.22 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD bn Cash collateral received Collateralized by equity and debt instruments Secured by real estate Other collateral Netting Credit derivative contracts Guarantees and sub- participations Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 16.7 16.7 Derivative financial instruments 4 150.1 5.9 133.5 10.7 Brokerage receivables 17.6 17.3 0.3 Financial assets at fair value not held for trading – debt instruments 5 44.8 11.4 33.4 Total financial assets measured at fair value 229.2 0.0 34.6 0.0 0.0 133.5 0.0 0.0 61.2 Guarantees 0.2 0.2 0.0 1 The maximum exposure to loss not considered as these positions are generally managed under the market risk framework. not recognized collateralized by equity and debt instruments consisted of structured loans and reverse repurchase and securities borrowing agreements. |
Disclosure Of Fair Value Of Financial Instruments Not Measured At Fair Value Explanatory | Financial instruments not measured at fair value 31.12.23 31.12.22 Carrying amount Fair value Carrying amount Fair value USD bn Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets Cash and balances at central banks 171.8 171.7 0.0 0.1 0.0 171.8 169.4 169.4 0.1 0.0 0.0 169.4 Amounts due from banks 28.2 12.5 0.0 15.4 0.2 28.2 14.7 13.9 0.0 0.7 0.0 14.6 Receivables from securities financing transactions measured at amortized cost 74.1 68.7 0.0 3.9 1.5 74.1 67.8 64.3 0.0 1.8 1.7 67.8 Cash collateral receivables on derivative instruments 32.3 32.3 0.0 0.0 0.0 32.3 35.0 35.0 0.0 0.0 0.0 35.0 Loans and advances to customers 405.6 131.8 0.0 44.3 220.4 396.5 390.0 136.9 0.0 45.9 195.0 377.7 Other financial assets measured at amortized cost 54.3 9.0 12.8 29.6 2.6 54.1 53.4 13.0 10.3 25.1 2.5 51.0 Liabilities Amounts due to banks 16.7 8.8 0.0 8.0 0.0 16.7 11.6 8.9 0.0 2.7 0.0 11.6 Payables from securities financing transactions measured at amortized cost 5.8 5.1 0.0 0.4 0.4 5.8 4.2 3.5 0.0 0.7 0.0 4.2 Cash collateral payables on derivative instruments 34.9 34.9 0.0 0.0 0.0 34.9 36.4 36.4 0.0 0.0 0.0 36.4 Customer deposits 555.7 482.1 0.0 74.5 0.0 556.6 527.2 493.0 0.0 33.9 0.0 526.9 Funding from UBS Group AG measured at amortized cost 67.3 3.3 0.0 64.4 0.0 67.7 56.1 2.0 0.0 53.7 0.0 55.7 Debt issued measured at amortized cost 69.8 18.1 0.0 51.7 0.0 69.8 59.5 13.4 0.0 45.5 0.0 58.9 Other financial liabilities measured at amortized cost 2 9.8 9.8 0.0 0.0 0.0 9.8 7.2 7.2 0.0 0.0 0.0 7.2 1 Includes certain financial instruments where the carrying with a remaining maturity (excluding the effects of callable features) of three months or less). |
Offsetting financial assets a_2
Offsetting financial assets and financial liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Offsetting Financial Assets And Financial Liabilities Tables [Line Items] | |
Disclosure Of Offsetting Of Financial Assets Explanatory | Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.23, USD bn Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions measured at amortized cost 69.2 (12.2) 56.9 (1.5) (55.2) 0.3 17.2 17.5 74.1 Derivative financial instruments 128.8 (2.5) 126.3 (99.3) (23.4) 3.7 5.4 9.1 131.7 Cash collateral receivables on derivative instruments 1 31.5 0.0 31.5 (20.4) (2.5) 8.7 0.8 9.5 32.3 Financial assets at fair value not held for trading 96.3 (89.6) 6.7 (1.8) (4.9) 0.0 57.1 57.1 63.8 of which: reverse repurchase agreements 95.1 (89.6) 5.5 (1.8) (3.7) 0.0 0.0 0.0 5.5 Total assets 325.7 (104.3) 221.4 (122.9) (85.9) 12.6 80.5 93.1 301.9 As of 31.12.22, USD bn Receivables from securities financing transactions measured at amortized cost 60.8 (11.1) 49.6 (3.0) (46.4) 0.3 18.2 18.5 67.8 Derivative financial instruments 147.4 (2.5) 144.9 (110.9) (28.5) 5.5 5.2 10.7 150.1 Cash collateral receivables on derivative instruments 1 33.5 0.0 33.5 (20.9) (1.9) 10.6 1.5 12.1 35.0 Financial assets at fair value not held for trading 85.6 (76.8) 8.7 (1.5) (7.3) 0.0 50.7 50.7 59.4 of which: reverse repurchase agreements 84.4 (76.8) 7.6 (1.5) (6.1) 0.0 0.1 0.1 7.7 Total assets 327.2 (90.4) 236.8 (136.3) (84.1) 16.4 75.6 92.0 312.4 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross from securities financing transactions “Payables from securities financing transactions measured at amortized cost” and “Other financial liabilities designated at fair value” lines the amounts of financial instruments and cash collateral presented have been capped so as not to exceed the net amount of financial assets presented on the balance sheet; i.e., over-collateralization, where is not reflected in the table. |
Disclosure Of Offsetting Of Financial Liabilities Explanatory | Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.23, USD bn Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions measured at amortized cost 16.1 (12.1) 4.0 (0.8) (3.2) 0.0 1.8 1.8 5.8 Derivative financial instruments 135.9 (2.5) 133.5 (99.3) (24.5) 9.7 7.2 16.9 140.7 Cash collateral payables on derivative instruments 1 33.5 0.0 33.5 (17.2) (3.4) 12.9 1.4 14.3 34.9 Other financial liabilities designated at fair value 97.1 (89.8) 7.3 (2.5) (4.8) 0.0 20.1 20.1 27.4 of which: repurchase agreements 96.7 (89.8) 6.9 (2.5) (4.4) 0.0 0.0 0.0 6.9 Total liabilities 282.6 (104.3) 178.3 (119.7) (36.0) 22.5 30.4 53.0 208.7 As of 31.12.22, USD bn Payables from securities financing transactions measured at amortized cost 14.1 (11.1) 3.0 (1.3) (1.8) 0.0 1.2 1.2 4.2 Derivative financial instruments 150.3 (2.5) 147.8 (110.9) (26.2) 10.7 7.1 17.8 154.9 Cash collateral payables on derivative instruments 1 34.9 0.0 34.9 (20.0) (1.9) 13.0 1.6 14.5 36.4 Other financial liabilities designated at fair value 92.5 (76.9) 15.6 (3.2) (12.4) 0.0 16.4 16.4 32.0 of which: repurchase agreements 92.1 (76.9) 15.3 (3.2) (12.1) 0.0 0.1 0.1 15.3 Total liabilities 291.7 (90.4) 201.3 (135.3) (42.3) 23.7 26.3 49.9 227.6 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the “Netting with gross measured at amortized financing transactions measured at amortized cost” instruments and cash collateral presented have been capped so as not to exceed the net amount of financial liabilities presented on the balance sheet; table. |
Restricted financial assets (Ta
Restricted financial assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes Disclosure Restricted Financial Assets Tables [Line Items] | |
Disclosure of restricted financial assets [text block] | Restricted financial assets USD m 31.12.23 31.12.22 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties Financial assets pledged as collateral Cash and balances at central banks 1 709 Financial assets at fair value held for trading 76,579 44,524 57,435 36,742 Loans and advances to customers 28,105 15,195 Financial assets at fair value not held for trading 3,099 2,110 1,509 1,220 Debt securities classified as Other financial assets measured 7,043 6,299 3,432 2,685 Total financial assets pledged as collateral 115,535 77,571 Other restricted financial assets Amounts due from banks 2,543 3,689 Financial assets at fair value held for trading 169 162 Cash collateral receivables on derivative instruments 4,685 5,155 Loans and advances to customers 28 1,127 Other financial assets measured at amortized cost 3,334 2 815 Financial assets at fair value not held for trading 17,844 14,090 Financial assets measured at fair value through other comprehensive 1,846 1,842 Other 249 44 Total other restricted financial assets 30,698 26,924 Total financial assets pledged and other restricted financial assets 3 146,233 104,495 1 Assets pledged to the depositor protection system in Switzerland following new requirements that became effective in 2023. to secure (31 December 2023: USD 9.7 bn; 31 December 2022: USD 5.9 bn). |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition Explanatory | Transferred financial assets subject to continued recognition in full USD m 31.12.23 31.12.22 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 44,524 23,374 36,742 16,470 Financial assets at fair value not held for trading that may be sold or repledged counterparties 2,110 1,976 1,220 1,050 Debt securities classified as Other financial assets measured sold or repledged by counterparties 6,299 5,928 2,685 2,302 Total financial assets transferred 52,933 31,278 40,647 19,822 |
Disclosure Of Off Balance Sheet Assets Received Table [Text Block] | Off-balance sheet assets received USD m 31.12.23 31.12.22 Fair value of assets received that can be sold or repledged 489,476 434,023 of which: sold or repledged 357,020 331,805 1 Includes securities services. 16.0 bn; 31 December 2022: USD 9.9 bn) placed with central banks related to undrawn settlement purposes for which there are no associated liabilities or contingent liabilities. |
Maturity analysis of assets and
Maturity analysis of assets and liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Offsetting Financial Assets And Financial Liabilities Tables [Line Items] | |
Disclosure of maturity analysis for financial liabilities [text block] | 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.2 2.6 3.9 0.3 4.4 0.0 17.4 Payables from securities financing transactions 4.0 1.1 0.7 5.8 Cash collateral payables on derivative instruments 34.9 34.9 Customer deposits 433.5 49.7 51.6 16.9 9.8 0.3 561.8 Funding from UBS Group AG measured at amortized cost 2 2.8 1.7 1.7 11.0 31.9 24.1 12.9 86.1 Debt issued measured at amortized cost 6.4 11.9 27.4 7.0 12.8 8.1 73.6 Other financial liabilities measured at amortized cost 6.2 0.1 0.4 0.5 1.1 1.1 9.4 0.0 0.1 0.4 0.5 1.1 1.1 3.3 Total financial liabilities measured at amortized cost 494.1 67.0 85.7 35.6 60.1 33.6 12.9 789.1 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 140.7 140.7 Brokerage payables designated at fair value 42.3 42.3 Debt issued designated at fair value 6 13.1 11.8 22.5 25.7 8.1 11.8 93.0 Other financial liabilities designated at fair value 22.1 0.1 0.8 0.3 0.3 7.2 30.8 Total financial liabilities measured at fair value through profit or loss 249.9 11.9 23.3 26.0 8.4 19.0 338.4 Total 744.0 78.9 109.0 61.6 68.5 52.6 12.9 1,127.5 Guarantees, loan commitments and forward starting transactions Irrevocable loan commitments 7 43.0 0.5 0.4 0.0 0.0 44.0 Guarantees 33.4 33.4 Forward starting reverse repurchase and securities borrowing agreements 7 10.4 10.4 Irrevocable committed prolongation of existing loans 2.0 0.8 1.3 0.0 0.0 4.2 Total 88.8 1.4 1.8 0.0 0.0 91.9 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.3 2.6 1.9 0.3 0.6 0.0 11.7 Payables from securities financing transactions 3.3 0.3 0.4 0.3 0.0 4.4 Cash collateral payables on derivative instruments 36.4 36.4 Customer deposits 464.6 28.8 24.5 8.2 2.6 0.3 529.0 Funding from UBS Group AG measured at amortized cost 2 2.2 0.6 1.2 6.8 27.6 21.2 12.7 72.3 Debt issued measured at amortized cost 4.6 8.9 23.7 7.8 10.8 6.9 62.8 Other financial liabilities measured at amortized cost 5.6 0.1 0.4 0.5 1.2 1.3 9.2 0.1 0.1 0.4 0.5 1.2 1.3 3.7 Total financial liabilities measured at amortized cost 523.1 41.2 52.2 24.0 42.8 29.8 12.7 725.8 Financial liabilities at fair value held for trading 3,4 29.5 29.5 Derivative financial instruments 3,5 154.9 154.9 Brokerage payables designated at fair value 45.1 45.1 Debt issued designated at fair value 6 9.4 12.4 16.0 19.7 7.1 12.3 76.8 Other financial liabilities designated at fair value 27.1 1.4 0.4 0.4 0.5 5.0 34.8 Total financial liabilities measured at fair value through profit or loss 266.0 13.8 16.4 20.0 7.5 17.3 341.1 Total 789.2 55.0 68.6 44.0 50.3 47.1 12.7 1,066.9 Guarantees, loan commitments and forward starting transactions Irrevocable loan commitments 7 39.3 0.3 0.4 0.0 40.0 Guarantees 22.4 22.4 Forward starting reverse repurchase and securities borrowing agreements 7 3.8 3.8 Irrevocable committed prolongation of existing loans 4.7 4.7 Total 70.1 0.3 0.4 0.0 70.9 1 Except for financial liabilities at payments. cash flows 29.9 bn due (31 December 2022: USD 27.8 bn), USD 1.8 bn due between 1 1.7 bn) and USD 0 bn due between 1 0 bn). 52 m (31 December 2022: USD 46 m) related to fair contractual committed amount of USD 65.2 bn (31 December 2022: USD 34.4 bn) is presented in Note 10 under notional amounts. to the applicable interest rate prevailing as of loan commitments and forward starting reverse repurchase agreements measured at fair value (see footnote 5). |
Disclosure Of Maturity Analysis For Assets And Liabilities Explanatory | 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Assets Total financial assets measured at amortized cost 416.2 25.6 47.6 105.2 77.8 94.0 766.4 Amounts due from banks 12.0 0.5 5.4 10.0 0.2 0.1 28.2 Loans and advances to customers 135.5 12.1 33.3 89.4 61.4 74.0 405.6 Other financial assets measured at amortized cost 7.4 1.6 4.2 5.1 16.1 19.9 54.3 Total financial assets measured at fair value through profit or loss 312.5 6.7 7.8 7.4 11.8 3.4 1.9 351.5 Financial assets at fair value not held for trading 24.8 6.7 7.8 7.4 11.8 3.4 1.9 63.8 Financial assets measured at fair value through other comprehensive income 0.1 1.1 1.0 0.1 0.0 0.0 2.2 Total non-financial assets 6.6 0.2 1.2 0.4 27.5 35.9 Total assets 735.4 33.4 56.5 112.7 90.8 97.8 29.5 1,156.0 Liabilities Total financial liabilities measured at amortized cost 497.1 65.1 81.1 30.3 49.6 27.1 12.5 762.8 Customer deposits 433.2 48.9 49.6 15.3 8.4 0.3 555.7 Funding from UBS Group AG measured at amortized cost 2.5 0.8 8.2 24.3 19.0 12.5 67.3 Debt issued measured at amortized cost 6.4 11.7 26.8 6.3 11.8 6.8 69.8 of which: non-subordinated 6.4 11.7 24.3 6.0 11.6 6.8 66.8 of which: subordinated 2.5 0.3 0.2 3.0 Total financial liabilities measured at fair value through profit or loss 1 250.1 11.4 22.6 23.3 8.3 12.7 328.4 Debt issued designated at fair value 13.1 11.3 21.8 23.0 8.0 9.1 86.3 Total non-financial liabilities 5.2 2.8 0.5 9.2 Total liabilities 752.5 79.3 103.8 53.7 58.3 39.9 13.0 1,100.4 Guarantees, loan commitments and forward starting transactions 2 Irrevocable loan commitments 43.0 0.5 0.4 0.0 0.0 44.0 Guarantees 33.4 33.4 Forward starting reverse repurchase and securities borrowing agreements 10.4 10.4 Irrevocable committed prolongation of existing loans 2.0 0.8 1.3 0.0 0.0 4.2 Total 88.8 1.4 1.8 0.0 0.0 91.9 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 2 years Due between 2 and 5 years Due over 5 years Perpetual / Not applicable Total Assets Total financial assets measured at amortized cost 425.2 28.7 34.5 78.8 70.5 92.8 730.4 Amounts due from banks 13.3 0.6 0.6 0.0 0.0 0.1 14.7 Loans and advances to customers 141.9 16.3 28.3 74.9 55.6 73.0 390.0 Other financial assets measured at amortized cost 8.8 4.2 2.8 3.0 14.8 19.7 53.4 Total financial assets measured at fair value through profit or loss 300.4 10.0 7.8 3.6 9.9 2.0 1.5 335.1 Financial assets at fair value not held for trading 24.6 10.0 7.8 3.6 9.9 2.0 1.5 59.4 Financial assets measured at fair value through other comprehensive income 0.3 0.9 0.9 0.1 0.0 0.0 2.2 Total non-financial assets 7.1 0.2 2.0 0.4 28.0 37.7 Total assets 732.9 39.5 43.4 82.4 82.4 95.1 29.6 1,105.4 Liabilities Total financial liabilities measured at amortized cost 524.3 40.2 49.6 20.7 35.2 23.5 11.8 705.4 Customer deposits 464.5 28.5 23.8 7.7 2.3 0.3 527.2 Funding from UBS Group AG measured at amortized cost 2.0 4.8 21.2 16.3 11.8 56.1 Debt issued measured at amortized cost 4.6 8.8 23.3 7.2 10.0 5.7 59.5 of which: non-subordinated 4.6 8.8 23.3 4.8 9.5 5.7 56.5 of which: subordinated 2.4 0.5 3.0 Total financial liabilities measured at fair value through profit or loss 1 265.9 13.8 16.3 19.6 7.3 10.5 333.4 Debt issued designated at fair value 9.3 12.3 15.9 19.3 6.9 8.2 71.8 Total non-financial liabilities 6.7 2.6 0.5 9.7 Total liabilities 796.9 56.5 65.9 40.4 42.5 34.0 12.3 1,048.5 Guarantees, loan commitments and forward starting transactions 2 Irrevocable loan commitments 39.3 0.3 0.4 0.0 40.0 Guarantees 22.4 22.4 Forward starting reverse repurchase and securities borrowing agreements 3.8 3.8 Irrevocable committed prolongation of existing loans 4.7 4.7 Total 70.1 0.3 0.4 0.0 70.9 1 As of 31 December through profit or loss agreements, measured at information. |
Interest rate benchmark reform
Interest rate benchmark reform (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Interest Rate Benchmark Reform Maximum Exposure Tables [Line Items] | |
Disclosure Of Quantitative Information About Financial Instruments That Have Yet To Transition To Alternative Benchmark Rate Explanatory | 31.12.22 1 Measure USD LIBOR benchmark rates Carrying value of non-derivative financial instruments Total non-derivative financial assets USD m 14,269 2 Total non-derivative financial liabilities USD m 1,138 3 Trade count of derivative financial instruments Total derivative financial instruments Trade count 32,006 4 Off-balance sheet exposures Total irrevocable loan commitments USD m 4,606 5 1 As of 31 December 2022, non-USD balances and trade counts were minimal. 1 bn of loans related to revolving multi-currency credit lines, USD LIBOR. The remaining balances as of 31 December 2022 primarily related to US mortgages and corporate LIBOR, with transition dependent upon the actions of respective issuers. 2,000 30 June 2023. No further contractual fixing is required for these contracts. 3 bn of loan commitments that can be drawn in different currencies; however, efforts remained open as of 31 December 2022. |
Hedge accounting (Tables)
Hedge accounting (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes Hedge Accounting Tables [Line Items] | |
Disclosure Of Detailed Information About Hedging Instruments Explanatory | All hedges: designated hedging instruments As of or for the year ended 31.12.23 USD m Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 114,618 0 0 2,203 (2,195) 8 Cash flow hedges 83,333 3 0 (35) 57 22 Foreign exchange risk Fair value hedges 2 33,877 468 291 132 (151) (19) Hedges of net investments in foreign operations 13,260 3 455 (910) 912 3 As of or for the year ended 31.12.22 USD m Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 92,415 0 0 (5,195) 5,169 (27) Cash flow hedges 75,304 2 5 (5,813) 5,760 (53) Foreign exchange risk Fair value hedges 2 20,566 845 3 (1,088) 1,105 18 Hedges of net investments in foreign operations 13,844 7 528 318 (319) (1) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. |
Disclosure of fair value hedge accounting [text block] | Fair value hedges: designated hedged items 1 USD m 31.12.23 31.12.22 Interest rate risk FX risk Interest rate risk FX risk Loans and advances to customers Carrying amount of designated loans 15,296 14,270 of which: accumulated amount of fair value hedge adjustment (508) (1,249) of which: accumulated amount of fair value hedge adjustment subject portion of the portfolio that ceased to be part of hedge (179) (51) Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 6,333 4,577 (109) (180) Customer deposits Carrying amount of Customer deposits 8,972 50 Funding from UBS Group AG Carrying amount of designated debt instruments 63,760 17,693 57,250 14,828 (3,174) (5,055) Debt issued measured at amortized cost Carrying amount of designated debt issued 15,243 4,636 11,279 5,737 (412) (1,002) 1 In addition, as of 31 December 12 bn of intragroup debt instruments on these instruments impact consolidated profit or loss. No such designations were in place as of 31 December 2022. |
Disclosure of fair value hedge accounting related to debt issued and debt securities [text block] | Fair value hedges: profile of the timing of the 31.12.23 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 6 12 62 35 115 Cross-currency swaps 1 2 2 22 7 34 31.12.22 USD bn Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 4 10 53 26 92 Cross-currency swaps 0 1 2 12 5 21 |
Disclosure of cash flow hedge accounting [text block] | Cash flow hedge reserve on a pre-tax basis USD m 31.12.23 31.12.22 Amounts related to hedge relationships for which hedge (2,349) (4,692) Amounts related to hedge relationships for which hedge (1,331) (540) Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis (3,680) (5,232) |
Disclosure of foreign currecny translation hedge accounting [text block] | Foreign currency translation reserve on a pre-tax basis USD m 31.12.23 31.12.22 Amounts related to hedge relationships for which hedge (690) 250 Amounts related to hedge relationships for which hedge 266 266 Total other comprehensive income recognized directly in equity related to hedging instruments basis (424) 515 |
Disclosure Hedge Accounting Referencing LIBOR Explanatory | Hedging instruments referencing LIBOR 31.12.22 Carrying amount USD m Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 20,383 0 0 Cash flow hedges 2,179 0 0 |
Post-employment benefit plans (
Post-employment benefit plans (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Post-employment Benefit Plans Tables [Line Items] | |
Disclosure Of Defined Benefit Plans Explanatory | Defined benefit plans USD m Swiss plan UK plan US and German plans Total 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Defined benefit obligation at the beginning of the year 12,539 15,480 2,166 4,105 1,375 1,740 16,080 21,324 Current service cost 236 240 0 0 5 5 241 244 Interest expense 287 195 109 67 61 35 457 297 Plan participant contributions 163 154 0 0 0 0 163 154 Remeasurements 1,901 (2,424) 96 (1,474) 33 (267) 2,031 (4,165) of which: actuarial (gains) / losses due to changes in demographic 45 2 (75) (6) (2) 1 (31) (3) of which: actuarial (gains) / losses due to changes in financial 1,168 (2,653) 36 (1,575) 37 (279) 1,241 (4,506) of which: experience (gains) / losses 1 688 226 135 107 (3) 11 820 344 Past service cost related to plan amendments 0 0 0 0 0 0 0 0 Curtailments (3) (13) 0 0 0 0 (3) (13) Benefit payments (662) (796) (107) (123) (110) (111) (880) (1,030) Other movements 0 (5) 0 0 0 0 0 (5) Foreign currency translation 1,288 (291) 114 (408) 9 (28) 1,411 (727) Defined benefit obligation at the end of the year 15,748 12,539 2,379 2,166 1,373 1,375 19,500 16,080 of which: amounts owed to active members 9,336 7,103 73 65 209 169 9,618 7,336 of which: amounts owed to deferred members 0 0 950 656 527 528 1,478 1,184 of which: amounts owed to retirees 6,412 5,436 1,356 1,445 636 678 8,404 7,560 of which: funded plans 15,748 12,539 2,379 2,166 979 1,011 19,106 15,717 of which: unfunded plans 0 0 0 0 394 363 394 363 Fair value of plan assets at the beginning of the year 16,957 19,196 2,488 4,297 1,039 1,329 20,484 24,821 Return on plan assets excluding interest income 513 (1,942) 65 (1,312) 26 (223) 603 (3,476) Interest income 393 274 126 70 48 31 568 376 Employer contributions 290 401 19 5 17 16 327 422 Plan participant contributions 163 154 0 0 0 0 163 154 Benefit payments (662) (796) (107) (123) (110) (111) (880) (1,030) Administration expenses, taxes and premiums paid (8) (7) 0 0 (4) (3) (12) (11) Other movements 2 (1) 0 0 0 0 2 (1) Foreign currency translation 1,685 (322) 130 (450) 0 0 1,815 (772) Fair value of plan assets at the end of the year 19,333 16,957 2,720 2,488 1,017 1,039 23,070 20,484 Surplus / (deficit) 3,585 4,418 341 321 (356) (335) 3,570 4,404 Asset ceiling effect at the beginning of the year 4,418 3,716 0 0 0 0 4,418 3,716 Interest expense on asset ceiling effect 102 77 0 0 0 0 102 77 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect (1,332) 656 0 0 0 0 (1,332) 656 Foreign currency translation 397 (31) 0 0 0 0 397 (31) Asset ceiling effect at the end of the year 3,585 4,418 0 0 0 0 3,585 4,418 Net defined benefit asset / (liability) of major plans 0 0 341 321 (356) (335) (15) (14) Net defined benefit asset / (liability) of remaining plans (90) (80) Total net defined benefit asset / (liability) (105) (94) of which: Net defined benefit asset 383 355 of which: Net defined benefit liability 2 (487) (449) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD m Swiss plan UK plan US and German plans Total For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Current service cost 236 240 0 0 5 5 241 244 Interest expense related to defined benefit obligation 287 195 109 67 61 35 457 297 Interest income related to plan assets (393) (274) (126) (70) (48) (31) (568) (376) Interest expense on asset ceiling effect 102 77 0 0 0 0 102 77 Administration expenses, taxes and premiums paid 8 7 0 0 4 3 12 11 Past service cost related to plan amendments 0 0 0 0 0 0 0 0 Curtailments (3) (13) 0 0 0 0 (3) (13) Net periodic expenses recognized in net profit for major plans 236 230 (17) (3) 22 12 241 239 Net periodic expenses recognized in net profit for remaining plans 2 19 17 Total net periodic expenses recognized in net profit 259 256 1 Refer to Note 6. Other comprehensive income – gains / (losses) on defined benefit plans USD m Swiss plan UK plan US and German plans Total For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Remeasurement of defined benefit obligation (1,901) 2,424 (96) 1,474 (33) 267 (2,031) 4,165 of which: change in discount rate assumption (1,332) 3,078 (69) 1,451 (33) 317 (1,434) 4,846 of which: change in rate of pension increase assumption 0 0 34 123 1 (5) 34 118 of which: change in rate of interest credit on retirement savings 207 (408) 0 0 (9) (82) 198 (490) of which: change in life expectancy 0 0 75 5 0 (1) 75 4 of which: change in other actuarial assumptions (88) (19) 0 1 5 48 (83) 30 of which: experience gains / (losses) 1 (688) (226) (135) (107) 3 (11) (820) (344) Return on plan assets excluding interest income 513 (1,942) 65 (1,312) 26 (223) 603 (3,476) Asset ceiling effect excluding interest expense and foreign currency 1,332 (656) 0 0 0 0 1,332 (656) Total gains / (losses) recognized in other comprehensive income for major plans (56) (173) (31) 162 (8) 43 (95) 32 Total gains / (losses) recognized in other comprehensive income for remaining plans (8) 8 Total gains / (losses) recognized in other comprehensive income 2 (103) 40 1 Experience (gains) / occurred. |
Disclosure of maturity analysis of expected benefit payments [text block] | Swiss plan UK plan US and German plans 1 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Duration of the defined benefit obligation (in years) 14.1 13.4 14.5 13.7 7.8 7.9 Maturity analysis of benefits expected to be paid USD m Benefits expected to be paid within 12 months 811 702 137 107 133 123 Benefits expected to be paid between 1 and 3 years 1,627 1,445 256 234 235 232 Benefits expected to be paid between 3 and 6 years 2,552 2,183 415 384 336 335 Benefits expected to be paid between 6 and 11 years 4,233 3,751 721 667 502 502 Benefits expected to be paid between 11 and 16 years 3,878 3,519 723 667 376 388 Benefits expected to be paid in more than 16 years 13,751 13,243 2,703 2,570 417 516 1 The duration of the defined benefit obligation represents a weighted average across US and |
Disclosure of actuarial assumptions [text block] | Significant actuarial assumptions of plans Swiss plan UK plan US plans German plans In % 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Discount rate 1.48 2.34 4.79 5.02 4.72 1 4.92 1 3.28 3.81 Rate of pension increase 0.00 0.00 3.00 3.08 0.00 0.00 2.10 2.20 Rate of interest credit on retirement savings 2.48 3.39 0.00 0.00 6.28 2 5.73 2 0.00 0.00 1 Represents weighted average across US pension plans. |
Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory | Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss plan UK plan US and German plans USD m 31.12.23 31.12.22 31.12.23 31.12.22 31.12.23 31.12.22 Discount rate Increase by 50 basis points (857) (641) (164) (141) (50) (51) Decrease by 50 basis points 973 723 183 157 54 55 Rate of pension increase Increase by 50 basis points 639 487 137 127 4 4 Decrease by 50 basis points – 2 – 2 (129) (118) (4) (3) Rate of interest credit on retirement savings Increase by 50 basis points 144 106 – 3 – 3 9 9 Decrease by 50 basis points (144) (106) – 3 – 3 (8) (8) Life expectancy Increase in longevity by one additional year 416 304 78 65 39 39 1 The sensitivity analyses are based on a change in one increase was 0 % as of 31 December 2023 and as of 31 December 2022, a downward change in assumption assumption is not applicable. |
Disclosure of composition and fair value of plan assets [text block] | Composition and fair value of plan assets Swiss defined benefit plan 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 62 0 62 0 183 0 183 1 Real estate / property Domestic 0 2,426 2,426 13 0 2,130 2,130 13 Foreign 0 576 576 3 0 517 517 3 Investment funds Equity Domestic 489 0 489 3 418 0 418 2 Foreign 3,283 1,244 4,526 23 2,794 1,222 4,017 24 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 13 2,117 0 2,117 12 Foreign, AAA to BBB– 4,073 0 4,073 21 3,395 0 3,395 20 Foreign, below BBB– 668 0 668 3 598 0 598 4 Real estate Foreign 0 45 45 0 0 0 0 0 Other 1,094 1,910 3,004 16 867 1,997 2,864 17 Other investments 378 481 859 4 351 367 718 4 Total fair value of plan assets 12,652 6,681 19,333 100 10,724 6,233 16,957 100 31.12.23 31.12.22 Total fair value of plan assets 19,333 16,957 of which: 2 Bank accounts at UBS Group AG 69 189 UBS Group AG debt instruments 116 28 UBS Group AG shares 26 15 Securities lent to UBS Group AG 3 467 489 Property occupied by UBS Group AG 61 51 Derivative financial instruments, counterparty UBS Group AG 3 302 43 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s rating classification. positions disclosed 3 Securities lent to UBS AG and derivative of collateral, derivative financial instruments amounted to negative USD 19 m as of 31 December 2023 (31 December 2022: negative USD 5 m). Composition and fair value of plan assets UK defined benefit plan 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents (27) 0 (27) (1) 104 0 104 4 Bonds 1 Domestic, AAA to BBB– 2,375 0 2,375 87 1,729 0 1,729 69 Foreign, AAA to BBB– 357 0 357 13 297 0 297 12 Foreign, below BBB– 0 0 0 0 7 0 7 0 Investment funds Equity Domestic 9 3 12 0 19 3 22 1 Foreign 234 0 234 9 366 0 366 15 Bonds 1 Domestic, AAA to BBB– 310 38 348 13 367 90 457 18 Domestic, below BBB– 6 0 6 0 1 0 1 0 Foreign, AAA to BBB– 97 0 97 4 90 0 90 4 Foreign, below BBB– 93 0 93 3 114 0 114 5 Real estate Domestic 61 0 61 2 64 0 64 3 Foreign 4 12 16 1 6 31 36 1 Other 64 0 64 2 (280) 0 (280) (11) Repurchase agreements (947) 0 (947) (35) (612) 0 (612) (25) Other investments 15 16 31 1 66 27 94 4 Total fair value of plan assets 2,652 69 2,720 100 2,336 151 2,488 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s US and German defined benefit plans 31.12.23 31.12.22 Fair value Plan asset allocation % Fair value Plan asset allocation % USD m Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 4 0 4 0 7 0 7 1 Equity Domestic 54 0 54 5 55 0 55 5 Foreign 23 0 23 2 24 0 24 2 Bonds 1 Domestic, AAA to BBB– 308 0 308 30 359 0 359 35 Domestic, below BBB– 3 0 3 0 4 0 4 0 Foreign, AAA to BBB– 51 0 51 5 74 0 74 7 Foreign, below BBB– 2 0 2 0 3 0 3 0 Investment funds Equity Domestic 25 0 25 2 27 0 27 3 Foreign 43 0 43 4 33 0 33 3 Bonds 1 Domestic, AAA to BBB– 271 0 271 27 266 0 266 26 Domestic, below BBB– 172 0 172 17 109 0 109 10 Foreign, AAA to BBB– 4 0 4 0 2 0 2 0 Foreign, below BBB– 6 0 6 1 5 0 5 0 Real estate Domestic 0 9 9 1 0 11 11 1 Other 49 0 49 5 54 0 54 5 Other investments (8) 1 (7) (1) 5 1 6 1 Total fair value of plan assets 1,007 10 1,017 100 1,027 12 1,039 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s |
Actuarial Assumption Of Mortality Rates [Member] | |
Disclosure Of Post-employment Benefit Plans Tables [Line Items] | |
Disclosure of actuarial assumptions [text block] | Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.23 31.12.22 31.12.23 31.12.22 Switzerland BVG 2020 G with CMI 2022 projections 1 21.8 21.7 23.5 23.4 UK S3PA with CMI 2022 projections 2 22.2 23.5 23.4 24.6 USA Pri-2012 with MP-2021 projection scale 22.0 22.0 23.4 23.3 Germany Dr. K. Heubeck 2018 G 20.8 20.6 23.5 23.4 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.23 31.12.22 31.12.23 31.12.22 Switzerland BVG 2020 G with CMI 2022 projections 1 23.5 23.5 25.1 25.1 UK S3PA with CMI 2022 projections 2 24.0 25.0 25.7 26.4 USA Pri-2012 with MP-2021 projection scale 23.5 23.4 24.8 24.8 Germany Dr. K. Heubeck 2018 G 24.2 24.0 26.4 26.3 1 In 2022, BVG 2020 G with CMI 2021 projections was used. |
Employee benefits_ variable c_2
Employee benefits: variable compensation (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Equity Participation And Other Compensation Plans Tables [Line Items] | |
Disclosure of compensation-related personnel expenses [text block] | Variable compensation Expenses recognized in 2023 Expenses deferred to 2024 and later 1 USD m Related to the 2023 performance year Related to prior performance years Total Related to the 2023 performance year Related to prior performance years Total Non-deferred cash 1,884 (36) 1,848 0 0 0 Deferred compensation awards 356 637 993 537 731 1,268 of which: Equity Ownership Plan 95 319 415 180 235 416 of which: Deferred Contingent Capital Plan 124 233 357 216 436 652 of which: Long-Term Incentive Plan 121 39 160 112 33 145 of which: Fund Ownership Plan 15 45 61 28 27 55 Variable compensation – performance awards 2,240 601 2,841 537 731 1,268 Variable compensation – financial advisors 2 3,761 788 4,549 1,236 3,300 4,536 of which: non-deferred cash 3,440 (4) 3,436 0 0 0 of which: deferred share-based awards 110 87 197 113 209 321 of which: deferred cash-based awards 169 245 414 301 1,029 1,331 of which: compensation commitments with recruited financial 42 459 501 822 2,062 2,884 Variable compensation – other 3 168 111 279 224 214 438 Total variable compensation 6,169 1,500 7,669 4 1,997 4,245 6,242 1 Estimate as awards and is based on that are subject to vesting requirements. 4 Includes USD 818 m in expenses related to share-based compensation 575 m; other variable compensation: USD 46 m; financial advisor compensation: USD 197 m). A further USD 135 m in expenses related to share-based compensation 4 m related to role-based allowances; 109 m; other personnel expenses: USD 22 m related to the Equity Plus Plan). Variable compensation (continued) Expenses recognized in 2022 Expenses deferred to 2023 and later 1 USD m Related to the 2022 performance year Related to prior performance years Total Related to the 2022 performance year Related to prior performance years Total Non-deferred cash 2,012 (9) 2,003 0 0 0 Deferred compensation awards 346 561 907 582 730 1,312 of which: Equity Ownership Plan 191 225 416 294 240 534 of which: Deferred Contingent Capital Plan 123 211 334 238 395 634 of which: Long-Term Incentive Plan 11 30 41 30 40 70 of which: Fund Ownership Plan 21 95 116 20 54 74 Variable compensation – performance awards 2,358 552 2,910 582 730 1,312 Variable compensation – financial advisors 2 3,799 709 4,508 1,290 2,652 3,942 of which: non-deferred cash 3,481 0 3,481 0 0 0 of which: deferred share-based awards 104 62 166 122 180 302 of which: deferred cash-based awards 185 215 400 588 636 1,224 of which: compensation commitments with recruited financial 29 432 461 580 1,836 2,416 Variable compensation – other 3 146 72 217 230 189 419 Total variable compensation 6,304 1,332 7,636 4 2,101 3,571 5,672 1 Estimate as awards and is based on that are subject to vesting requirements. 4 Includes USD 680 m in expenses related to share-based compensation (performance awards: USD 457 m; other variable compensation: USD 56 m; financial advisor compensation: USD 166 m). A further USD 80 m in expenses related to 4 m related to 57 m; other expenses: USD 19 m related to the Equity Plus Plan). Variable compensation (continued) Expenses recognized in 2021 Expenses deferred to 2022 and later 1 USD m Related to the 2021 performance year Related to prior performance years Total Related to the 2021 performance year Related to prior performance years Total Non-deferred cash 2,136 (8) 2,128 0 0 0 Deferred compensation awards 389 399 788 767 606 1,373 of which: Equity Ownership Plan 175 174 350 374 180 553 of which: Deferred Contingent Capital Plan 134 151 285 290 318 608 of which: Long-Term Incentive Plan 51 17 69 48 32 79 of which: Fund Ownership Plan 29 55 84 56 77 133 Variable compensation – performance awards 2,525 391 2,916 767 606 1,373 Variable compensation – financial advisors 2 4,175 685 4,860 1,097 2,323 3,419 of which: non-deferred cash 3,858 (6) 3,853 0 0 0 of which: deferred share-based awards 106 51 157 123 146 269 of which: deferred cash-based awards 170 202 372 311 495 806 of which: compensation commitments with recruited financial 41 438 479 662 1,682 2,344 Variable compensation – other 3 163 33 196 210 178 388 Total variable compensation 6,863 1,109 7,973 4 2,074 3,107 5,181 1 Estimate as of 31 compensable revenues and firm tenure using vesting requirements. USD 631 m in expenses related to share-based compensation 419 m; other variable compensation: USD 56 m; financial advisor compensation: USD 157 m). A further USD 77 m in expenses related to share-based 5 m related to 59 m; other personnel USD 13 m related to the Equity Plus Plan). |
Disclosure of number and weighted average exercise prices of UBS share and performance share awards [text block] | Movements in outstanding share-based compensation Number of shares 2023 Weighted average grant date fair value (USD) Number of shares 2022 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 614,428 17 295,921 15 Awarded during the year 279,310 20 358,424 19 Distributed during the year (132,770) 15 (37,994) 14 Forfeited during the year (4,043) 19 (1,923) 15 Outstanding, at the end of the year 756,925 19 614,428 17 of which: shares vested for accounting purposes 217,420 174,329 |
Interests in subsidiaries (Tabl
Interests in subsidiaries (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Interests In Subsidiaries Tables [Line Items] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Individually significant subsidiaries of 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Items USD 2,900.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Items USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct 1,000 2,900,000,000 . USD 100,000 1,283,000,000 . |
Disclosure Of Investments In Associates And Joint Arrangements Explanatory | Investments in associates and joint ventures USD m 2023 2022 Carrying amount at the beginning of the year 1,101 1,243 Additions 1 3 Reclassifications 0 (44) Share of comprehensive income (180) (41) of which: share of net profit / (loss) 1 (163) 32 of which: share of other comprehensive income 2 (17) (73) Share of changes in retained earnings (1) 0 Dividends received (35) (31) Foreign currency translation 97 (30) Carrying amount at the end of the year 983 1,101 of which: associates 980 1,098 of which: SIX Group AG, Zurich 3 826 954 of which: other associates 154 144 of which: joint ventures 3 3 1 For 2023, consists of negative USD 163 m from associates (for 2022, consists of USD 27 m from associates and USD 5 m from joint ventures). 17 m from associates (for 2022, consists of negative USD 73 m from associates). 17 %. UBS AG is represented on the Board of Directors. |
Disclosure Of Interests In Unconsolidated Structured Entities Explanatory | 31.12.23 USD m, except where indicated Securitization vehicles 1 Client Vehicles sponsored by UBS 2 Investment funds Total Maximum exposure to loss 3 Financial assets at fair value held for trading 88 37 7,413 7,538 7,538 Derivative financial instruments 2 147 66 215 215 Loans and advances to customers 0 0 200 200 200 Financial assets at fair value not held for trading 0 0 143 143 143 Financial assets measured at fair value through other comprehensive income 0 0 0 0 0 Other financial assets measured at amortized cost 188 0 0 188 438 Total assets 278 185 7,821 8,285 8,534 Derivative financial instruments 1 8 590 598 2 Total liabilities 1 8 590 598 2 Assets held by the unconsolidated structured entities in which UBS AG had an interest (USD bn) 17 4 2 5 118 6 31.12.22 USD m, except where indicated Securitization vehicles 1,2 Client Vehicles sponsored by UBS 2 Investment funds Total Maximum exposure to loss 3 Financial assets at fair value held for trading 263 2 5,884 6,149 6,149 Derivative financial instruments 3 160 115 278 278 Loans and advances to customers 0 0 119 119 119 Financial assets at fair value not held for trading 0 0 108 108 108 Financial assets measured at fair value through other comprehensive income 0 0 0 0 0 Other financial assets measured at amortized cost 0 0 2 3 252 Total assets 266 162 6,228 6,657 6,907 Derivative financial instruments 1 35 763 798 2 Total liabilities 1 35 763 798 2 Assets held by the unconsolidated structured entities in which UBS AG had an interest (USD bn) 39 4 2 5 95 6 1 Includes securities issued by securitization structured entities sponsored by both UBS regulatory requirements and are not party funding vehicles of large multi-nationals have been excluded, with prior periods restated. The restatement resulted in a 852 m and a decrease in interests in client vehicles of USD 5,057 m as of 31 December 2022. There was a corresponding decrease 11 bn and a decrease in assets held by client vehicles in which UBS has an interest of USD 105 bn as of 31 December 2022. credit enhancements. amount of UBS’s interests in the investment funds not sponsored by UBS. |
UBS AG Subsidiaries | |
Disclosure Interests In Subsidiaries Tables [Line Items] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 153.8 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Items USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.7 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 2,841.6 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. |
Related parties (Tables)
Related parties (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Remuneration | |
Disclosure Of Transactions Between Related Parties [Line Items] | |
Disclosure Of Transactions Between Related Parties Explanatory | Remuneration of key management USD m, except where indicated 31.12.23 31.12.22 31.12.21 Base salaries and other cash payments 1 35 26 30 Incentive awards – cash 2 24 16 17 Annual incentive award under DCCP 36 23 26 Employer’s contributions to retirement benefit plans 3 2 2 Benefits in kind, fringe benefits (at market value) 1 1 1 Share-based compensation 3 63 42 45 Total 162 110 122 Total (CHF m) 4 147 106 112 1 May include role-based allowances in line with market practice is based on composed of LTIP US dollar amounts translated at the applicable performance award currency exchange rates (2023: USD 0.91 ; 2022: USD / CHF 0.96 ; 2021: USD / CHF 0.92 ). |
Equity holdings | |
Disclosure Of Transactions Between Related Parties [Line Items] | |
Disclosure Of Transactions Between Related Parties Explanatory | Equity holdings of key management personnel 1 31.12.23 31.12.22 Number of UBS Group AG shares held by members of the 2 5,121,564 2,443,580 1 No options were held in provisions. |
Key management personnel | Loans, advances and mortgages | |
Disclosure Of Transactions Between Related Parties [Line Items] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans, advances and mortgages to key management 1 USD m, except where indicated 2023 2022 Balance at the beginning of the year 28 28 Balance at the end of the year 2 55 28 Balance at the end of the year (CHF m) 2, 3 46 26 1 All loans are secured loans. 14 m (CHF 12 m) unused uncommitted credit facilities as of 31 December 2023 and no unused uncommitted credit facilities as of 31 December 2022. amounts disclosed represent the respective US dollar amounts translated at the relevant year-end |
Associates and joint ventures | Loans, advances and mortgages | |
Disclosure Of Transactions Between Related Parties [Line Items] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans to and outstanding receivables from associates USD m 2023 2022 Carrying amount at the beginning of the year 217 251 Additions 664 402 Reductions (716) (438) Foreign currency translation 18 1 Carrying amount at the end of the year 183 217 of which: unsecured loans and receivables 174 209 Other transactions with associates and As of or for the year ended USD m 31.12.23 31.12.22 Payments to associates and joint ventures for goods and services 155 138 Fees received for services provided to associates and joint ventures 10 4 Liabilities to associates and joint ventures 103 90 Commitments and contingent liabilities to associates 8 7 |
UBS Group AG and other subsidiaries of UBS Group AG | |
Disclosure Of Transactions Between Related Parties [Line Items] | |
Disclosure Of Transactions Between Related Parties Explanatory | USD m 31.12.23 31.12.22 Receivables Amounts due from banks 1 14,752 0 Cash collateral receivables on derivative instruments 312 1 Loans and advances to customers 4,889 2,807 Other financial assets measured at amortized cost 232 147 Financial assets at fair value held for trading 325 146 Derivative financial instruments 3,031 1 Payables Amounts due to banks 364 0 Cash collateral payables on derivative instruments 1,447 0 Customer deposits 3,069 2,119 Funding from UBS Group AG measured at amortized cost 67,282 56,147 Other financial liabilities measured at amortized cost 2,574 1,985 Derivative financial instruments 2,032 0 Other financial liabilities designated at fair value 2 2,995 1,796 1 Reflects funding provided to Credit Suisse. |
Invested assets and net new m_2
Invested assets and net new money (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Of Invested Assets And Net New Money Tables [Line Items] | |
Disclosure of invested assets and net new money [text block] | Invested assets and net new money As of or for the year ended USD bn 31.12.23 31.12.22 1 Fund assets managed by UBS 429 390 Discretionary assets 1,674 1,464 Other invested assets 2,402 2,127 Total invested assets 2 4,505 3,981 of which: double counts 411 340 Net new money 2 112 76 1 Comparative figures have been restated to include net new money and invested assets from associates. |
Development of invested assets | Development of invested assets USD bn 31.12.23 31.12.22 1 Total invested assets at the beginning of the year 2 3,981 4,614 Net new money 112 76 Market movements 3 379 (596) Foreign currency translation 69 (74) Other effects (37) (40) of which: acquisitions / (divestments) (25) (19) Total invested assets at the end of the year 2 4,505 3,981 1 Comparative figures have been restated to include net new money and invested assets from associates. |
Currency translation rates (Tab
Currency translation rates (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Foreign Exchange Rates Tables [Line Items] | |
Disclosure of foreign exchange rates [text block] | Closing exchange rate Average rate 1 As of For the year ended 31.12.23 31.12.22 31.12.23 31.12.22 31.12.21 1 CHF 1.19 1.08 1.11 1.05 1.09 1 EUR 1.10 1.07 1.08 1.05 1.18 1 GBP 1.28 1.21 1.25 1.23 1.37 100 JPY 0.71 0.76 0.71 0.76 0.91 1 Monthly income statement items of twelve month-end rates, weighted according to the income and expense may deviate from the weighted average rates for UBS AG. |
Supplemental guarantor inform_2
Supplemental guarantor information required under SEC regulations (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Supplemental Guarantor Information [Line Items] | |
Schedule Of Condensed Income Statement [Table Text Block] | Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2023 Interest income from financial instruments measured at fair value through other comprehensive income 11,181 7,229 9,057 (5,022) 22,444 Interest expense from financial instruments measured at (14,797) (3,055) (7,699) 5,907 (19,643) Net interest income from financial instruments measured profit or loss and other 891 785 952 (864) 1,765 Net interest income (2,725) 4,959 2,310 22 4,566 Other net income from financial instruments measured profit or loss 7,879 1,031 1,105 (81) 9,934 Fee and commission income 2,581 5,067 13,350 (598) 20,399 Fee and commission expense (705) (456) (1,214) 585 (1,790) Net fee and commission income 1,876 4,611 12,136 (13) 18,610 Other income 2,994 228 1,542 (4,198) 566 Total revenues 10,023 10,829 17,092 (4,269) 33,675 Credit loss expense / (release) 18 57 31 37 143 Personnel expenses 3,356 2,201 10,097 0 15,655 General and administrative expenses 3,951 3,840 6,155 (2,828) 11,118 Depreciation, amortization and impairment of non-financial 888 411 1,048 (109) 2,238 Operating expenses 8,195 6,452 17,301 (2,937) 29,011 Operating profit / (loss) before tax 1,810 4,320 (240) (1,370) 4,521 Tax expense / (benefit) 251 779 224 (48) 1,206 Net profit / (loss) 1,559 3,540 (463) (1,321) 3,315 Net profit / (loss) attributable to non-controlling interests 0 0 25 0 25 Net profit / (loss) attributable to shareholders 1,559 3,540 (488) (1,321) 3,290 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2022 Interest income from financial instruments measured at fair value through other comprehensive income 4,824 3,894 4,661 (1,575) 11,803 Interest expense from financial instruments measured at (5,449) (736) (2,604) 2,093 (6,696) Net interest income from financial instruments measured profit or loss and other 881 546 431 (449) 1,410 Net interest income 257 3,704 2,488 68 6,517 Other net income from financial instruments measured profit or loss 5,541 900 940 112 7,493 Fee and commission income 2,875 4,865 13,766 (660) 20,846 Fee and commission expense (684) (464) (1,327) 652 (1,823) Net fee and commission income 2,191 4,401 12,439 (8) 19,023 Other income 6,732 203 3,329 (8,382) 1,882 Total revenues 14,721 9,208 19,197 (8,210) 34,915 Credit loss expense / (release) (17) 50 (3) (1) 29 Personnel expenses 3,251 1,995 9,835 0 15,080 General and administrative expenses 3,374 3,258 5,029 (2,660) 9,001 Depreciation, amortization and impairment of non-financial 871 340 744 (109) 1,845 Operating expenses 7,496 5,592 15,607 (2,769) 25,927 Operating profit / (loss) before tax 7,242 3,566 3,592 (5,440) 8,960 Tax expense / (benefit) (28) 638 1,083 151 1,844 Net profit / (loss) 7,270 2,928 2,509 (5,592) 7,116 Net profit / (loss) attributable to non-controlling interests 0 0 32 0 32 Net profit / (loss) attributable to shareholders 7,270 2,928 2,477 (5,592) 7,084 1 Amounts presented for UBS AG under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Interest income from financial instruments measured at fair value through other comprehensive income 3,130 3,652 2,456 (703) 8,534 Interest expense from financial instruments measured at (2,847) (520) (1,024) 1,025 (3,366) Net interest income from financial instruments measured profit or loss and other 1,229 254 228 (274) 1,437 Net interest income 1,512 3,386 1,660 48 6,605 Other net income from financial instruments measured profit or loss 3,751 807 1,369 (83) 5,844 Fee and commission income 3,837 5,204 16,151 (770) 24,422 Fee and commission expense (810) (481) (1,450) 755 (1,985) Net fee and commission income 3,027 4,723 14,702 (14) 22,438 Other income 7,555 221 1,560 (8,396) 941 Total revenues 15,845 9,137 19,291 (8,445) 35,828 Credit loss expense / (release) (65) (98) (10) 24 (148) Personnel expenses 3,401 2,098 10,161 1 15,661 General and administrative expenses 4,255 3,442 4,474 (2,696) 9,476 Depreciation, amortization and impairment of non-financial 949 285 755 (114) 1,875 Operating expenses 8,605 5,825 15,390 (2,809) 27,012 Operating profit / (loss) before tax 7,305 3,409 3,910 (5,660) 8,964 Tax expense / (benefit) 203 622 1,090 (11) 1,903 Net profit / (loss) 7,102 2,788 2,820 (5,649) 7,061 Net profit / (loss) attributable to non-controlling interests 0 0 29 0 29 Net profit / (loss) attributable to shareholders 7,102 2,788 2,792 (5,649) 7,032 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, |
Condensed Statement Of Comprehensive Income [Table Text Block] | Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2023 Comprehensive income attributable to shareholders Net profit / (loss) 1,559 3,540 (488) (1,321) 3,290 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 79 1,523 222 (975) 849 Financial assets measured at fair value through other comprehensive income, net of tax 3 4 1 0 5 Cash flow hedges, net of tax 707 679 23 (9) 1,400 Cost of hedging, net of tax (19) 0 (19) Total other comprehensive income that may be reclassified to the income statement, net of tax 771 2,202 245 (984) 2,235 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (82) (36) (19) 0 (136) Own credit on financial liabilities designated at fair value, net of tax (790) (790) Total other comprehensive income that will not be reclassified to the income statement, net of tax (872) (36) (19) 0 (927) Total other comprehensive income (101) 2,167 226 (984) 1,308 Total comprehensive income attributable to shareholders 1,458 5,707 (262) (2,305) 4,598 Total comprehensive income attributable to non-controlling interests 27 27 Total comprehensive income 1,458 5,707 (235) (2,305) 4,625 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets Supplemental guarantor consolidated statement USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2022 Comprehensive income attributable to shareholders Net profit / (loss) 7,270 2,928 2,477 (5,592) 7,084 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (114) (197) (506) 298 (519) Financial assets measured at fair value through other comprehensive income, net of tax 3 (3) 0 9 0 6 Cash flow hedges, net of tax (2,791) (1,359) (631) (12) (4,793) Cost of hedging, net of tax 45 45 Total other comprehensive income that may be reclassified to the income statement, net of tax (2,863) (1,555) (1,128) 286 (5,260) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (112) 23 0 81 Own credit on financial liabilities designated at fair value, net of tax 796 796 Total other comprehensive income that will not be reclassified to the income statement, net of tax 966 (112) 23 0 877 Total other comprehensive income (1,897) (1,667) (1,104) 286 (4,383) Total comprehensive income attributable to shareholders 5,373 1,261 1,373 (5,306) 2,701 Total comprehensive income attributable to non-controlling interests 18 18 Total comprehensive income 5,373 1,261 1,391 (5,306) 2,719 1 Amounts presented for UBS under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG classified as Financial assets measured at fair value through other comprehensive income was reclassified to Other financial assets Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Comprehensive income attributable to shareholders Net profit / (loss) 7,102 2,788 2,792 (5,649) 7,032 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (1) (419) (607) 517 (510) Financial assets measured at fair value through other comprehensive income, net of tax 0 (157) 0 (157) Cash flow hedges, net of tax (1,129) (279) (250) (17) (1,675) Cost of hedging, net of tax (26) (26) Total other comprehensive income that may be reclassified to the income statement, net of tax (1,155) (699) (1,014) 500 (2,368) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (135) 67 0 102 Own credit on financial liabilities designated at fair value, net of tax 46 46 Total other comprehensive income that will not be reclassified to the income statement, net of tax 217 (135) 67 0 148 Total other comprehensive income (939) (834) (947) 500 (2,220) Total comprehensive income attributable to shareholders 6,163 1,954 1,845 (5,149) 4,813 Total comprehensive income attributable to non-controlling interests 13 13 Total comprehensive income 6,163 1,954 1,858 (5,149) 4,826 1 Amounts presented for UBS AG under “Complementary UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, |
Schedule Of Condensed Balance Sheet [Table Text Block] | Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2023 Assets Cash and balances at central banks 49,620 87,044 35,142 171,806 Amounts due from banks 61,579 6,241 16,696 (56,311) 28,206 Receivables from securities financing transactions measured at amortized cost 61,116 63 37,022 (24,073) 74,128 Cash collateral receivables on derivative instruments 34,048 1,640 9,124 (12,512) 32,300 Loans and advances to customers 91,940 255,205 93,581 (35,093) 405,633 Other financial assets measured at amortized cost 24,403 9,149 23,429 (2,647) 54,334 Total financial assets measured at amortized cost 322,705 359,343 214,995 (130,636) 766,407 Financial assets at fair value held for trading 121,947 101 14,463 (1,412) 135,098 of which: assets pledged as collateral that may be sold or repledged by counterparties 51,325 0 5,930 (12,731) 44,524 Derivative financial instruments 126,916 5,845 40,190 (41,223) 131,728 Brokerage receivables 12,924 7,959 0 20,883 Financial assets at fair value not held for trading 46,658 10,022 29,688 (22,613) 63,754 Total financial assets measured at fair value through profit or loss 308,444 15,968 92,300 (65,249) 351,463 Financial assets measured at fair value through other comprehensive income 1,957 276 2,233 Investments in subsidiaries and associates 52,134 37 2 (51,190) 983 Property, equipment and software 5,842 1,798 3,687 (284) 11,044 Goodwill and intangible assets 212 5,974 79 6,265 Deferred tax assets 1,488 147 7,633 (24) 9,244 Other non-financial assets 5,366 1,748 1,256 7 8,377 Total assets 698,149 379,042 326,124 (247,298) 1,156,016 Liabilities Amounts due to banks 55,680 44,170 58,769 (141,898) 16,720 Payables from securities financing transactions measured at amortized cost 14,329 336 15,288 (24,171) 5,782 Cash collateral payables on derivative instruments 35,148 1,076 11,091 (12,430) 34,886 Customer deposits 108,279 293,133 118,168 36,094 555,673 Funding from UBS Group AG measured at amortized cost 67,282 67,282 Debt issued measured at amortized cost 58,729 11,042 12 0 69,784 Other financial liabilities measured at amortized cost 6,589 2,974 6,147 (2,997) 12,713 Total financial liabilities measured at amortized cost 346,036 352,731 209,475 (145,402) 762,840 Financial liabilities at fair value held for trading 27,280 248 5,508 (1,325) 31,712 Derivative financial instruments 135,272 6,223 40,436 (41,225) 140,707 Brokerage payables designated at fair value 30,724 11,552 0 42,275 Debt issued designated at fair value 85,424 986 (69) 86,341 Other financial liabilities designated at fair value 14,392 21,081 (8,107) 27,366 Total financial liabilities measured at fair value through profit or loss 293,092 6,471 79,564 (50,726) 328,401 Provisions 1,903 208 413 (1) 2,524 Other non-financial liabilities 1,572 1,377 3,688 46 6,682 Total liabilities 642,602 360,788 293,140 (196,083) 1,100,448 Equity attributable to shareholders 55,546 18,254 32,649 (51,215) 55,234 Equity attributable to non-controlling interests 335 0 335 Total equity 55,546 18,254 32,984 (51,215) 55,569 Total liabilities and equity 698,149 379,042 326,124 (247,298) 1,156,016 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD m UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2022 Assets Cash and balances at central banks 48,689 84,465 36,291 0 169,445 Amounts due from banks 39,691 6,357 19,063 (50,441) 14,671 Receivables from securities financing transactions measured at amortized cost 51,493 903 34,110 (18,691) 67,814 Cash collateral receivables on derivative instruments 35,594 1,221 10,074 (11,856) 35,033 Loans and advances to customers 90,168 229,861 101,231 (31,233) 390,027 Other financial assets measured at amortized cost 24,005 9,532 21,880 (2,029) 53,389 Total financial assets measured at amortized cost 289,641 332,339 222,649 (114,250) 730,379 Financial assets at fair value held for trading 95,810 173 13,899 (1,848) 108,034 of which: assets pledged as collateral that may be sold or repledged by counterparties 41,056 0 5,578 (9,892) 36,742 Derivative financial instruments 149,447 5,925 35,106 (40,368) 150,109 Brokerage receivables 9,763 0 7,814 0 17,576 Financial assets at fair value not held for trading 45,302 4,354 26,843 (17,091) 59,408 Total financial assets measured at fair value through profit or loss 300,321 10,453 83,661 (59,308) 335,127 Financial assets measured at fair value through other comprehensive income 1,953 0 286 0 2,239 Investments in subsidiaries and associates 54,323 33 0 (53,255) 1,101 Property, equipment and software 5,852 1,654 4,077 (267) 11,316 Goodwill and intangible assets 213 0 6,050 5 6,267 Deferred tax assets 1,624 276 7,470 (16) 9,354 Other non-financial assets 6,930 1,768 951 4 9,652 Total assets 660,856 346,522 325,144 (227,087) 1,105,436 Liabilities Amounts due to banks 41,395 37,123 51,555 (118,477) 11,596 Payables from securities financing transactions measured at amortized cost 9,425 247 13,303 (18,774) 4,202 Cash collateral payables on derivative instruments 35,528 1,518 11,191 (11,800) 36,436 Customer deposits 98,628 273,316 132,619 22,608 527,171 Funding from UBS Group AG measured at amortized cost 56,147 0 0 56,147 Debt issued measured at amortized cost 50,706 8,965 1 (173) 59,499 Other financial liabilities measured at amortized cost 4,903 2,221 5,554 (2,287) 10,391 Total financial liabilities measured at amortized cost 296,733 323,391 214,222 (128,903) 705,442 Financial liabilities at fair value held for trading 25,059 183 5,843 (1,570) 29,515 Derivative financial instruments 153,778 6,177 35,314 (40,363) 154,906 Brokerage payables designated at fair value 32,346 0 12,746 (7) 45,085 Debt issued designated at fair value 71,444 0 508 (110) 71,842 Other financial liabilities designated at fair value 17,888 0 17,074 (2,928) 32,033 Total financial liabilities measured at fair value through profit or loss 300,514 6,360 71,484 (44,977) 333,382 Provisions 1,904 239 1,041 (2) 3,183 Other non-financial liabilities 1,630 1,019 3,742 98 6,489 Total liabilities 600,782 331,009 290,490 (173,785) 1,048,496 Equity attributable to shareholders 60,075 15,513 34,313 (53,303) 56,598 Equity attributable to non-controlling interests 342 0 342 Total equity 60,075 15,513 34,655 (53,303) 56,940 Total liabilities and equity 660,856 346,522 325,144 (227,087) 1,105,436 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, |
Schedule Of Condensed Cash Flow Statement [Table Text Block] | Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2023 Net cash flow from / (used in) operating activities (23,275) (3,041) (1,886) (28,202) Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (1) (3) (4) Disposal of subsidiaries, associates and intangible assets 2 109 109 Purchase of property, equipment and software (427) (287) (569) (1,283) Disposal of property, equipment and software 33 33 Net (purchase) / redemption of financial assets measured income 15 15 30 Purchase of debt securities measured at amortized cost (9,561) (1,431) (3,251) (14,244) Disposal and redemption of debt securities measured at amortized 4,890 1,625 3,920 10,435 Net cash flow from / (used in) investing activities (4,942) (94) 112 (4,924) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) 7,138 (1) 44 7,181 Distributions paid on UBS AG shares (6,000) (6,000) Issuance of debt designated at fair value and long-term debt measured 3 101,956 2,007 588 104,551 Repayment of debt designated at fair value and long-term debt measured 3 (84,366) (1,017) (159) (85,541) Net cash flows from other financing activities (249) (251) (501) Net activity related to group internal capital transactions and dividends 3,698 (2,944) (754) 0 Net cash flow from / (used in) financing activities 22,177 (1,954) (532) 19,690 Total cash flow Cash and cash equivalents at the beginning of the year 63,608 86,232 45,359 195,200 Net cash flow from / (used in) operating, investing and financing (6,040) (5,089) (2,306) (13,435) Effects of exchange rate differences on cash and cash equivalents 591 7,860 253 8,704 Cash and cash equivalents at the end of the year 4 58,159 89,003 43,307 190,469 of which: cash and balances at central banks 4 49,537 87,044 35,142 171,723 of which: amounts due from banks 4 2,763 1,448 7,866 12,078 of which: money market paper 4,5 5,858 511 299 6,668 1 Cash flows generally represent a third-party associates. 4,553 m of cash and cash equivalents were restricted. included in the balance sheet under Financial assets at fair value not held for trading, Other financial assets measured at amortized Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2022 Net cash flow from / (used in) operating activities 17,286 (1,165) (5,491) 10,630 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (3) (3) Disposal of subsidiaries, associates and intangible assets 2 157 453 1,120 1,729 Purchase of property, equipment and software (562) (292) (624) (1,478) Disposal of property, equipment and software 161 161 Net (purchase) / redemption of financial assets measured income (943) 244 (699) Purchase of debt securities measured at amortized cost (22,602) (2,690) (5,500) (30,792) Disposal and redemption of debt securities measured at amortized 14,442 870 3,487 18,799 Net cash flow from / (used in) investing activities (9,346) (1,663) (1,274) (12,283) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (12,215) (3) (31) (12,249) Distributions paid on UBS AG shares (4,200) (4,200) Issuance of debt designated at fair value and long-term debt measured 3 78,866 550 41 79,457 Repayment of debt designated at fair value and long-term debt measured 3 (66,526) (860) (284) (67,670) Net cash flows from other financing activities (258) (337) (595) Net activity related to group internal capital transactions and dividends 5,217 (2,088) (3,128) 0 Net cash flow from / (used in) financing activities 884 (2,401) (3,740) (5,257) Total cash flow Cash and cash equivalents at the beginning of the year 57,895 92,799 57,061 207,755 Net cash flow from / (used in) operating, investing and financing 8,824 (5,229) (10,505) (6,911) Effects of exchange rate differences on cash and cash equivalents (3,111) (1,338) (1,196) (5,645) Cash and cash equivalents at the end of the year 4 63,608 86,232 45,359 195,200 of which: cash and balances at central banks 4 48,607 84,465 36,291 169,363 of which: amounts due from banks 4 2,957 1,550 8,821 13,329 of which: money market paper 4,5 12,044 216 248 12,508 1 Cash flows generally represent sales of: UBS AG’s shareholding investments administration 4 Balances with an original maturity 4,253 m of cash and cash equivalents held for trading, Financial assets measured at fair value through other comprehensive income, Supplemental guarantor consolidated USD m UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2021 Net cash flow from / (used in) operating activities 5,714 2,131 22,718 30,563 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets (1) (1) Disposal of subsidiaries, associates and intangible assets 2 16 0 577 593 Purchase of property, equipment and software (656) (276) (650) (1,581) Disposal of property, equipment and software 294 1 295 Net (purchase) / redemption of financial assets measured income (817) 67 (750) Purchase of debt securities measured at amortized cost (1,840) (45) (3,038) (4,922) Disposal and redemption of debt securities measured at amortized 1,033 817 2,658 4,507 Net cash flow from / (used in) investing activities (1,970) 495 (385) (1,860) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (3,073) (21) 0 (3,093) Distributions paid on UBS AG shares (4,539) (4,539) Issuance of debt designated at fair value and long-term debt measured 3 97,250 1,177 193 98,619 Repayment of debt designated at fair value and long-term debt measured 3 (78,385) (1,093) (320) (79,799) Net cash flows from other financing activities (280) 20 (261) Net activity related to group internal capital transactions and dividends 5,240 (537) (4,702) 0 Net cash flow from / (used in) financing activities 16,212 (475) (4,811) 10,927 Total cash flow Cash and cash equivalents at the beginning of the year 39,400 93,342 40,689 173,430 Net cash flow from / (used in) operating, investing and financing 19,957 2,151 17,523 39,630 Effects of exchange rate differences on cash and cash equivalents (1,462) (2,693) (1,151) (5,306) Cash and cash equivalents at the end of the year 4 57,895 92,799 57,061 207,755 of which: cash and balances at central banks 4 53,729 91,031 47,946 192,706 of which: amounts due from banks 4 3,258 1,588 8,975 13,822 of which: money market paper 4,5 908 179 139 1,227 1 Cash flows generally represent sale of the minority stake in Clearstream Fund Centre AG and dividends received from USD 3,408 m of cash and cash equivalents were restricted. other comprehensive income, Financial assets at fair value not held for trading and Other financial |
MD&A - Risk management and co_2
MD&A - Risk management and control - Credit Risk (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
MDA Risk Management And Control Credit Risk Tables [Line Items] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa2 CCC+ to CCC CCC+ to CCC 13 >17 Caa3 to C CCC- to C CCC- to C Counterparty is in default Default Defaulted D D |
MD&A - Risk management and co_3
MD&A - Risk management and control - Market Risk (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
MDA Risk Management And Control Market Risk Tables [Line Items] | |
Disclosure of detailed information about management value-at-risk [text block] | Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of UBS AG business divisions and Group Items by general market risk type 1 For the year ended 31.12.23 USD m Equity Interest rates Credit spreads Foreign exchange Commodities Min. 3 9 3 1 1 Max. 19 21 19 10 10 Average 9 12 6 2 3 31.12.23 11 18 7 2 3 Total management VaR 7 25 15 19 Average (per business division and risk type) Global Wealth Management 1 2 1 2 0 1 2 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 5 23 14 18 9 12 5 2 3 Non-core and Legacy 1 2 1 1 0 1 1 0 0 Group Items 3 6 4 4 1 3 3 1 0 Diversification effect 2,3 (6) (6) (1) (4) (4) (1) 0 For the year ended 31.12.22 4 USD m Equity Interest rates Credit spreads Foreign exchange Commodities Min. 2 8 4 2 2 Max. 17 18 9 11 7 Average 6 10 5 3 3 31.12.22 6 10 4 3 3 Total management VaR 6 18 11 9 Average (per business division and risk type) Global Wealth Management 1 2 1 1 0 1 1 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 6 17 10 8 6 9 5 3 3 Group Functions (including Non-core and Legacy Portfolio) 3 5 4 5 1 4 3 1 0 Diversification effect 2,3 (5) (5) (1) (3) (4) (1) 0 1 Statistics at individual levels may not be summed to deduce the corresponding aggregate figures. business line or risk type, being driven time series, rendering invalid the simple summation of figures to arrive at the aggregate total. 3 As the minima and acquisition UBS values as the risk profile compared with UBS AG does not materially differ. |
Disclosure of interest rate sensitivity - banking book [text block] | Interest rate risk – banking book 31.12.23 USD m Effect on EVE 1 Effect on EVE 1 Scenarios CHF EUR GBP USD Other Total Additional tier 1 (AT1) capital instruments Total +1 bp (4.3) (0.7) 0.0 (23.1) 0.1 (28.1) 4.8 (23.3) Parallel up 2 (608.9) (142.9) 2.2 (4,522.3) (15.0) (5,287.0) 888.3 (4,398.7) Parallel down 2 686.1 150.0 (11.8) 4,593.2 17.1 5,434.5 (1,028.0) 4,406.6 Steepener 3 (335.2) (16.0) (13.1) (973.6) (23.0) (1,361.0) 95.9 (1,265.1) Flattener 4 214.1 (6.8) 12.3 (94.1) 17.5 142.9 104.7 247.6 Short-term up 5 (38.5) (48.4) 13.4 (1,909.8) 7.1 (1,976.3) 477.4 (1,498.9) Short-term down 6 42.9 49.8 (14.3) 2,036.8 (10.0) 2,105.3 (498.9) 1,606.4 31.12.22 USD m Effect on EVE 1 Effect on EVE 1 Scenarios CHF EUR GBP USD Other Total Additional tier 1 (AT1) capital instruments Total +1 bp (4.1) (0.6) 0.1 (20.4) (0.1) (25.0) 3.4 (21.5) Parallel up 2 (576.5) (111.6) 33.4 (3,936.5) (26.3) (4,617.2) 652.5 (3,964.7) Parallel down 2 644.2 142.2 (45.7) 4,066.1 21.9 4,828.5 (702.8) 4,125.7 Steepener 3 (256.7) (93.2) (28.2) (1,026.7) (3.3) (1,408.2) (47.3) (1,455.5) Flattener 4 144.7 75.4 32.7 95.4 (2.6) 345.8 191.1 536.9 Short-term up 5 (84.1) 37.1 42.4 (1,514.7) (13.9) (1,532.9) 440.8 (1,092.2) Short-term down 6 88.1 (36.1) (42.6) 1,654.0 13.4 1,676.6 (457.8) 1,218.8 1 Economic value increase. |
Share capital (Narrative) (Deta
Share capital (Narrative) (Detail) | 12 Months Ended | ||
Dec. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2023 SFr / shares | Dec. 31, 2022 shares | |
Ordinary share capital | |||
Shares issued | shares | 3,858,408,466 | 3,858,408,466 | |
Par value of shares | $ / shares | $ 0.10 | ||
Share capital | $ | $ 385,840,846.60 | ||
Par value per share before alignment with entity's presentation currency | SFr / shares | SFr 0.10 | ||
Conditional share capital | |||
Additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | shares | 380,000,000 | ||
Value of additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | $ | $ 38,000,000 | ||
Authorized share capital | |||
Shares issued held by parent entity | 100% |
Reclassification of financial a
Reclassification of financial assets (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Apr. 01, 2022 | |
Disclosure Of Reclassification Of Financial Assets [Line Items] | ||
Reclassification of financial assets out of measured at fair value through other comprehensive income into measured at amortised cost | $ 6,900 | |
Reclassification of financial assets to Other financial assets measured at amortized cost, before tax | (449) | |
Reclassification of financial assets to Other financial assets measured at amortized cost, net of tax | $ (333) | |
Carrying amount of financial assets reclassified out of fair value through other comprehensive income category into amortised cost category | $ 7,400 |
Segment reporting (Detail)
Segment reporting (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | $ 4,566 | $ 6,517 | $ 6,605 |
Non-interest income | 29,109 | 28,398 | 29,222 |
Total revenues | 33,675 | 34,915 | 35,828 |
Credit loss expense / (release) | 143 | 29 | (148) |
Operating expenses | 29,011 | 25,927 | 27,012 |
Operating profit / (loss) before tax | 4,521 | 8,960 | 8,964 |
Tax expense / (benefit) | 1,206 | 1,844 | 1,903 |
Net profit / (loss) | 3,315 | 7,116 | 7,061 |
Additional information | |||
Total assets | 1,156,016 | 1,105,436 | 1,116,145 |
Additions to non-current assets | 1,400 | 1,862 | 1,791 |
Effect of change in methodology of allocation of balance sheet resources from Group Items to business divisions if applied retrospectively | 26,000 | ||
Global Wealth Management | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | 5,436 | 5,274 | 4,244 |
Non-interest income | 13,194 | 13,689 | 15,175 |
Total revenues | 18,631 | 18,963 | 19,419 |
Credit loss expense / (release) | 25 | 0 | (29) |
Operating expenses | 14,900 | 14,069 | 14,743 |
Operating profit / (loss) before tax | 3,705 | 4,894 | 4,706 |
Additional information | |||
Total assets | 369,176 | 388,624 | 395,235 |
Additions to non-current assets | 666 | 42 | 56 |
Personal & Corporate Banking | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | 3,128 | 2,192 | 2,120 |
Non-interest income | 2,158 | 2,113 | 2,144 |
Total revenues | 5,285 | 4,304 | 4,264 |
Credit loss expense / (release) | 50 | 39 | (86) |
Operating expenses | 2,889 | 2,475 | 2,623 |
Operating profit / (loss) before tax | 2,346 | 1,790 | 1,726 |
Additional information | |||
Total assets | 257,068 | 235,330 | 225,425 |
Additions to non-current assets | 219 | 13 | 16 |
Asset Management | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | (39) | (19) | (15) |
Non-interest income | 2,108 | 2,980 | 2,632 |
Total revenues | 2,069 | 2,961 | 2,617 |
Credit loss expense / (release) | (1) | 0 | 1 |
Operating expenses | 1,706 | 1,565 | 1,593 |
Operating profit / (loss) before tax | 364 | 1,396 | 1,023 |
Additional information | |||
Total assets | 19,662 | 16,971 | 25,202 |
Additions to non-current assets | 70 | 1 | 1 |
Asset Management | Mitsubishi Corp.-UBS Realty Inc. | |||
Additional information | |||
Net gains / (losses) from disposals of investments in associates and joint ventures | 848 | ||
Investment Bank | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | (2,612) | (241) | 481 |
Non-interest income | 10,371 | 8,958 | 8,978 |
Total revenues | 7,759 | 8,717 | 9,459 |
Credit loss expense / (release) | 67 | (12) | (34) |
Operating expenses | 7,588 | 6,890 | 6,902 |
Operating profit / (loss) before tax | 104 | 1,839 | 2,592 |
Additional information | |||
Total assets | 381,023 | 391,495 | 346,641 |
Additions to non-current assets | 445 | 33 | 30 |
Effect of change in methodology of allocation of balance sheet resources from Group Items to business divisions if applied retrospectively | 14,000 | ||
Non-core and Legacy | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | 25 | 1 | (11) |
Non-interest income | 34 | 236 | 70 |
Total revenues | 59 | 237 | 60 |
Credit loss expense / (release) | 1 | 2 | 0 |
Operating expenses | 1,010 | 104 | 138 |
Operating profit / (loss) before tax | (952) | 131 | (78) |
Additional information | |||
Total assets | 13,845 | 13,367 | 25,153 |
Additions to non-current assets | 0 | 0 | 0 |
Group Items | |||
Disclosure Of Operating Segments [Line Items] | |||
Net interest income | (1,372) | (690) | (215) |
Non-interest income | 1,244 | 423 | 224 |
Total revenues | (128) | (267) | 9 |
Credit loss expense / (release) | 1 | 0 | 0 |
Operating expenses | 919 | 823 | 1,014 |
Operating profit / (loss) before tax | (1,048) | (1,091) | (1,005) |
Additional information | |||
Total assets | 115,242 | 59,649 | 98,488 |
Additions to non-current assets | $ 0 | $ 1,773 | $ 1,689 |
Segment reporting by geographic
Segment reporting by geographic location (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ 33,675 | $ 34,915 | $ 35,828 |
Total revenues (Share %) | 100% | 100% | 100% |
Total non-current assets | $ 18,300 | $ 18,700 | $ 19,300 |
Total non-current assets (Share %) | 100% | 100% | 100% |
Americas | |||
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ 13,300 | $ 13,800 | $ 14,500 |
Total revenues (Share %) | 39% | 40% | 40% |
Total non-current assets | $ 8,600 | $ 9,000 | $ 9,000 |
Total non-current assets (Share %) | 47% | 48% | 47% |
Asia Pacific | |||
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ 5,200 | $ 5,600 | $ 6,500 |
Total revenues (Share %) | 15% | 16% | 18% |
Total non-current assets | $ 1,200 | $ 1,500 | $ 1,400 |
Total non-current assets (Share %) | 7% | 8% | 7% |
Europe, Middle East and Africa (excluding Switzerland) | |||
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ 6,100 | $ 7,000 | $ 7,000 |
Total revenues (Share %) | 18% | 20% | 20% |
Total non-current assets | $ 2,600 | $ 2,600 | $ 2,600 |
Total non-current assets (Share %) | 14% | 14% | 13% |
Switzerland | |||
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ 9,200 | $ 7,700 | $ 7,800 |
Total revenues (Share %) | 27% | 22% | 22% |
Total non-current assets | $ 5,900 | $ 5,600 | $ 6,300 |
Total non-current assets (Share %) | 32% | 30% | 33% |
Global | |||
Disclosure Of Geographical Areas [Line Items] | |||
Total revenues | $ (100) | $ 800 | $ 100 |
Total revenues (Share %) | 0% | 2% | 0% |
Total non-current assets | $ 0 | $ 0 | $ 0 |
Total non-current assets (Share %) | 0% | 0% | 0% |
Net interest income and other_2
Net interest income and other net income from fair value changes on financial instruments (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Interest Income And Other Net Income From Fair Value Changes On Financial Instruments [Line Items] | |||
Other net income from financial instruments measured at fair value through profit or loss | $ 9,934 | $ 7,493 | $ 5,844 |
of which: net gains / (losses) from financial liabilities designated at fair value | (4,065) | 17,036 | (6,457) |
Net income from financial instruments measured at fair value through profit or loss and other | 11,698 | 8,903 | 7,281 |
Interest income from loans and deposits | 19,637 | 9,634 | 6,489 |
Interest income from securities financing transactions measured at amortised cost | 3,450 | 1,378 | 513 |
Interest income from other financial instruments measured at amortized cost | 1,152 | 545 | 284 |
Interest income from debt instruments measured at fair value through other comprehensive income | 103 | 74 | 115 |
Interest income from derivative instruments designated as cash flow hedges | (1,898) | 173 | 1,133 |
Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 22,444 | 11,803 | 8,534 |
Interest expense on loans and deposits | 14,977 | 4,488 | 1,655 |
Interest expense on securities financing transactions measured at amortised cost | 1,714 | 1,089 | 1,102 |
Interest expense on debt issued | 2,855 | 1,031 | 512 |
Interest expense on lease liabilities | 97 | 88 | 98 |
Total interest expense from financial instruments measured at amortized cost | 19,643 | 6,696 | 3,366 |
Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 2,801 | 5,108 | 5,168 |
Net interest income from financial instruments measured at fair value through profit or loss and other | 1,765 | 1,410 | 1,437 |
Total net interest income | 4,566 | 6,517 | 6,605 |
Asset Management | |||
Net Interest Income And Other Net Income From Fair Value Changes On Financial Instruments [Line Items] | |||
Total net interest income | (39) | (19) | (15) |
Net gains / (losses) on financial liabilities related to unit-linked investment contracts, which are designated at fair value through profit of loss | $ (2,045) | $ 4,112 | $ (2,068) |
Net fee and commission income_2
Net fee and commission income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net fee And Commission Income [Line Items] | |||
Underwriting fees | $ 637 | $ 633 | $ 1,512 |
M&A and corporate finance fees | 669 | 804 | 1,102 |
Brokerage fees | 3,323 | 3,487 | 4,383 |
Investment fund fees | 4,730 | 4,942 | 5,790 |
Portfolio management and related services | 9,091 | 9,059 | 9,762 |
Other | 1,950 | 1,921 | 1,874 |
Total fee and commission income | 20,399 | 20,846 | 24,422 |
Total fee and commission expense | 1,790 | 1,823 | 1,985 |
Net fee and commission income | 18,610 | 19,023 | 22,438 |
Global Wealth Management | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 12,687 | 12,990 | 14,545 |
Personal & Corporate Banking | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 1,840 | 1,657 | 1,645 |
Asset Management | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 2,723 | 2,840 | 3,337 |
Investment Bank | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 3,153 | 3,350 | 4,863 |
Non-core and Legacy | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 7 | 0 | 0 |
Group Items | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | (11) | 10 | 33 |
of which: recurring | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 14,008 | 14,229 | 15,410 |
of which: transaction-based | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | 6,320 | 6,550 | 8,743 |
of which: performance-based | |||
Net fee And Commission Income [Line Items] | |||
Total fee and commission income | $ 71 | $ 68 | $ 269 |
Other income (Detail)
Other income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from acquisitions and disposals of subsidiaries | $ 24 | $ 148 | $ (11) |
Net gains / (losses) from disposals of investments in associates | 0 | 844 | 41 |
Share of net profits of associates and joint ventures | (163) | 32 | 105 |
Total | (138) | 1,024 | 134 |
Net gains / (losses) from disposals of financial assets measured at fair value through other comprehensive income | (1) | (1) | 9 |
Income from properties | 18 | 20 | 22 |
Net gains / (losses) from properties held for sale | 8 | 71 | 100 |
Income from shared services provided to UBS Group AG or its subsidiaries | 568 | 460 | 451 |
Other | 112 | 308 | 224 |
Total other income | 566 | 1,882 | 941 |
Gains related to the repurchase of entity's own debt instruments | 21 | 23 | (17) |
Other income related to a legacy bankruptcy claim | 111 | ||
UBS Wealth Management business in Spain | |||
Associates, joint ventures and subsidiaries | |||
Other | 111 | ||
Gains (losses) on the sale of subsidiaries | 133 | ||
Mitsubishi Corp.-UBS Realty Inc. | |||
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from disposals of investments in associates and joint ventures | $ 848 | ||
SIX Group AG, Zurich | |||
Associates, joint ventures and subsidiaries | |||
Impairments related to associates | 255 | ||
SIX Group AG, Zurich | Personal & Corporate Banking | |||
Associates, joint ventures and subsidiaries | |||
Impairments related to associates | 191 | ||
SIX Group AG, Zurich | Global Wealth Management | |||
Associates, joint ventures and subsidiaries | |||
Impairments related to associates | $ 64 | ||
Wealth management business in Austria | |||
Associates, joint ventures and subsidiaries | |||
Other | $ 100 |
Personnel expenses (Detail)
Personnel expenses (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Personnel Expenses [Line Items] | |||
Salaries | $ 5,898 | $ 5,528 | $ 5,723 |
Variable compensation | 7,669 | 7,636 | 7,973 |
of which: performance awards | 2,841 | 2,910 | 2,916 |
of which: financial advisors | 4,549 | 4,508 | 4,860 |
of which: other | 279 | 217 | 196 |
Contractors | 98 | 119 | 142 |
Social security | 835 | 730 | 762 |
Post-employment benefit plans | 579 | 555 | 582 |
of which: defined benefit plans | 259 | 256 | 280 |
of which: defined contribution plans | 320 | 299 | 303 |
Other personnel expenses | 576 | 513 | 479 |
Total personnel expenses | 15,655 | 15,080 | 15,661 |
Curtailments | 3 | $ 13 | $ 49 |
Increase / (decrease) in personnel expenses | 575 | ||
Integration-related personnel expenses | $ 626 |
General and administrative ex_3
General and administrative expenses (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
General And Administrative Expenses [Line Items] | |||
Outsourcing costs | $ 478 | $ 451 | $ 426 |
Technology costs | 558 | 502 | 490 |
Consulting, legal and audit fees | 650 | 494 | 465 |
Real estate and logistics costs | 679 | 507 | 530 |
Market data services | 400 | 367 | 367 |
Marketing and communication | 209 | 195 | 171 |
Travel and entertainment | 205 | 156 | 66 |
Litigation, regulatory and similar matters | 816 | 348 | 910 |
Other | 7,123 | 5,981 | 6,051 |
of which: shared service costs charged by UBS Group AG or its subsidiaries | 6,203 | 5,264 | 5,321 |
Total general and administrative expenses | 11,118 | $ 9,001 | $ 9,476 |
Increase / (decrease) in general and administrative expenses | 2,117 | ||
Integration-related general and administrative expenses | $ 491 |
Income taxes (Narrative) (Detai
Income taxes (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Income Taxes [Line Items] | |||
Projected Tax Rate | 24% | ||
Net tax expense / (benefit) recognized in other comprehensive income | $ 288 | $ (1,095) | |
Net tax expense / (benefit) recognized in share premium | (12) | $ (5) | $ 102 |
Non-Swiss | |||
Disclosure Income Taxes [Line Items] | |||
Current tax expense (benefit) from US corporate alternative minimum tax | 100 | ||
Current tax expense (benefit) from Non-Swiss Subsidiaries and Branches | 518 | ||
Deferred tax expense / (benefit) resulting from the decrease or increase in the expected value of future tax deductions for deferred compensation awards | (274) | ||
Deferred tax expense / (benefit) resulting from recognition of DTAs for tax credits carried forward | (100) | ||
Amortisation of deferred tax assets | $ 112 |
Income taxes (Detail 1)
Income taxes (Detail 1) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Major Components Of Tax Expense Income [Line Items] | |||
Current | $ 1,400 | ||
Income tax expense / (benefit) | 1,206 | $ 1,844 | $ 1,903 |
Swiss | |||
Major Components Of Tax Expense Income [Line Items] | |||
Current | 810 | 664 | 614 |
Deferred | 39 | (22) | 26 |
Income tax expense / (benefit) | 849 | 642 | 640 |
Non-Swiss | |||
Major Components Of Tax Expense Income [Line Items] | |||
Current | 618 | 689 | 857 |
Deferred | (262) | 513 | 406 |
Income tax expense / (benefit) | $ 356 | $ 1,202 | $ 1,263 |
Income taxes (Detail 2)
Income taxes (Detail 2) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Major Components Of Tax Expense Income [Line Items] | |||
Operating profit / (loss) before tax | $ 4,521 | $ 8,960 | $ 8,964 |
Income taxes at Swiss tax rate of 18.5% for 2023, 18% for 2022 and 18.5% for 2021 | 836 | 1,613 | 1,658 |
Increase / (decrease) resulting from: | |||
Non-Swiss tax rates differing from Swiss tax rate | (43) | 267 | 217 |
Tax effects of losses not recognized | 71 | 74 | 124 |
Previously unrecognized tax losses now utilized | (401) | (217) | (179) |
Non-taxable and lower taxed income | (165) | (316) | (252) |
Non-deductible expenses and additional taxable income | 1,017 | 414 | 487 |
Adjustments related to prior years - current tax | (15) | (33) | (38) |
Adjustments related to prior years - deferred tax | 10 | 19 | (3) |
Change in deferred tax recognition | (273) | (217) | (341) |
Adjustments to deferred tax balances arising from changes in tax rates | 0 | 0 | (1) |
Other items | 169 | 240 | 230 |
Income tax expense / (benefit) | $ 1,206 | $ 1,844 | $ 1,903 |
Applicable tax rate | 18.50% | 18% | 18.50% |
of which: Swiss | |||
Major Components Of Tax Expense Income [Line Items] | |||
Operating profit / (loss) before tax | $ 3,174 | $ 4,052 | $ 2,983 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | 849 | 642 | 640 |
of which: Non-Swiss | |||
Major Components Of Tax Expense Income [Line Items] | |||
Operating profit / (loss) before tax | 1,347 | 4,907 | 5,981 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | $ 356 | $ 1,202 | $ 1,263 |
Income taxes - DTA (Detail 3.1)
Income taxes - DTA (Detail 3.1) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | $ 18,319 | $ 18,482 |
Valuation allowance | (9,076) | (9,128) |
Recognized | 9,244 | 9,354 |
Deferred tax assets recognized by UBS entities that incurred losses in either the current or preceding year based on projections of future taxable profits | 408 | 471 |
of which: USA | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Recognized | 8,505 | 8,294 |
of which: related to other locations | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Recognized | 739 | 1,060 |
Tax loss carry-forwards | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 11,453 | 12,708 |
Valuation allowance | (8,496) | (8,720) |
Recognized | 2,957 | 3,988 |
Unused tax credits | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 95 | 0 |
Valuation allowance | 0 | 0 |
Recognized | 95 | 0 |
Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 6,771 | 5,774 |
Valuation allowance | (579) | (408) |
Recognized | 6,192 | 5,365 |
of which: related to real estate costs capitalized for US tax purposes | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 2,703 | 2,485 |
Valuation allowance | 0 | 0 |
Recognized | 2,703 | 2,485 |
of which: related to compensation and benefits | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 1,457 | 1,169 |
Valuation allowance | (205) | (175) |
Recognized | 1,252 | 993 |
of which: related to cash flow hedges | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 619 | 947 |
Valuation allowance | 0 | 0 |
Recognized | 619 | 947 |
of which: other | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] | ||
Gross | 1,992 | 1,173 |
Valuation allowance | (374) | (233) |
Recognized | $ 1,618 | $ 940 |
Income taxes - DTL (Detail 3.2)
Income taxes - DTL (Detail 3.2) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Deferred Tax Liabilities [Line Items] | ||
Total deferred tax liabilities | $ 162 | $ 233 |
Income taxes (Detail 4)
Income taxes (Detail 4) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | $ 30,630 | $ 32,091 |
of which: USA | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 12,354 | 13,350 |
of which: related to the UK | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,333 | 14,332 |
of which: related to other locations | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 3,943 | 4,409 |
Within 1 year | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 192 | 231 |
From 2 to 5 years | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 10,278 | 2,184 |
From 6 to 10 years | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 2,708 | 11,106 |
From 11 to 20 years | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 1,199 | 1,610 |
No expiry | ||
Unused Tax Losses For Which No Deferred Tax Asset Recognised [Line Items] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | $ 16,252 | $ 16,960 |
Financial assets at amortized_3
Financial assets at amortized cost and other positions in scope of expected credit loss measurement - On-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 768,640 | 732,618 | |
Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 766,407 | 730,379 | |
Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 171,806 | 169,445 | |
Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 28,206 | 14,671 | |
Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 74,128 | 67,814 | |
Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 32,300 | 35,033 | |
Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 405,633 | 390,027 | |
Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 174,400 | 156,930 | |
Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 54,305 | 46,470 | |
Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 14,431 | 12,226 | |
Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12,694 | 13,903 | |
Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 117,924 | 132,287 | |
Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,041 | 1,834 | |
Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,889 | 3,272 | |
Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 54,334 | 53,389 | |
of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,615 | 2,611 | |
Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,233 | 2,239 | |
Stage 1 and 2 positions | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | 580 | ||
Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (308) | (260) | (282) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 748,015 | 714,889 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 745,782 | 712,651 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 171,788 | 169,402 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 28,191 | 14,670 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 74,128 | 67,814 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 32,300 | 35,033 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 385,493 | 372,903 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 163,617 | 147,651 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 50,252 | 43,112 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12,594 | 10,733 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 10,662 | 12,211 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 117,874 | 132,196 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,564 | 1,420 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,873 | 3,261 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 53,882 | 52,829 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,422 | 2,357 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,233 | 2,239 | |
Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (272) | (267) | (220) |
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (89) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (26) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (66) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (38) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (13) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 18,475 | 16,044 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 18,475 | 16,044 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 18 | 44 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 14 | 1 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 18,131 | 15,587 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 9,955 | 8,579 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 4,038 | 3,349 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,331 | 1,189 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,524 | 1,342 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 438 | 382 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 312 | 413 | |
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 79 | 128 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Total allowance and provisions | (664) | (564) | $ (662) |
Lifetime expected credit losses | Stage 3 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,150 | 1,685 | |
Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,150 | 1,685 | |
Lifetime expected credit losses | Stage 3 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,009 | 1,538 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 828 | 699 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 15 | 9 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 506 | 303 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 508 | 351 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 50 | 91 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 39 | 31 | |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 4 | 11 | |
Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 141 | 147 | |
Lifetime expected credit losses | Stage 3 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 114 | 126 | |
Lifetime expected credit losses | Stage 3 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 769,696 | 733,508 | |
Gross carrying amount | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 767,462 | 731,269 | |
Gross carrying amount | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 171,832 | 169,457 | |
Gross carrying amount | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 28,213 | 14,676 | |
Gross carrying amount | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 74,130 | 67,816 | |
Gross carrying amount | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 32,300 | 35,034 | |
Gross carrying amount | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 406,568 | 390,810 | |
Gross carrying amount | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 174,555 | 157,091 | |
Gross carrying amount | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 54,351 | 46,511 | |
Gross carrying amount | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 14,671 | 12,356 | |
Gross carrying amount | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12,956 | 14,154 | |
Gross carrying amount | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 117,946 | 132,313 | |
Gross carrying amount | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,083 | 1,869 | |
Gross carrying amount | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 3,008 | 3,367 | |
Gross carrying amount | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 54,421 | 53,475 | |
Gross carrying amount | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,665 | 2,670 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 171,788 | 169,402 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 28,198 | 14,675 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 74,130 | 67,816 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 32,300 | 35,034 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 385,666 | 373,032 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 163,656 | 147,678 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 50,272 | 43,129 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12,628 | 10,757 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 10,696 | 12,237 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 117,879 | 132,205 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,571 | 1,427 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,881 | 3,266 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 53,897 | 52,846 | |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,426 | 2,364 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 43 | 56 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 15 | 1 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 18,316 | 15,767 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 10,044 | 8,686 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 4,063 | 3,372 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,363 | 1,204 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 1,548 | 1,364 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 449 | 393 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 12 | 0 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 317 | 419 | |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 80 | 130 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 2,586 | 2,012 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 856 | 727 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 16 | 9 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 680 | 395 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 712 | 553 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 67 | 108 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 63 | 50 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 115 | 101 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 206 | 210 | |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 159 | 176 | |
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (1,057) | (890) | |
Allowance for expected credit loss | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (1,057) | (890) | |
Allowance for expected credit loss | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (26) | (12) | |
Allowance for expected credit loss | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (7) | (6) | |
Allowance for expected credit loss | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (2) | (2) | |
Allowance for expected credit loss | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (935) | (783) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (156) | (161) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (46) | (41) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (241) | (130) | |
Allowance for expected credit loss | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (262) | (251) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (22) | (26) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (42) | (36) | |
Allowance for expected credit loss | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (119) | (96) | |
Allowance for expected credit loss | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (87) | (86) | |
Allowance for expected credit loss | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (49) | (59) | |
Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (197) | (154) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (197) | (154) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (6) | (5) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (2) | (2) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (173) | (129) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (39) | (27) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (20) | (17) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (34) | (24) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (34) | (26) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (5) | (9) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (6) | (7) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (7) | (6) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (16) | (17) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (4) | (7) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (217) | (199) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (217) | (199) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (26) | (12) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (1) | (1) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (185) | (180) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (89) | (107) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (25) | (23) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (32) | (14) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (24) | (22) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (11) | (10) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (5) | (6) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (1) | (2) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (643) | (537) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (643) | (537) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Receivables from securities financing transactions measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (577) | (474) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (28) | (28) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Real estate financing | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (1) | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (174) | (92) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: SME clients | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (204) | (203) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Lombard | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (17) | (17) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Credit cards | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (24) | (19) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | of which: Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (111) | (90) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (66) | (63) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | of which: Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | (44) | (51) | |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Line Items] | |||
Financial assets | $ 0 | $ 0 |
Financial assets at amortized_4
Financial assets at amortized cost and other positions in scope of expected credit loss measurement - Off-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | $ 139,206 | $ 114,337 | |
Total ECL provisions | (188) | (201) | |
Total allowance and provisions | (1,244) | (1,091) | $ (1,165) |
Guarantees | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 33,211 | 22,167 | |
Total ECL provisions | (40) | (48) | |
Guarantees | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 3,624 | 3,663 | |
Total ECL provisions | (10) | (26) | |
Guarantees | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,506 | 1,337 | |
Total ECL provisions | (7) | (5) | |
Guarantees | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 22,549 | 11,833 | |
Total ECL provisions | (12) | (12) | |
Guarantees | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 3,009 | 2,376 | |
Total ECL provisions | (1) | (1) | |
Guarantees | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,811 | 2,121 | |
Total ECL provisions | (1) | (1) | |
Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 44,018 | 39,996 | |
Total ECL provisions | (95) | (111) | |
Irrevocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 26,096 | 23,611 | |
Total ECL provisions | (76) | (93) | |
Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 10,373 | 3,801 | |
Total ECL provisions | 0 | 0 | |
Unconditionally revocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 47,421 | 43,677 | |
Total ECL provisions | (49) | (40) | |
Unconditionally revocable loan commitments | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 9,439 | 8,711 | |
Total ECL provisions | (4) | (6) | |
Unconditionally revocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 5,110 | 4,578 | |
Total ECL provisions | (6) | (4) | |
Unconditionally revocable loan commitments | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 5,408 | 4,723 | |
Total ECL provisions | (21) | (19) | |
Unconditionally revocable loan commitments | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 8,964 | 7,855 | |
Total ECL provisions | 0 | 0 | |
Unconditionally revocable loan commitments | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 10,458 | 9,390 | |
Total ECL provisions | (10) | (7) | |
Unconditionally revocable loan commitments | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 537 | 327 | |
Total ECL provisions | 0 | 0 | |
Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4,183 | 4,696 | |
Total ECL provisions | (4) | (2) | |
Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | 580 | ||
Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 134,410 | 107,545 | |
Total ECL provisions | (111) | (106) | |
Total allowance and provisions | (308) | (260) | (282) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 32,332 | 19,805 | |
Total ECL provisions | (14) | (13) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 3,051 | 2,883 | |
Total ECL provisions | (3) | (2) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,299 | 1,124 | |
Total ECL provisions | (1) | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 22,504 | 10,513 | |
Total ECL provisions | (8) | (8) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 3,009 | 2,376 | |
Total ECL provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,803 | 2,121 | |
Total ECL provisions | (1) | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 42,085 | 37,531 | |
Total ECL provisions | (55) | (59) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 24,444 | 21,488 | |
Total ECL provisions | (45) | (49) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 10,373 | 3,801 | |
Total ECL provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 45,452 | 41,809 | |
Total ECL provisions | (39) | (32) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 8,854 | 8,528 | |
Total ECL provisions | (3) | (6) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4,951 | 4,304 | |
Total ECL provisions | (4) | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 5,188 | 4,442 | |
Total ECL provisions | (17) | (16) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 8,964 | 7,854 | |
Total ECL provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 9,932 | 8,900 | |
Total ECL provisions | (8) | (5) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 537 | 327 | |
Total ECL provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4,169 | 4,600 | |
Total ECL provisions | (3) | (2) | |
Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4,562 | 6,522 | |
Total ECL provisions | (56) | (69) | |
Total allowance and provisions | (272) | (267) | (220) |
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (26) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (66) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (38) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (4) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (13) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 761 | 2,254 | |
Total ECL provisions | (7) | (9) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 486 | 721 | |
Total ECL provisions | (2) | (3) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 177 | 164 | |
Total ECL provisions | (1) | (1) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 46 | 1,320 | |
Total ECL provisions | (3) | (4) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 8 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,878 | 2,341 | |
Total ECL provisions | (38) | (52) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,622 | 2,024 | |
Total ECL provisions | (28) | (45) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1,913 | 1,833 | |
Total ECL provisions | (10) | (8) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 585 | 183 | |
Total ECL provisions | (1) | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 151 | 268 | |
Total ECL provisions | (3) | (2) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 191 | 256 | |
Total ECL provisions | (3) | (3) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 522 | 487 | |
Total ECL provisions | (2) | (2) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Unconditionally revocable loan commitments | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 11 | 94 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 234 | 270 | |
Total ECL provisions | (21) | (26) | |
Total allowance and provisions | (664) | (564) | $ (662) |
Lifetime expected credit losses | Stage 3 positions | Guarantees | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 118 | 108 | |
Total ECL provisions | (19) | (26) | |
Lifetime expected credit losses | Stage 3 positions | Guarantees | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 87 | 58 | |
Total ECL provisions | (6) | (21) | |
Lifetime expected credit losses | Stage 3 positions | Guarantees | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 31 | 49 | |
Total ECL provisions | (5) | (3) | |
Lifetime expected credit losses | Stage 3 positions | Guarantees | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Guarantees | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 1 | |
Total ECL provisions | (1) | (1) | |
Lifetime expected credit losses | Stage 3 positions | Guarantees | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 56 | 124 | |
Total ECL provisions | (2) | 0 | |
Lifetime expected credit losses | Stage 3 positions | Irrevocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 30 | 99 | |
Total ECL provisions | (2) | 0 | |
Lifetime expected credit losses | Stage 3 positions | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 56 | 36 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 8 | 5 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 29 | 26 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: Lombard | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 1 | 1 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4 | 3 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Unconditionally revocable loan commitments | of which: Commodity trade finance | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 0 | 0 | |
Total ECL provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Line Items] | |||
Gross exposure | 4 | 2 | |
Total ECL provisions | $ 0 | $ 0 |
Financial assets at amortized_5
Financial assets at amortized cost and other positions in scope of expected credit loss measurement - Coverage ratios (Narrative) (Detail) | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 0.22% | 0.21% |
Increase decrease in ECL coverage | 0.01% | |
Stage 1 and 2 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 0.10% | 0.10% |
Stage 1 and 2 positions | Twelve-month expected credit losses | ||
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 0.06% | 0.05% |
Stage 1 and 2 positions | Lifetime expected credit losses | ||
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 1.05% | 1.12% |
Stage 3 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 22% | |
Stage 3 positions | Lifetime expected credit losses | ||
Disclosure Of Provision Matrix [Line Items] | ||
Total combined on- and off-balance sheet coverage ratio | 21.57% | 22.42% |
Financial assets at amortized_6
Financial assets at amortized cost and other positions in scope of expected credit loss measurement - Coverage ratios (Detail 1) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.22% | 0.21% |
Total on- and off-balance sheet | $ 538,065 | $ 504,016 |
Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 768,640 | 732,618 |
Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 766,407 | 730,379 |
Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 405,633 | 390,027 |
Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 174,400 | 156,930 |
Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 54,305 | 46,470 |
Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 14,431 | 12,226 |
Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12,694 | 13,903 |
Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 117,924 | 132,287 |
Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,041 | 1,834 |
Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,889 | 3,272 |
Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 54,334 | 53,389 |
Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ 2,615 | $ 2,611 |
Stage 1 and 2 positions | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.10% | 0.10% |
Stage 3 positions | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 22% | |
Twelve-month expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.06% | 0.05% |
Total on- and off-balance sheet | $ 512,129 | $ 479,140 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 748,015 | 714,889 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 745,782 | 712,651 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 385,493 | 372,903 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 163,617 | 147,651 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 50,252 | 43,112 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12,594 | 10,733 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 10,662 | 12,211 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 117,874 | 132,196 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,564 | 1,420 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,873 | 3,261 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 53,882 | 52,829 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ 2,422 | $ 2,357 |
Lifetime expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 1.05% | 1.12% |
Total on- and off-balance sheet | $ 22,958 | $ 22,418 |
Lifetime expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 18,475 | 16,044 |
Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 18,475 | 16,044 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 18,131 | 15,587 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 9,955 | 8,579 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 4,038 | 3,349 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,331 | 1,189 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,524 | 1,342 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 438 | 382 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 312 | 413 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ 79 | $ 128 |
Lifetime expected credit losses | Stage 3 positions | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 21.57% | 22.42% |
Total on- and off-balance sheet | $ 2,978 | $ 2,458 |
Lifetime expected credit losses | Stage 3 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,150 | 1,685 |
Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,150 | 1,685 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,009 | 1,538 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 828 | 699 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 15 | 9 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 506 | 303 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 508 | 351 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 50 | 91 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 39 | 31 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 4 | 11 |
Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 141 | 147 |
Lifetime expected credit losses | Stage 3 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 114 | 126 |
Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 769,696 | 733,508 |
Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 767,462 | 731,269 |
Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 406,568 | 390,810 |
Gross carrying amount | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 174,555 | 157,091 |
Gross carrying amount | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 54,351 | 46,511 |
Gross carrying amount | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 14,671 | 12,356 |
Gross carrying amount | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12,956 | 14,154 |
Gross carrying amount | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 117,946 | 132,313 |
Gross carrying amount | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,083 | 1,869 |
Gross carrying amount | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 3,008 | 3,367 |
Gross carrying amount | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 26,997 | 23,149 |
Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 54,421 | 53,475 |
Gross carrying amount | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,665 | 2,670 |
Gross carrying amount | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 409,232 | 393,480 |
Gross carrying amount | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 228,906 | 203,602 |
Gross carrying amount | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 27,627 | 26,510 |
Gross carrying amount | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 152,699 | 163,368 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 385,666 | 373,032 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 163,656 | 147,678 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 50,272 | 43,129 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12,628 | 10,757 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 10,696 | 12,237 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 117,879 | 132,205 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,571 | 1,427 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,881 | 3,266 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 26,083 | 22,333 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 53,897 | 52,846 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,426 | 2,364 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 388,092 | 375,396 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 213,928 | 190,807 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 23,324 | 22,994 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 150,840 | 161,595 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 18,316 | 15,767 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 10,044 | 8,686 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 4,063 | 3,372 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,363 | 1,204 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,548 | 1,364 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 449 | 393 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 12 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 837 | 748 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 317 | 419 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 80 | 130 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 18,396 | 15,896 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 14,107 | 12,059 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,911 | 2,567 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,378 | 1,270 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,586 | 2,012 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 856 | 727 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 16 | 9 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 680 | 395 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 712 | 553 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 67 | 108 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 63 | 50 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 115 | 101 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 77 | 68 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 206 | 210 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 159 | 176 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 2,744 | 2,188 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 872 | 736 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 1,392 | 949 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | 481 | 503 |
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (1,057) | (890) |
Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (1,057) | (890) |
Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (935) | (783) |
Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (156) | $ (161) |
ECL coverage | 0.09% | 0.10% |
Allowance for expected credit loss | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (46) | $ (41) |
ECL coverage | 0.09% | 0.09% |
Allowance for expected credit loss | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (241) | $ (130) |
ECL coverage | 1.64% | 1.05% |
Allowance for expected credit loss | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (262) | $ (251) |
ECL coverage | 2.02% | 1.77% |
Allowance for expected credit loss | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (22) | $ (26) |
ECL coverage | 0.02% | 0.02% |
Allowance for expected credit loss | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (42) | $ (36) |
ECL coverage | 2% | 1.90% |
Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (119) | $ (96) |
ECL coverage | 3.94% | 2.85% |
Allowance for expected credit loss | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.18% | 0.18% |
Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (87) | $ (86) |
Allowance for expected credit loss | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (49) | $ (59) |
ECL coverage | 1.85% | 2.21% |
Allowance for expected credit loss | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.24% | 0.21% |
Allowance for expected credit loss | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.09% | 0.10% |
Allowance for expected credit loss | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 1.82% | 1.44% |
Allowance for expected credit loss | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.18% | 0.16% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.07% | 0.09% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.08% | 0.09% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.48% | 0.32% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.47% | 0.36% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0% | 0.01% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.87% | 0.91% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.25% | 0.18% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.11% | 0.07% |
Allowance for expected credit loss | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.20% | 0.33% |
Allowance for expected credit loss | Stage 1 and 2 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.09% | 0.08% |
Allowance for expected credit loss | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.08% | 0.09% |
Allowance for expected credit loss | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.48% | 0.34% |
Allowance for expected credit loss | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.04% | 0.03% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (197) | $ (154) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (197) | (154) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (173) | (129) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (39) | $ (27) |
ECL coverage | 0.02% | 0.02% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (20) | $ (17) |
ECL coverage | 0.04% | 0.04% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (34) | $ (24) |
ECL coverage | 0.27% | 0.22% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (34) | $ (26) |
ECL coverage | 0.32% | 0.22% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (5) | $ (9) |
ECL coverage | 0% | 0.01% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (6) | $ (7) |
ECL coverage | 0.40% | 0.46% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (7) | $ (6) |
ECL coverage | 0.25% | 0.18% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.10% | 0.06% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (16) | $ (17) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (4) | $ (7) |
ECL coverage | 0.17% | 0.28% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.05% | 0.04% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.03% | 0.02% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.29% | 0.22% |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.03% | 0.03% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (217) | $ (199) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (217) | (199) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (185) | (180) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (89) | $ (107) |
ECL coverage | 0.88% | 1.23% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (25) | $ (23) |
ECL coverage | 0.61% | 0.70% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (32) | $ (14) |
ECL coverage | 2.37% | 1.20% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (24) | $ (22) |
ECL coverage | 1.55% | 1.61% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ 0 | $ 0 |
ECL coverage | 0% | 0% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (11) | $ (10) |
ECL coverage | 2.53% | 2.56% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ 0 | $ 0 |
ECL coverage | 0.62% | 0% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.44% | 0.38% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (5) | $ (6) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (1) | $ (2) |
ECL coverage | 1.22% | 1.24% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 1.01% | 1.14% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 0.81% | 1.08% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 1.93% | 1.42% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 1.17% | 1.14% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (643) | $ (537) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (643) | (537) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | (577) | (474) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (28) | $ (28) |
ECL coverage | 3.26% | 3.81% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (1) | $ 0 |
ECL coverage | 5.94% | 2.32% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (174) | $ (92) |
ECL coverage | 25.58% | 23.25% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (204) | $ (203) |
ECL coverage | 28.61% | 36.64% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (17) | $ (17) |
ECL coverage | 24.87% | 15.80% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (24) | $ (19) |
ECL coverage | 38.01% | 37.79% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (111) | $ (90) |
ECL coverage | 96.76% | 89.01% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 23.79% | 37.69% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (66) | $ (63) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
Gross carrying amount | $ (44) | $ (51) |
ECL coverage | 27.93% | 28.70% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 22.63% | 23.98% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total | Total real estate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 3.31% | 3.79% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total | Total corporate lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 27.14% | 31.06% |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total | Total other lending | ||
Disclosure Of Credit Risk Exposure [Line Items] | ||
ECL coverage | 44.62% | 40.16% |
Financial assets at amortized_7
Financial assets at amortized cost and other positions in scope of expected credit loss measurement - Coverage ratios (Detail 2) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 139,206 | $ 114,337 |
ECL coverage | 0.22% | 0.21% |
Total on- and off-balance sheet | $ 538,065 | $ 504,016 |
Total | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 128,833 | $ 110,537 |
ECL coverage | 0.15% | 0.18% |
Total | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 6,801 | $ 6,535 |
ECL coverage | 0.08% | 0.05% |
Total | Real estate financing | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 10,662 | $ 10,054 |
ECL coverage | 0.06% | 0.06% |
Total | Total real estate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 17,463 | $ 16,589 |
ECL coverage | 0.06% | 0.06% |
Total | Large corporate clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 34,829 | $ 32,126 |
ECL coverage | 0.27% | 0.38% |
Total | Total corporate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 7,872 | $ 7,122 |
ECL coverage | 0.47% | 0.47% |
Total | SME clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 42,702 | $ 39,247 |
ECL coverage | 0.30% | 0.40% |
Total | Lombard | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 13,609 | $ 12,919 |
ECL coverage | 0.01% | 0.02% |
Total | Credit cards | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 10,458 | $ 9,390 |
ECL coverage | 0.10% | 0.07% |
Total | Commodity trade finance | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 2,354 | $ 2,459 |
ECL coverage | 0.04% | 0.03% |
Total | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 25,378 | $ 18,128 |
ECL coverage | 0.05% | 0.07% |
Total | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 16,869 | $ 11,803 |
ECL coverage | 0.12% | 0.11% |
Total | Total other lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 68,668 | $ 54,700 |
ECL coverage | 0.07% | 0.06% |
Stage 1 and 2 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.10% | 0.10% |
Stage 1 and 2 positions | Total | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.13% | 0.16% |
Stage 1 and 2 positions | Total | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.08% | 0.04% |
Stage 1 and 2 positions | Total | Real estate financing | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.06% | 0.06% |
Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.06% | 0.06% |
Stage 1 and 2 positions | Total | Large corporate clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.25% | 0.32% |
Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.41% | 0.43% |
Stage 1 and 2 positions | Total | SME clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.28% | 0.34% |
Stage 1 and 2 positions | Total | Lombard | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.01% | 0.01% |
Stage 1 and 2 positions | Total | Credit cards | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.10% | 0.07% |
Stage 1 and 2 positions | Total | Commodity trade finance | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.04% | 0.03% |
Stage 1 and 2 positions | Total | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.05% | 0.07% |
Stage 1 and 2 positions | Total | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.08% | 0.09% |
Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 0.06% | 0.06% |
Stage 3 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
ECL coverage | 22% | |
Twelve-month expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 134,410 | $ 107,545 |
ECL coverage | 0.06% | 0.05% |
Total on- and off-balance sheet | $ 512,129 | $ 479,140 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 124,037 | $ 103,745 |
ECL coverage | 0.09% | 0.10% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 6,560 | $ 6,296 |
ECL coverage | 0.07% | 0.04% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Real estate financing | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 10,064 | $ 9,779 |
ECL coverage | 0.05% | 0.07% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 16,624 | $ 16,075 |
ECL coverage | 0.06% | 0.06% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Large corporate clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 32,446 | $ 28,950 |
ECL coverage | 0.16% | 0.18% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 7,337 | $ 6,525 |
ECL coverage | 0.29% | 0.30% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | SME clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 39,782 | $ 35,475 |
ECL coverage | 0.18% | 0.20% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Lombard | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 13,609 | $ 12,918 |
ECL coverage | 0.01% | 0.01% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Credit cards | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 9,932 | $ 8,900 |
ECL coverage | 0.08% | 0.05% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Commodity trade finance | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 2,346 | $ 2,459 |
ECL coverage | 0.04% | 0.03% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 25,148 | $ 16,464 |
ECL coverage | 0.04% | 0.06% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 16,596 | $ 11,454 |
ECL coverage | 0.05% | 0.08% |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 67,630 | $ 52,195 |
ECL coverage | 0.04% | 0.05% |
Lifetime expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 4,562 | $ 6,522 |
ECL coverage | 1.05% | 1.12% |
Total on- and off-balance sheet | $ 22,958 | $ 22,418 |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 4,562 | $ 6,522 |
ECL coverage | 1.22% | 1.06% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 226 | $ 236 |
ECL coverage | 0.29% | 0.18% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Real estate financing | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 599 | $ 275 |
ECL coverage | 0.22% | 0% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total real estate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 824 | $ 511 |
ECL coverage | 0.24% | 0.02% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Large corporate clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 2,259 | $ 3,013 |
ECL coverage | 1.47% | 1.65% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total corporate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 456 | $ 499 |
ECL coverage | 2.30% | 2.14% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | SME clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 2,715 | $ 3,513 |
ECL coverage | 1.61% | 1.72% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Lombard | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 0 | $ 0 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Credit cards | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 522 | $ 487 |
ECL coverage | 0.35% | 0.36% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Commodity trade finance | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 8 | $ 0 |
ECL coverage | 0.36% | 0% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 230 | $ 1,664 |
ECL coverage | 1.57% | 0.25% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 264 | $ 346 |
ECL coverage | 1.70% | 0.68% |
Lifetime expected credit losses | Stage 1 and 2 positions | Total | Total other lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 1,024 | $ 2,498 |
ECL coverage | 0.97% | 0.33% |
Lifetime expected credit losses | Stage 3 positions | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 234 | $ 270 |
ECL coverage | 21.57% | 22.42% |
Total on- and off-balance sheet | $ 2,978 | $ 2,458 |
Lifetime expected credit losses | Stage 3 positions | Total | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 234 | $ 270 |
ECL coverage | 9.08% | 9.80% |
Lifetime expected credit losses | Stage 3 positions | Total | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 15 | $ 3 |
ECL coverage | 0.40% | 11.83% |
Lifetime expected credit losses | Stage 3 positions | Total | Real estate financing | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 0 | $ 0 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Total real estate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 15 | $ 3 |
ECL coverage | 0.40% | 12.88% |
Lifetime expected credit losses | Stage 3 positions | Total | Large corporate clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 125 | $ 163 |
ECL coverage | 6.28% | 12.63% |
Lifetime expected credit losses | Stage 3 positions | Total | Total corporate lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 80 | $ 98 |
ECL coverage | 6.26% | 3.04% |
Lifetime expected credit losses | Stage 3 positions | Total | SME clients | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 205 | $ 260 |
ECL coverage | 6.27% | 9.03% |
Lifetime expected credit losses | Stage 3 positions | Total | Lombard | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 1 | $ 1 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Credit cards | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 4 | $ 3 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Commodity trade finance | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 0 | $ 0 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 0 | $ 0 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 9 | $ 3 |
ECL coverage | 0% | 0% |
Lifetime expected credit losses | Stage 3 positions | Total | Total other lending | ||
Disclosure Of Provision Matrix [Line Items] | ||
Gross exposure | $ 14 | $ 7 |
ECL coverage | 59.21% | 0% |
Derivative instruments (Narrati
Derivative instruments (Narrative) (Detail) - USD ($) $ in Trillions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Maturity Profile Of Derivatives Notionals [Line Items] | ||
Increase / (decrease) in other notional amounts | $ 2.5 | |
Interest rate swap contract | Over-the-counter | Within 1 year | ||
Maturity Profile Of Derivatives Notionals [Line Items] | ||
Maturity profile of derivatives based on notional amount | 51% | 46% |
Interest rate swap contract | Over-the-counter | Due between 1 and 5 years | ||
Maturity Profile Of Derivatives Notionals [Line Items] | ||
Maturity profile of derivatives based on notional amount | 30% | 32% |
Interest rate swap contract | Over-the-counter | Due after 5 years | ||
Maturity Profile Of Derivatives Notionals [Line Items] | ||
Maturity profile of derivatives based on notional amount | 19% | 22% |
Derivative instruments (Detail)
Derivative instruments (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Derivative [Line Items] | ||
Derivative financial assets | $ 131,728 | $ 150,109 |
Derivative financial liabilities | 140,707 | 154,906 |
Notional amounts related to derivative financial assets and liabilities | 10,337,600 | 9,302,100 |
Other amounts values | 14,028,400 | 11,376,500 |
Interest rate risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 35,300 | 39,800 |
Derivative financial liabilities | 32,800 | 37,500 |
Notional amounts related to derivative financial assets and liabilities | 2,471,700 | 2,080,300 |
Other amounts values | 13,749,000 | 11,255,400 |
Credit derivative | ||
Derivative [Line Items] | ||
Derivative financial assets | 1,800 | 1,000 |
Derivative financial liabilities | 1,600 | 1,200 |
Notional amounts related to derivative financial assets and liabilities | 93,100 | 73,900 |
Foreign exchange risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 65,400 | 85,500 |
Derivative financial liabilities | 71,700 | 88,500 |
Notional amounts related to derivative financial assets and liabilities | 6,367,100 | 6,080,100 |
Other amounts values | 179,600 | 40,100 |
Equity / index | ||
Derivative [Line Items] | ||
Derivative financial assets | 27,300 | 22,200 |
Derivative financial liabilities | 32,900 | 26,100 |
Notional amounts related to derivative financial assets and liabilities | 1,191,100 | 885,800 |
Other amounts values | 84,300 | 63,400 |
Commodities | ||
Derivative [Line Items] | ||
Derivative financial assets | 1,600 | 1,400 |
Derivative financial liabilities | 1,300 | 1,400 |
Notional amounts related to derivative financial assets and liabilities | 128,600 | 132,300 |
Other amounts values | 15,500 | 17,600 |
Other | ||
Derivative [Line Items] | ||
Derivative financial assets | 300 | 200 |
Derivative financial liabilities | 400 | 100 |
Notional amounts related to derivative financial assets and liabilities | 86,000 | 49,700 |
of which: forwards | Over-the-counter (OTC) contracts | Interest rate risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 100 | 200 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial assets and liabilities | 114,000 | 72,300 |
Other amounts values | 1,061,400 | 792,700 |
of which: forwards | Over-the-counter (OTC) contracts | Foreign exchange risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 15,600 | 26,500 |
Derivative financial liabilities | 18,900 | 28,600 |
Notional amounts related to derivative financial assets and liabilities | 1,881,700 | 1,763,800 |
of which: forwards | Exchange-traded derivatives (ETD) | Commodities | ||
Derivative [Line Items] | ||
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial assets and liabilities | 31,500 | 47,700 |
of which: swaps | Over-the-counter (OTC) contracts | Interest rate risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 23,000 | 25,200 |
Derivative financial liabilities | 18,200 | 19,800 |
Notional amounts related to derivative financial assets and liabilities | 788,000 | 607,100 |
Other amounts values | 11,884,100 | 9,728,600 |
of which: swaps | Over-the-counter (OTC) contracts | Foreign exchange risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 43,500 | 49,600 |
Derivative financial liabilities | 46,700 | 50,400 |
Notional amounts related to derivative financial assets and liabilities | 3,587,200 | 3,233,000 |
Other amounts values | 178,700 | 38,400 |
of which: swaps | Over-the-counter (OTC) contracts | Equity / index | ||
Derivative [Line Items] | ||
Derivative financial assets | 6,000 | 5,300 |
Derivative financial liabilities | 8,900 | 6,600 |
Notional amounts related to derivative financial assets and liabilities | 263,400 | 217,400 |
of which: swaps | Over-the-counter (OTC) contracts | Commodities | ||
Derivative [Line Items] | ||
Derivative financial assets | 700 | 500 |
Derivative financial liabilities | 500 | 700 |
Notional amounts related to derivative financial assets and liabilities | 44,800 | 38,500 |
of which: options | Over-the-counter (OTC) contracts | Interest rate risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 12,100 | 14,200 |
Derivative financial liabilities | 14,400 | 17,500 |
Notional amounts related to derivative financial assets and liabilities | 1,569,400 | 1,392,500 |
of which: options | Over-the-counter (OTC) contracts | Foreign exchange risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 6,200 | 9,300 |
Derivative financial liabilities | 6,100 | 9,200 |
Notional amounts related to derivative financial assets and liabilities | 892,600 | 1,073,200 |
of which: options | Over-the-counter (OTC) contracts | Equity / index | ||
Derivative [Line Items] | ||
Derivative financial assets | 2,800 | 2,800 |
Derivative financial liabilities | 5,900 | 4,400 |
Notional amounts related to derivative financial assets and liabilities | 193,400 | 140,600 |
of which: options | Over-the-counter (OTC) contracts | Commodities | ||
Derivative [Line Items] | ||
Derivative financial assets | 600 | 400 |
Derivative financial liabilities | 300 | 300 |
Notional amounts related to derivative financial assets and liabilities | 38,400 | 29,100 |
of which: options | Exchange-traded derivatives (ETD) | Interest rate risk | ||
Derivative [Line Items] | ||
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial assets and liabilities | 200 | 8,300 |
Other amounts values | 96,100 | 127,700 |
of which: options | Exchange-traded derivatives (ETD) | Equity / index | ||
Derivative [Line Items] | ||
Derivative financial assets | 10,300 | 9,000 |
Derivative financial liabilities | 10,000 | 8,100 |
Notional amounts related to derivative financial assets and liabilities | 732,700 | 526,700 |
Other amounts values | 6,900 | 11,200 |
of which: futures | Exchange-traded derivatives (ETD) | Interest rate risk | ||
Derivative [Line Items] | ||
Other amounts values | 707,400 | 606,300 |
of which: futures | Exchange-traded derivatives (ETD) | Equity / index | ||
Derivative [Line Items] | ||
Other amounts values | 77,300 | 52,200 |
of which: futures | Exchange-traded derivatives (ETD) | Commodities | ||
Derivative [Line Items] | ||
Other amounts values | 13,000 | 16,400 |
of which: client-cleared transactions | Exchange-traded derivatives (ETD) | Equity / index | ||
Derivative [Line Items] | ||
Derivative financial assets | 8,100 | 5,100 |
Derivative financial liabilities | 8,000 | 7,000 |
of which: client-cleared transactions | Exchange-traded derivatives (ETD) | Commodities | ||
Derivative [Line Items] | ||
Derivative financial assets | 200 | 200 |
Derivative financial liabilities | 300 | 300 |
of which: credit default swaps | Over-the-counter (OTC) contracts | Credit derivative | ||
Derivative [Line Items] | ||
Derivative financial assets | 1,600 | 900 |
Derivative financial liabilities | 1,500 | 1,000 |
Notional amounts related to derivative financial assets and liabilities | 91,400 | 71,000 |
of which: total return swaps | Over-the-counter (OTC) contracts | Credit derivative | ||
Derivative [Line Items] | ||
Derivative financial assets | 0 | 100 |
Derivative financial liabilities | 100 | 200 |
Notional amounts related to derivative financial assets and liabilities | $ 700 | $ 1,200 |
Financial assets measured at fa
Financial assets measured at fair value through OCI (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt instruments | ||
Total financial assets measured at fair value through other comprehensive income | $ 2,233 | $ 2,239 |
Property, equipment and softw_3
Property, equipment and software (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | $ 11,316 | $ 11,712 |
Balance at the end of the year | 11,044 | 11,316 |
Historical cost | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 24,893 | 24,542 |
Additions | 1,393 | 1,859 |
Disposals / write-offs | (1,449) | (414) |
Reclassifications | 378 | (894) |
Foreign currency translation | 954 | (200) |
Balance at the end of the year | 26,169 | 24,893 |
Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 13,577 | 12,830 |
Depreciation | 1,974 | 1,819 |
Impairment | 238 | 2 |
Disposals / write-offs | (1,445) | (410) |
Reclassifications | 206 | (566) |
Foreign currency translation | 576 | (99) |
Balance at the end of the year | 15,126 | 13,577 |
Owned properties and equipment | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 3,655 | |
Balance at the end of the year | 3,842 | 3,655 |
Owned properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 10,352 | |
Additions | 106 | |
Disposals / write-offs | (299) | |
Reclassifications | 550 | |
Foreign currency translation | 653 | |
Balance at the end of the year | 11,362 | 10,352 |
Owned properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 6,697 | |
Depreciation | 457 | |
Impairment | 15 | |
Disposals / write-offs | (296) | |
Reclassifications | 207 | |
Foreign currency translation | 439 | |
Balance at the end of the year | 7,520 | 6,697 |
Leased properties and equipment | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 2,637 | |
Balance at the end of the year | 2,321 | 2,637 |
Cash outflows on lease | 594 | 589 |
Leased properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 4,275 | |
Additions | 96 | |
Disposals / write-offs | (63) | |
Reclassifications | 0 | |
Foreign currency translation | 71 | |
Balance at the end of the year | 4,379 | 4,275 |
Leased properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 1,638 | |
Depreciation | 446 | |
Impairment | 0 | |
Disposals / write-offs | (62) | |
Reclassifications | 0 | |
Foreign currency translation | 36 | |
Balance at the end of the year | 2,058 | 1,638 |
Software | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 3,978 | |
Balance at the end of the year | 4,241 | 3,978 |
Software | Historical cost | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 9,220 | |
Additions | 81 | |
Disposals / write-offs | (1,087) | |
Reclassifications | 1,390 | |
Foreign currency translation | 185 | |
Balance at the end of the year | 9,789 | 9,220 |
Software | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 5,242 | |
Depreciation | 1,070 | |
Impairment | 223 | |
Disposals / write-offs | (1,087) | |
Reclassifications | (2) | |
Foreign currency translation | 101 | |
Balance at the end of the year | 5,548 | 5,242 |
Projects in progress | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 1,046 | |
Balance at the end of the year | 640 | 1,046 |
Internally generated software in progress | 415 | |
Own use properties in progress | 224 | |
Projects in progress | Historical cost | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 1,046 | |
Additions | 1,110 | |
Disposals / write-offs | 0 | |
Reclassifications | (1,561) | |
Foreign currency translation | 45 | |
Balance at the end of the year | 640 | 1,046 |
Projects in progress | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Line Items] | ||
Balance at the beginning of the year | 0 | |
Depreciation | 0 | |
Impairment | 0 | |
Disposals / write-offs | 0 | |
Reclassifications | 0 | |
Foreign currency translation | 0 | |
Balance at the end of the year | $ 0 | $ 0 |
Goodwill and intangible asset_2
Goodwill and intangible assets (Narrative) (Detail) $ in Billions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | |
Goodwill | $ 6 |
Change in forecast earnings available to shareholders used for goodwill impairment sensitivity analysis | 20% |
Change in discount rates used for goodwill impairment sensitivity analysis | 1.50% |
Change in long-term growth rates used for goodwill impairment sensitivity analysis | 0.75% |
Global Wealth Management Americas | |
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | |
Goodwill | $ 3.7 |
Global Wealth Management Switzerland and International | |
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | |
Goodwill | 1.2 |
Asset Management | |
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | |
Goodwill | $ 1.1 |
Goodwill and intangible asset_3
Goodwill and intangible assets (Detail 1) | Dec. 31, 2023 | Dec. 31, 2022 |
Global Wealth Management Americas | ||
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | ||
Discount rates current year | 9.50% | |
Discount rates previous year | 10.50% | |
Growth rates | 3.80% | 3.80% |
Global Wealth Management Switzerland and International | ||
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | ||
Discount rates current year | 9.50% | |
Discount rates previous year | 9.40% | |
Growth rates | 3.40% | 3.60% |
Asset Management | ||
Disclosure Of Information For IndividualAsset Or Cash-generating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Line Items] | ||
Discount rates current year | 9% | |
Discount rates previous year | 9.50% | |
Growth rates | 3.30% | 3.40% |
Goodwill and intangible asset_4
Goodwill and intangible assets (Detail 2) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | $ 6,267 | |
Balance at the end of the year | 6,265 | $ 6,267 |
of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 3,740 | |
Balance at the end of the year | 3,748 | 3,740 |
of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 1,225 | |
Balance at the end of the year | 1,233 | 1,225 |
of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 1,167 | |
Balance at the end of the year | 1,149 | 1,167 |
of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 135 | |
Balance at the end of the year | 135 | 135 |
Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 7,641 | 7,739 |
Additions | 6 | 0 |
Disposals | (40) | (22) |
Foreign currency translation | 38 | (76) |
Balance at the end of the year | 7,645 | 7,641 |
Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 1,374 | 1,360 |
Amortization | 26 | 26 |
Impairment | 0 | (1) |
Disposals | (30) | 0 |
Foreign currency translation | 9 | (11) |
Balance at the end of the year | 1,379 | 1,374 |
Goodwill | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 6,043 | |
Goodwill | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 3,712 | |
Goodwill | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 1,182 | |
Goodwill | of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 1,149 | |
Goodwill | of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 0 | |
Goodwill | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 6,043 | |
Additions | 0 | |
Disposals | (10) | |
Foreign currency translation | 10 | |
Balance at the end of the year | 6,043 | 6,043 |
Goodwill | Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 0 | |
Impairment | 0 | |
Disposals | 0 | |
Foreign currency translation | 0 | |
Balance at the end of the year | 0 | 0 |
Intangible assets | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 223 | |
Intangible assets | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 36 | |
Intangible assets | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 52 | |
Intangible assets | of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 0 | |
Intangible assets | of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the end of the year | 135 | |
Intangible assets | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 1,598 | |
Additions | 6 | |
Disposals | (30) | |
Foreign currency translation | 28 | |
Balance at the end of the year | 1,602 | 1,598 |
Intangible assets | Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] | ||
Balance at the beginning of the year | 1,374 | |
Amortization | 26 | |
Impairment | 0 | |
Disposals | (30) | |
Foreign currency translation | 9 | |
Balance at the end of the year | $ 1,379 | $ 1,374 |
Goodwill and intangible asset_5
Goodwill and intangible assets (Detail 3) $ in Millions | Dec. 31, 2023 USD ($) |
Estimated Aggregated Amortization Expenses [Line Items] | |
2024 | $ 27 |
2025 | 26 |
2026 | 26 |
2027 | 25 |
2028 | 19 |
Thereafter | 98 |
Not amortized due to indefinite useful life | 2 |
Total | $ 223 |
Other financial assets measured
Other financial assets measured at amortized cost (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Apr. 01, 2022 | |
Disclosure Of Financial Assets [Line Item] | |||
Debt securities | $ 43,245 | $ 44,594 | |
Loans to financial advisors | 2,615 | 2,611 | |
Fee- and commission-related receivables | 1,883 | 1,803 | |
Finance lease receivables | 1,427 | 1,314 | |
Settlement and clearing accounts | 311 | 1,174 | |
Accrued interest income | 2,004 | 1,276 | |
Other | 2,849 | 618 | |
Total other financial assets measured at amortized cost | 54,334 | $ 53,389 | |
Reclassification of financial assets out of measured at fair value through other comprehensive income into measured at amortised cost | 6,900 | ||
Reclassification of financial assets to Other financial assets measured at amortized cost | (449) | ||
Reclassification of financial assets to Other financial assets measured at amortized cost, net of tax | $ (333) | ||
Carrying amount of financial assets reclassified out of fair value through other comprehensive income category into amortised cost category | $ 7,400 |
Other non-financial assets (Det
Other non-financial assets (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Other Non-Financial Assets [Line Items] | ||
Precious metals and other physical commodities | $ 4,426 | $ 4,471 |
Deposits and collateral provided in connection with litigation, regulatory and similar matters | 1,379 | 2,205 |
Prepaid expenses | 1,062 | 709 |
VAT, withholding tax and other tax receivables | 746 | 1,405 |
Properties and other non-current assets held for sale | 105 | 279 |
Other | 660 | 583 |
Total other non-financial assets | $ 8,377 | $ 9,652 |
Customer deposits (Detail)
Customer deposits (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Deposits From Customers [Line Items] | ||
Demand deposits | $ 146,163 | $ 182,307 |
Retail savings / deposits | 152,683 | 149,310 |
Sweep deposits | 41,045 | 69,223 |
Time deposits | 215,782 | 126,331 |
Customer deposits | $ 555,673 | $ 527,171 |
Funding from Group and other su
Funding from Group and other subsidiaries (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Funding From Group And Other Subsidiaries [Line Items] | ||
Debt contributing to total loss-absorbing capacity (TLAC) | $ 51,102 | $ 42,073 |
Debt eligible as high-trigger loss-absorbing additional tier 1 capital instruments | 11,286 | 10,654 |
Debt eligible as low-trigger loss-absorbing additional tier 1 capital instruments | 1,212 | 1,187 |
Other | 3,682 | 2,232 |
Total | 67,282 | 56,147 |
Adjustment to Funding measured at amortized cost, hedge accounting application | (3,200) | $ (5,100) |
Funding measured at amortized cost, fixed interest rate | 65,600 | |
Funding measured at amortized cost, floating interest rate | $ 1,700 |
Debt issued designated at fai_3
Debt issued designated at fair value (Detail 1) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Issued debt instruments | ||
Equity-linked | $ 46,269 | $ 41,901 |
Rates-linked | 16,880 | 16,276 |
Credit-linked | 4,506 | 2,170 |
Fixed-rate | 14,295 | 6,538 |
Commodity-linked | 3,704 | 4,294 |
Other | 687 | 663 |
Total debt issued designated at fair value | 86,341 | 71,842 |
of which: issued by UBS AG with original maturity greater than one year | $ 73,544 | $ 57,750 |
Unsecured portion of issued debt instruments with original maturity greater than one year | 100% | 100% |
Debt issued measured at amort_2
Debt issued measured at amortized cost (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Financial Liabilities [Line Items] | ||
Short-term debt | $ 37,285 | $ 29,676 |
Senior unsecured debt | 18,450 | 17,892 |
of which: issued by UBS AG with original maturity greater than one year | 18,446 | 17,892 |
Covered bonds | 1,006 | 0 |
Subordinated debt | 3,008 | 2,968 |
of which: eligible as low-trigger loss-absorbing tier 2 capital instruments | 0 | 2,422 |
of which: eligible as non-Basel III-compliant tier 2 capital instruments | 538 | 536 |
Debt issued through the Swiss central mortgage institutions | 10,035 | 8,962 |
Long-term debt | 32,499 | 29,823 |
Total debt issued measured at amortized cost | $ 69,784 | $ 59,499 |
Unsecured portion of total debt issued measured at amortized cost | 100% |
Debt issued measured at amort_3
Debt issued measured at amortized cost (Narrative) (Detail) - USD ($) $ in Billions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Issued Held At Amortized Cost [Line Items] | ||
Hedge accounting impact on carrying amount | $ (0.4) | $ (1) |
Provisions (Detail)
Provisions (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Other Provisions [Line Items] | ||
Provisions other than provisions for expected credit losses | $ 2,336 | $ 2,982 |
Provisions for expected credit losses | 188 | 201 |
Total provisions | $ 2,524 | $ 3,183 |
Provisions - additional informa
Provisions - additional information (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Other Provisions [Line Items] | ||
Balance at the beginning of the year | $ 2,982 | |
Increase in provisions recognized in the income statement | 1,148 | |
Release of provisions recognized in the income statement | (77) | |
Provisions used in conformity with designated purpose | (1,795) | |
Foreign currency translation and other movements | 79 | |
Balance at the end of the year | 2,336 | |
Litigation, regulatory and similar matters | ||
Disclosure Of Other Provisions [Line Items] | ||
Balance at the beginning of the year | 2,586 | |
Increase in provisions recognized in the income statement | 866 | |
Release of provisions recognized in the income statement | (47) | |
Provisions used in conformity with designated purpose | (1,642) | |
Foreign currency translation and other movements | 48 | |
Balance at the end of the year | 1,810 | |
Restructuring | ||
Disclosure Of Other Provisions [Line Items] | ||
Balance at the beginning of the year | 98 | |
Increase in provisions recognized in the income statement | 234 | |
Release of provisions recognized in the income statement | (13) | |
Provisions used in conformity with designated purpose | (114) | |
Foreign currency translation and other movements | 4 | |
Balance at the end of the year | 209 | |
Real estate related onerous contracts restucturing provision | 146 | $ 28 |
Personnel-related restructuring provisions | 64 | $ 70 |
Real estate | ||
Disclosure Of Other Provisions [Line Items] | ||
Balance at the beginning of the year | 122 | |
Increase in provisions recognized in the income statement | 8 | |
Release of provisions recognized in the income statement | 0 | |
Provisions used in conformity with designated purpose | (12) | |
Foreign currency translation and other movements | 18 | |
Balance at the end of the year | 135 | |
Other | ||
Disclosure Of Other Provisions [Line Items] | ||
Balance at the beginning of the year | 175 | |
Increase in provisions recognized in the income statement | 41 | |
Release of provisions recognized in the income statement | (17) | |
Provisions used in conformity with designated purpose | (27) | |
Foreign currency translation and other movements | 10 | |
Balance at the end of the year | $ 181 |
Litigation, regulatory and si_2
Litigation, regulatory and similar matters (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | $ 2,982 |
Increase in provisions recognized in the income statement | 1,148 |
Release of provisions recognized in the income statement | (77) |
Provisions used in conformity with designated purpose | (1,795) |
Foreign currency translation and other movements | 79 |
Balance at the end of the year | 2,336 |
Litigation, regulatory and similar matters | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 2,586 |
Increase in provisions recognized in the income statement | 866 |
Release of provisions recognized in the income statement | (47) |
Provisions used in conformity with designated purpose | (1,642) |
Foreign currency translation and other movements | 48 |
Balance at the end of the year | 1,810 |
Litigation, regulatory and similar matters | Global Wealth Management | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 1,182 |
Increase in provisions recognized in the income statement | 113 |
Release of provisions recognized in the income statement | (7) |
Provisions used in conformity with designated purpose | (98) |
Foreign currency translation and other movements | 31 |
Balance at the end of the year | 1,220 |
Litigation, regulatory and similar matters | Personal & Corporate Banking | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 159 |
Increase in provisions recognized in the income statement | 0 |
Release of provisions recognized in the income statement | (9) |
Provisions used in conformity with designated purpose | 0 |
Foreign currency translation and other movements | 6 |
Balance at the end of the year | 156 |
Litigation, regulatory and similar matters | Asset Management | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 8 |
Increase in provisions recognized in the income statement | 5 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | (1) |
Foreign currency translation and other movements | 0 |
Balance at the end of the year | 12 |
Litigation, regulatory and similar matters | Investment Bank | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 308 |
Increase in provisions recognized in the income statement | 81 |
Release of provisions recognized in the income statement | (2) |
Provisions used in conformity with designated purpose | (106) |
Foreign currency translation and other movements | 5 |
Balance at the end of the year | 286 |
Litigation, regulatory and similar matters | Non-core and Legacy | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 771 |
Increase in provisions recognized in the income statement | 665 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | (1,435) |
Foreign currency translation and other movements | 4 |
Balance at the end of the year | 4 |
Litigation, regulatory and similar matters | Group Items | |
Disclosure Of Other Provisions [Line Items] | |
Balance at the beginning of the year | 158 |
Increase in provisions recognized in the income statement | 2 |
Release of provisions recognized in the income statement | (29) |
Provisions used in conformity with designated purpose | (1) |
Foreign currency translation and other movements | 1 |
Balance at the end of the year | $ 132 |
Litigation, regulatory and si_3
Litigation, regulatory and similar matters (Narrative) (Detail) - 12 months ended Dec. 31, 2023 € in Thousands, $ in Millions | EUR (€) | USD ($) |
Inquiries regarding cross-border wealth management businesses | Investigations in France | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Fine decision French Court | € 3,700,000 | |
Civil damages award announcement of the French Court | 800,000 | |
Fine decision French Court of Appeal | 3,750 | |
Bail ("caution") ordered to be confiscated, verdict of the French Court of Appeal | 1,000,000 | |
Civil damages award announcement of the French Court of Appeal | 800,000 | |
Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS AG | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Bail ("caution") ordered to be paid | 1,100,000 | |
Fine overturned French Supreme Court | 3,750 | |
Confiscation overturned French Supreme Court | 1,000,000 | |
Civil damages award overturned French Supreme Court | 800,000 | |
Civil damages award reimbursed | 800,000 | |
Madoff | claims filed in Luxembourg by liquidators of two Luxembourg funds against UBS entities, non-UBS entities and certain individuals | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Minimum total claims against all defendants | 2,100,000 | |
Madoff | claims filed in the US by BMIS Trustee against UBS entities and various other parties | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Amounts claimed | $ | $ 125 | |
Minimum total claims against all defendants | $ | 2,000 | |
Foreign exchange, LIBOR and benchmark rates, and other trading practices | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Fine provided in announcement of the European Commission | € 172,000 | |
Foreign exchange, LIBOR and benchmark rates, and other trading practices - Foreign exchange-related civil litigation | Claims under the Commodity Exchange Act | ||
Disclosure Of Litigation Regulatory And Similar Matters [Line Items] | ||
Settlement made | $ | $ 141 |
Other financial liabilities mea
Other financial liabilities measured at amortized cost (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Financial Liabilities [Line Items] | ||
Other accrued expenses | $ 1,613 | $ 1,564 |
Accrued interest expenses | 4,186 | 2,008 |
Settlement and clearing accounts | 1,314 | 1,060 |
Lease liabilities | 2,904 | 3,211 |
Other | 2,695 | 2,549 |
Total other financial liabilities measured at amortized cost | $ 12,713 | $ 10,391 |
Other financial liabilities des
Other financial liabilities designated at fair value (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Financial Liabilities [Line Items] | ||
Financial liabilities related to unit-linked investment contracts | $ 15,922 | $ 13,221 |
Securities financing transactions | 6,927 | 15,333 |
Over-the-counter debt instruments and other | 1,566 | 1,684 |
Funding from UBS Group AG | 2,950 | 1,796 |
Total other financial liabilities designated at fair value | $ 27,366 | $ 32,033 |
Other non-financial liabilities
Other non-financial liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Other Non-Financial Liabilities [Line Items] | ||
Compensation-related liabilities | $ 4,526 | $ 4,424 |
of which: financial advisor compensation plans | 1,472 | 1,463 |
of which: other compensation plans | 1,955 | 2,023 |
of which: net defined benefit liability | 487 | 449 |
of which: other compensation-related liabilities | 611 | 490 |
Current tax liabilities | 932 | 1,044 |
Deferred tax liabilities | 162 | 233 |
VAT, withholding tax and other tax payables | 712 | 472 |
Deferred income | 276 | 233 |
Other | 74 | 84 |
Total other non-financial liabilities | $ 6,682 | $ 6,489 |
Expected credit loss measurem_3
Expected credit loss measurement - ECL in the period (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | $ 143 | $ 29 | $ (148) |
Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 67 | (12) | (34) |
Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 50 | 39 | (86) |
Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 25 | 0 | (29) |
Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 23 | 29 | (123) |
Stage 1 and 2 positions | Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 11 | 6 | (34) |
Stage 1 and 2 positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 13 | 27 | (62) |
Stage 1 and 2 positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | (2) | (5) | (28) |
Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 120 | 0 | (25) |
Stage 3 positions | Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 56 | (18) | 0 |
Stage 3 positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 37 | 12 | (24) |
Stage 3 positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | $ 27 | $ 5 | $ (1) |
Expected credit loss measurem_4
Expected credit loss measurement - Credit loss expense / (release) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | $ 143 | $ 29 | $ (148) |
Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 25 | 0 | (29) |
Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 50 | 39 | (86) |
Asset Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | (1) | 0 | 1 |
Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 67 | (12) | (34) |
Non-core and Legacy | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 1 | 2 | 0 |
Group Items | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 1 | 0 | 0 |
Stages 1 and 2 | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 23 | 29 | (123) |
Stages 1 and 2 | Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | (2) | (5) | (28) |
Stages 1 and 2 | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 13 | 27 | (62) |
Stages 1 and 2 | Asset Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 0 | 0 | 0 |
Stages 1 and 2 | Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 11 | 6 | (34) |
Stages 1 and 2 | Non-core and Legacy | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 0 | 0 | 0 |
Stages 1 and 2 | Group Items | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 1 | 0 | 0 |
Stage 3 | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 120 | 0 | (25) |
Stage 3 | Global Wealth Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 27 | 5 | (1) |
Stage 3 | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 37 | 12 | (24) |
Stage 3 | Asset Management | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | (1) | 0 | 1 |
Stage 3 | Investment Bank | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 56 | (18) | 0 |
Stage 3 | Non-core and Legacy | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 1 | 2 | 0 |
Stage 3 | Group Items | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | $ 0 | $ 0 | $ 0 |
Expected credit loss measurem_5
Expected credit loss measurement - Changes to ECL models, scenarios, scenario weights and key inputs (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | 580 | ||
Stage 1 and 2 positions | Twelve-month expected credit losses | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (308) | (260) | (282) |
Stage 1 and 2 positions | Lifetime expected credit losses | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (272) | (267) | (220) |
Stage 3 positions | Lifetime expected credit losses | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | $ (664) | $ (564) | $ (662) |
Mild debt crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Assigned weights | 15% | 0% | |
Total allowance and provisions | $ (492) | ||
Global crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Assigned weights | 0% | 15% | |
Total allowance and provisions | $ (638) | ||
Stagflationary geopolitical crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Assigned weights | 25% | 25% | |
Total allowance and provisions | $ (1,322) | $ (1,204) | |
Baseline | |||
Disclosure Of Provision Matrix [Line Items] | |||
Assigned weights | 60% | 60% | |
Total allowance and provisions | $ (396) | $ (329) | |
Asset price inflation | |||
Disclosure Of Provision Matrix [Line Items] | |||
Assigned weights | 0% | 0% | |
Total allowance and provisions | $ (219) | $ (295) | |
Large corporate clients | Stage 1 and 2 positions | Lifetime expected credit losses | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (66) | ||
Large corporate clients | Mild debt crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (146) | ||
Large corporate clients | Global crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (174) | ||
Large corporate clients | Stagflationary geopolitical crisis | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (252) | (199) | |
Large corporate clients | Baseline | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (108) | (97) | |
Large corporate clients | Asset price inflation | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total allowance and provisions | (53) | (84) | |
Model updates | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 27 | ||
Post-model adjustment | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 133 | $ 131 | |
Investment Bank | Model updates | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 16 | ||
Personal & Corporate Banking | Model updates | Large corporate clients and SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | $ 12 |
Expected credit loss measurem_6
Expected credit loss measurement - Economic scenarios and weights applied (Detail) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Asset price inflation | ||
Disclosure Of Provision Matrix [Line Items] | ||
Assigned weights | 0% | 0% |
Baseline | ||
Disclosure Of Provision Matrix [Line Items] | ||
Assigned weights | 60% | 60% |
Mild debt crisis | ||
Disclosure Of Provision Matrix [Line Items] | ||
Assigned weights | 15% | 0% |
Stagflationary geopolitical crisis | ||
Disclosure Of Provision Matrix [Line Items] | ||
Assigned weights | 25% | 25% |
Global crisis | ||
Disclosure Of Provision Matrix [Line Items] | ||
Assigned weights | 0% | 15% |
Expected credit loss measurem_7
Expected credit loss measurement - Scenario assumptions (Detail) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
100% Asset price inflation | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4% | 4% |
100% Asset price inflation | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 3% | 3% |
100% Asset price inflation | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 3% | 3% |
100% Asset price inflation | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.50% | 2.50% |
100% Asset price inflation | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.30% | 2.30% |
100% Asset price inflation | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.10% | 2.10% |
100% Asset price inflation | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 3% | 3% |
100% Asset price inflation | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6% | 6% |
100% Asset price inflation | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.60% | 1.70% |
100% Asset price inflation | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.13% | 0.25% |
100% Asset price inflation | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.20% | 0.20% |
100% Asset price inflation | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.25% | 0.25% |
100% Asset price inflation | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 20% | 20% |
100% Asset price inflation | Within 1 year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 20% | 17% |
100% Asset price inflation | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 15% | 14% |
100% Asset price inflation | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.60% | 6.60% |
100% Asset price inflation | Within 1 year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 8.10% | 7.80% |
100% Asset price inflation | Within 1 year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 7% | 7% |
100% Asset price inflation | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 9.10% | 9.10% |
100% Asset price inflation | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.20% | 6.20% |
100% Asset price inflation | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.60% | 6.60% |
100% Asset price inflation | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 8.10% | 8.10% |
100% Asset price inflation | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 7.40% | 7.40% |
100% Asset price inflation | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.20% | 6.20% |
100% Asset price inflation | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 3% | 3% |
100% Asset price inflation | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6% | 6% |
100% Asset price inflation | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.50% | 1.50% |
100% Asset price inflation | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.37% | 0.70% |
100% Asset price inflation | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.58% | 0.58% |
100% Asset price inflation | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.63% | 0.63% |
100% Asset price inflation | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 51.70% | 51.70% |
100% Asset price inflation | cumulative 3-year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 46.60% | 42.90% |
100% Asset price inflation | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 39.20% | 37.90% |
100% Asset price inflation | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 14% | 14% |
100% Asset price inflation | cumulative 3-year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 19.70% | 19.10% |
100% Asset price inflation | cumulative 3-year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 15.40% | 15.40% |
Baseline | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.10% | (0.30%) |
Baseline | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.50% | 0.60% |
Baseline | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.40% | 0.70% |
Baseline | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.30% | 2.60% |
Baseline | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2% | 5% |
Baseline | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.50% | 1.60% |
Baseline | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.40% | 3.90% |
Baseline | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.90% | 7% |
Baseline | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.30% | 2.30% |
Baseline | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.82%) | (0.06%) |
Baseline | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.90%) | 0.48% |
Baseline | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.41%) | 0.46% |
Baseline | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 15.30% | 7.40% |
Baseline | Within 1 year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 12% | 17.20% |
Baseline | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.60% | 5.60% |
Baseline | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.50%) | 1.10% |
Baseline | Within 1 year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.60% | (4.50%) |
Baseline | Within 1 year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.60% | (2.70%) |
Baseline | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.40% | 3.20% |
Baseline | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.90% | 2.50% |
Baseline | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.40% | 3.50% |
Baseline | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 7.10% | 6.50% |
Baseline | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.10% | 9.60% |
Baseline | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.30% | 3.90% |
Baseline | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.40% | 5.30% |
Baseline | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.80% | 7.10% |
Baseline | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.30% | 2.60% |
Baseline | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.78%) | (0.13%) |
Baseline | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.78%) | 0.45% |
Baseline | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.34%) | 0.57% |
Baseline | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 28.10% | 22.80% |
Baseline | cumulative 3-year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 22.90% | 29.20% |
Baseline | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 15.90% | 19.30% |
Baseline | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.80% | 2.30% |
Baseline | cumulative 3-year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 5.80% | (0.60%) |
Baseline | cumulative 3-year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.40% | 2% |
Mild debt crisis | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.60%) | |
Mild debt crisis | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.70%) | |
Mild debt crisis | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.20%) | |
Mild debt crisis | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.10%) | |
Mild debt crisis | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.20%) | |
Mild debt crisis | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.40%) | |
Mild debt crisis | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 6.30% | |
Mild debt crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 8.20% | |
Mild debt crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.90% | |
Mild debt crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (2.15%) | |
Mild debt crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.85%) | |
Mild debt crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.73%) | |
Mild debt crisis | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (26.60%) | |
Mild debt crisis | Within 1 year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (26.40%) | |
Mild debt crisis | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (24.50%) | |
Mild debt crisis | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (4.40%) | |
Mild debt crisis | Within 1 year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (8.60%) | |
Mild debt crisis | Within 1 year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (5.90%) | |
Mild debt crisis | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.60% | |
Mild debt crisis | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.10%) | |
Mild debt crisis | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.30% | |
Mild debt crisis | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.30% | |
Mild debt crisis | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.80% | |
Mild debt crisis | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 0.80% | |
Mild debt crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 7.70% | |
Mild debt crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 9% | |
Mild debt crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 3.80% | |
Mild debt crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.55%) | |
Mild debt crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.40%) | |
Mild debt crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.28%) | |
Mild debt crisis | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (12.20%) | |
Mild debt crisis | cumulative 3-year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (16.60%) | |
Mild debt crisis | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (11.20%) | |
Mild debt crisis | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (3.00%) | |
Mild debt crisis | cumulative 3-year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (5.20%) | |
Mild debt crisis | cumulative 3-year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (5.20%) | |
Stagflationary geopolitical crisis | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (4.80%) | (4.80%) |
Stagflationary geopolitical crisis | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (5.60%) | (5.60%) |
Stagflationary geopolitical crisis | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (4.80%) | (4.80%) |
Stagflationary geopolitical crisis | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 10% | 10% |
Stagflationary geopolitical crisis | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 9.60% | 9.60% |
Stagflationary geopolitical crisis | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 5.80% | 5.80% |
Stagflationary geopolitical crisis | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 9.20% | 9.20% |
Stagflationary geopolitical crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 10.60% | 10.90% |
Stagflationary geopolitical crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.10% | 4.30% |
Stagflationary geopolitical crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.70% | 2.35% |
Stagflationary geopolitical crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.25% | 2.50% |
Stagflationary geopolitical crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.95% | 2.20% |
Stagflationary geopolitical crisis | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (51.50%) | (51.50%) |
Stagflationary geopolitical crisis | Within 1 year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (51.60%) | (51.60%) |
Stagflationary geopolitical crisis | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (51.60%) | (51.60%) |
Stagflationary geopolitical crisis | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (18.50%) | (16.70%) |
Stagflationary geopolitical crisis | Within 1 year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (20.00%) | (12.80%) |
Stagflationary geopolitical crisis | Within 1 year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (8.40%) | (8.40%) |
Stagflationary geopolitical crisis | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (4.40%) | (4.40%) |
Stagflationary geopolitical crisis | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (5.70%) | (5.70%) |
Stagflationary geopolitical crisis | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (4.90%) | (4.90%) |
Stagflationary geopolitical crisis | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 15.80% | 15.80% |
Stagflationary geopolitical crisis | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 14.80% | 14.80% |
Stagflationary geopolitical crisis | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 10.70% | 10.70% |
Stagflationary geopolitical crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 11.80% | 11.80% |
Stagflationary geopolitical crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 11.80% | 12.20% |
Stagflationary geopolitical crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 5% | 5.10% |
Stagflationary geopolitical crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 2.45% | 2.05% |
Stagflationary geopolitical crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.95% | 2.20% |
Stagflationary geopolitical crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.80% | 2.05% |
Stagflationary geopolitical crisis | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (45.60%) | (45.60%) |
Stagflationary geopolitical crisis | cumulative 3-year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (47.20%) | (47.20%) |
Stagflationary geopolitical crisis | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (47.20%) | (47.20%) |
Stagflationary geopolitical crisis | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (28.60%) | (32.90%) |
Stagflationary geopolitical crisis | cumulative 3-year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (30.20%) | (35.80%) |
Stagflationary geopolitical crisis | cumulative 3-year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (12.90%) | (14.70%) |
Global crisis | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (6.40%) | |
Global crisis | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (8.50%) | |
Global crisis | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (6.70%) | |
Global crisis | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.50%) | |
Global crisis | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.70%) | |
Global crisis | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.80%) | |
Global crisis | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 10% | |
Global crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 11.90% | |
Global crisis | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.40% | |
Global crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (3.26%) | |
Global crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (2.71%) | |
Global crisis | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (2.10%) | |
Global crisis | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (50.00%) | |
Global crisis | Within 1 year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (50.00%) | |
Global crisis | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (46.00%) | |
Global crisis | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (19.90%) | |
Global crisis | Within 1 year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (19.30%) | |
Global crisis | Within 1 year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (8.90%) | |
Global crisis | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.80%) | |
Global crisis | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (8.30%) | |
Global crisis | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (3.70%) | |
Global crisis | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 1.20% | |
Global crisis | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (0.70%) | |
Global crisis | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.60%) | |
Global crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 9.40% | |
Global crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 13% | |
Global crisis | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | 4.90% | |
Global crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (2.91%) | |
Global crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (2.47%) | |
Global crisis | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (1.60%) | |
Global crisis | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (27.90%) | |
Global crisis | cumulative 3-year | Equity indices (% change) | EuroStoxx 50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (39.30%) | |
Global crisis | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (32.90%) | |
Global crisis | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (23.90%) | |
Global crisis | cumulative 3-year | Other real estate (% change) | United States (S&P / Case Shiller) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (32.70%) | |
Global crisis | cumulative 3-year | Other real estate (% change) | Eurozone (House Price Index) | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | ||
Economic forecast | (17.50%) |
Expected credit loss measurem_8
Expected credit loss measurement - Development of ECL allowances and provisions (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
ECL movement with profit or loss impact | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (143) | (29) | |
Net movement from new and derecognized transactions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (11) | (7) | |
Net movement from new and derecognized transactions | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (5) | (6) | |
Net movement from new and derecognized transactions | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (2) | (3) | |
Net movement from new and derecognized transactions | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 2 | 8 | |
Net movement from new and derecognized transactions | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (3) | (1) | |
Net movement from new and derecognized transactions | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (4) | (6) | |
Net movement from new and derecognized transactions | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | 0 | |
Net movement from new and derecognized transactions | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Remeasurements with stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (140) | (65) | |
Remeasurements with stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | (10) | |
Remeasurements with stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (2) | 7 | |
Remeasurements with stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (76) | (33) | |
Remeasurements with stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (56) | (23) | |
Remeasurements with stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (10) | (6) | |
Remeasurements with stage transfers | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Remeasurements with stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 1 | |
Remeasurements without stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 35 | 13 | |
Remeasurements without stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 5 | (12) | |
Remeasurements without stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 5 | 13 | |
Remeasurements without stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 15 | 32 | |
Remeasurements without stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 44 | (6) | |
Remeasurements without stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (34) | (15) | |
Remeasurements without stage transfers | of which: Sovereigns | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (15) | (8) | |
Remeasurements without stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (7) | (3) | |
Model changes | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (27) | 30 | |
Movements without profit or loss impact (write-off, FX and other) | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (10) | 104 | |
Stage 1 and 2 positions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | 580 | ||
Stage 1 and 2 positions | ECL movement with profit or loss impact | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (23) | ||
Stage 1 and 2 positions | Remeasurements without stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 21 | ||
Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 23 | ||
Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Sovereigns | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (15) | ||
Stage 1 and 2 positions | Movements without profit or loss impact (write-off, FX and other) | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (31) | ||
Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (308) | (260) | (282) |
Twelve-month expected credit losses | Stage 1 and 2 positions | ECL movement with profit or loss impact | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (30) | 20 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (27) | (21) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (8) | (6) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (4) | (5) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (8) | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (3) | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (4) | (8) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | (2) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 8 | 20 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 3 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 2 | (1) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | 16 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 2 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 1 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 2 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 7 | (8) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (5) | 5 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 2 | 3 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 13 | (11) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | (10) | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (2) | 5 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Sovereigns | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 3 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Model changes | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (18) | 29 | |
Twelve-month expected credit losses | Stage 1 and 2 positions | Movements without profit or loss impact (write-off, FX and other) | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (18) | 3 | |
Lifetime expected credit losses | Stage 1 and 2 positions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (272) | (267) | (220) |
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (89) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (26) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (66) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (38) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (33) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | ECL movement with profit or loss impact | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 7 | (49) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 9 | 16 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | 2 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | 11 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 3 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 2 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Net movement from new and derecognized transactions | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (7) | (39) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | (12) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (5) | 8 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (3) | (28) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | (2) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | (4) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | 0 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements with stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | (1) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 14 | (27) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 14 | (18) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 3 | 10 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 10 | 2 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 1 | (9) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (14) | (12) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Sovereigns | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (15) | (8) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Remeasurements without stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | (1) | |
Lifetime expected credit losses | Stage 1 and 2 positions | Model changes | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (9) | 1 | |
Lifetime expected credit losses | Stage 1 and 2 positions | Movements without profit or loss impact (write-off, FX and other) | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (13) | 1 | |
Lifetime expected credit losses | Stage 3 positions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Total ECL allowances and provisions | (664) | (564) | $ (662) |
Lifetime expected credit losses | Stage 3 positions | ECL movement with profit or loss impact | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (120) | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 7 | (2) | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 7 | (2) | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Net movement from new and derecognized transactions | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (142) | (46) | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (76) | (21) | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (55) | (22) | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (11) | (3) | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Financial intermediaries and hedge funds | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements with stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 14 | 48 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: Private clients with mortgages | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (3) | 1 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: Real estate financing | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (1) | 0 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: Large corporate clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (8) | 41 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: SME clients | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 44 | 14 | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: Other | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (18) | (8) | |
Lifetime expected credit losses | Stage 3 positions | Remeasurements without stage transfers | of which: Loans to financial advisors | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | (8) | (6) | |
Lifetime expected credit losses | Stage 3 positions | Model changes | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Stage 3 positions | Movements without profit or loss impact (write-off, FX and other) | |||
Reconciliation Of Changes In Allowance Account For Credit Losses Of Financial Assets [Line Items] | |||
Development of ECL allowances and provisions | $ 21 | $ 99 |
Expected credit loss measurem_9
Expected credit loss measurement - Development of ECL allowances and provisions (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | $ 143 | $ 29 | $ (148) |
Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 23 | 29 | (123) |
Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Credit loss expense / (release) | 120 | 0 | $ (25) |
ECL movement with profit or loss impact | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (143) | (29) | |
ECL movement with profit or loss impact | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (23) | ||
ECL movement with profit or loss impact | Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (30) | 20 | |
ECL movement with profit or loss impact | Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 7 | (49) | |
ECL movement with profit or loss impact | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (120) | 0 | |
Net movement from new and derecognized transactions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (11) | (7) | |
Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 2 | 8 | |
Net movement from new and derecognized transactions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (4) | (6) | |
Net movement from new and derecognized transactions | Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (27) | (21) | |
Net movement from new and derecognized transactions | Twelve-month expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (8) | (1) | |
Net movement from new and derecognized transactions | Twelve-month expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (4) | (8) | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 9 | 16 | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 3 | 11 | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 0 | 3 | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 7 | (2) | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 3 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 7 | (2) | |
Net movement from new and derecognized transactions | Lifetime expected credit losses | Stage 3 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 0 | 0 | |
Remeasurements with stage transfers | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (140) | (65) | |
Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (76) | (33) | |
Remeasurements with stage transfers | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (10) | (6) | |
Remeasurements with stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 8 | 20 | |
Remeasurements with stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 3 | 16 | |
Remeasurements with stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 1 | 1 | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (7) | (39) | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (3) | (28) | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 0 | (4) | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (142) | (46) | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 3 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (76) | (21) | |
Remeasurements with stage transfers | Lifetime expected credit losses | Stage 3 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (11) | (3) | |
Remeasurements without stage transfers | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 35 | 13 | |
Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 15 | 32 | |
Remeasurements without stage transfers | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (34) | (15) | |
Remeasurements without stage transfers | Single sovereign counterparty | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (15) | (8) | |
Remeasurements without stage transfers | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 21 | ||
Remeasurements without stage transfers | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 23 | ||
Remeasurements without stage transfers | Stage 1 and 2 positions | Total real estate lending | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 14 | ||
Remeasurements without stage transfers | Stage 1 and 2 positions | Single sovereign counterparty | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (15) | ||
Remeasurements without stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 7 | (8) | |
Remeasurements without stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 13 | (11) | |
Remeasurements without stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (2) | 5 | |
Remeasurements without stage transfers | Twelve-month expected credit losses | Stage 1 and 2 positions | Single sovereign counterparty | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 0 | 0 | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 14 | (27) | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 10 | 2 | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (14) | (12) | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 1 and 2 positions | Single sovereign counterparty | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (15) | (8) | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 14 | 48 | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 3 positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (8) | 41 | |
Remeasurements without stage transfers | Lifetime expected credit losses | Stage 3 positions | Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (18) | (8) | |
Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (10) | 104 | |
Movements without profit or loss impact (write-off, FX and other) | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (31) | ||
Movements without profit or loss impact (write-off, FX and other) | Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (18) | 3 | |
Movements without profit or loss impact (write-off, FX and other) | Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | (13) | 1 | |
Movements without profit or loss impact (write-off, FX and other) | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 21 | $ 99 | |
Write offs / recoveries | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | 69 | ||
FX and other movements | Lifetime expected credit losses | Stage 3 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Increase / decrease in ECL allowances | $ (48) |
Expected credit loss measure_10
Expected credit loss measurement - ECL stage 2 allowances / provisions - classification by trigger (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 580 | ||
Twelve-month expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (308) | (260) | (282) |
Lifetime expected credit losses | Stage 1 and 2 positions | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (272) | $ (267) | $ (220) |
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Private clients with mortgages | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (89) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (26) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (66) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (38) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (4) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Loans to financial advisors | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (13) | ||
Lifetime expected credit losses | Stage 1 and 2 positions | of which: Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (33) | ||
Lifetime expected credit losses | of which: PD layer | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (197) | ||
Lifetime expected credit losses | of which: PD layer | of which: Private clients with mortgages | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (69) | ||
Lifetime expected credit losses | of which: PD layer | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (21) | ||
Lifetime expected credit losses | of which: PD layer | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (48) | ||
Lifetime expected credit losses | of which: PD layer | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (23) | ||
Lifetime expected credit losses | of which: PD layer | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (4) | ||
Lifetime expected credit losses | of which: PD layer | of which: Loans to financial advisors | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: PD layer | of which: Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (31) | ||
Lifetime expected credit losses | of which: watch list | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (23) | ||
Lifetime expected credit losses | of which: watch list | of which: Private clients with mortgages | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (15) | ||
Lifetime expected credit losses | of which: watch list | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (5) | ||
Lifetime expected credit losses | of which: watch list | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | of which: Loans to financial advisors | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | of which: Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (2) | ||
Lifetime expected credit losses | of which: 30 days past due | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (53) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Private clients with mortgages | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (21) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Real estate financing | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (5) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Large corporate clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (2) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: SME clients | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (9) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Loans to financial advisors | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Credit cards | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | (13) | ||
Lifetime expected credit losses | of which: 30 days past due | of which: Other | |||
Disclosure Of Provision Matrix [Line Items] | |||
Total ECL allowances and provisions | $ (1) |
Expected credit loss measure_11
Expected credit loss measurement - Maximum exposure to credit risk (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | ||
Credit enhancements | ||
Collateral and credit enhancements related to credit-impaired financial assets measured at amortized cost | $ 1,637 | $ 1,372 |
Collateral and credit enhancements related to off-balance sheet financial instruments and other credit lines for credit-impaired positions | 105 | 113 |
Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 768,600 | 732,600 |
Collateral | ||
Cash collateral received | 31,500 | 36,200 |
Collateralized by equity and debt instruments | 176,800 | 181,000 |
Secured by real estate | 222,700 | 197,900 |
Other collateral | 33,900 | 23,400 |
Credit enhancements | ||
Netting | 22,800 | 22,900 |
Credit derivative contracts | 0 | 0 |
Guarantees and sub-participations | 2,900 | 3,000 |
Exposure to credit risk after collateral and credit enhancements | 277,900 | 268,300 |
Total financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 766,400 | 730,400 |
Collateral | ||
Cash collateral received | 31,500 | 36,200 |
Collateralized by equity and debt instruments | 176,800 | 181,000 |
Secured by real estate | 222,700 | 197,900 |
Other collateral | 33,900 | 23,400 |
Credit enhancements | ||
Netting | 22,800 | 22,900 |
Credit derivative contracts | 0 | 0 |
Guarantees and sub-participations | 2,900 | 3,000 |
Exposure to credit risk after collateral and credit enhancements | 275,700 | 266,100 |
Cash and balances at central banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 171,800 | 169,400 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 171,800 | 169,400 |
Amounts due from banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 28,200 | 14,700 |
Collateral | ||
Collateralized by equity and debt instruments | 200 | 0 |
Other collateral | 4,800 | |
Credit enhancements | ||
Guarantees and sub-participations | 100 | 100 |
Exposure to credit risk after collateral and credit enhancements | 23,100 | 14,600 |
Receivables from securities financing transactions measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 74,100 | 67,800 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by equity and debt instruments | 70,700 | 64,500 |
Other collateral | 2,800 | 2,400 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 700 | 900 |
Cash collateral receivables on derivative instruments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 32,300 | 35,000 |
Credit enhancements | ||
Netting | 22,800 | 22,900 |
Exposure to credit risk after collateral and credit enhancements | 9,500 | 12,100 |
Loans and advances to customers | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 405,600 | 390,000 |
Collateral | ||
Cash collateral received | 31,400 | 36,100 |
Collateralized by equity and debt instruments | 105,200 | 115,900 |
Secured by real estate | 222,700 | 197,800 |
Other collateral | 24,900 | 19,600 |
Credit enhancements | ||
Guarantees and sub-participations | 2,800 | 3,000 |
Exposure to credit risk after collateral and credit enhancements | 18,700 | 17,600 |
Other financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 54,300 | 53,400 |
Collateral | ||
Cash collateral received | 100 | 100 |
Collateralized by equity and debt instruments | 800 | 500 |
Secured by real estate | 0 | 0 |
Other collateral | 1,500 | 1,300 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 51,900 | 51,400 |
Financial assets measured at fair value through other comprehensive income - debt | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 2,200 | 2,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 2,200 | 2,200 |
Total maximum exposure to credit risk not reflected on the balance sheet | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 134,800 | 109,400 |
Collateral | ||
Cash collateral received | 2,300 | 1,600 |
Collateralized by equity and debt instruments | 41,300 | 24,400 |
Secured by real estate | 9,000 | 7,500 |
Other collateral | 15,700 | 14,700 |
Credit enhancements | ||
Netting | 0 | 0 |
Credit derivative contracts | 0 | 100 |
Guarantees and sub-participations | 3,500 | 3,300 |
Exposure to credit risk after collateral and credit enhancements | 62,900 | 58,000 |
Guarantees | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 33,200 | 22,100 |
Collateral | ||
Cash collateral received | 1,600 | 1,200 |
Collateralized by equity and debt instruments | 19,800 | 9,300 |
Secured by real estate | 200 | 100 |
Other collateral | 1,800 | 2,000 |
Credit enhancements | ||
Guarantees and sub-participations | 2,000 | 1,800 |
Exposure to credit risk after collateral and credit enhancements | 7,800 | 7,700 |
Loan commitments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 43,900 | 39,900 |
Collateral | ||
Cash collateral received | 200 | 200 |
Collateralized by equity and debt instruments | 2,000 | 3,100 |
Secured by real estate | 1,800 | 1,300 |
Other collateral | 8,900 | 6,500 |
Credit enhancements | ||
Credit derivative contracts | 0 | 100 |
Guarantees and sub-participations | 1,000 | 1,000 |
Exposure to credit risk after collateral and credit enhancements | 30,000 | 27,800 |
Forward starting reverse repurchase and securities borrowing agreements | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 10,400 | 3,800 |
Collateral | ||
Collateralized by equity and debt instruments | 10,400 | 3,800 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
Committed unconditionally revocable credit lines | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Line Items] | ||
Maximum exposure to credit risk | 47,400 | 43,600 |
Collateral | ||
Cash collateral received | 500 | 200 |
Collateralized by equity and debt instruments | 9,100 | 8,200 |
Secured by real estate | 7,100 | 6,000 |
Other collateral | 5,100 | 6,200 |
Credit enhancements | ||
Guarantees and sub-participations | 600 | 500 |
Exposure to credit risk after collateral and credit enhancements | $ 25,100 | $ 22,500 |
Expected credit loss measure_12
Expected credit loss measurement - Financial assets subject to credit risk by rating category (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | $ 768,640 | $ 732,618 |
Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 766,407 | 730,379 |
Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,806 | 169,445 |
Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 28,206 | 14,671 |
Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 74,128 | 67,814 |
Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 32,300 | 35,033 |
Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 405,633 | 390,027 |
Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 54,334 | 53,389 |
Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,233 | 2,239 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 748,015 | 714,889 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 745,782 | 712,651 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,788 | 169,402 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 28,191 | 14,670 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 74,128 | 67,814 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 32,300 | 35,033 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 385,493 | 372,903 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 53,882 | 52,829 |
Lifetime expected credit losses | Stage 1 and 2 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 18,475 | 16,044 |
Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 18,475 | 16,044 |
Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 18 | 44 |
Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 14 | 1 |
Lifetime expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 18,131 | 15,587 |
Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 312 | 413 |
Lifetime expected credit losses | Stage 3 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,150 | 1,685 |
Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,150 | 1,685 |
Lifetime expected credit losses | Stage 3 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,009 | 1,538 |
Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 141 | 147 |
Gross carrying amount | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 769,696 | 733,508 |
Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 767,462 | 731,269 |
Gross carrying amount | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,832 | 169,457 |
Gross carrying amount | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 28,213 | 14,676 |
Gross carrying amount | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 74,130 | 67,816 |
Gross carrying amount | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 32,300 | 35,034 |
Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 406,568 | 390,810 |
Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 54,421 | 53,475 |
Gross carrying amount | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,233 | 2,239 |
Gross carrying amount | 0-1 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 250,024 | 243,966 |
Gross carrying amount | 0-1 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 248,802 | 242,660 |
Gross carrying amount | 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,573 | 168,525 |
Gross carrying amount | 0-1 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 811 | 862 |
Gross carrying amount | 0-1 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 36,689 | 27,158 |
Gross carrying amount | 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 8,009 | 10,613 |
Gross carrying amount | 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 5,993 | 6,491 |
Gross carrying amount | 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 25,727 | 29,011 |
Gross carrying amount | 0-1 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,222 | 1,307 |
Gross carrying amount | 2-3 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 273,131 | 275,178 |
Gross carrying amount | 2-3 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 272,281 | 274,337 |
Gross carrying amount | 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 215 | 877 |
Gross carrying amount | 2-3 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 25,095 | 11,150 |
Gross carrying amount | 2-3 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 15,958 | 15,860 |
Gross carrying amount | 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 13,575 | 12,978 |
Gross carrying amount | 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 196,897 | 216,824 |
Gross carrying amount | 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 20,541 | 16,649 |
Gross carrying amount | 2-3 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 850 | 840 |
Gross carrying amount | 4-5 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 97,400 | 85,731 |
Gross carrying amount | 4-5 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 97,400 | 85,731 |
Gross carrying amount | 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | 4-5 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,359 | 832 |
Gross carrying amount | 4-5 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,073 | 8,870 |
Gross carrying amount | 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,423 | 7,138 |
Gross carrying amount | 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 82,867 | 68,444 |
Gross carrying amount | 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 678 | 447 |
Gross carrying amount | 4-5 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | 6-8 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 115,547 | 103,308 |
Gross carrying amount | 6-8 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 115,386 | 103,216 |
Gross carrying amount | 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | 6-8 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 463 | 996 |
Gross carrying amount | 6-8 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 14,319 | 15,207 |
Gross carrying amount | 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 4,095 | 4,157 |
Gross carrying amount | 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 89,738 | 76,147 |
Gross carrying amount | 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,770 | 6,708 |
Gross carrying amount | 6-8 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 161 | 92 |
Gross carrying amount | 9-13 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 30,802 | 23,102 |
Gross carrying amount | 9-13 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 30,802 | 23,102 |
Gross carrying amount | 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 43 | 56 |
Gross carrying amount | 9-13 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 485 | 837 |
Gross carrying amount | 9-13 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,091 | 721 |
Gross carrying amount | 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 198 | 147 |
Gross carrying amount | 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 28,486 | 20,891 |
Gross carrying amount | 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 499 | 450 |
Gross carrying amount | 9-13 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Credit-impaired (defaulted) | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,792 | 2,222 |
Gross carrying amount | Credit-impaired (defaulted) | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,792 | 2,222 |
Gross carrying amount | Credit-impaired (defaulted) | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Credit-impaired (defaulted) | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Credit-impaired (defaulted) | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Credit-impaired (defaulted) | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Credit-impaired (defaulted) | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,586 | 2,012 |
Gross carrying amount | Credit-impaired (defaulted) | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 206 | 210 |
Gross carrying amount | Credit-impaired (defaulted) | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,788 | 169,402 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 28,198 | 14,675 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 74,130 | 67,816 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 32,300 | 35,034 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 385,666 | 373,032 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 53,897 | 52,846 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 171,573 | 168,525 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 811 | 862 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 36,689 | 27,158 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 8,009 | 10,613 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 5,993 | 6,491 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 25,727 | 29,011 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 215 | 877 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 25,095 | 11,150 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 15,958 | 15,860 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 13,575 | 12,978 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 195,590 | 215,332 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 20,539 | 16,646 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,354 | 832 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,073 | 8,870 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,423 | 7,138 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 80,534 | 66,202 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 659 | 427 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 462 | 996 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 14,319 | 15,207 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 4,095 | 4,157 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 82,633 | 69,450 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 6,619 | 6,426 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 476 | 836 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,091 | 721 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 198 | 147 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 20,916 | 15,557 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 353 | 336 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 43 | 56 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 15 | 1 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 18,316 | 15,767 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 317 | 419 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1,307 | 1,493 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2 | 2 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 5 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,333 | 2,242 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 19 | 20 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 1 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 7,106 | 6,698 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 151 | 283 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 43 | 56 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 9 | 1 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 7,570 | 5,334 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 146 | 114 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,586 | 2,012 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 206 | 210 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 0-1 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 2-3 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 4-5 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 6-8 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 9-13 | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 2,586 | 2,012 |
Gross carrying amount | Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 206 | 210 |
Allowance for expected credit loss | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (1,057) | (890) |
Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (1,057) | (890) |
Allowance for expected credit loss | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (26) | (12) |
Allowance for expected credit loss | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (7) | (6) |
Allowance for expected credit loss | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (2) | (2) |
Allowance for expected credit loss | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (935) | (783) |
Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (87) | (86) |
Allowance for expected credit loss | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (197) | (154) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (197) | (154) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (6) | (5) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (2) | (2) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (173) | (129) |
Allowance for expected credit loss | Twelve-month expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (16) | (17) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (217) | (199) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (217) | (199) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (26) | (12) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (1) | (1) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (185) | (180) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 1 and 2 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (5) | (6) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (643) | (537) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (643) | (537) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Amounts due from banks | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Receivables from securities financing transactions measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | (577) | (474) |
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Line Items] | ||
Financial assets | $ (66) | $ (63) |
Expected credit loss measure_13
Expected credit loss measurement - Off balance sheet positions subject to expected credit loss by rating category (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | $ 139,206 | $ 114,337 |
Total ECL provisions | (188) | (201) |
Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 87,601 | 65,964 |
Total ECL provisions | (134) | (159) |
Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 33,211 | 22,167 |
Total ECL provisions | (40) | (48) |
Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 44,018 | 39,996 |
Total ECL provisions | (95) | (111) |
Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,373 | 3,801 |
Total ECL provisions | 0 | 0 |
Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 51,604 | 48,373 |
Total ECL provisions | (53) | (42) |
Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 47,421 | 43,677 |
Total ECL provisions | (49) | (40) |
Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,183 | 4,696 |
Total ECL provisions | (4) | (2) |
0-1 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 29,643 | 11,803 |
0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17,771 | 7,252 |
0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,720 | 1,770 |
0-1 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,152 | 2,781 |
0-1 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,609 | 2,295 |
0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,604 | 2,288 |
0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4 | 7 |
2-3 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 21,228 | 20,874 |
2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,306 | 5,961 |
2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,920 | 14,912 |
2-3 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2 | 2 |
2-3 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 19,105 | 18,421 |
2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17,303 | 16,483 |
2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,803 | 1,939 |
4-5 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 14,186 | 11,769 |
4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,268 | 4,772 |
4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 9,834 | 6,986 |
4-5 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 84 | 11 |
4-5 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11,939 | 10,736 |
4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,893 | 9,247 |
4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,045 | 1,489 |
6-8 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 14,077 | 14,153 |
6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,800 | 3,049 |
6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11,142 | 10,097 |
6-8 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 135 | 1,007 |
6-8 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 12,776 | 12,753 |
6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11,950 | 11,885 |
6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 826 | 868 |
9-13 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,293 | 7,132 |
9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 948 | 1,025 |
9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,345 | 6,107 |
9-13 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
9-13 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,117 | 4,131 |
9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,616 | 3,739 |
9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 501 | 392 |
Credit-impaired (defaulted) | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 174 | 233 |
Credit-impaired (defaulted) | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 118 | 108 |
Credit-impaired (defaulted) | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 124 |
Credit-impaired (defaulted) | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Credit-impaired (defaulted) | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 59 | 37 |
Credit-impaired (defaulted) | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 36 |
Credit-impaired (defaulted) | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4 | 2 |
Twelve-month expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 134,410 | 107,545 |
Total ECL provisions | (111) | (106) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 32,332 | 19,805 |
Total ECL provisions | (14) | (13) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 42,085 | 37,531 |
Total ECL provisions | (55) | (59) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,373 | 3,801 |
Total ECL provisions | 0 | 0 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 45,452 | 41,809 |
Total ECL provisions | (39) | (32) |
Twelve-month expected credit losses | Stage 1 and 2 positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,169 | 4,600 |
Total ECL provisions | (3) | (2) |
Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17,771 | 7,252 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,720 | 1,770 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,604 | 2,288 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4 | 7 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,267 | 5,917 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,920 | 14,789 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 16,903 | 15,777 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,803 | 1,938 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,219 | 3,812 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 9,781 | 6,818 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,553 | 8,960 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,045 | 1,411 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,301 | 2,229 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,845 | 9,625 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11,452 | 11,355 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 824 | 864 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 774 | 596 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,818 | 4,529 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,941 | 3,429 |
Twelve-month expected credit losses | Stage 1 and 2 positions | 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 493 | 380 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,562 | 6,522 |
Total ECL provisions | (56) | (69) |
Lifetime expected credit losses | Stage 1 and 2 positions | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 761 | 2,254 |
Total ECL provisions | (7) | (9) |
Lifetime expected credit losses | Stage 1 and 2 positions | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,878 | 2,341 |
Total ECL provisions | (38) | (52) |
Lifetime expected credit losses | Stage 1 and 2 positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Total ECL provisions | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,913 | 1,833 |
Total ECL provisions | (10) | (8) |
Lifetime expected credit losses | Stage 1 and 2 positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11 | 94 |
Total ECL provisions | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 39 | 44 |
Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 123 |
Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 400 | 705 |
Lifetime expected credit losses | Stage 1 and 2 positions | 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 1 |
Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 49 | 960 |
Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 53 | 168 |
Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 341 | 287 |
Lifetime expected credit losses | Stage 1 and 2 positions | 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 78 |
Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 499 | 821 |
Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 298 | 472 |
Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 497 | 531 |
Lifetime expected credit losses | Stage 1 and 2 positions | 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2 | 4 |
Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 174 | 429 |
Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,527 | 1,578 |
Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 675 | 310 |
Lifetime expected credit losses | Stage 1 and 2 positions | 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 9 | 11 |
Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 1 and 2 positions | Credit-impaired (defaulted) | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 234 | 270 |
Total ECL provisions | (21) | (26) |
Lifetime expected credit losses | Stage 3 positions | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 118 | 108 |
Total ECL provisions | (19) | (26) |
Lifetime expected credit losses | Stage 3 positions | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 124 |
Total ECL provisions | (2) | 0 |
Lifetime expected credit losses | Stage 3 positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Total ECL provisions | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 36 |
Total ECL provisions | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4 | 2 |
Total ECL provisions | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 118 | 108 |
Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 124 |
Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 56 | 36 |
Lifetime expected credit losses | Stage 3 positions | Credit-impaired (defaulted) | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Line Items] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | $ 4 | $ 2 |
Expected credit loss measure_14
Expected credit loss measurement - Sensitivity analysis (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
Weighted average | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (580) | $ (526) | |
ECL with adjusted probabilities of scenario weights in percent of baseline | 146% | 160% | |
Baseline | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (396) | $ (329) | |
Lifetime weighted average | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (1,193) | $ (1,267) | |
Stage 1 and 2 positions | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ 580 |
Expected credit loss measure_15
Expected credit loss measurement - Potential effect on stage 1 and stage 2 positions from changing key parameters (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
100% Baseline | Fixed income: Government bonds (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | $ (3,000) |
100% Baseline | Fixed income: Government bonds (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 3,000 |
100% Baseline | Fixed income: Government bonds (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 7,000 |
100% Baseline | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (4,000) |
100% Baseline | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (2,000) |
100% Baseline | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 2,000 |
100% Baseline | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 5,000 |
100% Baseline | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 10,000 |
100% Baseline | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 6,000 |
100% Baseline | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (3,000) |
100% Baseline | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (5,000) |
100% Baseline | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 16,000 |
100% Baseline | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 8,000 |
100% Baseline | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (7,000) |
100% Baseline | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (11,000) |
100% Baseline | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 4,000 |
100% Baseline | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 2,000 |
100% Baseline | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (2,000) |
100% Baseline | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (3,000) |
100% Stagflationary geopolitical crisis | Fixed income: Government bonds (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (104,000) |
100% Stagflationary geopolitical crisis | Fixed income: Government bonds (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 125,000 |
100% Stagflationary geopolitical crisis | Fixed income: Government bonds (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 274,000 |
100% Stagflationary geopolitical crisis | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (142,000) |
100% Stagflationary geopolitical crisis | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (76,000) |
100% Stagflationary geopolitical crisis | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 89,000 |
100% Stagflationary geopolitical crisis | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 188,000 |
100% Stagflationary geopolitical crisis | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 27,000 |
100% Stagflationary geopolitical crisis | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 13,000 |
100% Stagflationary geopolitical crisis | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (12,000) |
100% Stagflationary geopolitical crisis | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (22,000) |
100% Stagflationary geopolitical crisis | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 174,000 |
100% Stagflationary geopolitical crisis | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 84,000 |
100% Stagflationary geopolitical crisis | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (76,000) |
100% Stagflationary geopolitical crisis | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (149,000) |
100% Stagflationary geopolitical crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 10,000 |
100% Stagflationary geopolitical crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 5,000 |
100% Stagflationary geopolitical crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (5,000) |
100% Stagflationary geopolitical crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (8,000) |
100% Mild debt crisis | Fixed income: Government bonds (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (3,000) |
100% Mild debt crisis | Fixed income: Government bonds (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 6,000 |
100% Mild debt crisis | Fixed income: Government bonds (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 14,000 |
100% Mild debt crisis | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (6,000) |
100% Mild debt crisis | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (3,000) |
100% Mild debt crisis | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 3,000 |
100% Mild debt crisis | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 7,000 |
100% Mild debt crisis | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 11,000 |
100% Mild debt crisis | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 6,000 |
100% Mild debt crisis | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (6,000) |
100% Mild debt crisis | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (7,000) |
100% Mild debt crisis | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 25,000 |
100% Mild debt crisis | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 12,000 |
100% Mild debt crisis | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (9,000) |
100% Mild debt crisis | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (19,000) |
100% Mild debt crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 8,000 |
100% Mild debt crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 3,000 |
100% Mild debt crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (3,000) |
100% Mild debt crisis | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (5,000) |
Weighted average | Fixed income: Government bonds (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (14,000) |
Weighted average | Fixed income: Government bonds (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 17,000 |
Weighted average | Fixed income: Government bonds (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 42,000 |
Weighted average | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (20,000) |
Weighted average | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (11,000) |
Weighted average | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 13,000 |
Weighted average | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 26,000 |
Weighted average | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 14,000 |
Weighted average | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 8,000 |
Weighted average | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (6,000) |
Weighted average | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (10,000) |
Weighted average | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 46,000 |
Weighted average | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 21,000 |
Weighted average | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (18,000) |
Weighted average | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (34,000) |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 6,000 |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | 2,000 |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | (2,000) |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items] | |
Economic forecast financial effect | $ (4,000) |
Expected credit loss measure_16
Expected credit loss measurement - Potential effect on stage 1 and stage 2 positions from changing scenario weights or moving to an ECL lifetime calculation (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (1,244) | $ (1,091) | $ (1,165) |
Weighted average | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (580) | $ (526) | |
ECL with adjusted probabilities of scenario weights in percent of baseline | 146% | 160% | |
Weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (133) | $ (136) | |
Weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (52) | (43) | |
Weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (152) | (136) | |
Weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (103) | (86) | |
Weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (140) | (125) | |
100% Baseline | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (396) | (329) | |
100% Baseline | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (43) | (25) | |
100% Baseline | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (34) | (26) | |
100% Baseline | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (108) | (97) | |
100% Baseline | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (85) | (67) | |
100% Baseline | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (126) | (114) | |
100% Asset price inflation | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (219) | (295) | |
100% Asset price inflation | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (10) | (13) | |
100% Asset price inflation | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (21) | (22) | |
100% Asset price inflation | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (53) | (84) | |
100% Asset price inflation | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (57) | (66) | |
100% Asset price inflation | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (78) | (111) | |
100% Stagflationary geopolitical crisis | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (1,322) | (1,204) | |
100% Stagflationary geopolitical crisis | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (521) | (523) | |
100% Stagflationary geopolitical crisis | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (200) | (176) | |
100% Stagflationary geopolitical crisis | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (252) | (199) | |
100% Stagflationary geopolitical crisis | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (186) | (162) | |
100% Stagflationary geopolitical crisis | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (162) | (145) | |
100% Mild debt crisis | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (492) | ||
100% Mild debt crisis | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (63) | ||
100% Mild debt crisis | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (36) | ||
100% Mild debt crisis | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (146) | ||
100% Mild debt crisis | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (96) | ||
100% Mild debt crisis | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (151) | ||
100% Global crisis | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (638) | ||
100% Global crisis | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (184) | ||
100% Global crisis | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (30) | ||
100% Global crisis | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (174) | ||
100% Global crisis | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (97) | ||
100% Global crisis | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (153) | ||
Lifetime weighted average | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (1,193) | (1,267) | |
Lifetime weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (368) | (473) | |
Lifetime weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (125) | (126) | |
Lifetime weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (234) | (235) | |
Lifetime weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | (164) | (153) | |
Lifetime weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Line Items] | |||
Total ECL allowances and provisions | $ (302) | $ (281) |
Fair value measurement (Narrati
Fair value measurement (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Fair Value Measurement [Line Items] | |||
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax | $ (861) | $ 867 | $ 46 |
FVM - Fair value hierarchy - As
FVM - Fair value hierarchy - Assets (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | $ 135,098 | $ 108,034 |
Derivative financial instruments | 131,728 | 150,109 |
Brokerage receivables | 20,883 | 17,576 |
Financial assets at fair value not held for trading | 63,754 | 59,408 |
Financial assets measured at fair value through other comprehensive income | 2,233 | 2,239 |
Non-financial assets - Precious metals and other physical commodities | 4,426 | 4,471 |
Other non-financial assets measured at fair value | 17 | 21 |
Total assets measured at fair value | 358,139 | 341,858 |
Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 100,372 | 84,010 |
Financial assets at fair value not held for trading | 1,112 | 849 |
Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 9,052 | 6,464 |
Financial assets at fair value not held for trading | 16,594 | 16,741 |
Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 9,098 | 7,330 |
Financial assets at fair value not held for trading | 804 | 675 |
Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 13,586 | 8,026 |
Financial assets at fair value not held for trading | 16,994 | 14,366 |
Financial assets measured at fair value through other comprehensive income | 276 | 335 |
Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 2,775 | 1,807 |
Financial assets at fair value not held for trading | 5,426 | 4,337 |
Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 215 | 397 |
Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 65,387 | 85,459 |
Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 35,311 | 39,805 |
Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 27,317 | 22,195 |
Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 1,752 | 1,038 |
Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 1,639 | 1,365 |
Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 1,208 | 1,326 |
Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 5,545 | 7,704 |
Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 15,814 | 13,072 |
Commercial paper and certificates of deposit | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets measured at fair value through other comprehensive income | 1,948 | 1,878 |
Level 1 | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 115,345 | 96,263 |
Derivative financial instruments | 593 | 769 |
Brokerage receivables | 0 | 0 |
Financial assets at fair value not held for trading | 29,529 | 26,572 |
Financial assets measured at fair value through other comprehensive income | 68 | 57 |
Non-financial assets - Precious metals and other physical commodities | 4,426 | 4,471 |
Other non-financial assets measured at fair value | 0 | 0 |
Total assets measured at fair value | 149,962 | 128,132 |
Level 1 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 99,510 | 83,095 |
Financial assets at fair value not held for trading | 24 | 57 |
Level 1 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 6,843 | 5,496 |
Financial assets at fair value not held for trading | 13,262 | 13,103 |
Level 1 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 8,008 | 6,673 |
Financial assets at fair value not held for trading | 367 | 307 |
Level 1 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 982 | 976 |
Financial assets at fair value not held for trading | 62 | 35 |
Financial assets measured at fair value through other comprehensive income | 68 | 57 |
Level 1 | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 0 | 0 |
Financial assets at fair value not held for trading | 0 | 0 |
Level 1 | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 3 | 22 |
Level 1 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 317 | 575 |
Level 1 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 0 | 1 |
Level 1 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 0 | 0 |
Level 1 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 0 | 0 |
Level 1 | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 15,814 | 13,071 |
Level 1 | Commercial paper and certificates of deposit | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets measured at fair value through other comprehensive income | 0 | 0 |
Level 2 | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 17,936 | 10,284 |
Derivative financial instruments | 129,871 | 147,876 |
Brokerage receivables | 20,883 | 17,576 |
Financial assets at fair value not held for trading | 30,124 | 29,110 |
Financial assets measured at fair value through other comprehensive income | 2,165 | 2,182 |
Non-financial assets - Precious metals and other physical commodities | 0 | 0 |
Other non-financial assets measured at fair value | 0 | 0 |
Total assets measured at fair value | 200,979 | 207,028 |
Level 2 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 721 | 789 |
Financial assets at fair value not held for trading | 0 | 0 |
Level 2 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 2,195 | 950 |
Financial assets at fair value not held for trading | 3,332 | 3,638 |
Level 2 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 1,082 | 596 |
Financial assets at fair value not held for trading | 233 | 178 |
Level 2 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 11,956 | 6,509 |
Financial assets at fair value not held for trading | 16,716 | 14,101 |
Financial assets measured at fair value through other comprehensive income | 207 | 278 |
Level 2 | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 1,870 | 1,179 |
Financial assets at fair value not held for trading | 4,172 | 3,602 |
Level 2 | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 111 | 261 |
Level 2 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 65,070 | 84,882 |
Level 2 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 35,028 | 39,345 |
Level 2 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 26,649 | 21,542 |
Level 2 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 1,452 | 719 |
Level 2 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 1,627 | 1,334 |
Level 2 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 0 | 0 |
Level 2 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 5,541 | 7,590 |
Level 2 | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 0 | 1 |
Level 2 | Commercial paper and certificates of deposit | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets measured at fair value through other comprehensive income | 1,948 | 1,878 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 1,817 | 1,488 |
Derivative financial instruments | 1,264 | 1,464 |
Brokerage receivables | 0 | 0 |
Financial assets at fair value not held for trading | 4,101 | 3,725 |
Financial assets measured at fair value through other comprehensive income | 0 | 0 |
Non-financial assets - Precious metals and other physical commodities | 0 | 0 |
Other non-financial assets measured at fair value | 17 | 21 |
Total assets measured at fair value | 7,198 | 6,698 |
Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 140 | 126 |
Financial assets at fair value not held for trading | 1,088 | 792 |
Level 3 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 14 | 18 |
Financial assets at fair value not held for trading | 0 | 0 |
Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 9 | 61 |
Financial assets at fair value not held for trading | 205 | 190 |
Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 648 | 541 |
Financial assets at fair value not held for trading | 215 | 230 |
Financial assets measured at fair value through other comprehensive income | 0 | 0 |
Level 3 | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 904 | 628 |
Financial assets at fair value not held for trading | 1,254 | 736 |
Level 3 | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value held for trading | 101 | 114 |
Level 3 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 0 | 2 |
Level 3 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 284 | 460 |
Level 3 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 667 | 653 |
Level 3 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 301 | 318 |
Level 3 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Derivative financial instruments | 12 | 30 |
Level 3 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 1,208 | 1,326 |
Level 3 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 4 | 114 |
Level 3 | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets at fair value not held for trading | 0 | 0 |
Level 3 | Commercial paper and certificates of deposit | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Financial assets measured at fair value through other comprehensive income | $ 0 | $ 0 |
FVM - Fair value hierarchy - Li
FVM - Fair value hierarchy - Liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | $ 31,712 | $ 29,515 |
Derivative financial instruments | 140,707 | 154,906 |
Brokerage payables designated at fair value | 42,275 | 45,085 |
Debt issued designated at fair value | 86,341 | 71,842 |
Other financial liabilities designated at fair value | 27,366 | 32,033 |
Total financial liabilities measured at fair value through profit or loss | 328,401 | 333,382 |
Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 16,632 | 16,951 |
Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 4,979 | 4,707 |
Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 9,126 | 6,587 |
Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 915 | 1,229 |
Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 71,743 | 88,508 |
Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 32,763 | 37,545 |
Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 32,926 | 26,148 |
Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 1,614 | 1,199 |
Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 1,291 | 1,361 |
Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 15,922 | 13,221 |
Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 6,927 | 15,333 |
Funding from UBS Group AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 2,950 | 1,796 |
Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 1,566 | 1,684 |
Level 1 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 25,451 | 23,578 |
Derivative financial instruments | 716 | 640 |
Brokerage payables designated at fair value | 0 | 0 |
Debt issued designated at fair value | 0 | 0 |
Other financial liabilities designated at fair value | 0 | 0 |
Total financial liabilities measured at fair value through profit or loss | 26,167 | 24,219 |
Level 1 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 16,310 | 16,521 |
Level 1 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 28 | 36 |
Level 1 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 8,320 | 5,880 |
Level 1 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 794 | 1,141 |
Level 1 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 400 | 587 |
Level 1 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 0 | 0 |
Level 1 | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 1 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 1 | Funding from UBS Group AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 1 | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 2 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 6,110 | 5,823 |
Derivative financial instruments | 136,833 | 152,582 |
Brokerage payables designated at fair value | 42,275 | 45,085 |
Debt issued designated at fair value | 78,509 | 62,603 |
Other financial liabilities designated at fair value | 25,069 | 30,055 |
Total financial liabilities measured at fair value through profit or loss | 288,796 | 296,148 |
Level 2 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 236 | 352 |
Level 2 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 4,893 | 4,643 |
Level 2 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 806 | 706 |
Level 2 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 117 | 84 |
Level 2 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 71,322 | 87,897 |
Level 2 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 32,656 | 37,429 |
Level 2 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 30,209 | 24,963 |
Level 2 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 1,341 | 920 |
Level 2 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 1,271 | 1,309 |
Level 2 | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 15,922 | 13,221 |
Level 2 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 6,927 | 15,333 |
Level 2 | Funding from UBS Group AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 1,327 | 508 |
Level 2 | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 892 | 993 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 151 | 114 |
Derivative financial instruments | 3,158 | 1,684 |
Brokerage payables designated at fair value | 0 | 0 |
Debt issued designated at fair value | 7,832 | 9,240 |
Other financial liabilities designated at fair value | 2,297 | 1,978 |
Total financial liabilities measured at fair value through profit or loss | 13,438 | 13,015 |
Effect of change in methodology of testing for observability on liabilities measured at fair value, if applied retrospectively | (1,300) | |
Change in methodology of testing for observability on liabilities measured at fair value, balance affected | 1,900 | |
Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 87 | 78 |
Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 58 | 27 |
Level 3 | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 0 | 1 |
Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Financial liabilities at fair value held for trading | 4 | 3 |
Level 3 | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 21 | 24 |
Level 3 | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 107 | 116 |
Level 3 | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 2,717 | 1,184 |
Level 3 | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 273 | 279 |
Level 3 | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Derivative financial instruments | 20 | 52 |
Level 3 | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 3 | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 0 | 0 |
Level 3 | Funding from UBS Group AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | 1,623 | 1,287 |
Level 3 | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Other financial liabilities designated at fair value | $ 674 | $ 691 |
FVM - Valuation adjustment rese
FVM - Valuation adjustment reserves on the balance sheet (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Valuation Adjustment Reserves On The Balance Sheet [Line Items] | ||||
Deferred day-1 profit or loss reserves | $ 397 | $ 422 | $ 418 | $ 269 |
Own credit adjustments on financial liabilities designated at fair value | $ (312) | $ 556 | $ (315) |
FVM - Valuation adjustments_ De
FVM - Valuation adjustments: Deferred day-1 P&L (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Deferred Day-1 Profit Or Loss [Line Items] | |||
Reserve balance at the beginning of the period | $ 422 | $ 418 | $ 269 |
Profit / (loss) deferred on new transactions | 250 | 299 | 459 |
(Profit) / loss recognized in the income statement | (275) | (295) | (308) |
Foreign currency translation | 0 | 0 | (2) |
Reserve balance at the end of the period | $ 397 | $ 422 | $ 418 |
FVM - Valuation adjustments_ Ow
FVM - Valuation adjustments: Own credit adjustments on financial liabilities designated at fair value (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Recognized during the period: | |||
Realized gain / (loss) | $ 8 | $ 1 | $ (14) |
Unrealized gain / (loss) | (869) | 866 | 60 |
Total gain / (loss), before tax | (861) | 867 | 46 |
Recognized on the balance sheet as of the end of the period: | |||
Unrealized life-to-date gain / (loss) | (312) | 556 | (315) |
of which: debt issued designated at fair value | (208) | 289 | (144) |
of which: other financial liabilities designated at fair value | $ (105) | $ 266 | $ (172) |
FVM - Valuation adjustments_ Va
FVM - Valuation adjustments: Valuation adjustments on financial instruments (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Valuation Adjustments On Financial Instruments [Line Items] | ||
Credit valuation adjustments | $ (37) | $ (33) |
Funding and debit valuation adjustments | (82) | (46) |
Other valuation adjustments | (730) | (839) |
of which: liquidity | (308) | (311) |
of which: model uncertainty | $ (423) | $ (529) |
FVM - Level 3 instruments_ Valu
FVM - Level 3 instruments: Valuation techniques and inputs (Detail) - Level 3 $ in Billions | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 0.9 | $ 0.8 |
Financial liabilities measured at fair value | $ 0.1 | $ 0 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.09 | 0.14 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 1.14 | 1.12 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | Weighted average | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.93 | 0.85 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0491 | 0.0412 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0491 | 0.0412 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 2.3 | $ 1.7 |
Financial liabilities measured at fair value | $ 0 | $ 0 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.06 | 0.30 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 1.01 | 1 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | Weighted average | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.98 | 0.97 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0200 | 0.0200 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0275 | 0.0200 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0252 | 0.0200 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0162 | 0.0145 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.1849 | 0.1350 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | Weighted average | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0318 | 0.0322 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 1.2 | $ 1.3 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0135 | 0.0115 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0205 | 0.0196 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0150 | 0.0144 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Investment fund units | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 0.2 | $ 0.3 |
Financial liabilities measured at fair value | 0 | 0 |
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Equity instruments | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | 1.2 | 0.9 |
Financial liabilities measured at fair value | 0.1 | 0.1 |
Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial liabilities measured at fair value | 7.8 | 9.2 |
Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial liabilities measured at fair value | $ 2.3 | $ 2 |
Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0051 | 0.0023 |
Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0201 | 0.0175 |
Derivative financial instruments: Interest rate contracts | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 0.3 | $ 0.5 |
Financial liabilities measured at fair value | $ 0.1 | $ 0.1 |
Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0084 | 0.0075 |
Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0112 | 0.0143 |
Derivative financial instruments: Credit derivative contracts | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 0.3 | $ 0.3 |
Financial liabilities measured at fair value | $ 0.3 | $ 0.3 |
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.02 | 0.03 |
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 2.42 | 2.77 |
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0001 | 0.0009 |
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.0306 | 0.0565 |
Derivative financial instruments: Equity / index contracts | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Financial assets measured at fair value | $ 0.7 | $ 0.7 |
Financial liabilities measured at fair value | $ 2.7 | $ 1.2 |
Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0 | 0 |
Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.14 | 0.20 |
Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.04 | 0.04 |
Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 1.04 | 1.20 |
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | (0.40) | (0.29) |
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.70 | 0.84 |
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | low | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 0.13 | (0.25) |
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | high | ||
Disclosure Of Fair Value Measurement [Line Items] | ||
Significant unobservable input(s) | 1 | 1 |
FVM - Level 3 instruments_ Sens
FVM - Level 3 instruments: Sensitivity to changes in unobservable input assumptions (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | $ 781 | $ 738 |
Unfavorable changes | (648) | (696) |
Traded loans, loans designated at fair value, loan commitments and guarantees | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 22 | 19 |
Unfavorable changes | (29) | (12) |
Securities financing transactions | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 24 | 33 |
Unfavorable changes | (24) | (37) |
Auction rate securities | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 67 | 46 |
Unfavorable changes | (21) | (46) |
Asset-backed securities | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 25 | 27 |
Unfavorable changes | (22) | (27) |
Equity instruments | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 189 | 183 |
Unfavorable changes | (178) | (161) |
Interest rate derivative contracts, net | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 27 | 18 |
Unfavorable changes | (18) | (12) |
Credit derivative contracts, net | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 2 | 3 |
Unfavorable changes | (5) | (4) |
Foreign exchange derivative contracts, net | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 5 | 10 |
Unfavorable changes | (4) | (5) |
Equity / index derivative contracts, net | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 358 | 361 |
Unfavorable changes | (285) | (330) |
Other | ||
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items] | ||
Favorable changes | 62 | 39 |
Unfavorable changes | $ (62) | $ (62) |
FVM - Movements of level 3 inst
FVM - Movements of level 3 instruments - Assets (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | $ 341,858 | |
Balance at the end of period | 358,139 | $ 341,858 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 6,698 | |
Balance at the end of period | 7,198 | 6,698 |
Level 3 | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 1,500 | 2,300 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | (300) |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | (300) |
Purchases | 400 | 300 |
Sales | (800) | (1,800) |
Issuances | 800 | 500 |
Settlements | 0 | 0 |
Transfers into Level 3 | 200 | 700 |
Transfers out of Level 3 | (300) | (300) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,800 | 1,500 |
Level 3 | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 100 | 0 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | |
Purchases | 0 | |
Sales | 0 | |
Issuances | 0 | |
Settlements | 0 | |
Transfers into Level 3 | 100 | |
Transfers out of Level 3 | 0 | |
Foreign currency translation | 0 | |
Balance at the end of period | 100 | |
Level 3 | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 500 | 600 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 400 | 300 |
Sales | (300) | (600) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 400 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 600 | 500 |
Level 3 | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 600 | 1,400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | (100) |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | (100) |
Purchases | 100 | 0 |
Sales | (400) | (1,100) |
Issuances | 800 | 500 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (200) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 900 | 600 |
Level 3 | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 100 | |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | |
Purchases | 0 | |
Sales | (100) | |
Issuances | 0 | |
Settlements | 0 | |
Transfers into Level 3 | 200 | |
Transfers out of Level 3 | 0 | |
Foreign currency translation | 0 | |
Balance at the end of period | 100 | 100 |
Level 3 | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 3,700 | 4,200 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 200 | 100 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 200 | 100 |
Purchases | 800 | 700 |
Sales | (700) | (1,200) |
Issuances | 0 | 100 |
Settlements | 0 | 0 |
Transfers into Level 3 | 100 | 200 |
Transfers out of Level 3 | (100) | (300) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 4,100 | 3,700 |
Level 3 | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 700 | 900 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 300 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 300 | 0 |
Purchases | 300 | 400 |
Sales | 0 | (400) |
Issuances | 0 | 100 |
Settlements | 0 | 0 |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (100) | (300) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,300 | 700 |
Level 3 | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 1,300 | 1,600 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 100 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | (100) | (300) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,200 | 1,300 |
Level 3 | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 800 | 700 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 400 | 100 |
Sales | (200) | (100) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,100 | 800 |
Level 3 | Derivatives [Member] | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 1,500 | 1,100 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (300) | 600 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (300) | 300 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 700 | 400 |
Settlements | (500) | (700) |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,300 | 1,500 |
Level 3 | Derivatives [Member] | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 500 | 500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 300 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 300 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 100 | 0 |
Settlements | (200) | (200) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (100) | (100) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 500 |
Level 3 | Derivatives [Member] | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 700 | 400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (200) | 200 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (200) | 100 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 600 | 400 |
Settlements | (100) | (300) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (200) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 700 | 700 |
Level 3 | Derivatives [Member] | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Line Items] | ||
Balance at the beginning of the period | 300 | 200 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | 100 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | (100) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 100 | 0 |
Settlements | (100) | (200) |
Transfers into Level 3 | 100 | 0 |
Transfers out of Level 3 | 0 | 100 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | $ 300 | $ 300 |
FVM - Movements of level 3 in_2
FVM - Movements of level 3 instruments - Liabilities (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | $ 333,382 | |
Balance at the end of period | 328,401 | $ 333,382 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 13,015 | |
Balance at the end of period | 13,438 | 13,015 |
Level 3 | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 1,700 | 2,200 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 300 | (800) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 300 | (400) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 1,900 | 1,100 |
Settlements | (600) | (900) |
Transfers into Level 3 | 0 | 300 |
Transfers out of Level 3 | (200) | (200) |
Foreign currency translation | 0 | (100) |
Balance at the end of period | 3,200 | 1,700 |
Level 3 | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 100 | 300 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 0 | (300) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 100 |
Settlements | (100) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 100 | 100 |
Level 3 | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 1,200 | 1,500 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 300 | (400) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 300 | (300) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 1,800 | 800 |
Settlements | (400) | (700) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (200) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 2,700 | 1,200 |
Level 3 | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 300 | 300 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 0 | (100) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 100 | 100 |
Settlements | 0 | (100) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (100) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 300 |
Level 3 | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 9,200 | 11,900 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 400 | (1,300) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 300 | (900) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 3,500 | 4,700 |
Settlements | (3,200) | (3,100) |
Transfers into Level 3 | 500 | 700 |
Transfers out of Level 3 | (2,600) | (3,300) |
Foreign currency translation | 0 | (300) |
Balance at the end of period | 7,800 | 9,200 |
Level 3 | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Line Items] | ||
Balance at the beginning of the period | 2,000 | 3,200 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 300 | (1,000) |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 400 | (1,000) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 200 | 0 |
Settlements | (200) | (100) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | 0 | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | $ 2,300 | $ 2,000 |
Maximum exposure to credit risk
Maximum exposure to credit risk - assets at fair value (Detail) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Credit enhancements | ||
Notional amounts of derivatives | $ 65.2 | $ 34.4 |
Total financial assets measured at fair value | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 224.3 | 229.2 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by equity and debt instruments | 35.8 | 34.6 |
Secured by real estate | 0 | 0 |
Other collateral | 0 | 0 |
Credit enhancements | ||
Netting | 117.6 | 133.5 |
Credit derivative contracts | 0 | 0 |
Guarantees and sub-participations | 0 | 0 |
Exposure to credit risk after collateral and credit enhancements | 70.9 | 61.2 |
Financial assets at fair value held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 25.6 | 16.7 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 25.6 | 16.7 |
Derivatives [Member] | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 131.7 | 150.1 |
Collateral | ||
Collateralized by equity and debt instruments | 5.1 | 5.9 |
Credit enhancements | ||
Netting | 117.6 | 133.5 |
Exposure to credit risk after collateral and credit enhancements | 9.1 | 10.7 |
Brokerage receivables | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 20.9 | 17.6 |
Collateral | ||
Collateralized by equity and debt instruments | 20.5 | 17.3 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0.4 | 0.3 |
Financial assets at fair value not held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 46 | 44.8 |
Collateral | ||
Collateralized by equity and debt instruments | 10.2 | 11.4 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 35.8 | 33.4 |
Guarantees | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Line Items] | ||
Maximum Exposure To Credit Risk | 0.1 | 0.2 |
Credit enhancements | ||
Guarantees and sub-participations | 0.1 | 0.2 |
Exposure to credit risk after collateral and credit enhancements | $ 0 | $ 0 |
FVM - Financial instruments not
FVM - Financial instruments not measured at fair value - Assets (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Carrying amount | ||
Cash and balances at central banks | $ 171,806 | $ 169,445 |
Loans and advances to banks | 28,206 | 14,671 |
Receivables from securities financing transactions measured at amortized cost | 74,128 | 67,814 |
Cash collateral receivables on derivative instruments | 32,300 | 35,033 |
Loans and advances to customers | 405,633 | 390,027 |
Other financial assets measured at amortized cost | 54,334 | 53,389 |
Not measured at fair value | ||
Carrying amount | ||
Cash and balances at central banks | 171,800 | 169,400 |
Loans and advances to banks | 28,200 | 14,600 |
Receivables from securities financing transactions measured at amortized cost | 74,100 | 67,800 |
Cash collateral receivables on derivative instruments | 32,300 | 35,000 |
Loans and advances to customers | 396,500 | 377,700 |
Other financial assets measured at amortized cost | 54,100 | 51,000 |
Not measured at fair value | Carrying amount approximates fair value | ||
Carrying amount | ||
Cash and balances at central banks | 171,700 | 169,400 |
Loans and advances to banks | 12,500 | 13,900 |
Receivables from securities financing transactions measured at amortized cost | 68,700 | 64,300 |
Cash collateral receivables on derivative instruments | 32,300 | 35,000 |
Loans and advances to customers | 131,800 | 136,900 |
Other financial assets measured at amortized cost | 9,000 | 13,000 |
Not measured at fair value | Level 1 | ||
Carrying amount | ||
Cash and balances at central banks | 0 | 100 |
Loans and advances to banks | 0 | 0 |
Receivables from securities financing transactions measured at amortized cost | 0 | 0 |
Cash collateral receivables on derivative instruments | 0 | 0 |
Loans and advances to customers | 0 | 0 |
Other financial assets measured at amortized cost | 12,800 | 10,300 |
Not measured at fair value | Level 2 | ||
Carrying amount | ||
Cash and balances at central banks | 100 | 0 |
Loans and advances to banks | 15,400 | 700 |
Receivables from securities financing transactions measured at amortized cost | 3,900 | 1,800 |
Cash collateral receivables on derivative instruments | 0 | 0 |
Loans and advances to customers | 44,300 | 45,900 |
Other financial assets measured at amortized cost | 29,600 | 25,100 |
Not measured at fair value | Level 3 | ||
Carrying amount | ||
Cash and balances at central banks | 0 | 0 |
Loans and advances to banks | 200 | 0 |
Receivables from securities financing transactions measured at amortized cost | 1,500 | 1,700 |
Cash collateral receivables on derivative instruments | 0 | 0 |
Loans and advances to customers | 220,400 | 195,000 |
Other financial assets measured at amortized cost | $ 2,600 | $ 2,500 |
FVM - Financial instruments n_2
FVM - Financial instruments not measured at fair value - Liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Carrying amount | ||
Amounts due to banks | $ 16,720 | $ 11,596 |
Payables from securities financing transactions measured at amortized cost | 5,782 | 4,202 |
Cash collateral payables on derivative instruments | 34,886 | 36,436 |
Customer deposits | 555,673 | 527,171 |
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 |
Debt issued measured at amortized cost | 69,784 | 59,499 |
Other financial liabilities measured at amortized cost | 9,800 | 7,200 |
Not measured at fair value | ||
Carrying amount | ||
Amounts due to banks | 16,700 | 11,600 |
Payables from securities financing transactions measured at amortized cost | 5,800 | 4,200 |
Cash collateral payables on derivative instruments | 34,900 | 36,400 |
Customer deposits | 556,600 | 526,900 |
Funding from UBS Group AG measured at amortized cost | 67,700 | 55,700 |
Debt issued measured at amortized cost | 69,800 | 58,900 |
Other financial liabilities measured at amortized cost | 9,800 | 7,200 |
Not measured at fair value | Carrying amount approximates fair value | ||
Carrying amount | ||
Amounts due to banks | 8,800 | 8,900 |
Payables from securities financing transactions measured at amortized cost | 5,100 | 3,500 |
Cash collateral payables on derivative instruments | 34,900 | 36,400 |
Customer deposits | 482,100 | 493,000 |
Funding from UBS Group AG measured at amortized cost | 3,300 | 2,000 |
Debt issued measured at amortized cost | 18,100 | 13,400 |
Other financial liabilities measured at amortized cost | 9,800 | 7,200 |
Not measured at fair value | Level 1 | ||
Carrying amount | ||
Amounts due to banks | 0 | 0 |
Payables from securities financing transactions measured at amortized cost | 0 | 0 |
Cash collateral payables on derivative instruments | 0 | 0 |
Customer deposits | 0 | 0 |
Funding from UBS Group AG measured at amortized cost | 0 | 0 |
Debt issued measured at amortized cost | 0 | 0 |
Other financial liabilities measured at amortized cost | 0 | 0 |
Not measured at fair value | Level 2 | ||
Carrying amount | ||
Amounts due to banks | 8,000 | 2,700 |
Payables from securities financing transactions measured at amortized cost | 400 | 700 |
Cash collateral payables on derivative instruments | 0 | 0 |
Customer deposits | 74,500 | 33,900 |
Funding from UBS Group AG measured at amortized cost | 64,400 | 53,700 |
Debt issued measured at amortized cost | 51,700 | 45,500 |
Other financial liabilities measured at amortized cost | 0 | 0 |
Not measured at fair value | Level 3 | ||
Carrying amount | ||
Amounts due to banks | 0 | 0 |
Payables from securities financing transactions measured at amortized cost | 400 | 0 |
Cash collateral payables on derivative instruments | 0 | 0 |
Customer deposits | 0 | 0 |
Funding from UBS Group AG measured at amortized cost | 0 | 0 |
Debt issued measured at amortized cost | 0 | 0 |
Other financial liabilities measured at amortized cost | $ 0 | $ 0 |
Offsetting financial assets (De
Offsetting financial assets (Detail) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Netting recognized on the balance sheet | ||
Gross assets before netting | $ 325.7 | $ 327.2 |
Netting with gross liabilities | (104.3) | (90.4) |
Net assets recognized on the balance sheet | 221.4 | 236.8 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (122.9) | (136.3) |
Collateral received | (85.9) | (84.1) |
Assets after consideration of netting potential | 12.6 | 16.4 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 80.5 | 75.6 |
Total assets | ||
Total assets, after consideration of further netting potential | 93.1 | 92 |
Total assets recognized on the balance sheet | 301.9 | 312.4 |
Receivables from securities financing transactions measured at amortized cost | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 69.2 | 60.8 |
Netting with gross liabilities | (12.2) | (11.1) |
Net assets recognized on the balance sheet | 56.9 | 49.6 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.5) | (3) |
Collateral received | (55.2) | (46.4) |
Assets after consideration of netting potential | 0.3 | 0.3 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 17.2 | 18.2 |
Total assets | ||
Total assets, after consideration of further netting potential | 17.5 | 18.5 |
Total assets recognized on the balance sheet | 74.1 | 67.8 |
Derivatives [Member] | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 128.8 | 147.4 |
Netting with gross liabilities | (2.5) | (2.5) |
Net assets recognized on the balance sheet | 126.3 | 144.9 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (99.3) | (110.9) |
Collateral received | (23.4) | (28.5) |
Assets after consideration of netting potential | 3.7 | 5.5 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 5.4 | 5.2 |
Total assets | ||
Total assets, after consideration of further netting potential | 9.1 | 10.7 |
Total assets recognized on the balance sheet | 131.7 | 150.1 |
Cash collateral receivables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 31.5 | 33.5 |
Netting with gross liabilities | 0 | 0 |
Net assets recognized on the balance sheet | 31.5 | 33.5 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (20.4) | (20.9) |
Collateral received | (2.5) | (1.9) |
Assets after consideration of netting potential | 8.7 | 10.6 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 0.8 | 1.5 |
Total assets | ||
Total assets, after consideration of further netting potential | 9.5 | 12.1 |
Total assets recognized on the balance sheet | 32.3 | 35 |
Financial assets at fair value not held for trading | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 96.3 | 85.6 |
Netting with gross liabilities | (89.6) | (76.8) |
Net assets recognized on the balance sheet | 6.7 | 8.7 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.8) | (1.5) |
Collateral received | (4.9) | (7.3) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 57.1 | 50.7 |
Total assets | ||
Total assets, after consideration of further netting potential | 57.1 | 50.7 |
Total assets recognized on the balance sheet | 63.8 | 59.4 |
of which: reverse repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 95.1 | 84.4 |
Netting with gross liabilities | (89.6) | (76.8) |
Net assets recognized on the balance sheet | 5.5 | 7.6 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.8) | (1.5) |
Collateral received | (3.7) | (6.1) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 0 | 0.1 |
Total assets | ||
Total assets, after consideration of further netting potential | 0 | 0.1 |
Total assets recognized on the balance sheet | $ 5.5 | $ 7.7 |
Offsetting financial liabilitie
Offsetting financial liabilities (Detail) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Netting recognized on the balance sheet | ||
Gross liabilities before netting | $ 282.6 | $ 291.7 |
Netting with gross assets | (104.3) | (90.4) |
Net liabilities recognized on the balance sheet | 178.3 | 201.3 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (119.7) | (135.3) |
Collateral pledged | (36) | (42.3) |
Liabilities after consideration of netting potential | 22.5 | 23.7 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 30.4 | 26.3 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 53 | 49.9 |
Total liabilities recognized on the balance sheet | 208.7 | 227.6 |
Payables from securities financing transactions | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 16.1 | 14.1 |
Netting with gross assets | (12.1) | (11.1) |
Net liabilities recognized on the balance sheet | 4 | 3 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (0.8) | (1.3) |
Collateral pledged | (3.2) | (1.8) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.8 | 1.2 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 1.8 | 1.2 |
Total liabilities recognized on the balance sheet | 5.8 | 4.2 |
Derivative financial instruments | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 135.9 | 150.3 |
Netting with gross assets | (2.5) | (2.5) |
Net liabilities recognized on the balance sheet | 133.5 | 147.8 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (99.3) | (110.9) |
Collateral pledged | (24.5) | (26.2) |
Liabilities after consideration of netting potential | 9.7 | 10.7 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 7.2 | 7.1 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 16.9 | 17.8 |
Total liabilities recognized on the balance sheet | 140.7 | 154.9 |
Cash collateral payables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 33.5 | 34.9 |
Netting with gross assets | 0 | 0 |
Net liabilities recognized on the balance sheet | 33.5 | 34.9 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (17.2) | (20) |
Collateral pledged | (3.4) | (1.9) |
Liabilities after consideration of netting potential | 12.9 | 13 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.4 | 1.6 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 14.3 | 14.5 |
Total liabilities recognized on the balance sheet | 34.9 | 36.4 |
Other financial liabilities designated at fair value | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 97.1 | 92.5 |
Netting with gross assets | (89.8) | (76.9) |
Net liabilities recognized on the balance sheet | 7.3 | 15.6 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.5) | (3.2) |
Collateral pledged | (4.8) | (12.4) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 20.1 | 16.4 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 20.1 | 16.4 |
Total liabilities recognized on the balance sheet | 27.4 | 32 |
of which: repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 96.7 | 92.1 |
Netting with gross assets | (89.8) | (76.9) |
Net liabilities recognized on the balance sheet | 6.9 | 15.3 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.5) | (3.2) |
Collateral pledged | (4.4) | (12.1) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 0 | 0.1 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 0 | 0.1 |
Total liabilities recognized on the balance sheet | $ 6.9 | $ 15.3 |
Restricted financial assets (De
Restricted financial assets (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Financial assets pledged as collateral | ||
Cash and balances at central banks pledged as collateral | $ 709 | |
Financial assets at fair value held for trading | 76,579 | $ 57,435 |
of which: assets pledged as collateral which may be sold or repledged by counterparties | 44,524 | 36,742 |
Loans and advances to customers | 28,105 | 15,195 |
Financial assets at fair value not held for trading | 3,099 | 1,509 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 2,110 | 1,220 |
Debt securities classified as Other financial assets measured at amortized cost | 7,043 | 3,432 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 6,299 | 2,685 |
Total financial assets pledged as collateral | 115,535 | 77,571 |
Other restricted financial assets | ||
Amounts due from banks | 2,543 | 3,689 |
Financial assets at fair value held for trading | 169 | 162 |
Cash collateral receivables on derivative instruments | 4,685 | 5,155 |
Loans and advances to customers | 28 | 1,127 |
Other financial assets measured at amortized cost | 3,334 | 815 |
Financial assets at fair value not held for trading | 17,844 | 14,090 |
Financial assets measured at fair value through other comprehensive income | 1,846 | 1,842 |
Other | 249 | 44 |
Total other restricted financial assets | 30,698 | 26,924 |
Total financial assets pledged and other restricted financial assets | 146,233 | 104,495 |
Assets placed with central banks related to undrawn credit lines and for payment, clearing and settlement purposes | 9,700 | 5,900 |
Assets placed with central banks to meet local statutory minimum reserve requirement. | $ 4,700 | $ 4,400 |
Restricted financial assets (Na
Restricted financial assets (Narrative) (Detail) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Restricted Financial Assets [Line Items] | ||
Pledged mortgage loans that could be withdrawn or used for future liabilities or covered bond issuances without breaching existing collateral requirements | $ 2 | $ 3.1 |
Liabilities against Swiss central mortgage institutions and US Federal Home Loan Banks, and for existing covered bond issuances | 15.4 | 9 |
Assets placed with central banks to meet local statutory minimum reserve requirement. | $ 4.7 | $ 4.4 |
Transferred financial assets _3
Transferred financial assets that are not derecognized in their entirety (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Line Items] | ||
Carrying amount of transferred assets | $ 52,933 | $ 40,647 |
Carrying amount of associated liabilities recognized on balance sheet | 31,278 | 19,822 |
Financial assets at fair value held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Line Items] | ||
Carrying amount of transferred assets | 44,524 | 36,742 |
Carrying amount of associated liabilities recognized on balance sheet | 23,374 | 16,470 |
Financial assets at fair value not held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Line Items] | ||
Carrying amount of transferred assets | 2,110 | 1,220 |
Carrying amount of associated liabilities recognized on balance sheet | 1,976 | 1,050 |
Debt securities classified as Other financial assets measured at amortized cost that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Line Items] | ||
Carrying amount of transferred assets | 6,299 | 2,685 |
Carrying amount of associated liabilities recognized on balance sheet | $ 5,928 | $ 2,302 |
Transferred financial assets _4
Transferred financial assets that are not derecognized in their entirety (Narrative) (Detail) | Dec. 31, 2023 |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Line Items] | |
Minimum haircut applied to transferred assets in securities lending and repurchase agreements | 0% |
Maximum haircut applied to transferred assets in securities lending and repurchase agreements | 15% |
Off-balance sheet assets rece_2
Off-balance sheet assets received (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Off Balance Sheet Assets Received [Line Items] | ||
Fair value of assets received that can be sold or repledged | $ 489,476 | $ 434,023 |
of which: sold or repledged | 357,020 | 331,805 |
Off balance sheet securities placed with central banks related to undrawn credit lines and for payment clearing and settlement purposes | $ 16,000 | $ 9,900 |
Maturity analysis of assets a_2
Maturity analysis of assets and liabilities (Detail] - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Assets | |||
Total financial assets measured at amortized cost | $ 766,407 | $ 730,379 | |
Amounts due from banks | 28,206 | 14,671 | |
Loans and advances to customers | 405,633 | 390,027 | |
Other Financial Assets At Amortised Cost | 54,334 | 53,389 | |
Total financial assets measured at fair value through profit or loss | 351,463 | 335,127 | |
Financial assets at fair value not held for trading | 63,754 | 59,408 | |
Financial assets measured at fair value through other comprehensive income | 2,233 | 2,239 | |
Total non-financial assets | 35,900 | 37,700 | |
Total assets | 1,156,016 | 1,105,436 | $ 1,116,145 |
Liabilities | |||
Total financial liabilities measured at amortized cost | 762,840 | 705,442 | |
Customer deposits | 555,673 | 527,171 | |
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 | |
Debt issued measured at amortized cost | 69,784 | 59,499 | |
Total financial liabilities measured at fair value through profit or loss | 328,401 | 333,382 | |
Debt issued designated at fair value | 86,341 | 71,842 | |
Total non-financial liabilities | 9,200 | 9,700 | |
Total liabilities | 1,100,448 | 1,048,496 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 44,000 | 40,000 | |
Guarantees | 33,400 | 22,400 | |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 10,400 | 3,800 | |
Irrevocable committed prolongation of existing loans | 4,200 | 4,700 | |
Total | 91,900 | 70,900 | |
Due within 1 month | |||
Assets | |||
Total financial assets measured at amortized cost | 416,200 | 425,200 | |
Amounts due from banks | 12,000 | 13,300 | |
Loans and advances to customers | 135,500 | 141,900 | |
Other Financial Assets At Amortised Cost | 7,400 | 8,800 | |
Total financial assets measured at fair value through profit or loss | 312,500 | 300,400 | |
Financial assets at fair value not held for trading | 24,800 | 24,600 | |
Financial assets measured at fair value through other comprehensive income | 100 | 300 | |
Total non-financial assets | 6,600 | 7,100 | |
Total assets | 735,400 | 732,900 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 497,100 | 524,300 | |
Customer deposits | 433,200 | 464,500 | |
Funding from UBS Group AG measured at amortized cost | 2,500 | 2,000 | |
Debt issued measured at amortized cost | 6,400 | 4,600 | |
Total financial liabilities measured at fair value through profit or loss | 250,100 | 265,900 | |
Debt issued designated at fair value | 13,100 | 9,300 | |
Total non-financial liabilities | 5,200 | 6,700 | |
Total liabilities | 752,500 | 796,900 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 43,000 | 39,300 | |
Guarantees | 33,400 | 22,400 | |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 10,400 | 3,800 | |
Irrevocable committed prolongation of existing loans | 2,000 | 4,700 | |
Total | 88,800 | 70,100 | |
Due between 1 and 3 months | |||
Assets | |||
Total financial assets measured at amortized cost | 25,600 | 28,700 | |
Amounts due from banks | 500 | 600 | |
Loans and advances to customers | 12,100 | 16,300 | |
Other Financial Assets At Amortised Cost | 1,600 | 4,200 | |
Total financial assets measured at fair value through profit or loss | 6,700 | 10,000 | |
Financial assets at fair value not held for trading | 6,700 | 10,000 | |
Financial assets measured at fair value through other comprehensive income | 1,100 | 900 | |
Total assets | 33,400 | 39,500 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 65,100 | 40,200 | |
Customer deposits | 48,900 | 28,500 | |
Funding from UBS Group AG measured at amortized cost | 800 | ||
Debt issued measured at amortized cost | 11,700 | 8,800 | |
Total financial liabilities measured at fair value through profit or loss | 11,400 | 13,800 | |
Debt issued designated at fair value | 11,300 | 12,300 | |
Total non-financial liabilities | 2,800 | 2,600 | |
Total liabilities | 79,300 | 56,500 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 500 | 300 | |
Irrevocable committed prolongation of existing loans | 800 | ||
Total | 1,400 | 300 | |
Due between 3 and 12 months | |||
Assets | |||
Total financial assets measured at amortized cost | 47,600 | 34,500 | |
Amounts due from banks | 5,400 | 600 | |
Loans and advances to customers | 33,300 | 28,300 | |
Other Financial Assets At Amortised Cost | 4,200 | 2,800 | |
Total financial assets measured at fair value through profit or loss | 7,800 | 7,800 | |
Financial assets at fair value not held for trading | 7,800 | 7,800 | |
Financial assets measured at fair value through other comprehensive income | 1,000 | 900 | |
Total non-financial assets | 200 | 200 | |
Total assets | 56,500 | 43,400 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 81,100 | 49,600 | |
Customer deposits | 49,600 | 23,800 | |
Debt issued measured at amortized cost | 26,800 | 23,300 | |
Total financial liabilities measured at fair value through profit or loss | 22,600 | 16,300 | |
Debt issued designated at fair value | 21,800 | 15,900 | |
Total liabilities | 103,800 | 65,900 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 400 | 400 | |
Irrevocable committed prolongation of existing loans | 1,300 | ||
Total | 1,800 | 400 | |
Due between 1 and 2 years | |||
Assets | |||
Total financial assets measured at amortized cost | 105,200 | 78,800 | |
Amounts due from banks | 10,000 | 0 | |
Loans and advances to customers | 89,400 | 74,900 | |
Other Financial Assets At Amortised Cost | 5,100 | 3,000 | |
Total financial assets measured at fair value through profit or loss | 7,400 | 3,600 | |
Financial assets at fair value not held for trading | 7,400 | 3,600 | |
Financial assets measured at fair value through other comprehensive income | 100 | 100 | |
Total assets | 112,700 | 82,400 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 30,300 | 20,700 | |
Customer deposits | 15,300 | 7,700 | |
Funding from UBS Group AG measured at amortized cost | 8,200 | 4,800 | |
Debt issued measured at amortized cost | 6,300 | 7,200 | |
Total financial liabilities measured at fair value through profit or loss | 23,300 | 19,600 | |
Debt issued designated at fair value | 23,000 | 19,300 | |
Total liabilities | 53,700 | 40,400 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 0 | 0 | |
Irrevocable committed prolongation of existing loans | 0 | ||
Total | 0 | 0 | |
Due between 2 and 5 years | |||
Assets | |||
Total financial assets measured at amortized cost | 77,800 | 70,500 | |
Amounts due from banks | 200 | 0 | |
Loans and advances to customers | 61,400 | 55,600 | |
Other Financial Assets At Amortised Cost | 16,100 | 14,800 | |
Total financial assets measured at fair value through profit or loss | 11,800 | 9,900 | |
Financial assets at fair value not held for trading | 11,800 | 9,900 | |
Financial assets measured at fair value through other comprehensive income | 0 | 0 | |
Total non-financial assets | 1,200 | 2,000 | |
Total assets | 90,800 | 82,400 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 49,600 | 35,200 | |
Customer deposits | 8,400 | 2,300 | |
Funding from UBS Group AG measured at amortized cost | 24,300 | 21,200 | |
Debt issued measured at amortized cost | 11,800 | 10,000 | |
Total financial liabilities measured at fair value through profit or loss | 8,300 | 7,300 | |
Debt issued designated at fair value | 8,000 | 6,900 | |
Total liabilities | 58,300 | 42,500 | |
Guarantees, commitments and forward starting transactions | |||
Irrevocable loan commitments | 0 | ||
Irrevocable committed prolongation of existing loans | 0 | ||
Total | 0 | ||
Due after 5 years | |||
Assets | |||
Total financial assets measured at amortized cost | 94,000 | 92,800 | |
Amounts due from banks | 100 | 100 | |
Loans and advances to customers | 74,000 | 73,000 | |
Other Financial Assets At Amortised Cost | 19,900 | 19,700 | |
Total financial assets measured at fair value through profit or loss | 3,400 | 2,000 | |
Financial assets at fair value not held for trading | 3,400 | 2,000 | |
Financial assets measured at fair value through other comprehensive income | 0 | 0 | |
Total non-financial assets | 400 | 400 | |
Total assets | 97,800 | 95,100 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 27,100 | 23,500 | |
Customer deposits | 300 | 300 | |
Funding from UBS Group AG measured at amortized cost | 19,000 | 16,300 | |
Debt issued measured at amortized cost | 6,800 | 5,700 | |
Total financial liabilities measured at fair value through profit or loss | 12,700 | 10,500 | |
Debt issued designated at fair value | 9,100 | 8,200 | |
Total liabilities | 39,900 | 34,000 | |
Perpetual / Not applicable | |||
Assets | |||
Total financial assets measured at fair value through profit or loss | 1,900 | 1,500 | |
Financial assets at fair value not held for trading | 1,900 | 1,500 | |
Total non-financial assets | 27,500 | 28,000 | |
Total assets | 29,500 | 29,600 | |
Liabilities | |||
Total financial liabilities measured at amortized cost | 12,500 | 11,800 | |
Funding from UBS Group AG measured at amortized cost | 12,500 | 11,800 | |
Total non-financial liabilities | 500 | 500 | |
Total liabilities | 13,000 | 12,300 | |
of which: non-subordinated | |||
Liabilities | |||
Debt issued measured at amortized cost | 66,800 | 56,500 | |
of which: non-subordinated | Due within 1 month | |||
Liabilities | |||
Debt issued measured at amortized cost | 6,400 | 4,600 | |
of which: non-subordinated | Due between 1 and 3 months | |||
Liabilities | |||
Debt issued measured at amortized cost | 11,700 | 8,800 | |
of which: non-subordinated | Due between 3 and 12 months | |||
Liabilities | |||
Debt issued measured at amortized cost | 24,300 | 23,300 | |
of which: non-subordinated | Due between 1 and 2 years | |||
Liabilities | |||
Debt issued measured at amortized cost | 6,000 | 4,800 | |
of which: non-subordinated | Due between 2 and 5 years | |||
Liabilities | |||
Debt issued measured at amortized cost | 11,600 | 9,500 | |
of which: non-subordinated | Due after 5 years | |||
Liabilities | |||
Debt issued measured at amortized cost | 6,800 | 5,700 | |
of which: subordinated | |||
Liabilities | |||
Debt issued measured at amortized cost | 3,000 | 3,000 | |
of which: subordinated | Due between 3 and 12 months | |||
Liabilities | |||
Debt issued measured at amortized cost | 2,500 | ||
of which: subordinated | Due between 1 and 2 years | |||
Liabilities | |||
Debt issued measured at amortized cost | 300 | 2,400 | |
of which: subordinated | Due between 2 and 5 years | |||
Liabilities | |||
Debt issued measured at amortized cost | $ 200 | $ 500 |
Maturity analysis of financia_2
Maturity analysis of financial liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | $ 17,400 | $ 11,700 |
Payables from securities financing transactions | 5,800 | 4,400 |
Cash collateral payables on derivative instruments | 34,900 | 36,400 |
Customer deposits | 561,800 | 529,000 |
Funding from UBS Group AG measured at amortized cost | 86,100 | 72,300 |
Debt issued measured at amortized cost | 73,600 | 62,800 |
Other financial liabilities measured at amortized cost | 9,400 | 9,200 |
of which: lease liabilities | 3,300 | 3,700 |
Total financial liabilities measured at amortized cost | 789,100 | 725,800 |
Financial liabilities at fair value held for trading | 31,712 | 29,515 |
Derivative financial instruments | 140,707 | 154,906 |
Brokerage payables designated at fair value | 42,300 | 45,100 |
Debt issued designated at fair value | 93,000 | 76,800 |
Other financial liabilities designated at fair value | 30,800 | 34,800 |
Total financial liabilities measured at fair value through profit or loss | 338,400 | 341,100 |
Total financial liabilities, undiscounted cash flows | 1,127,500 | 1,066,900 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 44,000 | 40,000 |
Guarantees | 33,400 | 22,400 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 10,400 | 3,800 |
Irrevocable committed prolongation of existing loans | 4,200 | 4,700 |
Total | 91,900 | 70,900 |
Trading portfolio liabilities contractually due within one month | 29,900 | 27,800 |
Trading portfolio liabilities contractually due between one month and one year | 1,800 | 1,700 |
Trading portfolio liabilities contractually due between 1 and 5 years | 0 | 0 |
Loan commitments and forward starting reverse repurchase agreements classified as derivatives | 52 | 46 |
Notional amounts of derivatives | 65,200 | 34,400 |
Due within 1 month | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 6,200 | 6,300 |
Payables from securities financing transactions | 4,000 | 3,300 |
Cash collateral payables on derivative instruments | 34,900 | 36,400 |
Customer deposits | 433,500 | 464,600 |
Funding from UBS Group AG measured at amortized cost | 2,800 | 2,200 |
Debt issued measured at amortized cost | 6,400 | 4,600 |
Other financial liabilities measured at amortized cost | 6,200 | 5,600 |
of which: lease liabilities | 0 | 100 |
Total financial liabilities measured at amortized cost | 494,100 | 523,100 |
Financial liabilities at fair value held for trading | 31,700 | 29,500 |
Derivative financial instruments | 140,700 | 154,900 |
Brokerage payables designated at fair value | 42,300 | 45,100 |
Debt issued designated at fair value | 13,100 | 9,400 |
Other financial liabilities designated at fair value | 22,100 | 27,100 |
Total financial liabilities measured at fair value through profit or loss | 249,900 | 266,000 |
Total financial liabilities, undiscounted cash flows | 744,000 | 789,200 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 43,000 | 39,300 |
Guarantees | 33,400 | 22,400 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 10,400 | 3,800 |
Irrevocable committed prolongation of existing loans | 2,000 | 4,700 |
Total | 88,800 | 70,100 |
Due between 1 and 3 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 2,600 | 2,600 |
Payables from securities financing transactions | 1,100 | 300 |
Customer deposits | 49,700 | 28,800 |
Funding from UBS Group AG measured at amortized cost | 1,700 | 600 |
Debt issued measured at amortized cost | 11,900 | 8,900 |
Other financial liabilities measured at amortized cost | 100 | 100 |
of which: lease liabilities | 100 | 100 |
Total financial liabilities measured at amortized cost | 67,000 | 41,200 |
Debt issued designated at fair value | 11,800 | 12,400 |
Other financial liabilities designated at fair value | 100 | 1,400 |
Total financial liabilities measured at fair value through profit or loss | 11,900 | 13,800 |
Total financial liabilities, undiscounted cash flows | 78,900 | 55,000 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 500 | 300 |
Irrevocable committed prolongation of existing loans | 800 | |
Total | 1,400 | 300 |
Due between 3 and 12 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 3,900 | 1,900 |
Payables from securities financing transactions | 700 | 400 |
Customer deposits | 51,600 | 24,500 |
Funding from UBS Group AG measured at amortized cost | 1,700 | 1,200 |
Debt issued measured at amortized cost | 27,400 | 23,700 |
Other financial liabilities measured at amortized cost | 400 | 400 |
of which: lease liabilities | 400 | 400 |
Total financial liabilities measured at amortized cost | 85,700 | 52,200 |
Debt issued designated at fair value | 22,500 | 16,000 |
Other financial liabilities designated at fair value | 800 | 400 |
Total financial liabilities measured at fair value through profit or loss | 23,300 | 16,400 |
Total financial liabilities, undiscounted cash flows | 109,000 | 68,600 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 400 | 400 |
Irrevocable committed prolongation of existing loans | 1,300 | |
Total | 1,800 | 400 |
Due between 1 and 2 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 300 | 300 |
Payables from securities financing transactions | 300 | |
Customer deposits | 16,900 | 8,200 |
Funding from UBS Group AG measured at amortized cost | 11,000 | 6,800 |
Debt issued measured at amortized cost | 7,000 | 7,800 |
Other financial liabilities measured at amortized cost | 500 | 500 |
of which: lease liabilities | 500 | 500 |
Total financial liabilities measured at amortized cost | 35,600 | 24,000 |
Debt issued designated at fair value | 25,700 | 19,700 |
Other financial liabilities designated at fair value | 300 | 400 |
Total financial liabilities measured at fair value through profit or loss | 26,000 | 20,000 |
Total financial liabilities, undiscounted cash flows | 61,600 | 44,000 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 0 | 0 |
Irrevocable committed prolongation of existing loans | 0 | |
Total | 0 | 0 |
Due between 2 and 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 4,400 | 600 |
Customer deposits | 9,800 | 2,600 |
Funding from UBS Group AG measured at amortized cost | 31,900 | 27,600 |
Debt issued measured at amortized cost | 12,800 | 10,800 |
Other financial liabilities measured at amortized cost | 1,100 | 1,200 |
of which: lease liabilities | 1,100 | 1,200 |
Total financial liabilities measured at amortized cost | 60,100 | 42,800 |
Debt issued designated at fair value | 8,100 | 7,100 |
Other financial liabilities designated at fair value | 300 | 500 |
Total financial liabilities measured at fair value through profit or loss | 8,400 | 7,500 |
Total financial liabilities, undiscounted cash flows | 68,500 | 50,300 |
Guarantees, commitments and forward starting transactions | ||
Irrevocable loan commitments | 0 | |
Irrevocable committed prolongation of existing loans | 0 | |
Total | 0 | |
Due after 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks | 0 | 0 |
Payables from securities financing transactions | 0 | |
Customer deposits | 300 | 300 |
Funding from UBS Group AG measured at amortized cost | 24,100 | 21,200 |
Debt issued measured at amortized cost | 8,100 | 6,900 |
Other financial liabilities measured at amortized cost | 1,100 | 1,300 |
of which: lease liabilities | 1,100 | 1,300 |
Total financial liabilities measured at amortized cost | 33,600 | 29,800 |
Debt issued designated at fair value | 11,800 | 12,300 |
Other financial liabilities designated at fair value | 7,200 | 5,000 |
Total financial liabilities measured at fair value through profit or loss | 19,000 | 17,300 |
Total financial liabilities, undiscounted cash flows | 52,600 | 47,100 |
Perpetual / Not applicable | ||
Financial liabilities recognized on balance sheet | ||
Funding from UBS Group AG measured at amortized cost | 12,900 | 12,700 |
Total financial liabilities measured at amortized cost | 12,900 | 12,700 |
Total financial liabilities, undiscounted cash flows | $ 12,900 | $ 12,700 |
Interest rate benchmark refor_2
Interest rate benchmark reform (Narrative) (Detail) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Maximum Exposure To Interest Rate Benchmark Reform [Line Items] | ||
US mortgages linked to USD LIBOR | $ 9 | |
Funding from UBS Group AG in JPY and USD resettable to LIBOR | $ 2 |
Interest rate benchmark refor_3
Interest rate benchmark reform (Detail) $ in Millions | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) |
Disclosure Of Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Line Items] | ||
Total off-balance sheet irrevocable loan commitments | $ 44,000 | $ 40,000 |
Interest rate benchmark reform | ||
Disclosure Of Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Line Items] | ||
Carrying value of loans related to revolving multi-currency credit lines where IBOR transition efforts are complete, except for USD LIBOR | $ 1,000 | |
Number Of Contracts With Last USD LIBOR Fixing Before Contractual Maturity Date | 2,000 | |
Multicurrency loan commitments that have only USD LIBOR exposure remaining | $ 3,000 | |
LIBOR benchmark rate USD | Interest rate benchmark reform | ||
Disclosure Of Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Line Items] | ||
Total carrying value of non-derivative financial assets | 14,269 | |
Total carrying value of non-derivative financial liabilities | $ 1,138 | |
Trade count of derivative financial instruments | 32,006 | |
Total off-balance sheet irrevocable loan commitments | $ 4,606 |
Hedge accounting (Detail 1)
Hedge accounting (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Fair value hedges | Interest rate risk | ||
Disclosure Of Hedge Accounting [Line Items] | ||
Notional amount | $ 114,618 | $ 92,415 |
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
Changes in fair value of hedging instruments | 2,203 | (5,195) |
Changes in fair value of hedged items | (2,195) | 5,169 |
Hedge ineffectiveness recognized in the income statement | 8 | (27) |
Fair value hedges | Foreign exchange risk | ||
Disclosure Of Hedge Accounting [Line Items] | ||
Notional amount | 33,877 | 20,566 |
Derivative financial assets | 468 | 845 |
Derivative financial liabilities | 291 | 3 |
Changes in fair value of hedging instruments | 132 | (1,088) |
Changes in fair value of hedged items | (151) | 1,105 |
Hedge ineffectiveness recognized in the income statement | (19) | 18 |
Cash flow hedges | Interest rate risk | ||
Disclosure Of Hedge Accounting [Line Items] | ||
Notional amount | 83,333 | 75,304 |
Derivative financial assets | 3 | 2 |
Derivative financial liabilities | 0 | 5 |
Changes in fair value of hedging instruments | (35) | (5,813) |
Changes in fair value of hedged items | 57 | 5,760 |
Hedge ineffectiveness recognized in the income statement | 22 | (53) |
Hedges of net investments in foreign operations | Foreign exchange risk | ||
Disclosure Of Hedge Accounting [Line Items] | ||
Notional amount | 13,260 | 13,844 |
Derivative financial assets | 3 | 7 |
Derivative financial liabilities | 455 | 528 |
Changes in fair value of hedging instruments | (910) | 318 |
Changes in fair value of hedged items | 912 | (319) |
Hedge ineffectiveness recognized in the income statement | $ 3 | $ (1) |
Hedge accounting (Detail 2)
Hedge accounting (Detail 2) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt issued measured at amortized cost | ||
Fair value hedges of FX risk | $ 12,000 | |
Interest rate risk | ||
Loans and advances to customers | ||
Carrying amount of designated loans | 15,296 | $ 14,270 |
of which: accumulated amount of fair value hedge adjustment | (508) | (1,249) |
of which: accumulated amount of fair value hedge adjustment, subject to amortization attributable to the portion of the portfolio that ceased to be part of hedge accounting | (179) | (51) |
Other financial assets measured at amortized cost - debt securities | ||
Carrying amount of designated debt securities | 6,333 | 4,577 |
of which: accumulated amount of fair value hedge adjustment | (109) | (180) |
Customer deposits | ||
Carrying amount of customer deposits | 8,972 | |
of which: accumulated amount of fair value hedge adjustment | 50 | |
Funding from UBS Group AG | ||
Carrying amount of designated debt instruments | 63,760 | 57,250 |
of which: accumulated amount of fair value hedge adjustment | (3,174) | (5,055) |
Debt issued measured at amortized cost | ||
Carrying amount of designated debt issued | 15,243 | 11,279 |
of which: accumulated amount of fair value hedge adjustment | (412) | (1,002) |
Foreign exchange risk | ||
Funding from UBS Group AG | ||
Carrying amount of designated debt instruments | 17,693 | 14,828 |
Debt issued measured at amortized cost | ||
Carrying amount of designated debt issued | $ 4,636 | $ 5,737 |
Hedge accounting (Detail 3)
Hedge accounting (Detail 3) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Interest rate swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | $ 115 | $ 92 |
Interest rate swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 1 | 0 |
Interest rate swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 6 | 4 |
Interest rate swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 12 | 10 |
Interest rate swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 62 | 53 |
Interest rate swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 35 | 26 |
Cross-currency swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 34 | 21 |
Cross-currency swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 1 | 0 |
Cross-currency swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 2 | 1 |
Cross-currency swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 2 | 2 |
Cross-currency swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | 22 | 12 |
Cross-currency swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Line Items] | ||
Hedging instruments | $ 7 | $ 5 |
Hedge accounting (Detail 4)
Hedge accounting (Detail 4) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Cash Flow Hedge Reserves [Line Items] | ||
Amounts related to hedge relationships for which hedge accounting continues to be applied | $ (2,349) | $ (4,692) |
Amounts related to hedge relationships for which hedge accounting is no longer applied | (1,331) | (540) |
Total Other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis | $ (3,680) | $ (5,232) |
Hedge accounting (Detail 5)
Hedge accounting (Detail 5) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Foreign Currency Basis Spreads Reserves [Line Items] | ||
Amounts related to hedge relationships for which hedge accounting continues to be applied | $ (690) | $ 250 |
Amounts related to hedge relationships for which hedge accounting is no longer applied | 266 | 266 |
Total other comprehensive income recognized directly in equity related to hedging instruments in net investment hedges, on a pre-tax basis | $ (424) | $ 515 |
Hedge accounting (Detail 6)
Hedge accounting (Detail 6) - Interest rate risk - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Fair value hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Line Items] | ||
Derivative financial assets | $ 0 | $ 0 |
Derivative financial liabilities | 0 | 0 |
Fair value hedges | Interest rate benchmark reform exceptions effect on cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Line Items] | ||
Nominal amount | 20,383 | |
Derivative financial assets | 0 | |
Derivative financial liabilities | 0 | |
Cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Line Items] | ||
Derivative financial assets | 3 | 2 |
Derivative financial liabilities | $ 0 | 5 |
Cash flow hedges | Interest rate benchmark reform exceptions effect on cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Line Items] | ||
Nominal amount | 2,179 | |
Derivative financial assets | 0 | |
Derivative financial liabilities | $ 0 |
Post-employment benefit plans_2
Post-employment benefit plans (Narrative) (Detail) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 USD ($) yr | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Disclosure Of Defined Benefit Plans [Line Items] | |||
Total employer contributions to defined contribution plans | $ 320 | $ 299 | $ 303 |
Major defined benefit plans | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Surplus / (deficit) | $ 3,570 | $ 4,404 | |
Swiss defined benefit plan | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Normal retirement age | yr | 65 | ||
Minimum age required to draw early retirement benefits | yr | 58 | ||
Maximum retirement age starting 2019 | yr | 70 | ||
Maximum period to restore full funding in case an underfunded situation occurs | 10 years | ||
Maximum obligation from the employer on the additional contributions required if a Swiss pension plan were to become significantly underfunded | 50% | ||
Technical funding ratio | 119.20% | 119% | |
Surplus / (deficit) | $ 3,585 | $ 4,418 | |
Swiss defined benefit plan | 2024 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Regular employer contributions expected for the next year | $ 315 | ||
Swiss defined benefit plan | Maximum | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Employer contributions on contributory base salary (as a percent) | 27.50% | ||
Employer contributions on contributory variable compensation (as a percent) | 9% | ||
Employee contributions on contributory base salary (as a percent) | 13.50% | ||
Employee contributions on contributory variable compensation (as a percent) | 9% | ||
Swiss defined benefit plan | Minimum | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Employer contributions on contributory base salary (as a percent) | 6.50% | ||
Employer contributions on contributory variable compensation (as a percent) | 2.80% | ||
Employee contributions on contributory base salary (as a percent) | 2.50% | ||
Employee contributions on contributory variable compensation (as a percent) | 0% | ||
UK defined benefit plan | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Normal retirement age older population | yr | 60 | ||
Normal retirement age | yr | 65 | ||
Surplus / (deficit) | $ 341 | 321 | |
Employer contributions | 19 | 5 | |
Collateral pool established for pension fund | 260 | 292 | |
UK defined benefit plan | 2024 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Employer contributions | 19 | ||
US and German defined benefit plans | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Surplus / (deficit) | $ (356) | $ (335) | |
US defined benefit plans | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Normal retirement age | yr | 65 | ||
US defined benefit plans | 2024 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Employer contributions | $ 12 | ||
German defined benefit plans | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Normal retirement age | yr | 65 | ||
German defined benefit plans | 2024 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Employer contributions | $ 14 | ||
German defined benefit plans - Larger | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Interest rate | 5% | ||
German defined benefit plans - Smaller | before 2010 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Interest rate | 6% | ||
German defined benefit plans - Smaller | 2010-2017 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Interest rate | 4% | ||
German defined benefit plans - Smaller | time after 2017 | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Interest rate | 0.90% | ||
German defined benefit plans - New funded plan | |||
Disclosure Of Defined Benefit Plans [Line Items] | |||
Interest rate | 0% |
Defined benefit plans (Detail 4
Defined benefit plans (Detail 4.1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | $ (94) | |
At the end of the year | (105) | $ (94) |
Major defined benefit plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | (14) | |
Remeasurement of defined benefit obligation | (2,031) | 4,165 |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 603 | (3,476) |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,332 | (656) |
At the end of the year | (15) | (14) |
Major defined benefit plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 16,080 | 21,324 |
Current service cost | 241 | 244 |
Interest expense | 457 | 297 |
Plan participant contributions | 163 | 154 |
Remeasurement of defined benefit obligation | 2,031 | (4,165) |
of which: actuarial (gains) / losses due to changes in demographic assumptions | (31) | (3) |
of which: actuarial (gains) / losses due to changes in financial assumptions | 1,241 | (4,506) |
of which: experience (gains) / losses | 820 | 344 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | (3) | (13) |
Benefit payments | (880) | (1,030) |
Other movements | 0 | (5) |
Foreign currency translation | 1,411 | (727) |
At the end of the year | 19,500 | 16,080 |
Major defined benefit plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 20,484 | 24,821 |
Plan participant contributions | 163 | 154 |
Benefit payments | (880) | (1,030) |
Other movements | 2 | (1) |
Return on plan assets excluding interest income | 603 | (3,476) |
Interest income | 568 | 376 |
Employer contributions | 327 | 422 |
Administration expenses, taxes and premiums paid | (12) | (11) |
Foreign currency translation | 1,815 | (772) |
At the end of the year | 23,070 | 20,484 |
Major defined benefit plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 4,418 | 3,716 |
Interest expense on asset ceiling effect | 102 | 77 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,332) | 656 |
Foreign currency translation | 397 | (31) |
At the end of the year | 3,585 | 4,418 |
Swiss defined benefit plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 0 | |
Remeasurement of defined benefit obligation | (1,901) | 2,424 |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 513 | (1,942) |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,332 | (656) |
At the end of the year | 0 | 0 |
Swiss defined benefit plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 12,539 | 15,480 |
Current service cost | 236 | 240 |
Interest expense | 287 | 195 |
Plan participant contributions | 163 | 154 |
Remeasurement of defined benefit obligation | 1,901 | (2,424) |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 45 | 2 |
of which: actuarial (gains) / losses due to changes in financial assumptions | 1,168 | (2,653) |
of which: experience (gains) / losses | 688 | 226 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | (3) | (13) |
Benefit payments | (662) | (796) |
Other movements | 0 | (5) |
Foreign currency translation | 1,288 | (291) |
At the end of the year | 15,748 | 12,539 |
Swiss defined benefit plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 16,957 | 19,196 |
Plan participant contributions | 163 | 154 |
Benefit payments | (662) | (796) |
Other movements | 2 | (1) |
Return on plan assets excluding interest income | 513 | (1,942) |
Interest income | 393 | 274 |
Employer contributions | 290 | 401 |
Administration expenses, taxes and premiums paid | (8) | (7) |
Foreign currency translation | 1,685 | (322) |
At the end of the year | 19,333 | 16,957 |
Swiss defined benefit plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 4,418 | 3,716 |
Interest expense on asset ceiling effect | 102 | 77 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,332) | 656 |
Foreign currency translation | 397 | (31) |
At the end of the year | 3,585 | 4,418 |
UK defined benefit plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 321 | |
Remeasurement of defined benefit obligation | (96) | 1,474 |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 65 | (1,312) |
Employer contributions | 19 | 5 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | 341 | 321 |
UK defined benefit plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 2,166 | 4,105 |
Current service cost | 0 | 0 |
Interest expense | 109 | 67 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | 96 | (1,474) |
of which: actuarial (gains) / losses due to changes in demographic assumptions | (75) | (6) |
of which: actuarial (gains) / losses due to changes in financial assumptions | 36 | (1,575) |
of which: experience (gains) / losses | 135 | 107 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | 0 | 0 |
Benefit payments | (107) | (123) |
Other movements | 0 | 0 |
Foreign currency translation | 114 | (408) |
At the end of the year | 2,379 | 2,166 |
UK defined benefit plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 2,488 | 4,297 |
Plan participant contributions | 0 | 0 |
Benefit payments | (107) | (123) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 65 | (1,312) |
Interest income | 126 | 70 |
Employer contributions | 19 | 5 |
Administration expenses, taxes and premiums paid | 0 | 0 |
Foreign currency translation | 130 | (450) |
At the end of the year | 2,720 | 2,488 |
UK defined benefit plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
US and German defined benefit plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | (335) | |
Remeasurement of defined benefit obligation | (33) | 267 |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 26 | (223) |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | (356) | (335) |
US and German defined benefit plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 1,375 | 1,740 |
Current service cost | 5 | 5 |
Interest expense | 61 | 35 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | 33 | (267) |
of which: actuarial (gains) / losses due to changes in demographic assumptions | (2) | 1 |
of which: actuarial (gains) / losses due to changes in financial assumptions | 37 | (279) |
of which: experience (gains) / losses | (3) | 11 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | 0 | 0 |
Benefit payments | (110) | (111) |
Other movements | 0 | 0 |
Foreign currency translation | 9 | (28) |
At the end of the year | 1,373 | 1,375 |
US and German defined benefit plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 1,039 | 1,329 |
Plan participant contributions | 0 | 0 |
Benefit payments | (110) | (111) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 26 | (223) |
Interest income | 48 | 31 |
Employer contributions | 17 | 16 |
Administration expenses, taxes and premiums paid | (4) | (3) |
Foreign currency translation | 0 | 0 |
At the end of the year | 1,017 | 1,039 |
US and German defined benefit plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
Remaining plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Line Items] | ||
At the beginning of the year | (80) | |
At the end of the year | $ (90) | $ (80) |
Defined benefit plans (Detail_2
Defined benefit plans (Detail 4.2) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Details Of Net Defined Benefit Liability Asset [Line Items] | ||
of which: net defined benefit asset | $ 383 | $ 355 |
of which: net defined benefit liability | (487) | (449) |
Major defined benefit plans | ||
Disclosure Of Details Of Net Defined Benefit Liability Asset [Line Items] | ||
of which: amounts owed to active members | 9,618 | 7,336 |
of which: amounts owed to deferred members | 1,478 | 1,184 |
of which: amounts owed to retirees | 8,404 | 7,560 |
Swiss defined benefit plan | ||
Disclosure Of Details Of Net Defined Benefit Liability Asset [Line Items] | ||
of which: amounts owed to active members | 9,336 | 7,103 |
of which: amounts owed to deferred members | 0 | 0 |
of which: amounts owed to retirees | 6,412 | 5,436 |
UK defined benefit plan | ||
Disclosure Of Details Of Net Defined Benefit Liability Asset [Line Items] | ||
of which: amounts owed to active members | 73 | 65 |
of which: amounts owed to deferred members | 950 | 656 |
of which: amounts owed to retirees | 1,356 | 1,445 |
US and German defined benefit plans | ||
Disclosure Of Details Of Net Defined Benefit Liability Asset [Line Items] | ||
of which: amounts owed to active members | 209 | 169 |
of which: amounts owed to deferred members | 527 | 528 |
of which: amounts owed to retirees | $ 636 | $ 678 |
Defined benefit plans (Detail_3
Defined benefit plans (Detail 4.3) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Line Items] | ||
Net defined benefit asset / (liability) | $ (105) | $ (94) |
Total | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Line Items] | ||
Defined benefit obligation from funded plans | 19,106 | 15,717 |
Defined benefit obligation from unfunded plans | 394 | 363 |
Surplus / (deficit) | 3,570 | 4,404 |
Net defined benefit asset / (liability) | (15) | (14) |
Swiss defined benefit plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Line Items] | ||
Defined benefit obligation from funded plans | 15,748 | 12,539 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 19,333 | 16,957 |
Surplus / (deficit) | 3,585 | 4,418 |
Net defined benefit asset / (liability) | 0 | 0 |
UK defined benefit plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Line Items] | ||
Defined benefit obligation from funded plans | 2,379 | 2,166 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 2,720 | 2,488 |
Surplus / (deficit) | 341 | 321 |
Net defined benefit asset / (liability) | 341 | 321 |
US and German defined benefit plans | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Line Items] | ||
Defined benefit obligation from funded plans | 979 | 1,011 |
Defined benefit obligation from unfunded plans | 394 | 363 |
Plan assets | 1,017 | 1,039 |
Surplus / (deficit) | (356) | (335) |
Net defined benefit asset / (liability) | $ (356) | $ (335) |
Defined benefit plans (Detail 5
Defined benefit plans (Detail 5.1) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Curtailments | $ (3) | $ (13) | $ (49) |
Net periodic expenses recognized in net profit | 259 | 256 | $ 280 |
Major defined benefit plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Current service cost | 241 | 244 | |
Interest expense related to defined benefit obligation | 457 | 297 | |
Interest income related to plan assets | (568) | (376) | |
Interest expense on asset ceiling effect | 102 | 77 | |
Administration expenses, taxes and premiums paid | 12 | 11 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | (3) | (13) | |
Net periodic expenses recognized in net profit | 241 | 239 | |
Swiss defined benefit plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Current service cost | 236 | 240 | |
Interest expense related to defined benefit obligation | 287 | 195 | |
Interest income related to plan assets | (393) | (274) | |
Interest expense on asset ceiling effect | 102 | 77 | |
Administration expenses, taxes and premiums paid | 8 | 7 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | (3) | (13) | |
Net periodic expenses recognized in net profit | 236 | 230 | |
UK defined benefit plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Current service cost | 0 | 0 | |
Interest expense related to defined benefit obligation | 109 | 67 | |
Interest income related to plan assets | (126) | (70) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 0 | 0 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | (17) | (3) | |
US and German defined benefit plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Current service cost | 5 | 5 | |
Interest expense related to defined benefit obligation | 61 | 35 | |
Interest income related to plan assets | (48) | (31) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 4 | 3 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | 22 | 12 | |
Remaining plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Line Items] | |||
Net periodic expenses recognized in net profit | $ 19 | $ 17 |
Defined benefit plans (Detail_4
Defined benefit plans (Detail 5.2) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | $ (103) | $ 40 |
Major defined benefit plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (2,031) | 4,165 |
Return on plan assets excluding interest income | 603 | (3,476) |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,332 | (656) |
Total gains / (losses) recognized in other comprehensive income, before tax | (95) | 32 |
Major defined benefit plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (1,434) | 4,846 |
Major defined benefit plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 34 | 118 |
Major defined benefit plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 198 | (490) |
Major defined benefit plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 75 | 4 |
Major defined benefit plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (83) | 30 |
Major defined benefit plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (820) | (344) |
Swiss defined benefit plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (1,901) | 2,424 |
Return on plan assets excluding interest income | 513 | (1,942) |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,332 | (656) |
Total gains / (losses) recognized in other comprehensive income, before tax | (56) | (173) |
Swiss defined benefit plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (1,332) | 3,078 |
Swiss defined benefit plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
Swiss defined benefit plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 207 | (408) |
Swiss defined benefit plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
Swiss defined benefit plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (88) | (19) |
Swiss defined benefit plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (688) | (226) |
UK defined benefit plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (96) | 1,474 |
Return on plan assets excluding interest income | 65 | (1,312) |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | (31) | 162 |
UK defined benefit plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (69) | 1,451 |
UK defined benefit plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 34 | 123 |
UK defined benefit plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UK defined benefit plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 75 | 5 |
UK defined benefit plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 0 | 1 |
UK defined benefit plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (135) | (107) |
US and German defined benefit plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (33) | 267 |
Return on plan assets excluding interest income | 26 | (223) |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | (8) | 43 |
US and German defined benefit plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (33) | 317 |
US and German defined benefit plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 1 | (5) |
US and German defined benefit plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | (9) | (82) |
US and German defined benefit plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 0 | (1) |
US and German defined benefit plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 5 | 48 |
US and German defined benefit plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Remeasurement of defined benefit obligation | 3 | (11) |
Remaining plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Line Items] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | $ (8) | $ 8 |
Defined benefit plans (Detail 6
Defined benefit plans (Detail 6) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Swiss defined benefit plan | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Duration of the defined benefit obligation | 14 years 1 month 6 days | 13 years 4 months 24 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 811 | $ 702 |
Benefits expected to be paid between 1 and 3 years | 1,627 | 1,445 |
Benefits expected to be paid between 3 and 6 years | 2,552 | 2,183 |
Benefits expected to be paid between 6 and 11 years | 4,233 | 3,751 |
Benefits expected to be paid between 11 and 16 years | 3,878 | 3,519 |
Benefits expected to be paid in more than 16 years | $ 13,751 | $ 13,243 |
UK defined benefit plan | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Duration of the defined benefit obligation | 14 years 6 months | 13 years 8 months 12 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 137 | $ 107 |
Benefits expected to be paid between 1 and 3 years | 256 | 234 |
Benefits expected to be paid between 3 and 6 years | 415 | 384 |
Benefits expected to be paid between 6 and 11 years | 721 | 667 |
Benefits expected to be paid between 11 and 16 years | 723 | 667 |
Benefits expected to be paid in more than 16 years | $ 2,703 | $ 2,570 |
US and German defined benefit plans | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Duration of the defined benefit obligation | 7 years 9 months 18 days | 7 years 10 months 24 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 133 | $ 123 |
Benefits expected to be paid between 1 and 3 years | 235 | 232 |
Benefits expected to be paid between 3 and 6 years | 336 | 335 |
Benefits expected to be paid between 6 and 11 years | 502 | 502 |
Benefits expected to be paid between 11 and 16 years | 376 | 388 |
Benefits expected to be paid in more than 16 years | $ 417 | $ 516 |
Defined benefit plans (Detail 7
Defined benefit plans (Detail 7) | Dec. 31, 2023 | Dec. 31, 2022 |
Swiss defined benefit plan | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Discount rate | 1.48% | 2.34% |
Rate of pension increase | 0% | 0% |
Rate of interest credit on retirement savings | 2.48% | 3.39% |
UK defined benefit plan | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Discount rate | 4.79% | 5.02% |
Rate of pension increase | 3% | 3.08% |
Rate of interest credit on retirement savings | 0% | 0% |
US defined benefit plans | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Discount rate | 4.72% | 4.92% |
Rate of pension increase | 0% | 0% |
Rate of interest credit on retirement savings | 6.28% | 5.73% |
German defined benefit plans | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Discount rate | 3.28% | 3.81% |
Rate of pension increase | 2.10% | 2.20% |
Rate of interest credit on retirement savings | 0% | 0% |
Defined benefit plans (Detail 8
Defined benefit plans (Detail 8) - yr | Dec. 31, 2023 | Dec. 31, 2022 |
Switzerland | aged 65 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 21.8 | 21.7 |
Life expectancy at age 65 for a female member currently | 23.5 | 23.5 |
Switzerland | aged 45 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 23.5 | 23.4 |
Life expectancy at age 65 for a female member currently | 25.1 | 25.1 |
UK | aged 65 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 22.2 | 23.5 |
Life expectancy at age 65 for a female member currently | 24 | 25 |
UK | aged 45 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 23.4 | 24.6 |
Life expectancy at age 65 for a female member currently | 25.7 | 26.4 |
United States | aged 65 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 22 | 22 |
Life expectancy at age 65 for a female member currently | 23.5 | 23.4 |
United States | aged 45 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 23.4 | 23.3 |
Life expectancy at age 65 for a female member currently | 24.8 | 24.8 |
Germany | aged 65 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 20.8 | 20.6 |
Life expectancy at age 65 for a female member currently | 24.2 | 24 |
Germany | aged 45 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Line Items] | ||
Life expectancy at age 65 for a male member currently | 23.5 | 23.4 |
Life expectancy at age 65 for a female member currently | 26.4 | 26.3 |
Defined benefit plans (Detail 9
Defined benefit plans (Detail 9) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Swiss defined benefit plan | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 0% | 0% |
Swiss defined benefit plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (857) | $ (641) |
Decrease by 50 basis points | 973 | 723 |
Swiss defined benefit plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 639 | 487 |
Swiss defined benefit plan | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 144 | 106 |
Decrease by 50 basis points | (144) | (106) |
Swiss defined benefit plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 416 | $ 304 |
UK defined benefit plan | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 3% | 3.08% |
UK defined benefit plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (164) | $ (141) |
Decrease by 50 basis points | 183 | 157 |
UK defined benefit plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 137 | 127 |
Decrease by 50 basis points | (129) | (118) |
UK defined benefit plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | 78 | 65 |
US and German defined benefit plans | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | (50) | (51) |
Decrease by 50 basis points | 54 | 55 |
US and German defined benefit plans | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 4 | 4 |
Decrease by 50 basis points | (4) | (3) |
US and German defined benefit plans | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 9 | 9 |
Decrease by 50 basis points | (8) | (8) |
US and German defined benefit plans | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 39 | $ 39 |
Defined benefit plans (Detail 1
Defined benefit plans (Detail 10) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Swiss defined benefit plan | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 19,333 | $ 16,957 |
Plan asset allocation % | 100% | 100% |
Swiss defined benefit plan | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 62 | $ 183 |
Plan asset allocation % | 0% | 1% |
Swiss defined benefit plan | Real estate / property - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2,426 | $ 2,130 |
Plan asset allocation % | 13% | 13% |
Swiss defined benefit plan | Real estate / property - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 576 | $ 517 |
Plan asset allocation % | 3% | 3% |
Swiss defined benefit plan | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 489 | $ 418 |
Plan asset allocation % | 3% | 2% |
Swiss defined benefit plan | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 4,526 | $ 4,017 |
Plan asset allocation % | 23% | 24% |
Swiss defined benefit plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2,605 | $ 2,117 |
Plan asset allocation % | 13% | 12% |
Swiss defined benefit plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 4,073 | $ 3,395 |
Plan asset allocation % | 21% | 20% |
Swiss defined benefit plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 668 | $ 598 |
Plan asset allocation % | 3% | 4% |
Swiss defined benefit plan | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 45 | $ 0 |
Plan asset allocation % | 0% | 0% |
Swiss defined benefit plan | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 3,004 | $ 2,864 |
Plan asset allocation % | 16% | 17% |
Swiss defined benefit plan | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 859 | $ 718 |
Plan asset allocation % | 4% | 4% |
Swiss defined benefit plan | Quoted in an active market | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 12,652 | $ 10,724 |
Swiss defined benefit plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 62 | 183 |
Swiss defined benefit plan | Quoted in an active market | Real estate / property - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Quoted in an active market | Real estate / property - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 489 | 418 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 3,283 | 2,794 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 2,605 | 2,117 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 4,073 | 3,395 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 668 | 598 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 1,094 | 867 |
Swiss defined benefit plan | Quoted in an active market | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 378 | 351 |
Swiss defined benefit plan | Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 6,681 | 6,233 |
Swiss defined benefit plan | Other | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Other | Real estate / property - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 2,426 | 2,130 |
Swiss defined benefit plan | Other | Real estate / property - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 576 | 517 |
Swiss defined benefit plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 1,244 | 1,222 |
Swiss defined benefit plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
Swiss defined benefit plan | Other | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 45 | 0 |
Swiss defined benefit plan | Other | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 1,910 | 1,997 |
Swiss defined benefit plan | Other | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 481 | 367 |
UK defined benefit plan | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2,720 | $ 2,488 |
Plan asset allocation % | 100% | 100% |
UK defined benefit plan | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ (27) | $ 104 |
Plan asset allocation % | (1.00%) | 4% |
UK defined benefit plan | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2,375 | $ 1,729 |
Plan asset allocation % | 87% | 69% |
UK defined benefit plan | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 357 | $ 297 |
Plan asset allocation % | 13% | 12% |
UK defined benefit plan | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 0 | $ 7 |
Plan asset allocation % | 0% | 0% |
UK defined benefit plan | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 12 | $ 22 |
Plan asset allocation % | 0% | 1% |
UK defined benefit plan | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 234 | $ 366 |
Plan asset allocation % | 9% | 15% |
UK defined benefit plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 348 | $ 457 |
Plan asset allocation % | 13% | 18% |
UK defined benefit plan | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 6 | $ 1 |
Plan asset allocation % | 0% | 0% |
UK defined benefit plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 97 | $ 90 |
Plan asset allocation % | 4% | 4% |
UK defined benefit plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 93 | $ 114 |
Plan asset allocation % | 3% | 5% |
UK defined benefit plan | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 61 | $ 64 |
Plan asset allocation % | 2% | 3% |
UK defined benefit plan | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 16 | $ 36 |
Plan asset allocation % | 1% | 1% |
UK defined benefit plan | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 64 | $ (280) |
Plan asset allocation % | 2% | (11.00%) |
UK defined benefit plan | Repurchase agreements | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ (947) | $ (612) |
Plan asset allocation % | (35.00%) | (25.00%) |
UK defined benefit plan | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 31 | $ 94 |
Plan asset allocation % | 1% | 4% |
UK defined benefit plan | Quoted in an active market | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2,652 | $ 2,336 |
UK defined benefit plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | (27) | 104 |
UK defined benefit plan | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 2,375 | 1,729 |
UK defined benefit plan | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 357 | 297 |
UK defined benefit plan | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 7 |
UK defined benefit plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 9 | 19 |
UK defined benefit plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 234 | 366 |
UK defined benefit plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 310 | 367 |
UK defined benefit plan | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 6 | 1 |
UK defined benefit plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 97 | 90 |
UK defined benefit plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 93 | 114 |
UK defined benefit plan | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 61 | 64 |
UK defined benefit plan | Quoted in an active market | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 4 | 6 |
UK defined benefit plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 64 | (280) |
UK defined benefit plan | Quoted in an active market | Repurchase agreements | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | (947) | (612) |
UK defined benefit plan | Quoted in an active market | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 15 | 66 |
UK defined benefit plan | Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 69 | 151 |
UK defined benefit plan | Other | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 3 | 3 |
UK defined benefit plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 38 | 90 |
UK defined benefit plan | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Investment funds - Real estate - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 12 | 31 |
UK defined benefit plan | Other | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Repurchase agreements | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
UK defined benefit plan | Other | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 16 | 27 |
US and German defined benefit plans | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 1,017 | $ 1,039 |
Plan asset allocation % | 100% | 100% |
US and German defined benefit plans | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 4 | $ 7 |
Plan asset allocation % | 0% | 1% |
US and German defined benefit plans | Equity securities - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 54 | $ 55 |
Plan asset allocation % | 5% | 5% |
US and German defined benefit plans | Equity securities - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 23 | $ 24 |
Plan asset allocation % | 2% | 2% |
US and German defined benefit plans | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 308 | $ 359 |
Plan asset allocation % | 30% | 35% |
US and German defined benefit plans | Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 3 | $ 4 |
Plan asset allocation % | 0% | 0% |
US and German defined benefit plans | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 51 | $ 74 |
Plan asset allocation % | 5% | 7% |
US and German defined benefit plans | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 2 | $ 3 |
Plan asset allocation % | 0% | 0% |
US and German defined benefit plans | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 25 | $ 27 |
Plan asset allocation % | 2% | 3% |
US and German defined benefit plans | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 43 | $ 33 |
Plan asset allocation % | 4% | 3% |
US and German defined benefit plans | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 271 | $ 266 |
Plan asset allocation % | 27% | 26% |
US and German defined benefit plans | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 172 | $ 109 |
Plan asset allocation % | 17% | 10% |
US and German defined benefit plans | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 4 | $ 2 |
Plan asset allocation % | 0% | 0% |
US and German defined benefit plans | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 6 | $ 5 |
Plan asset allocation % | 1% | 0% |
US and German defined benefit plans | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 9 | $ 11 |
Plan asset allocation % | 1% | 1% |
US and German defined benefit plans | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 49 | $ 54 |
Plan asset allocation % | 5% | 5% |
US and German defined benefit plans | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ (7) | $ 6 |
Plan asset allocation % | (1.00%) | 1% |
US and German defined benefit plans | Quoted in an active market | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 1,007 | $ 1,027 |
US and German defined benefit plans | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 4 | 7 |
US and German defined benefit plans | Quoted in an active market | Equity securities - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 54 | 55 |
US and German defined benefit plans | Quoted in an active market | Equity securities - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 23 | 24 |
US and German defined benefit plans | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 308 | 359 |
US and German defined benefit plans | Quoted in an active market | Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 3 | 4 |
US and German defined benefit plans | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 51 | 74 |
US and German defined benefit plans | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 2 | 3 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 25 | 27 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 43 | 33 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 271 | 266 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 172 | 109 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 4 | 2 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 6 | 5 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 49 | 54 |
US and German defined benefit plans | Quoted in an active market | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | (8) | 5 |
US and German defined benefit plans | Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 10 | 12 |
US and German defined benefit plans | Other | Cash and cash equivalents | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Equity securities - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Equity securities - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 9 | 11 |
US and German defined benefit plans | Other | Investment funds - Other | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | 0 | 0 |
US and German defined benefit plans | Other | Other investments | ||
Disclosure Of Fair Value Of Plan Assets [Line Items] | ||
Fair value | $ 1 | $ 1 |
Defined benefit plans (Detail_5
Defined benefit plans (Detail 11) - Swiss defined benefit plan - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | $ 19,333 | $ 16,957 |
Derivative financial instruments, net of collateral | (19) | (5) |
Bank accounts at UBS Group AG | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | 69 | 189 |
UBS Group AG debt instruments | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | 116 | 28 |
UBS Group AG shares | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | 26 | 15 |
Securities lent to UBS Group AG | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | 467 | 489 |
Property occupied by UBS Group AG | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | 61 | 51 |
Derivative financial instruments, counterparty UBS Group AG | ||
Plan Assets At Fair Value By Plan [Line Items] | ||
Fair value | $ 302 | $ 43 |
Defined contribution plans (Nar
Defined contribution plans (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Defined Contribution Plans [Line Items] | |||
Total employer contributions to defined contribution plans | $ 320 | $ 299 | $ 303 |
Related party disclosure (Narra
Related party disclosure (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Related Party Disclosure On Pension And Other Post Employment Benefit Plans [Line Items] | ||
Fees | $ 20 | $ 20 |
Fair value | $ 396 | $ 253 |
Employee benefits_ variable c_3
Employee benefits: variable compensation (Narrative) (Detail 1) | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Contingent Capital Plan | |
Equity Participation And Other Compensation Plans [Line Items] | |
Percentage of awards that GEB members forfeit for each year during the vesting period in which UBS does not achieve an adjusted profit before tax | 20% |
Employee benefits_ variable c_4
Employee benefits: variable compensation (Narrative) (Detail 2) $ in Millions | Dec. 31, 2023 USD ($) yr | Dec. 31, 2022 USD ($) |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] | ||
Carrying amount of liability related to cash-settled share-based awards | $ | $ 14 | $ 7 |
Unvested share-based awards | ||
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] | ||
Weighted average remaining contractual term (years) | yr | 2.6 |
Employee benefits_ variable c_5
Employee benefits: variable compensation - Effect on income statement (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | $ 7,669 | $ 7,636 | $ 7,973 |
Variable compensation deferred to the next and following years | 6,242 | 5,672 | 5,181 |
Variable compensation related to share-based compensation | 818 | 680 | 631 |
Variable compensation related to share-based compensation - performance awards | 575 | 457 | 419 |
Variable compensation related to share-based compensation - other variable compensation | 46 | 56 | 56 |
Variable compensation related to share-based compensation - financial advisor variable compensation | 197 | 166 | 157 |
Variable compensation related to share-based compensation recognized within other personnel expenses categories | 135 | 80 | 77 |
Salaries related to share-based compensation | 4 | 4 | 5 |
Social security related to share-based compensation | 109 | 57 | 59 |
Personnel expenses related to share-based compensation - Equity Plus Plan | 22 | 19 | 13 |
Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 6,169 | 6,304 | 6,863 |
Variable compensation deferred to the next and following years | 1,997 | 2,101 | 2,074 |
Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 1,500 | 1,332 | 1,109 |
Variable compensation deferred to the next and following years | 4,245 | 3,571 | 3,107 |
Variable compensation - performance awards | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 2,841 | 2,910 | 2,916 |
Variable compensation deferred to the next and following years | 1,268 | 1,312 | 1,373 |
Variable compensation - performance awards | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 2,240 | 2,358 | 2,525 |
Variable compensation deferred to the next and following years | 537 | 582 | 767 |
Variable compensation - performance awards | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 601 | 552 | 391 |
Variable compensation deferred to the next and following years | 731 | 730 | 606 |
Non-deferred cash | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 1,848 | 2,003 | 2,128 |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
Non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 1,884 | 2,012 | 2,136 |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
Non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | (36) | (9) | (8) |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
Deferred compensation awards | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 993 | 907 | 788 |
Variable compensation deferred to the next and following years | 1,268 | 1,312 | 1,373 |
Deferred compensation awards | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 356 | 346 | 389 |
Variable compensation deferred to the next and following years | 537 | 582 | 767 |
Deferred compensation awards | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 637 | 561 | 399 |
Variable compensation deferred to the next and following years | 731 | 730 | 606 |
of which: Equity Ownership Plan | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 415 | 416 | 350 |
Variable compensation deferred to the next and following years | 416 | 534 | 553 |
of which: Equity Ownership Plan | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 95 | 191 | 175 |
Variable compensation deferred to the next and following years | 180 | 294 | 374 |
of which: Equity Ownership Plan | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 319 | 225 | 174 |
Variable compensation deferred to the next and following years | 235 | 240 | 180 |
of which: Deferred Contingent Capital Plan | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 357 | 334 | 285 |
Variable compensation deferred to the next and following years | 652 | 634 | 608 |
of which: Deferred Contingent Capital Plan | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 124 | 123 | 134 |
Variable compensation deferred to the next and following years | 216 | 238 | 290 |
of which: Deferred Contingent Capital Plan | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 233 | 211 | 151 |
Variable compensation deferred to the next and following years | 436 | 395 | 318 |
of which: Long Term Incentive Plan | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 160 | 41 | 69 |
Variable compensation deferred to the next and following years | 145 | 70 | 79 |
of which: Long Term Incentive Plan | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 121 | 11 | 51 |
Variable compensation deferred to the next and following years | 112 | 30 | 48 |
of which: Long Term Incentive Plan | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 39 | 30 | 17 |
Variable compensation deferred to the next and following years | 33 | 40 | 32 |
of which: Fund Ownership Plan | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 61 | 116 | 84 |
Variable compensation deferred to the next and following years | 55 | 74 | 133 |
of which: Fund Ownership Plan | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 15 | 21 | 29 |
Variable compensation deferred to the next and following years | 28 | 20 | 56 |
of which: Fund Ownership Plan | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 45 | 95 | 55 |
Variable compensation deferred to the next and following years | 27 | 54 | 77 |
Variable compensation - other | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 279 | 217 | 196 |
Variable compensation deferred to the next and following years | 438 | 419 | 388 |
Variable compensation - other | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 168 | 146 | 163 |
Variable compensation deferred to the next and following years | 224 | 230 | 210 |
Variable compensation - other | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 111 | 72 | 33 |
Variable compensation deferred to the next and following years | 214 | 189 | 178 |
Variable compensation - financial advisors | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 4,549 | 4,508 | 4,860 |
Variable compensation deferred to the next and following years | 4,536 | 3,942 | 3,419 |
Variable compensation - financial advisors | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 3,761 | 3,799 | 4,175 |
Variable compensation deferred to the next and following years | 1,236 | 1,290 | 1,097 |
Variable compensation - financial advisors | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 788 | 709 | 685 |
Variable compensation deferred to the next and following years | 3,300 | 2,652 | 2,323 |
of which: non-deferred cash | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 3,436 | 3,481 | 3,853 |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 3,440 | 3,481 | 3,858 |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | (4) | 0 | (6) |
Variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: deferred share-based awards | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 197 | 166 | 157 |
Variable compensation deferred to the next and following years | 321 | 302 | 269 |
of which: deferred share-based awards | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 110 | 104 | 106 |
Variable compensation deferred to the next and following years | 113 | 122 | 123 |
of which: deferred share-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 87 | 62 | 51 |
Variable compensation deferred to the next and following years | 209 | 180 | 146 |
of which: deferred cash-based awards | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 414 | 400 | 372 |
Variable compensation deferred to the next and following years | 1,331 | 1,224 | 806 |
of which: deferred cash-based awards | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 169 | 185 | 170 |
Variable compensation deferred to the next and following years | 301 | 588 | 311 |
of which: deferred cash-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 245 | 215 | 202 |
Variable compensation deferred to the next and following years | 1,029 | 636 | 495 |
of which : compensation commitments with recruited financial advisors | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 501 | 461 | 479 |
Variable compensation deferred to the next and following years | 2,884 | 2,416 | 2,344 |
of which : compensation commitments with recruited financial advisors | Related to performance year | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 42 | 29 | 41 |
Variable compensation deferred to the next and following years | 822 | 580 | 662 |
of which : compensation commitments with recruited financial advisors | Related to prior performance years | |||
Income Statement Compensation Items [Line Items] | |||
Variable compensation for the current year | 459 | 432 | 438 |
Variable compensation deferred to the next and following years | $ 2,062 | $ 1,836 | $ 1,682 |
Employee benefits_ variable c_6
Employee benefits: variable compensation - Movements (Detail) | 12 Months Ended | |
Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) shares | |
Share Awards [Line Items] | ||
Number of shares outstanding, at the beginning of the year | 614,428 | 295,921 |
Number of shares awarded during the year | 279,310 | 358,424 |
Number of share distributions during the year | (132,770) | (37,994) |
Number of shares forfeited during the year | (4,043) | (1,923) |
Number of shares outstanding, at the end of the year | 756,925 | 614,428 |
Number of shares vested for accounting purposes | 217,420 | 174,329 |
Weighted average grant date fair value of shares outstanding, at the beginning of the year | $ | $ 17 | $ 15 |
Weighted average grant date fair value of shares awarded during the year | $ | 20 | 19 |
Weighted average grant date fair value of share distributions during the year | $ | 15 | 14 |
Weighted average grant date fair value of shares forfeited during the year | $ | 19 | 15 |
Weighted average grant date fair value of shares outstanding, at the end of the year | $ | $ 19 | $ 17 |
Interests in subsidiaries (Deta
Interests in subsidiaries (Detail 1) € in Millions, SFr in Millions | 12 Months Ended | |||
Dec. 31, 2023 CHF (SFr) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Individually significant subsidiaries of UBS AG | ||||
Share capital | $ 386,000,000 | $ 338,000,000 | ||
UBS Americas Holding LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Holding LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Items | |||
Share capital | 2,900,000,000 | |||
Equity interest accumulated in % | 100% | |||
Common share capital | 1,000 | |||
Preference share capital | 2,900,000,000 | |||
UBS Americas Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Items | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100% | |||
UBS Asset Management AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Asset Management AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Asset Management | |||
Share capital | SFr | SFr 43.2 | |||
Equity interest accumulated in % | 100% | |||
UBS Bank USA | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Bank USA | |||
Registered office | Salt Lake City, Utah, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100% | |||
UBS Europe SE | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Europe SE | |||
Registered office | Frankfurt, Germany | |||
Primary business division | Global Wealth Management | |||
Share capital | € | € 446 | |||
Equity interest accumulated in % | 100% | |||
UBS Financial Services Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Financial Services Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100% | |||
UBS Securities LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Securities LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Investment Bank | |||
Share capital | 1,283,100,000 | |||
Equity interest accumulated in % | 100% | |||
Common share capital | 100,000 | |||
Preference share capital | $ 1,283,000,000 | |||
UBS Switzerland AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Switzerland AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Personal & Corporate Banking | |||
Share capital | SFr | SFr 10 | |||
Equity interest accumulated in % | 100% |
Interests in subsidiaries (De_2
Interests in subsidiaries (Detail 2) € in Millions, ¥ in Millions, £ in Millions, SFr in Millions, $ in Millions, $ in Millions, $ in Millions | 12 Months Ended | |||||||
Dec. 31, 2023 AUD ($) | Dec. 31, 2023 CHF (SFr) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 GBP (£) | Dec. 31, 2023 HKD ($) | Dec. 31, 2023 JPY (¥) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Share capital | $ 386 | $ 338 | ||||||
UBS Asset Management (Americas) Inc. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Asset Management (Americas) Inc. | |||||||
Registered office | Wilmington, Delaware, USA | |||||||
Primary business division | Asset Management | |||||||
Share capital | 0 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Asset Management (Hong Kong) Limited | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Asset Management (Hong Kong) Limited | |||||||
Registered office | Hong Kong SAR, China | |||||||
Primary business division | Asset Management | |||||||
Share capital | $ 153.8 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Asset Management Life Ltd | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Asset Management Life Ltd | |||||||
Registered office | London, United Kingdom | |||||||
Primary business division | Asset Management | |||||||
Share capital | £ | £ 15 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Asset Management Switzerland AG | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Asset Management Switzerland AG | |||||||
Registered office | Zurich, Switzerland | |||||||
Primary business division | Asset Management | |||||||
Share capital | SFr | SFr 0.5 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Business Solutions US LLC | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Business Solutions US LLC | |||||||
Registered office | Wilmington, Delaware, USA | |||||||
Primary business division | Group Items | |||||||
Share capital | 0 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Credit Corp. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Credit Corp. | |||||||
Registered office | Wilmington, Delaware, USA | |||||||
Primary business division | Global Wealth Management | |||||||
Share capital | 0 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Fund Management (Luxembourg) S.A. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Fund Management (Luxembourg) S.A. | |||||||
Registered office | Luxembourg, Luxembourg | |||||||
Primary business division | Asset Management | |||||||
Share capital | € | € 13.7 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Fund Management (Switzerland) AG | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Fund Management (Switzerland) AG | |||||||
Registered office | Basel, Switzerland | |||||||
Primary business division | Asset Management | |||||||
Share capital | SFr | SFr 1 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS (Monaco) S.A. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS (Monaco) S.A. | |||||||
Registered office | Monte Carlo, Monaco | |||||||
Primary business division | Global Wealth Management | |||||||
Share capital | € | € 49.2 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS O'Connor LLC | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS O‘Connor LLC | |||||||
Registered office | Wilmington, Delaware, USA | |||||||
Primary business division | Asset Management | |||||||
Share capital | 1 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Realty Investors LLC | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Realty Investors LLC | |||||||
Registered office | Boston, Massachusetts, USA | |||||||
Primary business division | Asset Management | |||||||
Share capital | $ 9 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Securities Australia Ltd | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Securities Australia Ltd | |||||||
Registered office | Sydney, Australia | |||||||
Primary business division | Investment Bank | |||||||
Share capital | $ 0.3 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Securities Hong Kong Limited | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Securities Hong Kong Limited | |||||||
Registered office | Hong Kong SAR, China | |||||||
Primary business division | Investment Bank | |||||||
Share capital | $ 2,841.6 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS Securities Japan Co., Ltd. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS Securities Japan Co., Ltd. | |||||||
Registered office | Tokyo, Japan | |||||||
Primary business division | Investment Bank | |||||||
Share capital | ¥ | ¥ 34,708.7 | |||||||
Equity interest accumulated in % | 100% | |||||||
UBS SuMi TRUST Wealth Management Co., Ltd. | ||||||||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Line Items] | ||||||||
Company | UBS SuMi TRUST Wealth Management Co., Ltd. | |||||||
Registered office | Tokyo, Japan | |||||||
Primary business division | Global Wealth Management | |||||||
Share capital | ¥ | ¥ 5,165 | |||||||
Equity interest accumulated in % | 51% |
Interests in associates and j_2
Interests in associates and joint ventures (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Investments In Associates And Joint Ventures [Line Items] | |||
Carrying amount at the beginning of the year | $ 1,101 | $ 1,243 | |
Additions | 1 | 3 | |
Reclassifications | 0 | (44) | |
Share of comprehensive income | (180) | (41) | |
of which: share of net profit / (loss) | (163) | 32 | $ 105 |
of which: share of other comprehensive income | (17) | (73) | |
Share of changes in retained earnings | (1) | 0 | |
Dividends received | (35) | (31) | |
Foreign currency translation | 97 | (30) | |
Carrying amount at the end of the year | 983 | 1,101 | $ 1,243 |
Share of profit (loss) of associates | (163) | 27 | |
Share of profit (loss) of joint ventures | 5 | ||
Share of other comprehensive income of associates | (17) | (73) | |
Joint ventures | |||
Disclosure Of Investments In Associates And Joint Ventures [Line Items] | |||
of which: joint ventures | 3 | 3 | |
Associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Line Items] | |||
of which: associates | 980 | 1,098 | |
SIX Group AG, Zurich | |||
Disclosure Of Investments In Associates And Joint Ventures [Line Items] | |||
of which: associates | $ 826 | 954 | |
Proportion of ownership interest in associate | 17% | ||
of which: other associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Line Items] | |||
of which: associates | $ 154 | $ 144 |
Interests in unconsolidated s_2
Interests in unconsolidated structured entities (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Sponsored [Member] | Non Existence Of Interest [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets transferred to client vehicles by UBS, at time of transfer | $ 500 | $ 1,000 |
Assets transferred to client vehicles by third parties, at time of transfer | 500 | 3,000 |
Total closing net asset value of sponsored investment funds | 44,000 | 38,000 |
Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 118 | 95 |
Interests in Investment funds not represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | $ 356,000 | $ 336,000 |
Interests in unconsolidated s_3
Interests in unconsolidated structured entities (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2023 | |
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Increase / (decrease) in interests in securitization vehicles | $ (852) | |
Increase / (decrease) in interests in client vehicles | (5,057) | |
Increase / (decrease) in assets held by securitization vehicles | (11,000) | |
Increase / (decrease) in assets held by client vehicles | (105,000) | |
Financial Assets [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 6,907 | $ 8,534 |
Total assets | 6,657 | 8,285 |
Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 6,149 | 7,538 |
Total assets | 6,149 | 7,538 |
Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 278 | 215 |
Total assets | 278 | 215 |
Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 119 | 200 |
Total assets | 119 | 200 |
Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 108 | 143 |
Total assets | 108 | 143 |
Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 0 | 0 |
Total assets | 0 | 0 |
Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 252 | 438 |
Total assets | 3 | 188 |
Financial Liabilities [Member[ | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 2 | 2 |
Total liabilities | 798 | 598 |
Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Maximum exposure to loss | 2 | 2 |
Total liabilities | 798 | 598 |
Securitization vehicles | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 39 | 17 |
Securitization vehicles | Financial Assets [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 266 | 278 |
Securitization vehicles | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 263 | 88 |
Securitization vehicles | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 3 | 2 |
Securitization vehicles | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Securitization vehicles | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Securitization vehicles | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Securitization vehicles | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 188 |
Securitization vehicles | Financial Liabilities [Member[ | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 1 | 1 |
Securitization vehicles | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 1 | 1 |
Client Vehicles sponsored by UBS | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 2 | 2 |
Client Vehicles sponsored by UBS | Financial Assets [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 162 | 185 |
Client Vehicles sponsored by UBS | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 2 | 37 |
Client Vehicles sponsored by UBS | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 160 | 147 |
Client Vehicles sponsored by UBS | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Client Vehicles sponsored by UBS | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Client Vehicles sponsored by UBS | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Client Vehicles sponsored by UBS | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Client Vehicles sponsored by UBS | Financial Liabilities [Member[ | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 35 | 8 |
Client Vehicles sponsored by UBS | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 35 | 8 |
Investment funds | Financial Assets [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 6,228 | 7,821 |
Investment funds | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 5,884 | 7,413 |
Investment funds | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 115 | 66 |
Investment funds | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 119 | 200 |
Investment funds | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 108 | 143 |
Investment funds | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 0 | 0 |
Investment funds | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total assets | 2 | 0 |
Investment funds | Financial Liabilities [Member[ | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 763 | 590 |
Investment funds | Derivative financial instruments | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Total liabilities | 763 | 590 |
Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Line Items] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | $ 95 | $ 118 |
Changes in organization and a_2
Changes in organization and acquisitions and disposals of subsidiaries and businesses (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Changes In Organisation [Line Items] | |||
Other income other | $ 112 | $ 308 | $ 224 |
Asset Management | |||
Disclosure Of Changes In Organisation [Line Items] | |||
Other income other | $ 23 | ||
UBS Hana Asset Management Co Ltd [Member] | |||
Disclosure Of Changes In Organisation [Line Items] | |||
Proportion of ownership interest in subsidiary | 51% |
Related parties (Narrative) (De
Related parties (Narrative) (Detail) SFr in Millions, $ in Millions | 12 Months Ended | ||||||
Dec. 31, 2023 CHF (SFr) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 CHF (SFr) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 CHF (SFr) | Dec. 31, 2021 USD ($) | Dec. 31, 2023 USD ($) | |
Related Parties [Line Items] | |||||||
Payments to external board members | SFr 10.6 | $ 11.7 | SFr 10.7 | $ 11.1 | SFr 6.9 | $ 7.5 | |
Outstanding deposit balances with key management personnel | SFr 18 | $ 21 |
Related parties (Detail 1)
Related parties (Detail 1) SFr in Millions, $ in Millions | 12 Months Ended | |||||
Dec. 31, 2023 CHF (SFr) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 CHF (SFr) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 CHF (SFr) | Dec. 31, 2021 USD ($) | |
Remuneration Of Key Management Personnel [Line Items] | ||||||
Base salaries and other cash payments | $ 35 | $ 26 | $ 30 | |||
Incentive awards - cash | 24 | 16 | 17 | |||
Annual incentive award under DCCP | 36 | 23 | 26 | |||
Employer's contributions to retirement benefit plans | 3 | 2 | 2 | |||
Benefits in kind, fringe benefits (at market value) | 1 | 1 | 1 | |||
Equity-based compensation | 63 | 42 | 45 | |||
Total | SFr 147 | $ 162 | SFr 106 | $ 110 | SFr 112 | $ 122 |
Applicable performance award currency exchange rate | 0.91 | 0.91 | 0.96 | 0.96 | 0.92 | 0.92 |
Related parties (Detail 2)
Related parties (Detail 2) - shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Equity Holdings Of Key Management Personnel [Line Items] | ||
Number of shares held by members of the BoD, GEB and parties closely linked to them | 5,121,564 | 2,443,580 |
Related parties (Detail 3)
Related parties (Detail 3) - Dec. 31, 2023 SFr in Millions, $ in Millions | CHF (SFr) | USD ($) |
Loans Advances And Mortgages To Key Management Personnel [Line Items] | ||
Unused uncommitted credit facilities | SFr 12 | $ 14 |
Related parties (Detail 4)
Related parties (Detail 4) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Outstanding Balances For Related Party Transactions [Line Items] | ||
Carrying amount at the beginning of the year | $ 217 | $ 251 |
Additions | 664 | 402 |
Reductions | (716) | (438) |
Foreign currency translation | 18 | 1 |
Carrying amount at the end of the year | 183 | 217 |
of which: unsecured loans and receivables | 174 | 209 |
Other transactions with associates and joint ventures | ||
Payments to associates and joint ventures for goods and services received | 155 | 138 |
Fees received for services provided to associates and joint ventures | 10 | 4 |
Liabilities to associates and joint ventures | 103 | 90 |
Commitments and contingent liabilities to associates and joint ventures | $ 8 | $ 7 |
Related parties (Detail 5)
Related parties (Detail 5) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Receivables | ||
Amounts due from banks | $ 14,752 | $ 0 |
Cash collateral receivables on derivative instruments | 312 | 1 |
Loans and advances to customers | 4,889 | 2,807 |
Other financial assets measured at amortized cost | 232 | 147 |
Financial assets at fair value held for trading | 325 | 146 |
Derivative financial instruments | 3,031 | 1 |
Payables | ||
Amounts due to banks | 364 | 0 |
Cash collateral payables on derivative instruments | 1,447 | 0 |
Customer deposits | 3,069 | 2,119 |
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 |
Other financial liabilities measured at amortized cost | 2,574 | 1,985 |
Derivative financial instruments | 2,032 | 0 |
Other financial liabilities designated at fair value | $ 2,995 | $ 1,796 |
Invested assets and net new m_3
Invested assets and net new money (Detail 1) - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Invested Assets And Net New Money [Line Items] | |||
Fund assets managed by UBS | $ 429 | $ 390 | |
Discretionary assets | 1,674 | 1,464 | |
Other invested assets | 2,402 | 2,127 | |
Total invested assets | 4,505 | 3,981 | $ 4,614 |
of which: double counts | 411 | 340 | |
Net new money | $ 112 | 76 | |
Asset Management | |||
Invested Assets And Net New Money [Line Items] | |||
Increase to invested assets | 24 | ||
Increase to new new money | $ 8 |
Invested assets and net new m_4
Invested assets and net new money (Detail 2) - USD ($) $ in Billions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Development Of Invested Assets [Line Items] | ||
Total invested assets at the beginning of the year | $ 3,981 | $ 4,614 |
Net new money | 112 | 76 |
Market movements | 379 | (596) |
Foreign currency translation | 69 | (74) |
Other effects | (37) | (40) |
of which: acquisitions / (divestments) | (25) | (19) |
Total invested assets at the end of the year | $ 4,505 | $ 3,981 |
Currency translation rates (Det
Currency translation rates (Detail) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
1 CHF | |||
Foreign Exchange Rates [Line Items] | |||
Closing exchange rate | 1.19 | 1.08 | |
Average rate | 1.11 | 1.05 | 1.09 |
1 EUR | |||
Foreign Exchange Rates [Line Items] | |||
Closing exchange rate | 1.10 | 1.07 | |
Average rate | 1.08 | 1.05 | 1.18 |
1 GBP | |||
Foreign Exchange Rates [Line Items] | |||
Closing exchange rate | 1.28 | 1.21 | |
Average rate | 1.25 | 1.23 | 1.37 |
100 JPY | |||
Foreign Exchange Rates [Line Items] | |||
Closing exchange rate | 0.71 | 0.76 | |
Average rate | 0.71 | 0.76 | 0.91 |
Main differences between IFRS_2
Main differences between IFRS and Swiss GAAP (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2023 | |
Main Differences Between IFRS And Swiss GAAP [Line Items] | |
Goodwill, maximum useful life for justified exceptional cases (in years) | 10 years |
Supplemental guarantor inform_3
Supplemental guarantor information (Narrative) (Detail) $ in Billions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Supplemental Guarantor Information [Line Items] | |
Joint and several liability | $ 3.3 |
Increase decrease in joint and several liability | $ (1) |
Supplemental guarantor consolid
Supplemental guarantor consolidated income statement (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Income Statements Captions [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $ 22,444 | $ 11,803 | $ 8,534 |
Interest expense from financial instruments measured at amortized cost | (19,643) | (6,696) | (3,366) |
Net interest income from financial instruments measured at fair value through profit or loss and other | 1,765 | 1,410 | 1,437 |
Net interest income | 4,566 | 6,517 | 6,605 |
Other net income from financial instruments measured at fair value through profit or loss | 9,934 | 7,493 | 5,844 |
Fee and commission income | 20,399 | 20,846 | 24,422 |
Fee and commission expense | (1,790) | (1,823) | (1,985) |
Net fee and commission income | 18,610 | 19,023 | 22,438 |
Other income | 566 | 1,882 | 941 |
Total revenues | 33,675 | 34,915 | 35,828 |
Credit loss expense / (release) | 143 | 29 | (148) |
Personnel expenses | 15,655 | 15,080 | 15,661 |
General and administrative expenses | 11,118 | 9,001 | 9,476 |
Depreciation, amortization and impairment of non-financial assets | 2,238 | 1,845 | 1,875 |
Operating expenses | 29,011 | 25,927 | 27,012 |
Operating profit / (loss) before tax | 4,521 | 8,960 | 8,964 |
Tax expense / (benefit) | 1,206 | 1,844 | 1,903 |
Net profit / (loss) | 3,315 | 7,116 | 7,061 |
Profit Loss Attributable To Noncontrolling Interests | 25 | 32 | 29 |
Net profit / (loss) attributable to shareholders | 3,290 | 7,084 | 7,032 |
Elimination entries | |||
Condensed Income Statements Captions [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | (5,022) | (1,575) | (703) |
Interest expense from financial instruments measured at amortized cost | 5,907 | 2,093 | 1,025 |
Net interest income from financial instruments measured at fair value through profit or loss and other | (864) | (449) | (274) |
Net interest income | 22 | 68 | 48 |
Other net income from financial instruments measured at fair value through profit or loss | (81) | 112 | (83) |
Fee and commission income | (598) | (660) | (770) |
Fee and commission expense | 585 | 652 | 755 |
Net fee and commission income | (13) | (8) | (14) |
Other income | (4,198) | (8,382) | (8,396) |
Total revenues | (4,269) | (8,210) | (8,445) |
Credit loss expense / (release) | 37 | (1) | 24 |
Personnel expenses | 0 | 0 | 1 |
General and administrative expenses | (2,828) | (2,660) | (2,696) |
Depreciation, amortization and impairment of non-financial assets | (109) | (109) | (114) |
Operating expenses | (2,937) | (2,769) | (2,809) |
Operating profit / (loss) before tax | (1,370) | (5,440) | (5,660) |
Tax expense / (benefit) | (48) | 151 | (11) |
Net profit / (loss) | (1,321) | (5,592) | (5,649) |
Profit Loss Attributable To Noncontrolling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | (1,321) | (5,592) | (5,649) |
UBS AG (standalone) | Reportable legal entities | |||
Condensed Income Statements Captions [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 11,181 | 4,824 | 3,130 |
Interest expense from financial instruments measured at amortized cost | (14,797) | (5,449) | (2,847) |
Net interest income from financial instruments measured at fair value through profit or loss and other | 891 | 881 | 1,229 |
Net interest income | (2,725) | 257 | 1,512 |
Other net income from financial instruments measured at fair value through profit or loss | 7,879 | 5,541 | 3,751 |
Fee and commission income | 2,581 | 2,875 | 3,837 |
Fee and commission expense | (705) | (684) | (810) |
Net fee and commission income | 1,876 | 2,191 | 3,027 |
Other income | 2,994 | 6,732 | 7,555 |
Total revenues | 10,023 | 14,721 | 15,845 |
Credit loss expense / (release) | 18 | (17) | (65) |
Personnel expenses | 3,356 | 3,251 | 3,401 |
General and administrative expenses | 3,951 | 3,374 | 4,255 |
Depreciation, amortization and impairment of non-financial assets | 888 | 871 | 949 |
Operating expenses | 8,195 | 7,496 | 8,605 |
Operating profit / (loss) before tax | 1,810 | 7,242 | 7,305 |
Tax expense / (benefit) | 251 | (28) | 203 |
Net profit / (loss) | 1,559 | 7,270 | 7,102 |
Profit Loss Attributable To Noncontrolling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | 1,559 | 7,270 | 7,102 |
UBS Switzerland AG (standalone) | Reportable legal entities | |||
Condensed Income Statements Captions [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 7,229 | 3,894 | 3,652 |
Interest expense from financial instruments measured at amortized cost | (3,055) | (736) | (520) |
Net interest income from financial instruments measured at fair value through profit or loss and other | 785 | 546 | 254 |
Net interest income | 4,959 | 3,704 | 3,386 |
Other net income from financial instruments measured at fair value through profit or loss | 1,031 | 900 | 807 |
Fee and commission income | 5,067 | 4,865 | 5,204 |
Fee and commission expense | (456) | (464) | (481) |
Net fee and commission income | 4,611 | 4,401 | 4,723 |
Other income | 228 | 203 | 221 |
Total revenues | 10,829 | 9,208 | 9,137 |
Credit loss expense / (release) | 57 | 50 | (98) |
Personnel expenses | 2,201 | 1,995 | 2,098 |
General and administrative expenses | 3,840 | 3,258 | 3,442 |
Depreciation, amortization and impairment of non-financial assets | 411 | 340 | 285 |
Operating expenses | 6,452 | 5,592 | 5,825 |
Operating profit / (loss) before tax | 4,320 | 3,566 | 3,409 |
Tax expense / (benefit) | 779 | 638 | 622 |
Net profit / (loss) | 3,540 | 2,928 | 2,788 |
Profit Loss Attributable To Noncontrolling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | 3,540 | 2,928 | 2,788 |
Other subsidiaries | Reportable legal entities | |||
Condensed Income Statements Captions [Line Items] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 9,057 | 4,661 | 2,456 |
Interest expense from financial instruments measured at amortized cost | (7,699) | (2,604) | (1,024) |
Net interest income from financial instruments measured at fair value through profit or loss and other | 952 | 431 | 228 |
Net interest income | 2,310 | 2,488 | 1,660 |
Other net income from financial instruments measured at fair value through profit or loss | 1,105 | 940 | 1,369 |
Fee and commission income | 13,350 | 13,766 | 16,151 |
Fee and commission expense | (1,214) | (1,327) | (1,450) |
Net fee and commission income | 12,136 | 12,439 | 14,702 |
Other income | 1,542 | 3,329 | 1,560 |
Total revenues | 17,092 | 19,197 | 19,291 |
Credit loss expense / (release) | 31 | (3) | (10) |
Personnel expenses | 10,097 | 9,835 | 10,161 |
General and administrative expenses | 6,155 | 5,029 | 4,474 |
Depreciation, amortization and impairment of non-financial assets | 1,048 | 744 | 755 |
Operating expenses | 17,301 | 15,607 | 15,390 |
Operating profit / (loss) before tax | (240) | 3,592 | 3,910 |
Tax expense / (benefit) | 224 | 1,083 | 1,090 |
Net profit / (loss) | (463) | 2,509 | 2,820 |
Profit Loss Attributable To Noncontrolling Interests | 25 | 32 | 29 |
Net profit / (loss) attributable to shareholders | $ (488) | $ 2,477 | $ 2,792 |
Supplemental guarantor consol_2
Supplemental guarantor consolidated statement of comprehensive income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | $ 3,315 | $ 7,116 | $ 7,061 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 2,235 | (5,260) | (2,368) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (924) | 864 | 132 |
Total other comprehensive income | 1,311 | (4,396) | (2,235) |
Total comprehensive income | 4,625 | 2,719 | 4,826 |
Comprehensive income attributable to shareholders | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 3,290 | 7,084 | 7,032 |
Foreign currency translation, net of tax | 849 | (519) | (510) |
Financial assets measured at fair value through other comprehensive income, net of tax | 5 | 6 | (157) |
Cash flow hedges, net of tax | 1,400 | (4,793) | (1,675) |
Cost of hedging, net of tax | (19) | 45 | (26) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 2,235 | (5,260) | (2,368) |
Defined benefit plans, net of tax | (136) | 81 | 102 |
Own credit on financial liabilities designated at fair value, net of tax | (790) | 796 | 46 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (927) | 877 | 148 |
Total other comprehensive income | 1,308 | (4,383) | (2,220) |
Total comprehensive income | 4,598 | 2,701 | 4,813 |
Comprehensive income attributable to non-controlling interests | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 25 | 32 | 29 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 2 | (14) | (16) |
Total other comprehensive income | 2 | (14) | (16) |
Total comprehensive income | 27 | 18 | 13 |
Elimination entries | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | (1,321) | (5,592) | (5,649) |
Total comprehensive income | (2,305) | (5,306) | (5,149) |
Elimination entries | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | (1,321) | (5,592) | (5,649) |
Foreign currency translation, net of tax | (975) | 298 | 517 |
Financial assets measured at fair value through other comprehensive income, net of tax | 0 | 0 | 0 |
Cash flow hedges, net of tax | (9) | (12) | (17) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (984) | 286 | 500 |
Defined benefit plans, net of tax | 0 | 0 | 0 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 0 | 0 | 0 |
Total other comprehensive income | (984) | 286 | 500 |
Total comprehensive income | (2,305) | (5,306) | (5,149) |
UBS AG (standalone) | Reportable legal entities | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 1,559 | 7,270 | 7,102 |
Total comprehensive income | 1,458 | 5,373 | 6,163 |
UBS AG (standalone) | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 1,559 | 7,270 | 7,102 |
Foreign currency translation, net of tax | 79 | (114) | (1) |
Financial assets measured at fair value through other comprehensive income, net of tax | 4 | (3) | 0 |
Cash flow hedges, net of tax | 707 | (2,791) | (1,129) |
Cost of hedging, net of tax | (19) | 45 | (26) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 771 | (2,863) | (1,155) |
Defined benefit plans, net of tax | (82) | 170 | 170 |
Own credit on financial liabilities designated at fair value, net of tax | (790) | 796 | 46 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (872) | 966 | 217 |
Total other comprehensive income | (101) | (1,897) | (939) |
Total comprehensive income | 1,458 | 5,373 | 6,163 |
UBS Switzerland AG (standalone) | Reportable legal entities | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 3,540 | 2,928 | 2,788 |
Total comprehensive income | 5,707 | 1,261 | 1,954 |
UBS Switzerland AG (standalone) | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | 3,540 | 2,928 | 2,788 |
Foreign currency translation, net of tax | 1,523 | (197) | (419) |
Financial assets measured at fair value through other comprehensive income, net of tax | 0 | ||
Cash flow hedges, net of tax | 679 | (1,359) | (279) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 2,202 | (1,555) | (699) |
Defined benefit plans, net of tax | (36) | (112) | (135) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (36) | (112) | (135) |
Total other comprehensive income | 2,167 | (1,667) | (834) |
Total comprehensive income | 5,707 | 1,261 | 1,954 |
Other subsidiaries | Reportable legal entities | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | (463) | 2,509 | 2,820 |
Total comprehensive income | (235) | 1,391 | 1,858 |
Other subsidiaries | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Income Captions [Line Items] | |||
Net profit / (loss) | (488) | 2,477 | 2,792 |
Foreign currency translation, net of tax | 222 | (506) | (607) |
Financial assets measured at fair value through other comprehensive income, net of tax | 1 | 9 | (157) |
Cash flow hedges, net of tax | 23 | (631) | (250) |
Cost of hedging, net of tax | 0 | ||
Total other comprehensive income that may be reclassified to the income statement, net of tax | 245 | (1,128) | (1,014) |
Defined benefit plans, net of tax | (19) | 23 | 67 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (19) | 23 | 67 |
Total other comprehensive income | 226 | (1,104) | (947) |
Total comprehensive income | (262) | 1,373 | 1,845 |
Other subsidiaries | Reportable legal entities | Comprehensive income attributable to non-controlling interests | |||
Condensed Statement Of Income Captions [Line Items] | |||
Total comprehensive income | $ 27 | $ 18 | $ 13 |
Supplemental guarantor consol_3
Supplemental guarantor consolidated balance sheet (Detail) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Assets | ||||
Cash and balances at central banks | $ 171,806 | $ 169,445 | ||
Amounts due from banks | 28,206 | 14,671 | ||
Receivables from securities financing transactions measured at amortized cost | 74,128 | 67,814 | ||
Cash collateral receivables on derivative instruments | 32,300 | 35,033 | ||
Loans and advances to customers | 405,633 | 390,027 | ||
Other financial assets measured at amortized cost | 54,334 | 53,389 | ||
Total financial assets measured at amortized cost | 766,407 | 730,379 | ||
Financial assets at fair value held for trading | 135,098 | 108,034 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 44,524 | 36,742 | ||
Derivative financial instruments | 131,728 | 150,109 | ||
Brokerage receivables | 20,883 | 17,576 | ||
Financial assets at fair value not held for trading | 63,754 | 59,408 | ||
Total financial assets measured at fair value through profit or loss | 351,463 | 335,127 | ||
Financial assets measured at fair value through other comprehensive income | 2,233 | 2,239 | ||
Investments in subsidiaries and associates | 983 | 1,101 | $ 1,243 | |
Property, equipment and software | 11,044 | 11,316 | 11,712 | |
Goodwill and intangible assets | 6,265 | 6,267 | ||
Deferred tax assets | 9,244 | 9,354 | ||
Other non-financial assets | 8,377 | 9,652 | ||
Total assets | 1,156,016 | 1,105,436 | 1,116,145 | |
Liabilities | ||||
Amounts due to banks | 16,720 | 11,596 | ||
Payables from securities financing transactions measured at amortized cost | 5,782 | 4,202 | ||
Cash collateral payables on derivative instruments | 34,886 | 36,436 | ||
Customer deposits | 555,673 | 527,171 | ||
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 | ||
Debt issued measured at amortized cost | 69,784 | 59,499 | ||
Other financial liabilities measured at amortized cost | 12,713 | 10,391 | ||
Total financial liabilities measured at amortized cost | 762,840 | 705,442 | ||
Financial liabilities at fair value held for trading | 31,712 | 29,515 | ||
Derivative financial instruments | 140,707 | 154,906 | ||
Brokerage payables designated at fair value | 42,275 | 45,085 | ||
Debt issued designated at fair value | 86,341 | 71,842 | ||
Other financial liabilities designated at fair value | 27,366 | 32,033 | ||
Total financial liabilities measured at fair value through profit or loss | 328,401 | 333,382 | ||
Provisions | 2,524 | 3,183 | ||
Other non-financial liabilities | 6,682 | 6,489 | ||
Total liabilities | 1,100,448 | 1,048,496 | ||
Equity | ||||
Equity attributable to shareholders | 55,234 | 56,598 | ||
Equity attributable to non-controlling interests | 335 | 342 | ||
Total equity | 55,569 | 56,940 | $ 58,442 | $ 58,073 |
Total liabilities and equity | 1,156,016 | 1,105,436 | ||
Elimination entries | ||||
Assets | ||||
Cash and balances at central banks | 0 | |||
Amounts due from banks | (56,311) | (50,441) | ||
Receivables from securities financing transactions measured at amortized cost | (24,073) | (18,691) | ||
Cash collateral receivables on derivative instruments | (12,512) | (11,856) | ||
Loans and advances to customers | (35,093) | (31,233) | ||
Other financial assets measured at amortized cost | (2,647) | (2,029) | ||
Total financial assets measured at amortized cost | (130,636) | (114,250) | ||
Financial assets at fair value held for trading | (1,412) | (1,848) | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | (12,731) | (9,892) | ||
Derivative financial instruments | (41,223) | (40,368) | ||
Brokerage receivables | 0 | 0 | ||
Financial assets at fair value not held for trading | (22,613) | (17,091) | ||
Total financial assets measured at fair value through profit or loss | (65,249) | (59,308) | ||
Financial assets measured at fair value through other comprehensive income | 0 | |||
Investments in subsidiaries and associates | (51,190) | (53,255) | ||
Property, equipment and software | (284) | (267) | ||
Goodwill and intangible assets | 79 | 5 | ||
Deferred tax assets | (24) | (16) | ||
Other non-financial assets | 7 | 4 | ||
Total assets | (247,298) | (227,087) | ||
Liabilities | ||||
Amounts due to banks | (141,898) | (118,477) | ||
Payables from securities financing transactions measured at amortized cost | (24,171) | (18,774) | ||
Cash collateral payables on derivative instruments | (12,430) | (11,800) | ||
Customer deposits | 36,094 | 22,608 | ||
Funding from UBS Group AG measured at amortized cost | 0 | |||
Debt issued measured at amortized cost | 0 | (173) | ||
Other financial liabilities measured at amortized cost | (2,997) | (2,287) | ||
Total financial liabilities measured at amortized cost | (145,402) | (128,903) | ||
Financial liabilities at fair value held for trading | (1,325) | (1,570) | ||
Derivative financial instruments | (41,225) | (40,363) | ||
Brokerage payables designated at fair value | 0 | (7) | ||
Debt issued designated at fair value | (69) | (110) | ||
Other financial liabilities designated at fair value | (8,107) | (2,928) | ||
Total financial liabilities measured at fair value through profit or loss | (50,726) | (44,977) | ||
Provisions | (1) | (2) | ||
Other non-financial liabilities | 46 | 98 | ||
Total liabilities | (196,083) | (173,785) | ||
Equity | ||||
Equity attributable to shareholders | (51,215) | (53,303) | ||
Equity attributable to non-controlling interests | 0 | 0 | ||
Total equity | (51,215) | (53,303) | ||
Total liabilities and equity | (247,298) | (227,087) | ||
UBS AG (standalone) | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 49,620 | 48,689 | ||
Amounts due from banks | 61,579 | 39,691 | ||
Receivables from securities financing transactions measured at amortized cost | 61,116 | 51,493 | ||
Cash collateral receivables on derivative instruments | 34,048 | 35,594 | ||
Loans and advances to customers | 91,940 | 90,168 | ||
Other financial assets measured at amortized cost | 24,403 | 24,005 | ||
Total financial assets measured at amortized cost | 322,705 | 289,641 | ||
Financial assets at fair value held for trading | 121,947 | 95,810 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 51,325 | 41,056 | ||
Derivative financial instruments | 126,916 | 149,447 | ||
Brokerage receivables | 12,924 | 9,763 | ||
Financial assets at fair value not held for trading | 46,658 | 45,302 | ||
Total financial assets measured at fair value through profit or loss | 308,444 | 300,321 | ||
Financial assets measured at fair value through other comprehensive income | 1,957 | 1,953 | ||
Investments in subsidiaries and associates | 52,134 | 54,323 | ||
Property, equipment and software | 5,842 | 5,852 | ||
Goodwill and intangible assets | 212 | 213 | ||
Deferred tax assets | 1,488 | 1,624 | ||
Other non-financial assets | 5,366 | 6,930 | ||
Total assets | 698,149 | 660,856 | ||
Liabilities | ||||
Amounts due to banks | 55,680 | 41,395 | ||
Payables from securities financing transactions measured at amortized cost | 14,329 | 9,425 | ||
Cash collateral payables on derivative instruments | 35,148 | 35,528 | ||
Customer deposits | 108,279 | 98,628 | ||
Funding from UBS Group AG measured at amortized cost | 67,282 | 56,147 | ||
Debt issued measured at amortized cost | 58,729 | 50,706 | ||
Other financial liabilities measured at amortized cost | 6,589 | 4,903 | ||
Total financial liabilities measured at amortized cost | 346,036 | 296,733 | ||
Financial liabilities at fair value held for trading | 27,280 | 25,059 | ||
Derivative financial instruments | 135,272 | 153,778 | ||
Brokerage payables designated at fair value | 30,724 | 32,346 | ||
Debt issued designated at fair value | 85,424 | 71,444 | ||
Other financial liabilities designated at fair value | 14,392 | 17,888 | ||
Total financial liabilities measured at fair value through profit or loss | 293,092 | 300,514 | ||
Provisions | 1,903 | 1,904 | ||
Other non-financial liabilities | 1,572 | 1,630 | ||
Total liabilities | 642,602 | 600,782 | ||
Equity | ||||
Equity attributable to shareholders | 55,546 | 60,075 | ||
Total equity | 55,546 | 60,075 | ||
Total liabilities and equity | 698,149 | 660,856 | ||
UBS Switzerland AG (standalone) | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 87,044 | 84,465 | ||
Amounts due from banks | 6,241 | 6,357 | ||
Receivables from securities financing transactions measured at amortized cost | 63 | 903 | ||
Cash collateral receivables on derivative instruments | 1,640 | 1,221 | ||
Loans and advances to customers | 255,205 | 229,861 | ||
Other financial assets measured at amortized cost | 9,149 | 9,532 | ||
Total financial assets measured at amortized cost | 359,343 | 332,339 | ||
Financial assets at fair value held for trading | 101 | 173 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 0 | 0 | ||
Derivative financial instruments | 5,845 | 5,925 | ||
Brokerage receivables | 0 | |||
Financial assets at fair value not held for trading | 10,022 | 4,354 | ||
Total financial assets measured at fair value through profit or loss | 15,968 | 10,453 | ||
Financial assets measured at fair value through other comprehensive income | 0 | |||
Investments in subsidiaries and associates | 37 | 33 | ||
Property, equipment and software | 1,798 | 1,654 | ||
Goodwill and intangible assets | 0 | |||
Deferred tax assets | 147 | 276 | ||
Other non-financial assets | 1,748 | 1,768 | ||
Total assets | 379,042 | 346,522 | ||
Liabilities | ||||
Amounts due to banks | 44,170 | 37,123 | ||
Payables from securities financing transactions measured at amortized cost | 336 | 247 | ||
Cash collateral payables on derivative instruments | 1,076 | 1,518 | ||
Customer deposits | 293,133 | 273,316 | ||
Funding from UBS Group AG measured at amortized cost | 0 | |||
Debt issued measured at amortized cost | 11,042 | 8,965 | ||
Other financial liabilities measured at amortized cost | 2,974 | 2,221 | ||
Total financial liabilities measured at amortized cost | 352,731 | 323,391 | ||
Financial liabilities at fair value held for trading | 248 | 183 | ||
Derivative financial instruments | 6,223 | 6,177 | ||
Brokerage payables designated at fair value | 0 | |||
Debt issued designated at fair value | 0 | |||
Other financial liabilities designated at fair value | 0 | |||
Total financial liabilities measured at fair value through profit or loss | 6,471 | 6,360 | ||
Provisions | 208 | 239 | ||
Other non-financial liabilities | 1,377 | 1,019 | ||
Total liabilities | 360,788 | 331,009 | ||
Equity | ||||
Equity attributable to shareholders | 18,254 | 15,513 | ||
Total equity | 18,254 | 15,513 | ||
Total liabilities and equity | 379,042 | 346,522 | ||
Other subsidiaries | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 35,142 | 36,291 | ||
Amounts due from banks | 16,696 | 19,063 | ||
Receivables from securities financing transactions measured at amortized cost | 37,022 | 34,110 | ||
Cash collateral receivables on derivative instruments | 9,124 | 10,074 | ||
Loans and advances to customers | 93,581 | 101,231 | ||
Other financial assets measured at amortized cost | 23,429 | 21,880 | ||
Total financial assets measured at amortized cost | 214,995 | 222,649 | ||
Financial assets at fair value held for trading | 14,463 | 13,899 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 5,930 | 5,578 | ||
Derivative financial instruments | 40,190 | 35,106 | ||
Brokerage receivables | 7,959 | 7,814 | ||
Financial assets at fair value not held for trading | 29,688 | 26,843 | ||
Total financial assets measured at fair value through profit or loss | 92,300 | 83,661 | ||
Financial assets measured at fair value through other comprehensive income | 276 | 286 | ||
Investments in subsidiaries and associates | 2 | 0 | ||
Property, equipment and software | 3,687 | 4,077 | ||
Goodwill and intangible assets | 5,974 | 6,050 | ||
Deferred tax assets | 7,633 | 7,470 | ||
Other non-financial assets | 1,256 | 951 | ||
Total assets | 326,124 | 325,144 | ||
Liabilities | ||||
Amounts due to banks | 58,769 | 51,555 | ||
Payables from securities financing transactions measured at amortized cost | 15,288 | 13,303 | ||
Cash collateral payables on derivative instruments | 11,091 | 11,191 | ||
Customer deposits | 118,168 | 132,619 | ||
Debt issued measured at amortized cost | 12 | 1 | ||
Other financial liabilities measured at amortized cost | 6,147 | 5,554 | ||
Total financial liabilities measured at amortized cost | 209,475 | 214,222 | ||
Financial liabilities at fair value held for trading | 5,508 | 5,843 | ||
Derivative financial instruments | 40,436 | 35,314 | ||
Brokerage payables designated at fair value | 11,552 | 12,746 | ||
Debt issued designated at fair value | 986 | 508 | ||
Other financial liabilities designated at fair value | 21,081 | 17,074 | ||
Total financial liabilities measured at fair value through profit or loss | 79,564 | 71,484 | ||
Provisions | 413 | 1,041 | ||
Other non-financial liabilities | 3,688 | 3,742 | ||
Total liabilities | 293,140 | 290,490 | ||
Equity | ||||
Equity attributable to shareholders | 32,649 | 34,313 | ||
Equity attributable to non-controlling interests | 335 | 342 | ||
Total equity | 32,984 | 34,655 | ||
Total liabilities and equity | $ 326,124 | $ 325,144 |
Supplemental guarantor consol_4
Supplemental guarantor consolidated statement of cash flows (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Cash Flow Statements Captions [Line Items] | |||
Net cash flow from / (used in) operating activities | $ (28,202) | $ 10,630 | $ 30,563 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (4) | (3) | (1) |
Disposal of subsidiaries, associates and intangible assets | 109 | 1,729 | 593 |
Purchase of property, equipment and software | (1,283) | (1,478) | (1,581) |
Disposal of property, equipment and software | 33 | 161 | 295 |
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income | 30 | (699) | (750) |
Purchase of debt securities measured at amortized cost | (14,244) | (30,792) | (4,922) |
Disposal and redemption of debt securities measured at amortized cost | 10,435 | 18,799 | 4,507 |
Net cash flow from / (used in) investing activities | (4,924) | (12,283) | (1,860) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | 7,181 | (12,249) | (3,093) |
Distributions paid on UBS AG shares | (6,000) | (4,200) | (4,539) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 104,551 | 79,457 | 98,619 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (85,541) | (67,670) | (79,799) |
Net cash flows from other financing activities | (501) | (595) | (261) |
Net activity related to group internal capital transactions and dividends | 0 | 0 | 0 |
Net cash flow from / (used in) financing activities | 19,690 | (5,257) | 10,927 |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 195,200 | 207,755 | 173,430 |
Net cash flow from / (used in) operating, investing and financing activities | (13,435) | (6,911) | 39,630 |
Effects of exchange rate differences on cash and cash equivalents | 8,704 | (5,645) | (5,306) |
Cash and cash equivalents at the end of the year | 190,469 | 195,200 | 207,755 |
of which: cash and balances at central banks | 171,723 | 169,363 | 192,706 |
of which: loans and advances to banks | 12,078 | 13,329 | 13,822 |
of which: money market paper | 6,668 | 12,508 | 1,227 |
Restricted cash and cash equivalents | 4,553 | 4,253 | 3,408 |
UBS AG (standalone) | Reportable legal entities | |||
Condensed Cash Flow Statements Captions [Line Items] | |||
Net cash flow from / (used in) operating activities | (23,275) | 17,286 | 5,714 |
Cash flow from / (used in) investing activities | |||
Disposal of subsidiaries, associates and intangible assets | 109 | 157 | 16 |
Purchase of property, equipment and software | (427) | (562) | (656) |
Disposal of property, equipment and software | 33 | 161 | 294 |
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income | 15 | (943) | (817) |
Purchase of debt securities measured at amortized cost | (9,561) | (22,602) | (1,840) |
Disposal and redemption of debt securities measured at amortized cost | 4,890 | 14,442 | 1,033 |
Net cash flow from / (used in) investing activities | (4,942) | (9,346) | (1,970) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | 7,138 | (12,215) | (3,073) |
Distributions paid on UBS AG shares | (6,000) | (4,200) | (4,539) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 101,956 | 78,866 | 97,250 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (84,366) | (66,526) | (78,385) |
Net cash flows from other financing activities | (249) | (258) | (280) |
Net activity related to group internal capital transactions and dividends | 3,698 | 5,217 | 5,240 |
Net cash flow from / (used in) financing activities | 22,177 | 884 | 16,212 |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 63,608 | 57,895 | 39,400 |
Net cash flow from / (used in) operating, investing and financing activities | (6,040) | 8,824 | 19,957 |
Effects of exchange rate differences on cash and cash equivalents | 591 | (3,111) | (1,462) |
Cash and cash equivalents at the end of the year | 58,159 | 63,608 | 57,895 |
of which: cash and balances at central banks | 49,537 | 48,607 | 53,729 |
of which: loans and advances to banks | 2,763 | 2,957 | 3,258 |
of which: money market paper | 5,858 | 12,044 | 908 |
UBS Switzerland AG | Reportable legal entities | |||
Condensed Cash Flow Statements Captions [Line Items] | |||
Net cash flow from / (used in) operating activities | (3,041) | (1,165) | 2,131 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (3) | (1) |
Disposal of subsidiaries, associates and intangible assets | 453 | 0 | |
Purchase of property, equipment and software | (287) | (292) | (276) |
Purchase of debt securities measured at amortized cost | (1,431) | (2,690) | (45) |
Disposal and redemption of debt securities measured at amortized cost | 1,625 | 870 | 817 |
Net cash flow from / (used in) investing activities | (94) | (1,663) | 495 |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (1) | (3) | (21) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 2,007 | 550 | 1,177 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (1,017) | (860) | (1,093) |
Net activity related to group internal capital transactions and dividends | (2,944) | (2,088) | (537) |
Net cash flow from / (used in) financing activities | (1,954) | (2,401) | (475) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 86,232 | 92,799 | 93,342 |
Net cash flow from / (used in) operating, investing and financing activities | (5,089) | (5,229) | 2,151 |
Effects of exchange rate differences on cash and cash equivalents | 7,860 | (1,338) | (2,693) |
Cash and cash equivalents at the end of the year | 89,003 | 86,232 | 92,799 |
of which: cash and balances at central banks | 87,044 | 84,465 | 91,031 |
of which: loans and advances to banks | 1,448 | 1,550 | 1,588 |
of which: money market paper | 511 | 216 | 179 |
Other subsidiaries | Reportable legal entities | |||
Condensed Cash Flow Statements Captions [Line Items] | |||
Net cash flow from / (used in) operating activities | (1,886) | (5,491) | 22,718 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (3) | ||
Disposal of subsidiaries, associates and intangible assets | 1,120 | 577 | |
Purchase of property, equipment and software | (569) | (624) | (650) |
Disposal of property, equipment and software | 1 | ||
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income | 15 | 244 | 67 |
Purchase of debt securities measured at amortized cost | (3,251) | (5,500) | (3,038) |
Disposal and redemption of debt securities measured at amortized cost | 3,920 | 3,487 | 2,658 |
Net cash flow from / (used in) investing activities | 112 | (1,274) | (385) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | 44 | (31) | 0 |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 588 | 41 | 193 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (159) | (284) | (320) |
Net cash flows from other financing activities | (251) | (337) | 20 |
Net activity related to group internal capital transactions and dividends | (754) | (3,128) | (4,702) |
Net cash flow from / (used in) financing activities | (532) | (3,740) | (4,811) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 45,359 | 57,061 | 40,689 |
Net cash flow from / (used in) operating, investing and financing activities | (2,306) | (10,505) | 17,523 |
Effects of exchange rate differences on cash and cash equivalents | 253 | (1,196) | (1,151) |
Cash and cash equivalents at the end of the year | 43,307 | 45,359 | 57,061 |
of which: cash and balances at central banks | 35,142 | 36,291 | 47,946 |
of which: loans and advances to banks | 7,866 | 8,821 | 8,975 |
of which: money market paper | $ 299 | $ 248 | $ 139 |
MD&A - Risk management and co_4
MD&A - Risk management and control - Credit Risk (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2023 | |
Mortgage loan portfolio region Americas | |
Disclosure of Credit Risk [Line Items] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 80% |
Minimum LTV ratio within the standard approval process for any type of mortgage | 45% |
Mortgage loan portfolio regions EMEA and Asia Pacific | |
Disclosure of Credit Risk [Line Items] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 70% |
Minimum LTV ratio within the standard approval process for any type of mortgage | 30% |
MD&A - Risk management and co_5
MD&A - Risk management and control - Credit Risk (Detail) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure of Credit Risk [Line Items] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa2 CCC+ to CCC CCC+ to CCC 13 >17 Caa3 to C CCC- to C CCC- to C Counterparty is in default Default Defaulted D D |
MD&A - Risk management and co_6
MD&A - Risk management and control - Market Risk (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of Market Risk [Line Items] | |||
Confidence level applied for calculating VaR for internal management purpose | 95% | ||
Confidence level applied for calculating regulatory VaR | 99% | ||
Confidence level applied for calculating SVaR | 99% | ||
Total effect of economic value of equity for equity, goodwill and real estate | $ 22.4 | $ 19.6 | |
Equity instruments held as financial assets at fair value not held for trading and as investments in associates | 2,900 | ||
Equity instruments held as financial assets at fair value not held for trading | 1,900 | ||
Investments in associates | 983 | 1,101 | $ 1,243 |
+1 bp | |||
Disclosure of Market Risk [Line Items] | |||
Total effect on economic value of equity as per Pillar 3 requirement | (28.1) | (25) | |
Additional tier 1 (AT1) capital instruments | $ 4.8 | 3.4 | |
Parallel up | |||
Disclosure of Market Risk [Line Items] | |||
Regulatory Threshold For Outlier Test Of Tier 1 Capital | 15% | ||
Total effect on economic value of equity as per Pillar 3 requirement | $ (5,287) | (4,617.2) | |
Additional tier 1 (AT1) capital instruments | 888.3 | 652.5 | |
Change in tier 1 capital instruments, immediate effect | $ (500) | $ (400) | |
Percentage change in tier 1 capital instruments | 9.30% | 8.40% | |
Percentage change in tier 1 capital instruments, immediate effect | 0.90% | 0.70% | |
USD | |||
Disclosure of Market Risk [Line Items] | |||
Total effect of economic value of equity for equity, goodwill and real estate | $ 15.8 | $ 14 | |
USD | +1 bp | |||
Disclosure of Market Risk [Line Items] | |||
Total effect on economic value of equity as per Pillar 3 requirement | (23.1) | (20.4) | |
USD | Parallel up | |||
Disclosure of Market Risk [Line Items] | |||
Total effect on economic value of equity as per Pillar 3 requirement | (4,522.3) | (3,936.5) | |
CHF | |||
Disclosure of Market Risk [Line Items] | |||
Total effect of economic value of equity for equity, goodwill and real estate | 5.6 | 4.8 | |
CHF | +1 bp | |||
Disclosure of Market Risk [Line Items] | |||
Total effect on economic value of equity as per Pillar 3 requirement | (4.3) | (4.1) | |
CHF | Parallel up | |||
Disclosure of Market Risk [Line Items] | |||
Total effect on economic value of equity as per Pillar 3 requirement | $ (608.9) | $ (576.5) |
MD&A - Risk management and co_7
MD&A - Risk management and control - Market Risk (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Value At Risk [Line Items] | ||
Management VaR | $ 19 | $ 9 |
Diversification effect | (6) | (5) |
Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 1 |
Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 18 | 8 |
Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 4 | |
Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 5 | |
Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 7 | 6 |
Minimum | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | 1 |
Minimum | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Minimum | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Minimum | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 5 | 6 |
Minimum | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Minimum | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | |
Minimum | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | |
Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 25 | 18 |
Maximum | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 2 |
Maximum | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Maximum | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Maximum | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 23 | 17 |
Maximum | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | |
Maximum | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 6 | |
Maximum | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 5 | |
Average | ||
Value At Risk [Line Items] | ||
Management VaR | 15 | 11 |
Diversification effect | (6) | (5) |
Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | 1 |
Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 14 | 10 |
Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 4 | |
Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 4 | |
Equity prices | ||
Value At Risk [Line Items] | ||
Management VaR | 11 | 6 |
Equity prices | Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | 2 |
Equity prices | Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 19 | 17 |
Equity prices | Average | ||
Value At Risk [Line Items] | ||
Management VaR | 9 | 6 |
Diversification effect | (1) | (1) |
Equity prices | Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Equity prices | Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Equity prices | Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Equity prices | Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 9 | 6 |
Equity prices | Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | |
Equity prices | Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Equity prices | Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Interest rate risk | ||
Value At Risk [Line Items] | ||
Management VaR | 18 | 10 |
Interest rate risk | Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 9 | 8 |
Interest rate risk | Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 21 | 18 |
Interest rate risk | Average | ||
Value At Risk [Line Items] | ||
Management VaR | 12 | 10 |
Diversification effect | (4) | (3) |
Interest rate risk | Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | 1 |
Interest rate risk | Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Interest rate risk | Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Interest rate risk | Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 12 | 9 |
Interest rate risk | Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Interest rate risk | Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | |
Interest rate risk | Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 4 | |
Credit spreads | ||
Value At Risk [Line Items] | ||
Management VaR | 7 | 4 |
Credit spreads | Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | 4 |
Credit spreads | Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 19 | 9 |
Credit spreads | Average | ||
Value At Risk [Line Items] | ||
Management VaR | 6 | 5 |
Diversification effect | (4) | (4) |
Credit spreads | Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 1 |
Credit spreads | Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Credit spreads | Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Credit spreads | Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 5 | 5 |
Credit spreads | Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Credit spreads | Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | |
Credit spreads | Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | |
Foreign exchange | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 3 |
Foreign exchange | Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | 2 |
Foreign exchange | Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 10 | 11 |
Foreign exchange | Average | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 3 |
Diversification effect | (1) | (1) |
Foreign exchange | Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Foreign exchange | Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Foreign exchange | Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Foreign exchange | Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 2 | 3 |
Foreign exchange | Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | |
Foreign exchange | Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Foreign exchange | Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | |
Commodity | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | 3 |
Commodity | Minimum | ||
Value At Risk [Line Items] | ||
Management VaR | 1 | 2 |
Commodity | Maximum | ||
Value At Risk [Line Items] | ||
Management VaR | 10 | 7 |
Commodity | Average | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | 3 |
Diversification effect | 0 | 0 |
Commodity | Average | Global Wealth Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Commodity | Average | Personal & Corporate Banking | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Commodity | Average | Asset Management | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | 0 |
Commodity | Average | Investment Bank | ||
Value At Risk [Line Items] | ||
Management VaR | 3 | 3 |
Commodity | Average | Non-core and Legacy | ||
Value At Risk [Line Items] | ||
Management VaR | 0 | |
Commodity | Average | Group Items | ||
Value At Risk [Line Items] | ||
Management VaR | $ 0 | |
Commodity | Average | Group Functions | ||
Value At Risk [Line Items] | ||
Management VaR | $ 0 |
MD&A - Risk management and co_8
MD&A - Risk management and control - Market Risk (Detail 2) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
+1 bp | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | $ (28.1) | $ (25) |
Additional tier 1 (AT1) capital instruments | 4.8 | 3.4 |
Total including AT1 capital instruments | (23.3) | (21.5) |
+1 bp | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (4.3) | (4.1) |
+1 bp | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (0.7) | (0.6) |
+1 bp | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 0 | 0.1 |
+1 bp | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (23.1) | (20.4) |
+1 bp | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 0.1 | (0.1) |
Parallel up | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (5,287) | (4,617.2) |
Additional tier 1 (AT1) capital instruments | 888.3 | 652.5 |
Total including AT1 capital instruments | (4,398.7) | (3,964.7) |
Parallel up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (608.9) | (576.5) |
Parallel up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (142.9) | (111.6) |
Parallel up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2.2 | 33.4 |
Parallel up | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (4,522.3) | (3,936.5) |
Parallel up | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (15) | (26.3) |
Parallel down | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 5,434.5 | 4,828.5 |
Additional tier 1 (AT1) capital instruments | (1,028) | (702.8) |
Total including AT1 capital instruments | 4,406.6 | 4,125.7 |
Parallel down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 686.1 | 644.2 |
Parallel down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 150 | 142.2 |
Parallel down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (11.8) | (45.7) |
Parallel down | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 4,593.2 | 4,066.1 |
Parallel down | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 17.1 | 21.9 |
Steepener | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1,361) | (1,408.2) |
Additional tier 1 (AT1) capital instruments | 95.9 | (47.3) |
Total including AT1 capital instruments | (1,265.1) | (1,455.5) |
Steepener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (335.2) | (256.7) |
Steepener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (16) | (93.2) |
Steepener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (13.1) | (28.2) |
Steepener | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (973.6) | (1,026.7) |
Steepener | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (23) | (3.3) |
Flattener | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 142.9 | 345.8 |
Additional tier 1 (AT1) capital instruments | 104.7 | 191.1 |
Total including AT1 capital instruments | 247.6 | 536.9 |
Flattener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 214.1 | 144.7 |
Flattener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (6.8) | 75.4 |
Flattener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 12.3 | 32.7 |
Flattener | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (94.1) | 95.4 |
Flattener | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 17.5 | (2.6) |
Short-term up | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1,976.3) | (1,532.9) |
Additional tier 1 (AT1) capital instruments | 477.4 | 440.8 |
Total including AT1 capital instruments | (1,498.9) | (1,092.2) |
Short-term up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (38.5) | (84.1) |
Short-term up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (48.4) | 37.1 |
Short-term up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 13.4 | 42.4 |
Short-term up | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1,909.8) | (1,514.7) |
Short-term up | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 7.1 | (13.9) |
Short-term down | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,105.3 | 1,676.6 |
Additional tier 1 (AT1) capital instruments | (498.9) | (457.8) |
Total including AT1 capital instruments | 1,606.4 | 1,218.8 |
Short-term down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 42.9 | 88.1 |
Short-term down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 49.8 | (36.1) |
Short-term down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (14.3) | (42.6) |
Short-term down | USD | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,036.8 | 1,654 |
Short-term down | Other | ||
Interest Rate Sensitivity Of Banking Book [Line Items] | ||
Total effect on economic value of equity as per Pillar 3 requirement | $ (10) | $ 13.4 |
MD&A - Capital management (Narr
MD&A - Capital management (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Capital Management [Line Items] | |||
Increase (decrease) in CET1 capital | $ 1,200 | ||
Operating profit / (loss) before tax | 4,521 | $ 8,960 | $ 8,964 |
Increase (decrease) in CET1 capital through foreign currency translation effects before tax | 900 | ||
Increase (decrease) in CET1 capital through deferred tax assets on temporary differences | 200 | ||
Increase (decrease) in CET1 capital through accruals for proposed dividends | (3,000) | ||
Current tax expense / (benefit) | 1,400 | ||
Loss-absorbing AT1 capital | 12,500 | ||
Increase (decrease) in loss-absorbing AT1 capital | 700 | ||
Decrease in AT1 capital through call of capital instruments | 2,500 | ||
High-trigger loss-absorbing additional tier 1 capital instruments transferred to other entity | 1,100 | ||
Increase in AT1 capital through issuance of capital instruments | 3,500 | ||
TLAC-eligible senior unsecured debt included in gone concern loss-absorbing capacity | 53,900 | ||
Increase (decrease) in gone concern loss-absorbing capacity | 7,500 | ||
Gone concern loss-absorbing capacity | $ 54,500 |
MD&A - Capital management (Deta
MD&A - Capital management (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Reconciliation Of IFRS Equity To Swiss SRB Common Equity Tier One Capital [Line Items] | ||||
Total IFRS equity | $ 55,569 | $ 56,940 | $ 58,442 | $ 58,073 |
Equity attributable to non-controlling interests | (335) | (342) | ||
Defined benefit plans, net of tax | (336) | (311) | ||
Deferred tax assets recognized for tax loss carry-forwards | (3,004) | (4,077) | ||
Deferred tax assets on temporary differences, excess over threshold | (1,233) | (262) | ||
Goodwill, net of tax | (5,750) | (5,754) | ||
Intangible assets, net of tax | (146) | (150) | ||
Expected losses on advanced internal ratings-based portfolio less provisions | (532) | (471) | ||
Unrealized (gains) / losses from cash flow hedges, net of tax | 2,961 | 4,234 | ||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 313 | (523) | ||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (63) | (105) | ||
Prudential valuation adjustments | (177) | (201) | ||
Accruals for proposed dividends to shareholders | (3,000) | (6,000) | ||
Other | (39) | (51) | ||
Total common equity tier 1 capital | 44,130 | 42,929 | ||
Goodwill related to significant investments in financial institutions | $ 20 | $ 20 |
MD&A - Capital management (De_2
MD&A - Capital management (Detail 2) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Comparison Reconciliation Of IFRS Equity To Swiss SRB Common Equity Tier One Capital [Line Items] | ||||
Total IFRS equity | $ 55,569 | $ 56,940 | $ 58,442 | $ 58,073 |
Equity attributable to non-controlling interests | (335) | (342) | ||
Defined benefit plans, net of tax | (336) | (311) | ||
Deferred tax assets recognized for tax loss carry-forwards | (3,004) | (4,077) | ||
Deferred tax assets for unused tax credits | (97) | |||
Deferred tax assets on temporary differences, excess over threshold | (1,233) | (262) | ||
Goodwill, net of tax | (5,750) | (5,754) | ||
Intangible assets, net of tax | (146) | (150) | ||
Expected losses on advanced internal ratings-based portfolio less provisions | (532) | (471) | ||
Unrealized (gains) / losses from cash flow hedges, net of tax | 2,961 | 4,234 | ||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 313 | (523) | ||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (63) | (105) | ||
Prudential valuation adjustments | (177) | (201) | ||
Accruals for proposed dividends to shareholders | (3,000) | (6,000) | ||
Other | (39) | (51) | ||
Total common equity tier 1 capital | $ 44,130 | $ 42,929 |
MD&A - UBS shares (Narrative) (
MD&A - UBS shares (Narrative) (Detail) - USD ($) $ / shares in Units, $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Disclosure of Shares [Line Items] | ||
Par value of shares | $ 0.10 | |
Equity attributable to shareholders | $ 55,234 | $ 56,598 |
Shares issued | 3,858,408,466 | 3,858,408,466 |
Uncategorized Items - ubs-20231
Label | Element | Value |
Loans And Leases Receivable Related Parties | ubs_LoansAndLeasesReceivableRelatedParties | $ 55,000,000 |
Loans And Leases Receivable Related Parties | ubs_LoansAndLeasesReceivableRelatedParties | $ 46,000,000 |
Loans And Leases Receivable Related Parties | ubs_LoansAndLeasesReceivableRelatedParties | $ 28,000,000 |
Loans And Leases Receivable Related Parties | ubs_LoansAndLeasesReceivableRelatedParties | $ 26,000,000 |
Loans And Leases Receivable Related Parties | ubs_LoansAndLeasesReceivableRelatedParties | $ 28,000,000 |